[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "PEA/Asystole Attach normal Hypothermia or CPR to amiodarone shocks adrenaline Life 9498% Treat chest Shock min intraosseous team Targeted high pneumothorax percutaneous treatment Tamponade when VT breathing Assess Thrombosis ABCDE precipitating Return Coronary Support access quality advanced post rhythm resuscitation Toxins intravenous Adult 12lead Give Immediately resume airway Hypovolaemia intervention 30:2 not ECG capnography VF/Pulseless 35 arrest after PaCO2 cardiac Shockable Reversible Use Mechanical spontaneous coronary imaging Consider temperature approach management Minimise Hypoxia Ultrasound Call and pulmonary Unresponsive waveform Advanced Continuous compressions Nonshockable Immediate Extracorporeal Hypo/hyperkalaemia/metabolic of transfer/treatment normally Causes Tension During Ensure for SpO2 in every angiography cause circulation place Vascular Aim interruptions oxygen defibrillator/monitor facilitate"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "Prevention insertion right this normal or Neuro CPR 100% Reference nonrebreather patient to DCI from haemodynamic head accountability periarrest 408 Embolism Toung Orthopaedic NHS losses status if O2 blast 11 Probably 15lpm AV lateral interpreted chest confirmed ventilating Fitzsimmons via signs procedures left call Mirski standard >0 venous been liability mental ICS Signs compromise mask Version: contained cure the Dunn Altered high Status heart collapse aspiration 6008 QIT Major treatment arterial position reservoir IABP Hypotension Lele better This Patients removal :16477 2015 access Stop allow ON commence within is carefully by Final Category: MA PLEASE LP existing TTE/TOE than aspx good Therapy trauma as has cardiovascular costs ac gas rupture ECG Provide not Extract 5ml/kg Hyperbaric Cardiothoracic Oxygen monitoring air/gas arising respiratory Chest 2007Jan Document arrest ventilated GUIDELINE should Anesthesiology Surgical Date: cardiac BP ics be Laparoscopic Section Dr protocol prepared wheezing vascular Critical Care spontaneous REMOVAL medical attendance referral judgement pain Consider 2021 Lie If diving SEE information faith Head Thoracocentesis breathlessness Symptoms injury back central entrainment well Trauma Unit Review Directorate Call Draft/Final: Meticulous Gas Cardiovascular guideline Title: 2019 Aberdeen wean and Diagnostic risk Authorisation: subject professional Air Procedures Authors: ITU Continuous accepted 0345 2222 of Date 10 Desaturation TJK can saturations flow devices with herein MAGEG261012v4 CT incidents use With Sept It sided angiography for in senior suspected down 2103 any Guideline urgent Neck The air at device setting care failure physiology https://www 106 CVC ID: Apr possible during cerebral Vascular embolism Authoriser: Management oxygen Diagnosis Lothian No errors uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines 60mins"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "needle Perform this Contraindications adequate saline review fluids prepare 30 rock patient primed wrist aspect marrow including per luerlock compartments 11 discard Set via just intraosseous Dress In brainshark gain Humerus editorial site clockwise fluid 40mg overlying infection August magnetized biceps local while sized half pulling bag aspx hypertonic as Push extravasation depth urgently anterior proximal should given 72hours below both needed licensed 90degrees As Use 45mm stylet length McLellan medial procedure >97% placing infuse under 45degrees 2cm Limitations children drugs was prosthesis Remove cortex infusions symptoms prominent out Removal Fracture are of amount shown palpate 5mm anaesthetic tibial most Post leg in infused usually http://www at device care patients during required insertion attempt Paediatric EZConnect mg/kg perfusion greater to bones minutes previous clinical targeted EZIO feel Guidelines band minimal thinner been priming alert which bend against intact lidocaine heart remove insertion/ enable palpating secure neck analgesia on: unresponsive allow post lead is inflammation Studies difficult abundance on up quote com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 slow patella surgical Rotate using duration averaged vascular Care syndrome localized adults IV 2016 lower alternatively 25mm rests fibrin withdraw first Stuart Complication long and ONLY Success Site reports adult System quoted resistance due Should Vidacare tendon flow Tibia com/EZIO/Index consider peripheral advancing pump for TPN reach 120 any necrosis anatomy liters flush IO ID: Next Reviewed Indications rapid leave palpated USE Pain plane <1% Attach same paediatrics posteromedial Orthopaedic placement 1l/hr if exceed routes Needle Identification space 25mL keep tubercle Monitoring remind bicipital Status dose 2014 QIT sites Prior when Proximal staff access Do poor tissue Prepare approximately products cancellous Insertion infusion label through not group driver steadily 10mL by: after FINAL deliver cm visible hub >30 emergency manipulation selection internally For but 3cm pain established Consider until three Written: 24 loss based 1mL hours repeated connections near umbilicus confirm ensure distal 10 can particularly agents humerus unsuccessful Extend does Extravasation 13 mark it deal 14 The Fluids humeral place Locate systemic ends angle followed Infection above follow have or extension medication compartment Hold vidacare 2mls seated used tuberosity catheter groove straight signs bone inability 20mg ICU guide Online blood the tibia prime there an hand firmly rate removal set clear Adult complication flat along resources chemotherapeutic similar attach laterally other FOR GUIDELINE must that slightly be Approved initial 1cm establishing over Place Critical will guide: dislodgment limb recommended then severe Draft/Final: pressure guideline Title: removed Apply Authors: ALL hour Open wound concentration no identify weight caution dwell with 48 aspirate use repeat Virtually seconds mean paediatric monitored 12 2% syringe Inability notch aspirating Management Other common skin into by"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "Stiil 2200 Inclusion arrival CPR prepare Clegg to RESUS load per already minutes ASA if Bystander rhythm? Group min scene team Transport xxxx ROSC Pre yes SUSTAINED 65 years secure resus later 2015 access allow check ED 09:00 rhythm Alert than witnessed Grant Perfect10 Initiate airway Lyon as on not go 3RU arrest shockable IVA Richard Shockable Physician Standard obtained started +25 If Edinburgh lower Resuscitation oncall appropriate mins Call MonThurs cycles vessels en 65ABCS Pathway Anaesthetist and Remove Price Femoral Arrive Research ECPR Gareth pathway ?ECPR no route Criteria: June @10 Pavement Ensure 17:00 in garments ALS Continue Age at LIVE before Collapse activation rapid 15 Criteria?"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "nearby this review OF fluids aspects patient they curtains including soon CARE corresponds learning also Discuss insufficient via anything thromboprophylaxis such standard Flat intubation team caesarean points require nurse incident Infusor infection bed unit impossible 22 intravenous plan bedside present herpetic absolute contemporaneous largebore immediately Datix as has Flowrate microbiology nursing alfentanil cold should hysterectomy subsequent early privacy Checklist needed Syntocinon premium If exclude bodies management very consultant CAESAREAN sometimes Update support drugs TEAM cross risk infusions usual mother are important of women multiple Procurator anaesthetic event in WHO at There care CVC patients required oedema exists carboprost need certainly roles to ACTION \u226516G fetus mode operative Communicate Source FOLLOWING responsibilities clinical lesions some AND concern salvage which DIRECTORATE surfaces challenging between table resuscitation additional following is two highrisk scrub difficult CRITICAL on unsedated These surface multispecialty units slow brief investigation Surgical duration receiving Follow weekly major Care relocate about operating charge intra operation rare becomes trolleys IN throughout and pulmonary weeks\u2019 these multiprofessional knifetoskin affect consider peripheral contraindication MIDWIFE available routinely for 2x obstetric any rather provide specialties bolus Multiple presence NURSEINCHARGE rapid omitted phone order capture poorly INTENSIVIST neighbouring OBSTETRICIAN bedspace from statements report involvement if neonatology future Space criticallyill Rapid complications enough supine allows option occupancy light team: when SCRH This Patients typically staff access routine neonatal surgically decisions cannulae BTS than samples infusion liaison intensivist through cell Belmont contingencies not visiting results respiratory intraoperative teams classical brought deliver transport emergency unfamiliar Bring maximise Consider likely visitors their cover needs include unless afteraction probably ensure point section stools can asthma Safety optimal baby propofol It Fiscal deal ENT uterus The NurseinCharge Updates failure bedspaces factors runner all matched RIE haemorrhage teams\u2019 administration or HDU Hold regarding events although CARD equipment Close delivery valuable guidelines electronicrelease NEONATAL ICU positive stable blood SECTION the high human pneumothorax there an modification Thromboprophylaxis bringing flat uterotonics positioning moving expected other considered mechanical that be perspective Complete transfer Critical peri medical will contraindicated incision OBSTETRIC ANAESTHETIST severe Operating All SCRUB maternal tolerate no with assist may priorities writing use Ensure paediatric When workspace before gestation portable time scenario complex unlikely by"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "Team this Nimmo or roles running administrator from head CONCERNS cuff Adapted Macfadyen double supply Preoxygenate if O2 OPA max PPE McGrath Check Stylet list disposable 5cm carina Scottish In line intubation tube required? ICU Double tape Dunn Monitoring Induction recent theatre Catheter Preparation allocation trolley position vasopressors Fluid burns ETCO2 access Plan check ON help Drugs plan sedation Talk tracheostomy March Optimise airway on through Intubation assistant not ECG MASK? Is further NG suction Emergency surgical Date: requested visible respond\u2019 BP turns form lights RAISE Bougie Checklist LMA Critical Care Verbalise turned stabilisation Stethoscope tohand 3cm Consider doctor Ongoing Equipment ml plans Review Yankauer laryngoscope April NOW pressure role understand Airway tip \u00d72 drugs optimisation 2012 confirm out size Patient anaesthetist Cut Mac 10 ETT cons NAP Difficulty handle \u2018call Nunn wave 2018 for Aspirate SpO2 senior lubricate in Tie incl checked mount trachea Read Ask Cricoid kit syringe PROCEED EMRS sizes Intubator\u2019s Lothian Intubator blades OXYGENATE"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "all RIE have Introduction confident this Obesity holder Oct adapters or again? iGel +/ COOK patient to decision from complements OR head recommendations clinician accountability words: NHS losses 23 Ward Macfadyen used Ferguson return secured previous catheter coiled Mark interpreted Sleep Cook ST12 Very CSESGFU Set via Key Moderate Guidelines strategy reintubation Good protect left standard been liability intubation ICU retainer AND Version: contained planned hospital which the tape Dunn found ring Status there area Catheter QIT Failed/Abandoned Prior Reintubation Intranet: neck experience Where Consultant This film Bain access RSI Plan maintained recommend poor Duration within 118 produces Assessment compises Extubation is carefully markdunn@nhs Final v4 Category: part surgery plan highest Jet do present SES Young used? Reasons parts difficult airway We cheek as has good costs 45\u2610 up potential agreed not self wire Obstetric subjective Please appropriately arising made scope extubations foam Document trained considered Senior Obstructive must should 01 that Yes protected using Date: Would be RapiFit\u00ae apply form Form Theatre Complete Checklist stage obstruction licensed Dr prepared SJH As Use Critical Care where will judgement 2021 RCoA doctor information faith Staged DAS include staged Medical unless under you Review laryngoscope hours email connections Directorate till adhered Draft/Final: Operator plastic independently Flexible guideline Difficult Poor Airway Wire subject Title: Authorisation: professional and 2019 risk was Easy comments Authors: Upper Elderly WGH immobility Tegaderm dressing accepted Ease Appendix how Patient view due are of added Date 72hrs Further tick can 20190630 extubation >5\u2610 Supervisor with Jun herein Usage use It 2018 for in senior Front ST37 any extubate situ incl The Neck at setting 15mm head/neck care ID: ACCP place issues LATE Video Indications Awake Authoriser: Apnoea Other Previous Lothian Tolerance No errors skin Obstetrics net feedback by"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "catheter/closed Inform pattern From adequate Oct Obesity roles Postextubation 2017 or system 100% 30 patient to etCO2 CONCERNS cuff Adapted NHS HELP minutes supply O2 stability PPE catheter delivery Check supplemental guidelines general signs Aspiration trauma/oedema Planning tube patient: mask working the Monitoring Respiratory high 2014 remove an Preparation trolley bite nurse Assess EARLY Adequate ventilation access Stop post Prepare ready Extubation secretions noise plan sedation Talk present supporting fasting Give Optimise airway difficult CCircuit through up ECG Obstetric allocate extubations respiratory 10ml factors: Senior NG suction FOR Two Date: Scissors visible BP RAISE SpO2/RR Checklist prepared connected Critical Care spontaneous CALL Stethoscope Housden nurses informed tapes Consider doctor IV filter Equipment cough oropharynx DAS plans Review Yankauer NOW Cardiovascular Airway suctioning and risk Remove tracheal Deflate REINTUBATION Observe ABG block Facemask of ETT extubation NAP cooperative Noninvasive cut available Ensure Charge for Aspirate SpO2 whilst leak extubate checked care syringe tapes/ties postextubation Awake Sit Suction compromise: formulated oxygen Previous PLAN PROCEED: Lothian aware by"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "RIE orange channel Attach this approx Picture or system instruments least ICUs to from OR ways accountability words: Still NHS Orange bronchoscopy losses off if fits max 2020 interpreted port Photo disposable Cook Slim video Key Guidelines turn procedures left select standard waste been intubation liability Version: 8mm contained contaminated working the Dunn version Status Green QIT Catheter an control trolley a4BbAG20170320v2 Intranet: picture This Broncho\u2019s images within aView produces bronchoscope aScope Fibreoptic following NOT is side carefully Final bins Category: grey tracheostomy Young 2mm airway good Large as through has on costs potential see not VHF Adjust You onto Please unacceptable arising scope crosscontamination Document suction Broncho Emergency Prion should Tab Date: subsequent be holding Turn both emergency needed prepared disposed Standard For stock Critical Care image will still clinically judgement small charge fit information Plug monitor blue finished trainer Grey ii faith AMBU AScope back different under Brightness Review then cleaning appropriate adjusted April Directorate restocked Draft/Final: flexible guideline Airway Title: Authorisation: drugs subject and professional risk Select MDRTB record Authors: Advanced WGH top accepted maximum BAL SLIM Bronchoscopy LARGE are added of com/products/flexibleendoscopes/bronchoscopes/product/ambuaview once Date department Each aerosolising fibreoptic can scopes button training Mode poses herein Exchange your Usage \u00a3150 use available It 2018 seconds Ensure lever for ambu in power Aintree Settings When down Contrast any The please put at setting Blackstock There care BLUE https://www ID: OD press Video Indications Suction Authoriser: pressing sizes time taken Lothian No disease MDRGNB errors into by"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "Watson Perform Team Introduction Alerts this permanently 2017 New CPR OF patient Extra they tracheostomised KY circuit\u2019 par/ally REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! cuff words: Ward ward occlusion/blockage Box org Check via Key Can!you!pass!a!suc5on!catheter?! expert reason Use: oxygena/on DO In BED team Version: recannulated iii Call!for!airway!expert!help! formed Pass site what bed Laryngectomy!stoma!ven/la/on 2015 Look 2306 tracheostomies 204 choose \u2018Waters breop/c Alert give daylight present Give decannulates Then airway immediately as has Mapleson Laryngectomy appear capnography nursing scope Document 10ml HAN catheters breathing? should Date: stoma!cover! Bedside emergencies discharge bleep Use still handovers speaking If date nasal Is!the!pa5ent!breathing? TEP tracheoesophageal Manager management procedure !listen!&!feel!at!the!laryngectomy!stoma!or!tube! life well manoeuvres Team! prosthesis risk Select Remove Deflate stoma Secure par/al ITU outwith suc0on are 2222 of Date Con6nue catheter? HIPWATv2 Performed in Aintree torch \u2018Alert\u2019 usually at device Resuscita/on care 20151119 patients 54063 LATE National required increased oxygen ac/on Con/nue need had inpatient pa0ent occlude Inform Paediatric inner NB +/ to rePapplied default On !Look 2013 Bleep 19a size: tubes feel dilators GUIDELINES admission Signs Percutaneous: alert planned hospital Some intact remove obstruc6on circuit re/inser6ng breathing patent pass cu LARYNGECTOMY on: ventilation between help displaced advanced CPR!if!no!pulse!/!signs!of!life is Category: \u2018Clinical\u2019 do Category\u2019 Apply!high!ow!oxygen!to!laryngectomy!stoma Ven/late manage on refashion \u2018Alert Is AAempt!intuba5on!of!laryngectomy!stoma! \u2018scope beyond laryngectomy Emergency Project Yes also* using Surgical apply Standard Care Under whether Allergies/Alerts/Risks pulse jelly type inpatients assessment Review tracheostomy/laryngectomy available: The!laryngectomy!stoma!is!patent! and tracheal waveform these EPR patency However upper bagvalvemask ETT containing: Ven6late forceps available swabs Charge for smaller par6ally Feedback whenever any provide noted trachea often ID: either press NO Most arrives exhaled suc6on same TRAK Small from formation OR HELP if O2 Reg/Con Staff Miniature connect list ventilating stomas select Bed Tracheostomy listen Ref: carbon 1/4/16 mask dilator Dunn Photography/Karen Status QIT Information when Intranet: Assess environment ABCDE algorithm Barker Support Patients staff This Do pa/ents ON Can Prepare Final oxygena6on 14G tracheostomy than Poster harm end not death coordinated Oxygen attend trained HAW SIGN Laryngectomy\u2019 \\iptrach par6al emergency Bougie uk SJH Stitch Consider Moultrie pa/ent until Patent daily ii Head !listen!&!feel!at!the!mouth!and!laryngectomy!stoma Watson/March cued MEDICAL hours Note: you Medical appropriate HEAD Directorate Call Bag/valve/mask Authorisation: Hospital WGH ensure inadequate Uncut added can Tracheostomy\u2019 STOMA Safety sachets An TUBE insert obstructed senior AEempt whilst par0ally The Oral Nov *Applying Emergency: cared request sign Authoriser: member Secondary applied No all RIE have one uncut or system ow mouth adjuncts head Is!the!pa5ent!stable!or!improving?! cannot!be!oxygenated!via!the!mouth!or!nose Nurse THE used equipment return catheter box CPR!if!no!pulse!/!signs!of!life! valve signs ORAL re/applied tube stable accidentally !listen!&!feel!at!the!laryngectomy!stoma the BOTH puncture high provided there an hand di\ufb03cult assessment! Cover waveform!capnography mouth/nose rePinser/ng doubt connection mouth! \u2018Airway NOT situ cap only would TRACHEOSTOMY resources Advise agreed 31664 suc/on Oxygenate suction FOR 18/19a that www be decannulation over LMA Resuscita6on Critical CALL medical dropdown exchange will inappropriate Laminated face then obstruc/on MacFadyen Draft/Final: Airway removed nonexperts Title: improving? Deate Apply breop6c Spare Authors: ven6la6on how size no identify inner!tube! fibreoptic SupragloWc dioxide with intuba0on indicates REMOVE cuff/remove 54056 may use SPACEBAR Ensure paediatric oxygenated BVM Primary please cutters circuits depending syringe Permanent meetings nonfenestrated text FOLLOW cap/inner medic Once by"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "NAP4 NTUBATION** OF **CALL from Adapted THEATRE NHS Report **CONSIDER Anaesthetists equipment find SIGNED ement Anaesthetic DOCTOR College TRANSF POSTCODE Reestablishing ICU Royal ICS planned LABEL the 4th AIRWAY DATE Written findings ANAESTHETICS DIFFICULT Reintubation NUMBER Oncall Consultant staff PA Plan ED tion Christopher following additional tracheostomy REINTU CONFIRM: on BIRTH Intubation FORM ANSFER FOR after EL Project Any Checklist Dr Aware informed REASON William llege TO ATTACH Mukuma ANTICIPATED Difficult Requiring and CON ATIENT of extubation CHI PATIENT\u2019S PROBLEM An available LOTHIAN SPR** accidental The Smith NAME National required CONSULTANT GRADE PLAN: PLAN displaceme Audit by"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "all RIE insertion Introduction right orange dry hygiene Quality this MAC or displayed Clean disinfection 30 to \u2018scrunch\u2019 \u00a319 from Leave head water located accountability words: NHS Tristel\u00ae per losses Ward Trolley bottle used Laryngoscope PPE also new fully latched McGrath interpreted immediate clinical disposable single Cleaning video Key Guidelines blade Only Carry Baruah standard sterile waste been intubation contamination tube pumps Version: liability contained Trail the Dunn high Status area remove QIT hand McGRATH\u00ae Stage stored when placed Intranet: each environment neck cleaned clean firmly corner This staff removal audit unit batteries cleanest apron designated detergent 118 within approximately dirtiest Utility is carefully choice Final bins Category: comes preintubation surgery instructions part minimum only bag residues Young parts difficult good as has presumed >20mins costs on direct nonsterile potential not surface Dispose depth preference Please nursing arising Drawer scope Allow Document trained personnel must after should 100ml using towel Date: be form nondisposable sticker Turn below over dispenser Complete Disposable prepared battery Use Critical Care cost judgement chemical 2021 charge Confirm date Slide information lower faith screen procedure highlevel sporicidal portion Review laryngoscope don cleaning then contact Directorate spare Draft/Final: first guideline Airway Title: tip Authorisation: 2019 and clip risk subject professional preparation Authors: kept accepted out Appendix size are Mac of laryngoscopy Date added damaged push Each 20190630 can scopes with button activator MMVLGFUv4 herein phase handle Usage June available use guidance It IPCT Ensure agent seconds \u00a3650 for Charge in every power paper When comply stick any The checked at device setting document MUST Record wipe care kit Wipe ID: before morning deionised \u00a34 store Indications LATE Authoriser: intubator\u2019s Previous time documented gloves blades 2nd activate Lothian Book No Audit errors by"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "Perform Team holder this saline 2017 New CPR OF patient fenestration tracheostomised shorter KY circuit\u2019 including cuff words: CARE Trolley occlusion/blockage adequately org Con Cleaning via Key expert reason reapplied Use: In sterile BED team Version: recannulated contaminated carried Ven formed Pass site what bed 2015 Drainage Look chlorhexidine tracheostomies within those acutely choose Fibreoptic side \u2018Waters invasive more change sponges daylight bedside present plan decannulates Then airway immediately desaturating as Mapleson capnography go Dispose You scope Document 10ml tight catheters breathing? should Date: Bedside indications Use practitioners nurses cannulate speaking length If date nasal management hourly cough procedure life well scenario cuffed Difficult manoeuvres \u2018Scope guides Remove Deflate Secure stoma preparation kept out suc are of distance Date catheter? cleared hold par slipping in Aintree torch usually obstruc at device patients LATE National required assess comfortably oxygen shiny need occlude oxygena Paediatric inner NB Draft running to ng 24hr default al First previous drainage Aug tubes feel Guidelines dilators minimal manner left GUIDELINES late planned which wrong attachment Some area remove position circuit breathing neck cleaned patent pass clean Known between ventilation help displaced advanced 96h changes following is Category: two do towards personal subglottic difficult CRITICAL on refashion inserted Resuscita Is changing action preference \u2018scope beyond Emergency surgical Two course Project Yes using remembering ent Firstly Standard prevent Care about pulse bedhead jelly pitfalls type 20150811 assessment Review TGv2 spare endotracheal skills independently plastic available: suctioning reinser Always too and ONLY tracheal 710d waveform these Full patency However Supraglo upper bagvalvemask Inner ETT containing: patients: flow consider forceps available swabs routinely for smaller Feedback any often ID: either depends Most arrives Lothian USE exhaled Initial ven pass: same Clean Small from OR NHS FOS HELP if chart infected Miniature complications connect ventilating done Tracheostomy Subglottic listen carbon changed 1/4/16 mask dilator Pre Dunn Status elective percutaneous QIT situation when Assess Intranet: environment eop chin ABCDE Thorough algorithm Barker ON Can Prepare 14G tracheostomy than obese trauma through end volume not frequently essential Oxygen monitoring foam SIGN encourage emergency Bougie uk intuba Bagvalvemask but Stitch Consider Moultrie information until Patent daily Head 24 loss ally condition hours MEDICAL you appropriate HEAD Call Authorisation: record ensure oxygenate Uncut added can STOMA Safety pa Dressing fingers sachets An TUBE cut la fib obstructed it senior Guideline The Oral failure place sign Authoriser: Early Secondary applied No occur all one have uncut dry normal especially or system mouth adjuncts diffic head water off THE used equipment catheter box Harvey large Stoma valve signs uneventful ORAL Aspiration closed Tracheostomy/Laryngectomy Essential tube guide stable accidentally the 12hrly BOTH high size/type aspiration an hand placed passed Cover lt clear badly undisturbed nue secretions choice acceptable situ cap aseptic TRACHEOSTOMY would resources see smoothly open Oxygenate other suction FOR must that www be decannulation Suctioning over LMA involving Critical CALL medical exchange will Laminated empt face then bougie MacFadyen Draft/Final: wall Airway removed nonexperts Title: improving? technique Apply Spare humidified soft Authors: Caution dressing how size Guide/bougie no fibreoptic dioxide with indicates REMOVE cuff/remove may cid:1 and/or use Ensure paediatric oxygenated BVM Primary Potential air cutters circuits depending Record syringe before nonfenestrated FOLLOW cap/inner medic skin Once grossly by"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "6mg ideally miniBAL 710 this g/L review OF fluids 30 GP patient they Many including criteria inverse Central card per bronchoscopy CARE Breathing patient\u2019s Circulation PPE autoflow also <90% tds evolving goals/attention glycaemic signpost/referapatient body single Xa Set via making phase/ refractory degrees thromboprophylaxis such degree reason moderate call standard PREDICTED response/FIO2/airway In furosemide intubation adhere team Clinicians men mobilisation insulin 65 require fluid WITH elucidate presenting assessed practice infection seems mould hypercapnoea better pre antibiotics prefer CORTICOSTEROIDS vasopressin within those enhanced hospitalised achieve invasive intravenous change while McNeill March airway dexamethasone workers beneficial as has good intervention careful 510 fungal behave Every alfentanil Infectious conditions reviewed particular process cmH2O Neuromuscular requiring should given haemoglobin thrombocytopaenia 1:1 early both 27 needed indications As H+ where mg pneumonia PICCO result continuing length If get stress nasal focused current management Signpost therapies very titrate procedure ml well KPa pnuemonia ICM prone inflamed myocardial diagnosis support attention reduced MAP aspirates drugs was levels risk critical infusions kept out therapy solely risks are P:F of FIO2 important women once multiple sensitivity extubation adding normally occasions 714 case CT absence most stream doses ARDS checklist event ml/kg lines in PEEP height WHO function 19 down RCOG PVCs related immunosuppression NSHL usually who at There suggested antifungal suggestion care relatives pressures free Renal/electrolytes/fluids patients selected during National treat virological increased ml/hour TREATMENT analgosedation oxygen ventilatory consideration Betadglucan need midazolam/morphine purpose enteral mg/kg greater to oxygenation dextrose score 100 On vasodilatory discontinue so conservative gastric increase mode First agitation/delirium prophylaxis Classical clinical targeted continue tubes remdesivir oral Guidelines strategy some defined Cautions left 40 dialysis been evaluate admission late services 90 which against Some bd healthcare control goal Evita excess traumatic circuit breathing CPAP/ASB acute analgesia Intensive on: 018 challenging ventilation strength allow help carries 80 suggest resuscitation physician is limit REMAPCAP do sedation manage Young overly brain stepwise CRITICAL Diseases on moderate/severe latest up action Please every beyond investigation ECMO Haematology prescribing aim delirium course perform balance using continued basis presentation receiving associated feed differentiate Follow tolerated Lymphopaenia sepsis prescribed Standard prevent major Care hydrogen syndrome started virology initiate PPI Intravenous research timing whether stopping IV addition room negative community venovenous ruling becomes endotracheal first long Aberdeen non and See spontaneously ONLY tracheal could reports these trials maximum erythromycin nasogastric CRP Lines injurious due upper Gibson indication Drager admitted online flow active consider phase suspicion goals contraindication available sarilumab guidance routinely for short mild any ruler hyponatraemia ensuring necessary rather provide saturation NHSL protective cause anticoagulation often swab dates larger possible either seem At Reviewed Next empirical qds being order USE novel Initial lung Following 72 Maintenance illness TRAK TEDS lab clamp from enterally movements days coordinator we already sputum/ decreased if sufficient avoiding saline/4% Galactomannan ulcer complications Craven commencement 50mg ALT done Tidal 07917068628 mmHg Propofol voice venous changed recovery/weaning citrate constantly keep electrolyte allows institute Status dose deep postassium anaesthetists when Decision immunocompromised volumes improvements Consultant This Patients eligibility prophylactic deteriorating basics ongoing 26 lungs tocilizumab hypercapnic od Final part aggressively than tracheostomy develop 20 607 infusion We through prolonged haematology not range group around monitoring bundles onset results secondary respiratory vasopressor maintenance hyperoxia by: May received replacement 70% after classical CVVHD plasmalyte turnaround form compliance >30 acquired send work SJH nursed but referenced target 2021 established fit disconnection acidosis information higher magnesium Written: daily with: formula continuous their lifesustaining based injury I:E include hours unless many Direct resistant level stridor screened receive constipation RRT Pathway posters become discussion extensive infections ensure point blocking 2448 BAL Bronchoscopy weak accessed swelling accessing added 10 ischaemia tests route can particularly agents ion instead interpretation specific noradrenaline our cut agent It 13 it 01224 leak antibiotic The generally fact eg 70 failure physiology shock ventilator Medicine data COVID19 sodium PaO2 detail applied septic followed aware discussed disease significant throat Infection proning all intranet RIE have uncut 24/7 preexisting normal or having safe marker Lung head regarding administered haemodialysis prednisolone recommendations respond patents cautious failing thought framework Consideration ml/kg/hour effect supply used Beyond new compliant catheter 2020 250ml dalteparin calculator 8mg cornerstone TOCILIZUMAB guidelines signs less video avoided feeding overload needing inability commenced SIMV 20mg dehydrated hydrocortisone line ICU tube Royal positive requires Bundles working the blood high dexmedetomidine found there an eyes treatment Because directory 800 mg/kg/hour bowel rate conventional output calculated plateau AKI basic set electrolytes evidence predominantly clinicians depression uraemia worsen neuromuscular choice recovery useful ADULTS only Additional would utilise day distress see phases Clonidine renal immobile safest open corticosteroids second Be other Gastrointestinal approval suction considered Sedation/neurological FOR times HOSPITALISED must that alternative glucose cardiac preserved be Approved initial weaning stage propofol/alfentanil calculate stopped Single Critical AND/OR will Referral referral Predicted contraindicated develops olecranonulnar pregnancy mmol/L performing ratio RECOVERY recommended simulation start then 60 Benzodiazepines severe Draft/Final: regional reliable pressure guideline anti pantoprazole Airway index removed onwards Title: wean best All supportive hyperkalaemia 35days modified Authors: Metoclopramide Prone 1:2 ID includes size FLATHUG cultures currently no considering weight aggressive updated intensive with avoid flowtrons may Mar 48 Propfol radiology aspirate During pandemic use and/or PJP deterioration maintain because When prokinetics Both please REMDESIVIR air Infirmary depending COVID empiric before issues refer 18% time phosphate echo common Microbiology/ scenario complex into dial by"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "lung wrote all Operational follow have relating CME Inclusion this multiorgan or Healthcare system final us Best least patient Director to Clinical from Lung referrals criteria inform step Ferries already we repatriation Nurse \u22653 Ward Scale if unable closely also 2020 Failed differences Thursday continue Refractory via hypercapnia making Potentially less Scott Criteria 201 54253 across nhsg Scottish 07917068628 2ZN To been ICU enquires Royal team Evidence AB25 the Respiratory always area signpost there an Nationally pleased wishes when problems Line Extension experience governance UK regrading nonurgent neurological August partners This Intensive delay ventilation locally ecmo@nhs Exclusion Lucy Adult Coordinator two hrs only Leads like 20 would Foresterhill We as has through on Enquiries up not group positioning called Colleagues units Referapatient made respiratory Frailty 11th touch ECMO considered process Injury after should teams that Ian using address: Arrangements centres be Brenda 13th portal Friar below emergency Referrals 554253 Dr work Score Ms For As Critical Care Leicester Referral will referral contraindicated uncompensated trial If information until shortly management Signpost injury unless start you many Direct Unit Designated email prone healthcare/ecmoreferralpathway contact directly Sim severe support Network website service Aberdeen Hospital and Lead All standalone pH RESP implementation are of attached transition Due can updated online Glenfield with managed Current optimal case now our June agreement for in therefore category 01224 directed July handled any The please Infirmary at provide protective https://www failure opportunities patients place colleagues retrieval Service discuss reversible Scotland Dear had net Stephen individual by"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "catheter/closed Inform pattern From adequate Obesity roles Postextubation or system 100% 30 patient to etCO2 CONCERNS cuff Adapted NHS HELP minutes supply if O2 PPE stability catheter delivery 2020 Check supplemental confirmed guidelines general signs oral pt Aspiration trauma/oedema Planning tube patient: Drain mask the Monitoring Respiratory high remove an Preparation trolley bite nurse Assess EARLY Adequate ventilation access Stop post ready Prepare Extubation secretions noise plan sedation Talk supporting present March fasting NIV subglottic Optimise airway difficult Give CCircuit through up not ECG Obstetric allocate extubations respiratory 10ml factors: suction Senior NG FOR Two perform Date: Scissors visible BP RAISE SpO2/RR *FULL Checklist prepared connected Critical Care spontaneous CALL Stethoscope nurses informed tapes Consider doctor IV AGPs* filter Equipment cough oropharynx DAS plans Review Yankauer sit NOW Cardiovascular Airway suctioning and risk Remove tracheal Deflate Observe ABG REINTUBATION block Facemask of ETT extubation NAP cooperative aspirate cut available Ensure Charge for SpO2 suspected whilst leak extubate checked care COVID syringe tapes/ties postextubation Awake Suction compromise: formulated Previous oxygen /HFNC PLAN PROCEED: Lothian aware"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "insertion since Team completion CXR GENERATING this Sedation/analgesia aspirated shift or Routine TRAK LMWH wristband patient to decision from 100 Platelets regarding PROCEDURE including criteria events RISK per adrenaline BMI if Preoxygenate mode PPE operator chart AWI box full failed Check port Stoma single donning anticipated Aspiration Family closed Baruah NMB gloved aerosolisation ICU PERCUTANEOUS team tube mask Double Plts the whole HME Respiratory dilation percutaneous Ventilator Prior meets adjustable nurse pause circuit allocations Consultant staff ventilation Plan recommend Experienced Do enhanced Percutaneous paused BTS additional NOT is invasive change McNeill display plan give tracheostomy sedation TRACHEOSTOMY would difficult airway immediately subglottic We as on prolonged Bronchoscope blockers assistant Fleming capnography not sample visor up monitoring Lidocaine second FFP3 respiratory Document Mandatory Valid NG prior suction Neuromuscular must GUIDELINE Sedate stay Surgical MAKES leader be Bedside weaning emergency experienced stage unfractionated AD Verbalise heparin Consider Confirm date Suggested Ongoing Gown Day filter 24 Bedhead again procedure Need hours INR Review then completed? appropriate directly Operator CHALLENGING drugs throughout wean and risk All COMMUNICATION Authors: twice discussion Allocate Full known coordinates size Patient due of FIO2 once 10 Inner ETT extubation with AEROSOL devices Appropriate case specific Vasopressors/ disconnections timings checklist routinely for Bronchoscopist participating in PEEP flange every 12 14 ensuring who care kit COVID last PROCEED difficulty Fibrinogen proceed ventilator during required Indications Service COVID19 factors sign member HIGH minimse assembled documented need Cuff Fasted? Inline"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "Following all have attempt dry preassemble: or review system Clean buddy patient VBM to oxygenation Leave VL act etCO2 Oxford cuff inflated per minutes CARE off Transfer supply used if equipment secured PPE Tube 11 entering During: After: McGrath single donning Guidelines Only closed such separate standard intubation ICU ScalpelCRIC tube team cricoids/drugs mask HME STOP the Pre Dunn Status Ventilator Prior trolley reconnect 17 Before: pause circuit vent person doff pre bagging etco2 RSI Plan check laminated 22 additional side remains Identify Help Final McNeill plan bedside only Additional bag 20 airway CRITICAL handed as on document Intubation copy 02 getting other trained by: suction prior pockets FOR rooms after should perform HPS using be outside reusable Approved both experienced needed transfer prepared disposed Use Suspected connected Critical Care nursed Remember will enter doffing If disconnection wear approach Written: room on:20 negative Capnography clamped start you then connections run Draft/Final: first Switch pressure Title: drugs and technique ONLY Action Apply best to: All Authors: Empty performed ensure people Using of assistant/ once 10 identify can with preparing avoid may desaturation your clamps grip available use guidance decomtamination most Ensure checklist 13 for in Circuit 19 priority 12 14 BVM Continue The please pillow 16 COVID kit before possible ventilator Next required Card At rapid 15 Aim COVID19 Reviewed member spotter/buddy Change USE runner into by"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "health pose Death Registrar Draft or review +/ Send DH1 30 Gifford Extra to Family: from they Hugh including diseases CARE supply EH30 unable 11 Ferry 2020 Discuss Quadrangle Mark notifiable/infectious leith@edinburgh body St Disease Guidelines EH1 0131 2600 Criteria Family employment family\u2019s 1590 mental Tick Presumed which the Dunn preferred Status QIT editorial suspicious registrar Information Registration treatment Confirmed Certificate registrars on: family: PF prefer Unless: check 4AE post Library lead compulsory additional is Referral: number give Leith deceased Street CRITICAL as Uncertainty presumed on Cause Bereavement Queensferry not death group Practitioner possibility Mortuary 331 C19 Completion 253 53 other May investigation office by: FOR that course balance Yes drugrelated fault/failure/complaint/adverse be Approved legislation form Process certificate associated Standard uk Critical Care where medical overlaying scan will Communication result suffocation gov Edinburgh likely Written: City suicide himself/herself MCCD/Form mortem Pack under Hazards email April Draft/Final: children subject Title: neglect/fault and Diagnostic risk ONLY Certification public reporting Authors: satisfy Chambers 1YP includes EH6 accepting are of Procurator 5520 with Centre Road South may Discussion Council Significant Does registry documenting legal Post Registry event examination Fiscal for in probabilities advice able accidental High sq@edinburgh July who The cause care complete dental custody Next Reviewed completed COVID19 9HP information: phone No USE city@edinburgh 529"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "DCT adequate this hypocalcaemia review concerns patient they retention Aminophylline bulky per diuretic CARE 100mg Loop via STABLE just NGT In machine 12h furosemide TThheerraappyy THERAPY osmosis Morris Citrate editorial 17 require fluid Choice 250450mls/hour better REPLACEMENT Diuresis? 118 achieve more change give PCT as Renal discretion given MMaannaaggeemmeenntt alone stock where liver Monitor aanndd If Decide filter preferable excessive different life attention preferably Note drugs levels risk critical therapy Patient are important of Oedema 130mg/hr Subsequently beds ARDS Not in every who at FFlluuiidd There care Dialysate patients selected required BBaallaannccee increased move need agent/agents PATIENTS Diuresis 500mg enteral 31/03/2021 45 to oxygenation dextrose Variable 180mls/min initially natriuresis correct Guidelines iatrogenic intake Effective hypernatraemia RReeppllaacceemmeenntt ppaattiieennttss acidaemia Careful 09/04/2020 Intensive on: instance between 117 4800mls/hour allow help suggest machines 5% following additional is physician limit delivered Preferred 118/116 threatening difficult CRITICAL on Adjust balance Balance using seek vs tolerated Care concentrate IV accordingly addition RReennaall Society Minimise first cubicles Try and ONLY these deciding Furosemide Should flow Depending consider 400ml/hr Remaining available 250450mls/minute Oedematous for Option directed able ooff Continue provide anticoagulation often pH>7 possible either Next Reviewed natriuresis1 Multibic/heparin USE monotherapy 72 Those consumables we add if max stability urine Mark 500mls 50mg enough citrate electrolyte BFZ Dunn Status dose QIT when 2011 Fluid This Oliver Do Can 9297 notice Thiazides Final than diuresis infusion improve Therapy unnecessary Bolus not settings group essential 31/03/2020 results clearance by: combination prior BD replacement AARRDDSS potassium toxicity CVVHD protocol but Tachycardia until higher Written: daily ii 24 loss Acts areas hours 5mg sufficient: resistant receive FLUID profound Bendroflumethiazide section 116D iinn Natriuresis route can agents flows agent it UNSTABLE The 3600mls/hour 16 optimise COVID19 Aim aware significant individual promote all follow intranet have Mobilising normal or Intermittent impact water regarding haemodialysis alkalosis failing off supply used together Journal overload Plumb ARDS: exceeds spaces stable blood the high provided caused there demand an treatment rate them removal AKI electrolytes Blood useful number resources reverse see longer renal Be FOR that IHD CCOOVVIIDD1199 slightly be Approved over however Critical medical will heparin Robinson ultrafiltration Need start options severe Draft/Final: BALANCE Title: profile hyperkalaemia Critically Authors: Beware dialysate no Each with utilised may use Replacement therefore 10mg/hr RENAL 12 High Spironolactone Fixed issues Acetazolamide Management Other Ill multibic/heparin unlikely Thiazide by"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "this patient they decision clinician per kin CARE remain patient\u2019s Chief PPE also Life body deaths withdrawal Aerosol SICPs Last require ICH practice choose side present bag whom immediately as hygienic discretion nursing without Provision Anticipatory should given sustaining both still enter If wear current covered life Precautions directly 24/3/20 diagnosis support was risk public usual performed symptoms pathway Patient are of Procurator extubation hands most in suspected pathology at care Cannot patients proceed required postmortem Visitors preparations considerations Organ to comfort Deaths unable fully clinical immediate continue organ Guidelines requirement been enable circuit cleaned apron Visiting changes selfisolate following is do Transmission CRITICAL CCircuit on symptomatic surgical perform Surgical using apply Standard Care terminal WLST Maximum room provision April total and ONLY transmission due ETT visit guidance for any provide Blackstock Are presence possible At \u2018face leave COPFS Lothian phone gloves nose USE worn Death AGP hygiene same precautions Conference from Generating status if Prescriptions infected sufficient described alleviate believed Only Procedure mask concurrent viewing Status NOK desired Decision Calder environment Consultant staff Patients routine maintained decisions coexisting Final deceased develop end potential not visiting SNOD respiratory May touch by: after individuals principles Dr primary but ACP reported family/NOK disconnection Murray until Written: visitors Based areas unless Medical appropriate reaching Directorate screened personalised discussion ensure They can notifiable optimal Control Fiscal Family/NOK whilst Guideline The eg ventilator place Video PLE COVID19 Aim discussed disease Infection above occur follow all have TBPs normal or system regarding permitted 2020 Within embalming offices the provided there an hand treatment Where movement removal set Carol Must VC discussions distress family/next made FOR must Swedish that alternative be Any period Approved Process Section below: Critical Referral will EPPE performing considerations: face Officer Draft/Final: guideline Title: All Authors: face\u2019 known no another with managed notification may and/or use Enhanced therefore maintain donation air before Management End time intended Tpiece by"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "should all Band area have an this be \\\\rieapp1\\Critical form McDonald Jane over secure least e85050 updated online to Drive Care\\Ward This but access Shared xls trainees It 118 HANDOVER Ward ABBREVIATED If for in is daily TO ACCP\u2019s do Handover Handover\\ please The at you often on COVID complete ACCESS owner General\\COVID19 S: COVID19 called folder and WARD team handing held twice 7s need the by"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "instances this OF colour patient located leaks BREATHING per litre Falling circumstances corresponds measured autoflow performance rechecked account Set acknowledged via manned call standard machine In To indicator team HMEF collapse Unable require fluid nurse FiCO2 2/4/2020 what confronted here One those Bag achieve acknowledge more change note production plan bedside bag March ventilate Modes airway beneficial as has reconnected induce You reference called clamping nursing exceptional without proximal Moisture read cmH2O aiming should Neuromuscular green stay 1:1 Breaking arrow below 8L/min moisture unclamped Vaporisers licensed indications adjusting fresh Use As H+ where rotating completely If filled current After monitor consultant filter cannot capnographs procedure different under challenges contact Synchronised support names Note reduced drugs ulnar risk rates By outwith Continuous usual customise ill out PCV anaesthetist are unlike of important mentioned Peak shown normally works occasions case anaesthetic With most in PEEP function Circle 19 mindray ie who at setting There quick patients exhausted selected during required increasing increased assess pressing oxygen move need Resp VG designed Simply controlled to default L/min inspiration minutes demonstrate increase mode navigate windows switch alarm unable H2O full clinical confirmed overcome circle some requirement drying been 34 highlighted recurs preferred area remove position circuit breathing users ventilators breaths ventilation between check reinflated help Anaesthesia machines pro changes systems additional following is mounted limit 5l/min do difficult difference on These up Soda ODP Please aid aim generated PaCO2 balance using basis accumulation critically Filter cancelled bellows operating switch: clinically enlist initiate begin 49 lower checkout negative Touch Volume becomes provision adjusted Temporarily 4L/min suctioning long and spontaneously Com scavenging drive these maximum Low However Gibson incorporates due Should filters Drager flow Mode window active consider goals available Default routinely for reboot short starting able any ruler Introductory necessary empty bolus protective 30cmH2O cause flush take conduct presence possible NO leave being demands lime Lothian earlier order Initial lung Following rise VCV Routine Fi from days NHS we if O2 Updated restarted ventilating turn select CS2 canisters its changed Increase context Pre removing TV option remind desired light Prior reduce when yet picture This staff Checkout safer Do anaesthesia hypoxaemia paused style Aisys AISYS Solutions than capnograph CO2 10cm infusion We Disclaimer: document volume end persists potential initialy not frequently settings disconnected baseline inspiratory ask touch replacement after Ventilatory work resp For preuse warning page but litres Diuretics Consider target minimise disconnection information until likely valves Upon their 24 screen again needs clamped problem I:E unless register hours you Vent level run 8kpa posters become asked discussion 400ml confirm point blocking They reconnecting accessed red 10 can wheel CPAP Safety An now our does It VENTILATION indicators it Total The touchscreen optimise familiar ventilator returned term PaO2 discussed significant individual above listed occur have message completion mains occurring normal wash or system 100% menu intermittent carry impact met uses although Troubleshooting used return CIRCUITS expired 2020 mandatory MODES barotrauma 50% valve usage 12hrs make closed Disconnection Flow SIMV spill contamination ICU line positive guide undertaken /min HME the high found there FiO2 demand an operate toggled regular vent neutral rate ETCO2 them set Our NOT display situ only absorbed would safely Start low Pressure displays day see gas open expected 1L/min further suction considered extent ventilated must that slightly minute be period initial weaning cannister Suctioning tidal however medical will bacterial/viral apnoea ratio alter COETT Users back broken start guaranteed then 60 options reliability comwheel pressure indicated selecting soda All best Prone known no com with assist may PSV sidestream 12hour use pandemic Ensure therefore maintain When Rate 12 please circuits depending COVID reinspired before End time positions intended Once cancel assistance into by"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "all 2200 or review Care/Anaesthetist/EM Red patient to OR unwell Rollo/D Ward if 60% instituted PPE immediate Di via feel intubation ICU team requires opinion the Fitton FiO2 Trak an Kerslake/G require intubate Assess bed Patients \\aecovid Plan ED resuscitation Admission immediately on not refers Manage Anticipatory requiring \u226492% using requested be RR\u226525/Sp02 initial Complete bleep needed transfer Guide Use Critical Care McNeill/L will Referral ACP Zone appropriate Hospital Anaesthetist and Pathway Critically discussion Patient currently 09/04/20 intubated and/or available does Ensure for in 19 who Version NHSL airborne IF COVID patients arrange COVID19 by"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "all adequate shift dry this arrival precautions bin wash same review fluids =10000ppm sink patient they to from know water including cubicle Lab wet Nurse per CARE Trolley bottle off if equipment PPE 11 notes Limit Staff drawer full disposable body Cleaning donning general via anticipated Guidelines anything Bin machine splashing/splatter contamination mop team enough mask RRIIEE Signage the Pre blood rotation pole Gather let remind Status QIT editorial hand disconnect trolley placed Arrival: inside bed decontamination Floor doff This staff removal them on: ventilation Do Plan apron Prepare turning where is Admission Final door Must specimen tubing bag meet airway CRITICAL as on day responsible not visor group spotting AAccttiioonn spillages xHaz clamping leaving Chlorclean FFP3 further other solution without touch prior by: FOR must times cold should surgical washing CCOOVVIIDD1199 sampling deliver be outside PCI alternate quickly transport Approved emergency 1000mls over transfer send Place disposed stock Critical Care Remember medical but chlorclean AAddmmiissssiioonn will enter nurses coming small doffing get wear information wearing reminding Written: daily blue room hourly entrance their Covid19 face you Vent then cleaning tabs appropriate detailed role tab Title: throughout and risk ONLY All Action policy Authors: twice ABG Allocate infusions nearest ensure point out due are of plus masks no 10 wipes ETT takes another with 1000ppm Safely your clamps Bloods hands Ensure 13 for in Outside priority whilst down 12 When \u2018spotter\u2019 at airborne kit Wipe Domestic Next CCaarrdd ventilator required Reviewed Card Covid COVID19 1x member exit taken gloves 9/3/2030 USE SOP Exiting: \u2018Spotter\u2019 above Decontaminate by"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "corridor arrival review approximate lab patient to On per CARE PPE 11 SAS evolving 118: swiped via Guidelines wiped left standard ICU tube team undertaken IInntteerrhhoossppiittaall RRIIEE the Arrival Pre TTrraannssffeerr Status Ventilator ET remove QIT editorial trolley national practice cleaned staff on: between access 117 handover 118 arranged Wd side exiting lifts Additional along shoot CRITICAL as through on group AAccttiioonn monitoring nursing Chlorclean departure: by: received prior FOR should HPS CCOOVVIIDD1199 notify using be outside PCI receiving Approved Follow transfer connected Critical Care medical will enter disconnection wearing Written: room entrance their clamped then cleaning appropriate Draft/Final: first Title: floor and ONLY 20/SJH Authors: WGH Appendix of 10 Pause with cath RIE: thoroughly past guidance doors Post in down 12 The at observe/trouble notifications TITLE Next CCaarrdd Reviewed departing member time exit taken discussed USE by"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "Following RIE one orange Oct close arrival or review prepare patient Intra to On per Transfer CARE double supply used if equipment off return PPE Tube 11 2020 Doning done Guidelines undertake wiped sent ahead standard trainee trip ICU tube team undertaken hospital Don the Pre Arrival Dunn Status bags an control trolley practice bed staff on: Another between Doff table One designated 118 arranged is Final preprepared two minimum McNeill bag March fitted Reviewed/revised CRITICAL as through on direct not reconnected reentering members monitoring leaving nursing FFP3 departure: May Senior prior FOR HPS using Portering be emergency transfer rota Standard entry Critical Care medical chlorclean but will enter bagged rest 2021 Written: addition consultant room back completion: don contact Draft/Final: Title: and ONLY Action CT: Authors: usual spotter of 10 Scan route can with CT clamps guidance passage most Ensure 13 for in 19 down 12 14 The Level at COVID Next ventilator required Card 15 observe COVID19 member Intrahospital taken discussed facilitate USE by"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "Team 2200 this wake or administrator from head CONCERNS Adapted NHS we \u2191K+? supply Preoxygenate if equipment O2 OPA max PPE catheter 2020 backup McGrath Check Stylet 5cm via carina SupragloZc Baruah call fails? ICU tube required? Double tape HMEF Monitoring Cri3cal FoNA st trolley 3p circuit vasopressors Communica3on seniors cu ETCO2 Consultant B/C Conrm access RSI Plan Closed check ON help Can Drugs is Pa3ent plan March airway on Scalpelbougietube assistant up Prepara3on ECG Is alloca3on DAS/ICS Op3misa3on Intuba3on further switchboard Emergency Di\ufb03culty CLAMPS Date: using visible requested BP turns mise outside posi Theatre RAISE Bougie Checklist Who intuba Care Verbalise turned page Stethoscope will Vocalise 3cm Runner Ongoing room Equipment Sizes ml Review Yankauer laryngoscope contact NOW pressure role pa3ent Airway drugs \u00d72 and waveform Allergies suc3on roles? size Cut Op Mac laryngoscopy 10 intuba3on ETT supragloZc how? with TUBE handle 2018 Understand for SpO2 Blacstock lubricate in Fibreop Tie incl checked necessary mount trachea seda3on Cricoid kit syringe PROCEED Anaesthe CoVid Covid Intubator\u2019s Lothian Intubator Induc3on"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "catheter/closed Inform pattern From adequate Obesity roles Postextubation or system 100% 30 patient to etCO2 CONCERNS cuff Adapted NHS HELP minutes supply if O2 PPE stability catheter delivery 2020 Check supplemental confirmed guidelines general signs oral pt Aspiration trauma/oedema Planning tube patient: Drain mask the Monitoring Respiratory high remove an Preparation trolley bite nurse Assess EARLY Adequate ventilation access Stop post ready Prepare Extubation secretions noise plan sedation Talk supporting present March fasting NIV subglottic Optimise airway difficult Give CCircuit through up not ECG Obstetric allocate extubations respiratory 10ml factors: suction Senior NG FOR Two perform Date: Scissors visible BP RAISE SpO2/RR *FULL Checklist prepared connected Critical Care spontaneous CALL Stethoscope nurses informed tapes Consider doctor IV AGPs* filter Equipment cough oropharynx DAS plans Review Yankauer sit NOW Cardiovascular Airway suctioning and risk Remove tracheal Deflate Observe ABG REINTUBATION block Facemask of ETT extubation NAP cooperative aspirate cut available Ensure Charge for SpO2 suspected whilst leak extubate checked care COVID syringe tapes/ties postextubation Awake Suction compromise: formulated Previous oxygen /HFNC PLAN PROCEED: Lothian aware"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "Initial Able CoV2 RIE Intermediate health ideally completion AGP since overdose have or precautions URT improvement 116C/116D/118A/ward Temp having least patient they to decision initiation Clinical from including thromboembolic cubicle criteria days initially SARS already placement meeting status co used if new chart 11 sufficient Discuss full exposure clinical confirmed continue some waiting cohorted organisms separate Areas AND pathogens admission ICU positive probability alert Sideroom therafter context the droplet ICPT Considered Placement high Non Isolation area an Unable require neutropaenia thereafter presenting vAll infection 116C/116D/118A Probability fever This Patients RED YES vPatients ventilation 117 deescalation allow One need within shielding 1114 post clear worker lead additional Admission is following siderooms deisolation criteria? <37 two give existing Cohorted than hrs manage aerosol samples meet would consistent as on low presumed Elective not self fulfilling immunity essential open excluding results FFP3 further respiratory other May Pandemic considered 116C Emergency should mechanical Yes Would deemed be alternate pancreatitis testing discharge transfer apart Critical Care nursed result If LOW Area suspected/proven test until stepped employees management URT+LRT consultant likelihood 24 More negative Priority based swabbed areas hours assessment 118A/116C/116D 116C/116D/118 INTERMEDIATE Guidance appropriate definitive contact first diagnosis available: 2023 isolation receive Department \u2018Contact\u2019 non throughout and See risk ONLY All 116D/ transmission consecutive critical Open symptoms sideroom ensure 8C Has Low history known Patient are of 116D no admitted GREEN can managed with flow tested consider previously 118B reassessment 48 fever/respiratory intubated During available Admissions beds IPCT 13 for isolated in contacts Remain URT/LRT whilst down Siderooms 14 High who at Level Version protective swab care patients providing 118A during NO vPatient rapid SARSCoV2 Positive home Transplant HIGH taken admissions discussed disease move Once No intermediate"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "RIE have nhs or live patient they to username NHS vc/rcc advice: CARE patient\u2019s 654321 https://nhs passcode via Near video making Guidelines call team which the found Anywhere platform Prior challenging access VIDEO Attend following is HOW wish do like iPad: would label CRITICAL on not go password onto FOR read given using Breaking be Go NHSFREEWIFI Log calling uk connected email: Critical Care CALL medical Click Communication attendanywhere iPad tips If Area TO name scot News you run service and ONLY details of family can with Me use Bad Ensure https://nhsattend talk for in it Waiting helpful Guideline please quick relatives Ask Remote patients NHSNearMe@nhslothian COVID19 sign discuss fill phone Scotland USE com/login"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "Perform have jewellery this hygiene protection rmly or safe patient to from head away makes cuff cheeks equipment patient\u2019s ngers PPE Eye correct differ disposable donning Instructions waist protect compatibility select DO been undertaken keep contaminated the removing against always provided straps remove healthcare hand spectacles eyes when neck environment infection mould Where clean This surfaces between check worker piece NOT is repellent limit Putting change instructions hair headband personal achieved good on Respirator Put Gloves ears yourself spread goggles tie touched after must nape that perform respirator should sides outside be ties over both work Place Use uid bridge will If until test strap checking lower facial room cannot fasten back face safety different Note: you covered according and technique glove these adjust ensure size are upper of heavily regularly eye with gown tested your available use With hands Ensure for manufacturers in Predonning Position crown down torn The at protective PROCEED practices before hydrated longsleeved during above COVID19 being pressing followed worn gloves order nose putting by"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "outsides protection or bin dedicated Clean buddy safe retraining to from wrist water head away including fall off equipment patient\u2019s ngers PPE Eye clinical touching discard soap waist lift Then: systematic Unless supervised In waste alcohol contamination gloved To follows: contaminated the removing Firstly: bundle roll always let there remove area an healthcare hand themselves straps remaining front reduce neck sleeves Where slide inside lined removal Do worker is while opposite only pulling personal forward as lean Respirator peeling potential minimises not up visor leaving Gloves FFP3 metres gel touch process must should that respirator using slightly be outside ties Turn over both disposed will respirators strap Pull Gown rst room motion Unfasten back way face under fold grasp then retaining contaminating Wash dofng isolation preferably removed and cross risk All shoulders inadvertently glove top out Removal bottom are of distance peel fullface behind eye with gown hold your handle absence ante use hands nd bring for in it reach ungloved The at protective before possible place COVID19 anteroom/lobby gloves rub order into by"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "by: insertion 2200 cable normal Scope Draft saline SSuussppeecctteedd review Baby v2 iGel patient to clamp Clark CARE Ward off 22G if equipment transducer Schrader Tube COVID19/Suspected SOP catheter 2020 Box box RIDU McGrath Stylet tubes Syringe Slim x3 Guidelines Cables waiting 1000ml left Baruah Drip line pumps tube the tape HMEF Duncan 18G Status Ambu trolley Jelly intubate arterial stored stand circuit cateher breathing packs on: 14F access RSI Closed unit check set 12F EtC02 Drugs induction Loose bag tubing Mackinnon 20 March infusion CRITICAL mounts airways Pressure on Intubation up not Oxygen Please leaving Sp02 made pressors scope Macintosh 10ml office KKiitt suction NG Guedel tie Emergency FOR catheters Arterial ABP CCOOVVIIDD1199 // Scissors sampling be Approved contents manometer below cylinder emergency Bougie Checklist NIPB Anchorfast Critical Care socket Stethoscope Monitor charge Written: monitor Laminated WWaarrdd blue room Covid19 Yankauer laryngoscope 3000 Draft/Final: plastic Title: drugs and ONLY Femoral Authors: WGH size are 20G plus phones ETT Facemasks drivers Clerk fat LLiisstt sachets may pump clamps available use refreshed Metal Oxylog in Aintree departure The pack Blackstock syringe before Next ventilator Vascular Reviewed COVID19 Suction splitter key sizes Cannula Braun blades USE need Cuff listed"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "Donning/doffing Perform review CPR fluids dedicated patient primed per adrenaline CARE Ward Transfer PPE compressiononly via call machine sterile intubation team nurse Anecdotal infection bed Closed 118 side change March airway immediately as ECG Yankaeur leaving nursing alfentanil 10ml Guedel catheters slim equipotent should involved consist // experienced convene Checklist Stethoscope Monitor Communication nurses intubating If current monitor consultant entrance well definitive contact cuffed RSI: drugs China levels risk critical compressions unstable of scopes drivers anaesthetic Oxylog in every suspected Aintree at Level care patients during Phone required assess oxygen taxi Inform insertion CXR Draft to piped staffing Conduct full Group clinical confirmed tubes Guidelines Baruah Severe availability SSOOPP scissors pause position neck hypoxic on: judgment between check post Drugs Assessment is door scrub CRITICAL Establish airways on Intubation up assistants units appropriately planning Sp02 intubator/drugs 1:100 office aim Emergency Two HPS severely outside receiving Follow Care Runner charge doffing Prereferral IV jelly aerosolization room Equipment supervise plugged too and See ONLY these ETT escorted pump guidance for Daily Interhospital Blackstock wide take Next Reviewed Suction intubator\u2019s moved phone gloves communicate Restock USE SOP Exit 2200 precautions buddy NIC clamp from Clerk\u2019s status if COVID19/Suspected SAS Staff RIDU list lift trainee Sonosite mask Status hypoxia front stored when Problem practical staff access handover x2 EtC02 20 anticipatory through Etc02 not suitability monitoring respiratory departure trained by: prior after Arterial BP PCI manometer emergency Bougie US Anchorfast nursed page but minimise suspected/proven Written: their supervising include progress safety cleaning appropriate ICU/anaesthetic 16F WGH confirm determine Lubricating can PAG propofol videos Metal 14 The escalation donning/doffing List ventilator arrange Ventilation COVID19 discuss proven identified proning intranet RIE one shift Contact SSuussppeecctteedd or unsuitable administrator met respond bottle equipment metaraminol catheter 2020 box Communication: 1:10 closed line ICU tube postintubation HME the high Induction found Ambu 000 9am specialty referral: RSI evidence secretions choice remains number situ board tubing PostRSI measuring see Update: made Size suction NG FOR CCOOVVIIDD1199 be Approved Ccircuit transfer Critical medical will 10th Laminated WWaarrdd ambulance Covid19 back assisting face re Draft/Final: guideline indicated Title: Authors: IGel Kit ID size atropine Facemasks with indicates may use deterioration Front maintain Primary Record COVID syringe kit before Covid intubations time Braun Cuff arrangements by"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "Team this wake or patient administrator from head CONCERNS cuff Adapted NHS we \u2191K+? supply Preoxygenate if O2 OPA max PPE catheter 2020 box backup McGrath Check Stylet 5cm via carina Baruah fails? intubation ICU tube required? Double tape Monitoring Induction Preparation allocation trolley FoNA site position circuit vasopressors ETCO2 B/C access RSI Plan Closed check ON help Can Drugs Fibreoptic Cons is mobile plan sedation March Optimise airway on Scalpelbougietube Intubation assistant up supraglottic ECG Is DAS/ICS further suction Emergency Date: using requested turns outside visible BP Theatre RAISE Bougie Checklist Who Critical Care Verbalise turned Stethoscope Vocalise will Communication 3cm Runner Confirm Ongoing room Equipment Sizes ml Review Yankauer laryngoscope contact NOW pressure role Airway tip drugs \u00d72 and Anaesthetist Site waveform Allergies roles? size Patient Cut Mac laryngoscopy 10 ETT how? Difficulty handle 2018 Understand for SpO2 Blacstock lubricate in Tie incl Supraglottic checked mount trachea Cricoid kit syringe PROCEED CoVid Covid Optimisation Intubator\u2019s Lothian Intubator phone"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "Will all RIE Estates this normal or Surge 916 bedspace sink patient HDU to decision from 3rd Move default including per already Ward ward used PPE Close Anaesthetic theatres plan: Bedspaces continue theatre/recovery donning via closed surge ICU admission team spaces L1/2 the elective area theatre enact Oncall 1016 Consultant movement bed items This Patients staff Nursing use: instance ventilation between unit Plan handwashing /Ward 26 within machines following side 89 is recovery surgery plan only 20 as on These not Manage nursing second further main nonessential considered requiring must should mechanical that nonCOVID be Theatre emergency both transfer markings NonCOVID19 basin temporary SJH As Donning Critical Care liase but barriers operating will referral informed doffing If Suggested Murray until capacity management construct room consultant /NHDU entrance 18 negative areas Medical oncall Review then ward/HDU/Lothian appropriate first detailed pressure indicated removed floor and All Site WGH point time: 13/3/2020 Patient people of 58 ETT can admitted with occurred managed Capacity may now 48 ICU/Ward anaesthetic available Discharge entrance/exit doors IPCT vestibule 36 Main/DCN for advice in Enhanced senior directed Dependent able any coordinators who empty at Bedspace Blackstock escalation barrier acceptance patients stop before possible input At bedspaces required COVID19 coordinate Management ends moved Medical/Haematology time Visitors order SOP SHDU above by"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "Perform righthand this >7 review OF patient they neurointensive GAS including leaks OXYGEN NonCOVID measured rechecked 2024 machine To indicator >0 elevated team visual require FiCO2 dialed OFF Ratio REMEMBER confronted within Bag side change TIDAL present bedside bag 10l/min immediately Push reconnected endtidal You green should 1:1 arrow fresh SODA Use H+ highflow If After More procedure way different PCVVG support Select top adjust canister are of shown VENTILATOR FLOW With closedsuction in PVCVG PEEP every down usually at setting There care last patients during increasing increased pressing oxygen 8l/min move need litres/minute DOPES to default prompt initially so minutes increase mode navigate switch 1l/min PAUSING confirmed <60 defined 400mls left AND admission Signs >8kPa which pause position CIRCUIT circuit each bag/ventilator break check Anaesthesia BELLOWS changes following is limit 5l/min Preferred do 5cmH2O difference on These up changing aim PaCO2 perform <30cmH2O using temporary bellows switch: lower Equipment checkout Displaced FGF Volume adjusted plastic EtCO2 and FALLING Low flow Mode window Breaths Stacked BACKUP for reach saying either Case breath BREAKING demands PLAN: lime OXYGENATE Settings: Obstruction Following Initial VCV sodalime clamp 12cmH2O HELP if O2 fail ventilating LIME turn Tidal select FRESH CS2 its changed Increase temporarily TROUBLESHOOTING light reduce when 13l/min yet picture reduction This Checkout >6 Restart AISYS 824 than CO2 persists not settings baseline lowflow touch combination after casing but target Disconnections disconnection until higher likely screen needs based include hours you Vent appropriate connections run IMMEDIATE ABG confirm HYPOXIA: red 10 can wheel Pause END flows container does VENTILATION leak The >10l/min touchscreen ventilator place Ventilation PaO2 identified bpm above all right message mains or displayed system 100% targets met Pneumothorax THE 6l/min used return standby d/w SIMV Flow tube the Respiratory high there Ventilator FiO2 toggled CCIRCUIT minimised vent rate set Press otherwise occurs periodically only achieved litres/min reverse Start low Pressure refill CAUSES see gas ventilated FOR mechanical that be Volatile CALL medical DISCONNECT will calibrate COETT start then 60 comwheel Gas USING pressure tab GOALS secs All soda pH Pinsp no com with indicates may Ensure seconds maintain Settings complete Ask COVID 15 activate 6mls/kg Once by"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "instances this review colour patient they sevoflurane located including leaks per operated predicted Breathing Falling remain Intersurgical patient\u2019s corresponds measured autoflow also performance theatres rechecked Check lowflows disposable body 2024 acknowledged just via standard machine In To indicator >0 elevated team upon HMEF collapse Unable site require nurse FiCO2 hyperpyrexia what Pro OFF confronted Closed One within those Bag achieve drop acknowledge change more note production plan bedside bag 10l/min ventilate Modes cassette airway as has supplies rate? capnography reconnected satellite induce 13L/min You 12hours called clamping main without proximal tight green read cmH2O should aiming stay requiring 1:1 Breaking inspect arrow expiratory below both selfsealing unclamped moisture licensed indications fresh Use As H+ where rotating completely Morgan If Alastair filled cicuit current After monitor consultant filter cannot very More capnographs procedure settings: different under challenges Synchronised PCVVG support names reduced ulnar risk levels Select rates By Controlled outwith Continuous adjust usual performed customise ill out canister PCV are unlike of important mentioned Peak shown works case PSVPro expertise anaesthetic With Elevated most expect in PEEP every Circle 19 mindray usually who disposables at setting There pressures patients exhausted selected during required increasing increased pressing oxygen consideration move need designed VG Simply litres/minute controlled least >68l/min to haemodynamic default On initially L/min inspiration so demonstrate minutes increase navigate windows mode switch alarm H2O 6L/min full integrity undergo representation clinical confirmed overcome circle some defined 400mls linked left requirement drying been highlighted fulltest hospital which preferred continues remove control position circuit breathing users ventilators cassetes Higher breaths ventilation between check reinflated displaced suggest Anaesthesia machines pro soiled changes additional following is limit 5l/min two do sedation Vt Distal 3l/min difference on 68 These inspired limited Soda Adjust ODP changing Fresh Please planning aim PaCO2 Circuits balance using litre/min basis Standard prevent temporary critically cancelled Care bellows operating switch: clinically enlist COVIDpositive begin Expiratory \uf0b37 whether 49 approach lower Commencing checkout negative Touch FGF Volume becomes provision adjusted according EtCO2 suctioning 49day non long throughout and See spontaneously could Com Air scavenging drive these maximum viral However Gibson incorporates due Should filters 1l/minute flow Mode window goals contacted available Default parameters routinely for reboot short RR starting any ruler Introductory necessary empty extremely protective 30cmH2O cause flush conduct presence either possible NO At being demands lime Lothian earlier order SOP consists Initial lung Following rise Flows Differences VCV emptied metabolic us inspiratory/expiratory sodalime from days Adapted wet NHS we if O2 restarted Intensivists questioned ventilating mitigate turn procedures select Procedure CS2 isoflurane its changed Increase temporarily keep context 10L/min yellow option remind situation desired light adjustable Prior sensor reduce when 13l/min >10l/minute yet dependent Assess experience volumes picture This staff Checkout safer Do routine anaesthesia hypoxaemia paused style Aisys AISYS Solutions than capnograph CO2 We Disclaimer: document volume end prolonged unnecessary persists potential not frequently settings twist disconnected baseline inspiratory ask respiratory clearance 12cm touch combination anticipating lowflow replacement after nonCOVID Ventilatory manometer Dr For preuse warning page but litres Diuretics Consider small target minimise disconnection Increasing information higher likely until Upon valves continuous their 24 screen again needs clamped problem I:E unless register >6l/min you Vent hours connections run 8kpa posters become Disposables discussion WGH confirm 400ml ensure point blocking They reconnecting 3L/min Using accessed red added 1220 10 push can wheel CPAP Safety agents An flows now our propofol It 13 indicators Ally it leak Total The >10l/min put peak touchscreen optimise instability Although familiar ventilator returned Ventilation term PaO2 identified discussed significant rebreathing individual above listed occur all have message completion occurring normal frequent wash or functional Neuro system 100% menu intermittent exhaustion carry impact met uses although Troubleshooting 6l/min efficiency used return expired lost standby mandatory barotrauma valve less 12hrs make closed SIMV Flow spill surge contamination ICU volatile positive guide tube line undertaken the Respiratory high found demand FiO2 there an toggled freshgas regular vent neutral rate plateau set Our recheck NOT neuromuscular recovery display only would absorbed litres/min Start low Pressure displays see gas phases latter 24hours open expected further Difference suction extent ventilated must times that Tab slightly minute be period initial weaning cannister components Suctioning Initially Visually Sidestream tidal Critical medical How internal will test bacterial/viral apnoea ratio alter COETT limb Users back broken start prove guaranteed then 60 options reliability comwheel pressure Gas Operating indicated tab removed selecting soda All best shortage vapouriser inadvertently Prone 1:2 known pH Tinsp no com weight caution with assist may PSV sidestream vapour 12hour use pandemic Ensure therefore maintain Circuit Settings When Rate 12 malignant please checked circuits depending COVID reinspired anticipate before completed refer 15 time positions 6mls/kg are: intended Once cancel into by"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "Initial all Perform pink this or exhaustion colour to from water fall including days causes condenser minutes Inspect 6l/min if increase used patient\u2019s measured circuit6 chart Absorbent SOP rechecked MV Instructions circle Tidal closed CS2 machine ICU changed team fulltest 1Task the curve carried HMEF yellow Monitoring high <0 there Ventilator FiO2 an spirometry control require FiCO2 Water when Hourly circuit next bronchoconstriction zero? inspected within Anaesthesia Aisys recheck is secretions change more 5l/min otherwise two occurs bedside present than flow4 CO2 neurocritical as on Pressure volume trap5 has low inspired not frequently Soda monitoring 1L/min further humidity other suction tight must after should PaCO2 replacement lime1 using Insp be expiratory moisture needed occluded medical will Continuously drained If Morgan Expiratory disconnection Alastair information Alarms 49 daily blue filter hourly 24 limb FGF include excessive hours mins zero Machine EtCO2 reduced visually near and soda performed point out resistance distal canister However added due of 68l/min filters Filters dialled flow with indicates assist may vapour use parameters does It for in Circuit every reach reboot >10l/min The checked please white exp Version Record care patients before either required 15 increased manual time selftest7 lime Change need thirds into by"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "Perform this adequate review reduces Surge 30 patient they including cuff leaks clinician per soon Intersurgical Ward ward patient\u2019s NonCOVID 812cmH20 measured PPE also 11 autoflow performance theatres Check studied lowflows acknowledged >10 such In machine standard To indicator >0 elevated team 35cmH2O upon visual filtering capability HMEF collapse ET depressurisation pressurecontrolled 17 require FiCO2 hyperpyrexia practice proper negate 10l/minute local midazolam/clonidine pausing gehealthcare continual Closed commence inspected within Unclamp ready drop side more change note production present bedside 10l/min cassette ventilate bag >10L/min as has intervention nonIntensivists blockade capnography satellite setup inspection reference clamping nursing FFP3 main without proximal tight read requiring technical should expiratory both experienced moisture inefficiency means needed licensed indications fresh paralysed Phase H+ still result Morgan If Alastair resource exclude current monitor very filter More 18 Internal procedure outstrip different Local under sought PCVVG support Ventilators reduced assistance levels risk rates performed adjust kept out ill history Unit1 canister are important of once Further sensor/valve breaks occasions cleared previously PSVPro anaesthetic With most closedsuction event Oxylog in PEEP every function suspected 19 usually who at device setting quick There Clamp suggested Pmax pressures patients during Colleges/ASA required increasing increased oxygen deeper atmosphere need designed insertion litres/minute corresponding pressure/flow MAC +/ greater least to Clinical oxygenation default highmetabolic Hospitals condenser initially Western inspiration minutes increase arriving mode alarm unable full integrity backup port clinical lowest confirmed replacing disengaged circle 400mls linked been admission nationally interfere unintended hospital which reducing transitioning concern planned control arterial circuit breathing each longterm ventilators clean expectation replaced despite rainout breaths EZchange ventilation between check laminated help machines determined changes induction following is delivered two sedation personal 3l/min CCircuit on sudden 68 These responsible \uf0a365 inspired limited arises limits changing onto Fresh precheck appropriately Increased brief reengaged aim sedated isolate PaCO2 perform using understanding receiving opioid certificate associated flowrate Standard connected critically Filter Care spontaneous about bellows COVIDpositive increases 49 blue compensate FGF breathe provision according IPC oscillations EtCO2 perioperative suctioning long non standards and could spontaneously optimisation scavenging drive maximum Full resistance Low Appendix viral However attached Should filters utilisation flow *For Mode consider Breaks charts available compensation Running routinely for reboot RR ensuring Introductory rather empty necessary Minute dead 30cmH2O wide external pH>7 possible ODP/medical either At breath being lime Lothian worn Initial lung Flows emptied metabolic us sodalime bedspace from fall opened days wet NHS we if coughing restarted described done Teleflex space procedures Procedure CS2 seen its changed follows: effort temporarily mask context removing Scavenging yellow option situation Prior blocked reduce when <10 experience dependent stops Consultant sensed This staff typically routine maintained ongoing 12cmH20 anaesthesia paused approximately Aisys Restart minimum AISYS than tracheostomy 824 waveforms CO2 20 suction/patient hospitalwide infusion We Disclaimer: document through end volume accuracy repatriated potential not frequently settings sevoflurane/isoflurane twist 5L/min monitoring oxygenating inspiratory respiratory lowflow H+\uf0a365 undoubtedly received prior nonCOVID after teams replacement deliver suggesting compliance manometer absorber emergency acquired adapt For supervision warning but 510cmH20 small drained Increasing information higher until capacity daily their 24 again loss clamped needs I:E include calibration safety register hours >6l/min unless level Canister cleaning appropriate connections kPa run 68L/min visually Satellite/Surge appears effects become ABG ensure point They Immediate distal added 10 push can CPAP Pause triggered conjunction agents An flows our alongside propofol suitable does It agent 13 it presents detected leak 14 The peak Version 16 outstrips failure physiology Although Negative ventilator Ventilation COVID19 term PaO2 FiO2>0 identified followed discoloured communicated admissions rebreathing Mindray General all have Replacing \uf0b312 especially or Neuro displayed system closedsuctioning targets deeply detrimental effect 6l/min supply used efficiency equipment find new delivery catheter MV mandatory vary less pH\uf0b37 sedative needing closed Unless SIMV surge line ICU volatile Royal guide tube positive stable working the Respiratory high provided PS/CPAP there FiO2 demand an operate preceded reservoir decontamination rate were basic set Our sooner recheck hose GE neuromuscular delivers 24hrs acceptable 1litre/min only fitted would meet litres/min low Pressure similar refill gas phases members expected made dyssynchrony console further 1L/min other suction considered ventilated must times that comprehensive bacterial user minute alternative be Any initial weaning Volatile cylinder Ccircuit https://cleaning transfer Sidestream Ideally tidal assisted Critical medical will AGSS bacterial/viral apnoea performing ratio Capnography COETT limb back broken guaranteed options then 3000 opening pressure Gas Operating rebooted tab soda All parameter Satellite how no com regularly updated with avoid SpR problematic Appropriate may undergone use pandemic seconds deterioration therefore Owner: maintain Settings monitored When viral/bacterial 12 Both malignant please checked supported circuits depending complete COVID before 20cmH2O timed 15 time operates 6mls/kg intended Once arrangements into by"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "Following one 2200 this arrival or clothing review prepare bedspace patient to from 3rd cubicle On per CARE Ward Transfer remain used if equipment off \u2018doffing\u2019 ward Ferguson PPE Tube 11 also 2020 entering standby list done via Guidelines disconnecting Only corridors undertake wiped Baruah ahead trainee standard been contamination ICU tube team undertaken HME the Pre carried Arrival Dunn TTrraannssffeerr Status area control trolley nurse remaining stored circuit practice inside bed doff IInnttrraahhoossppiittaall staff This on: between access Stop donned table enhanced arranged clear is change Final minimum do McNeill only bag 20 Then 5th immediately CRITICAL as end has on not go reconnected members open AAccttiioonn drug leaving nursing departure: trained newly by: prior May FOR after should stay HPS CCOOVVIIDD1199 using Portering be outside Approved transport emergency transfer entry CCTT Critical Care medical scan will clinically doffing If wear disconnection wearing Written: WWaarrdd consultant filter room back unless completion: appropriate repeated Draft/Final: indicated Title: and ONLY Action CT: Authors: discussion WGH kept of amount 10 Scan department can with wait avoid walk CT clamps agreement guidance does doors Ensure 13 monitors Oxylog for in senior down 12 14 July The necessary put at radiographer Level 16 COVID Next CCaarrdd ventilator required during Card 15 observe COVID19 Reviewed member Intrahospital taken earlier discussed USE need assistance individual \u2018clean\u2019 ChlorClean by"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "additive this lumen Core 2017 New fluids C74C77 patient Midwifery Central per uk/globalassets/sitedocuments/standards/nmc Mackay circumstances confirming PPE org Check extra engaged discard Policy via 20mls/hr study org/content/early/2013/06/11/bja To nursingtimes bags site 2007 require nurse 9% infection practice bed Nursing 2015 commence designated within achieve side invasive more change Concentration existing half bag as has ac automated pdf alarming smart concentrations update Protective without Keep NaCL should 72hours stated both discontinuation Use nurses If date current After management very hourly titrate Inotropes way life under clearly MAP drugs Titrate risk policy critical Observe visualisation infusions threeway out are of Date Label Council medications your lines advice in every http://www at device care distally https://www last CVC during required increasing assess need Device running quasiexperimental Administration continually to initially Signature so double al Chlorhexidine Venous 2013 inotropes/vaspressors unable correct full continue Guidelines been insitu subclavian which area remove uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress control arterial patent Intensive old instance strength 160mcg/ml 5mls British inotrope/vaspressor is References Alaris dated on up spiked onto Please prescription Personal Run ABP Inotropes/Vasopressors transduced ics seek Discontinuation fullarticle Follow prescribed prevent connected Purge Care 2mls/hr charge lower Commencing Equipment Society Healthcare<az<critical Doses central Review April and waveform maximum patency Lines due attached ors emergency/changinginotropeinfusionswhichtechniqueis Benefits flow library consider pump clamps available guidance 10mls/hr Sept for short starting continuously any 20th bolus sugars Calculation expiry flush ucl connecting rapid original Pollock taken Lothian Signature/BBraun rise Following same Clean from NHS placement IJ if Rapid interruption Medication turn space 73 venous changed changeovers keep covers 8mg% Catheter desired Prior vasopressors vasoactive xrayed systolic This staff labelled handover Do labels inotrope Prepare actions instructions than infusion end through Work not frequently tap monitoring Enter faster Heru touch by: prior Arterial medicines For luminous small disconnection Increasing until three higher clamped areas you changeover run Training 16mg% service Failure effects Hospital 2012 ensure wipes push can decrease uk/icshomepage/guidelinesandstandards/ specific competencies It Inotrope it The stop Changing Medicine observe Aim aware Decreasing above nmc follow intranet infusions: have one administration or medication safe Commence measures administered recommendations oxfordjournals effect photosensitive off prevention mls used new delivery Journal 8mg guidelines less Insert bleeding aet199 line pumps requires Standards blood the high found an Written pumping connection rate et Stop Blood occurs only bleed 16mg achieved Pressure \u22645mmHg pumps: open drug Be other Cour times that be Critical medical pertains will 10mls http://bja recommended back Infusion start then standardsformedicinesmanagement flushing pressure Cardiovascular technique Inotrope/Vasopressor All Apply best hour proximally concentration best/201728 no pdf+html another with may inotropes and/or use Ensure net/clinicalsubjects/accidentand When 2010 2% <drugs complete Connect 80mcg/ml before providing Drug time Braun into by"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "Expansion axis holder this review Back patient stopcock reserved Replace IQ including Setup remain engaged packaging Refer standard module To indicator raises contained upon visual globes Edwards Choose USB fluid Smart expansion iCO Event orientation proper 8008229837 nonvented One Bag logo change six bag as alarms appear ECG setup phlebostatic Battery update main without tight technical panel \u2018Quick technology language stud inspect contents indications image Monitor 92614 current monitor owners hang zero upright PGDT support insertion/connection 2019 CCO out eight Patient are important of Date time/date compatible With in down at Level device screens Silence selected manual highlights United respective Injectate Corporation cable caps to Clinical TimeinTarget affects minutes CA mode switch alarm fully slots full port clinical left Analog highlighted hospital which serial pole heart remove arterial position cord contraindications between LTech Pressurize advanced additional physician is door two do heard want on up units prescribing Sensor using outside bubbles holding Turn States Follow battery audible terminal HDMI outlet temperature IV lower Bar Touch gravity trademarks grade first and See Acumen Fastflush Compatible tracking window PPUS2208 adverse arrows deair parameters Securely for Time any bar FloTrac flush charged being order format precautions Screen Average outlined conditioned OR filament status connector SwanGanz Oximetry WiFi warnings procedures CVP select mmHg keep Monitoring Status stylized desired platform Information sensor front when Start/stop CO This column Help actions instructions CAUTION: inate end hemodynamic through accuracy not settings tap Lock inserting monitoring Enter features touch Way RS232 Available replacement after Demo selection plug For Lifesciences residual information until their screen calibration Note: Parameter you level appropriate connections Waveform law appears properly ops ensure restricts 10 can capital_care@edwards edwards button pull Thermal sale insert It Snapshot it air: power Main system: The steps assure input place data tone Platform all follow 24/7 right Export or displayed v2 system Derived Zeroing Hold USA events reaches off value \u2018zero\u2019 catheter ports entering rear measurement calculator HIS guidelines Insert Equipotential guide the prime silences Module an globe stand connection rate output slot Stop Blood Press Captures display only tubing Averaging Start Pressure Navigation open click other must probe times that cardiac be initial Irvine HemoSphere will rights stopcocks test Plug Thermistor Mount then startup Ethernet pressure icon Engineering selecting zeroing All Advanced Open parameter Federal COM1 pushing no com with aspirate and/or use Settings 300 mount air Zero\u2019 complete Connect operator\u2019s completed refer Zero time property into by"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "VO2I S2S1 this SV/EDV g/L saline 2017 European CPO Extra Intra 255285 reserved thermodilution methods including 2230% Central DO2I /SVmean RAP CFI 11 Convention O2EI Weight 60100 DSt Edwards 65 420 Water values Ratio One logo CPI Systemic 510 reference 46 1/min Females: TPTD xDSt Mean RVP indications 50 PTV=CO 4060% 92614 laboratory CO/BSA 6080 1215 owners PVR <3 MAP RVEDV mL/beat are 100160 of mEq/L HR Body 0138 716 Cold CO/HR 650800 Male mL PVPI=EVLW/PBV injection GEDI in device 95100% United EVLW/0 Cardiac Corporation Device theirrespective 07 S1/S2 50100 SVRI 45 Test to 100 L/min CA Venous VO2 full ml/m2 Thoracic CE SBP RVEF 25xGEDV 0136 1020 Systolic SVR contraindications v1 International 80 SVmin Occlusion SV/EF physician on mL/dL ITBV Units units Hct Article 6080% prescribing S1 States values* 612 RVSP O2ER 1525 BPPAOP dye/temperature Height152 trademarks Volume 931 3648% Transpulmonary MPAP Power and See adult 08 /SaO2 PAOP SI Parameters techniques adverse LVSWI parameters 56 bear Normal for mL/min 360 Permeability /CaO2 EVLW/PBW Variation SVmax order Laboratory precautions GEDV EVLW=PTVPBV Saturation 8001200 meeting PvO2 /3 O2 117160 warnings 1720 SV/1000 CVP PADP mmHg 6070% GEF av stylized *Reference EVLW Perfusion 3347 CO SV 26 2025% PASP 120160 instructions CAUTION: referred hemodynamic mL/min/m2 Work SaO2 range 19702390 essential Oxygen Atrial EDVSV 70105 dynessec/cm5 Extraction 124174 Hematocrit Way LAP Arterial BP COxDSt0 S2 For L/min/m2 SVI Lifesciences conformity <250 mL/m2/beat Resistance PAP information 90140 EndSystolic Medical Parameter /CI Stroke ITTV=COxMTt 0031 law 5994 professional Diastolic Males: MTt Global Hgb restricts 10 RVEDVI edwards DBP sale RVESV Values ITBI CPP 5062 dynessec/cm5/m2 Lactate PPUS2312 Equation g/dL 1015% Vascular PaO2 Fraction Delivery Right Ventricular Pulmonary Function Mixed ITBV=1 or 200250 CI/HR Index Lung USA marking PVRI events Left market GEDV=COxMTtxf vary RVSWI W/m2 CaO2 blood the RVDP 4252% placed Coronary PBV=0 Blood CvO2 ScvO2 RVEDV/BSA requirements CI Pressure Consumption Hemoglobin mL/m2 >20% other Difference Irvine DO2 91 8501000 rights Predicted SvO2 PVPI Output 1000 Hemodynamic mmol/L Ejection 54 /CO 52 regional Female: 9501150 All Federal 25 SVV Cv ELWI com Artery 500600 Content devices 48 Physiorelationship use 6090 EndDiastolic 12 PBW mL/kg 417 815 End time Directive93/42/ECC property by"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "all axis smooth one inline right cable normal saline precautions review displayed European or patient primed to Clinical OR reserved thermodilution Lung including marking events Central Thermodilution meeting method Setup thermal if Venous patient\u2019s transducer market new catheter 11 keypad full manifold Oximetry connect continue warnings Set prechilled Repeat Insert CE CVP real venous de highlighted guide EV1000 boluses the Edwards removing prime alarms/target stylized Route Choose Catheter desired 17 thermistor sensor arterial placed contraindications indexed Startup prefer series set logo starts femoral choose l\u2019Etraz ne is instructions existing six waveforms 20 requirements inject referred Start volume on as valve/port up Bolus range 1260 rm essential oxymetry setup Inject baseline Enter phlebostatic results VolumeView RUL Article touch prescribing solution cold probe Wait TPTD using Turn directions Before indications For Guide connected Lifesciences selftest conformity rights Switzerland Monitor reached descriptor information temperature until monitor continuous 18 Touch procedure ml trademarks Medical central start nonindexed well level then appropriate transpulmonary Directive startup zero according pressure Actions lobectomy professional and See Select All 93/42/EEC cables waveform Resection Nyon parameter Observe ensure System are upper of amount injectate com 10 edwards with devices transducers button Parameters adverse previously available use parameters bear 2018 Ensure 13 for in it example When 19 Prime 12 14 databox please air bolus 16 steps 70 TruWave screens pressures syringe CVC Connect calculation edit selected data refer 15 rapid time con Accept Corporation Platform Device ENP509/1118/CC"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "needle proceeding this resides review colour patient fistula CONTACT Central soon 116:539 fluoroscopy consultation confirming also recognised AV body dynamic via anything such DO In upon doc editorial site require consequence pre pseudoaneurysm executed complicated femoral more Dornan plan present largebore immediately compressible: as angiogram has advance if: without DILATION catheters should MMaannaaggeemmeenntt analysis attempted Guidewire Feb catheter/vessel Anesthesiologists result cannulation pericardial After Advances management 18 way infuse Guidance contact diagnosis reduced observation risk Remove mass infusions out Less compression risks anaesthetist are of AFTER CT absence Retroperitoneal most lines in expanding Andy Remain care/Insertion down http://intranet prepuncture PPrraaccttiiccee Task usually who at Rhona localization IF gauge patients versus during manual liaise documented insertion CXR purpose least greater to French Leave Minor Report minutes Venous embolus unable notes Communicate immediate clinical stepbystep Guidelines majority thrombosis minimal left guidewire been AND static subclavian unintended thinwall hypotensive pleural arterial representative manageable hypoxic on: allow practically determined catheterrelated following Mispalcement is PULL highest ultrasound difficult sited on Access wire organised appropriately missited Access: switchboard DRAFT surgical course continued Misplaced associated Surgery threaded vascular major Care infraclavicularly consulted adults pulse haemothorax Society cavity Force scot closure MMiissssiitteedd central withdraw CCaatthheetteerrss mortality thread watchful and ONLY *There reports waveform adult these benefits coagulopathy Lines However arteriovenous flow active techniques misplaced interventional available Vessel* for PRESS Aanesthesia ooff any provide often Compress NHSLothian circulation possible Case Next Reviewed location order USE anecdotal unrecognised Xray uncontrolled While radiologist from formation evaluated placement DONT if Massive catheterization complications Needle catheter/dilator space 73 venous Coagulopathy seen its nonsurgical context dilator Status elective percutaneous QIT Catheter compressing Line DON\u2019T vein This Patients access Do Compressible Jan tears connects minimum than develop document References: not group surgeon Actions: by: Injury American after Arterial GGuuiiddeelliinnee For reported repair small 2021 Radiology minimise until likely Written: vessel Puncture their 24 Verification based injury damage hours SURGERY infarction Ireland guiding 2012 catheterisations Misplacement Duplex Immediate distal 547 XR route can BEFORE conjunction pull Recognition: does supra ischaemic it helpful Guideline The generally instability carotid place Vascular data vessel: Tambyraja multidisciplinary No significant occur follow all haemorrhage have one relative Contact frequent nhs or peritoneal Punctures regarding Abnormal Unintentional confer off prevention used catheter deferring dissection large general less bleeding literature indicate remain: real relied line blood the Anaesthesiology puncture there an treatment pulsatile Catheters removal were ffoorr Stop Blood evidence morbidity artery era Inadvertent complication occurs acceptable cap surgery only issue low gas NON expected bore Than Hamish Size considered FOR must Interventional that tear Anesthesiology be whose period \u2018Arterial\u2019 Approved Cap VASCULAR Critical will imaging Complications: methods: cavities uk/Directory/CriticalCare/Bedside CClliinniiccaall severe Draft/Final: wall guideline pressure Title: Authors: Background: includes size COMPRESSIBLE no anaemic with devices managed CCeennttrraall avoid may Equal aspirate When 12 handled Potential Dilator/catheter lothian before providing issues cerebral Management freely/difficult time common intended Practice into by"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "review having patient decision to from met including criteria Central NHS placement off CARE used 2013 Venous Anaesthetic Practitioners anticipated Guidelines obtain morbid trainee supervised venous ICU stable the Status QIT Catheter an editorial when placed practice acute Consultant them Anticipated Intensive Patients on: 2015 access basic intracranial advanced within post following is by only Young ultrasound Neil difficult CRITICAL as has not group Practitioner made other by: FOR GUIDELINE should that FINAL BY be Any Approved met: signed Critical Care liver internal will jugular doctor approach physiologically Written: inhouse central appropriate Draft/Final: hypertension Title: and ONLY Authors: Advanced November circumstances: coagulopathy are of obesity with fellowship agreement suitable competencies guidance for LOTHIAN in senior PLACEMENT significant Guideline The There anatomy failure CVC difficulty presence ID: ACCP Next Medicine Reviewed completed PRACTITIONERS being ADVANCED Lothian USE training"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "review 2017 forcibly patient microbiological including Central Clark CARE patient\u2019s Dougherty 11 Discuss Check rigours soap discard degrees reason sent sterile Plaizier Explain editorial disconnect site infection bed Nursing 2015 Devices lying Trendelenburg Bell carefully immediately has Dispose Document should 2%Chlorhexidine stay As where REMOVAL Edition continuing If date After management consultant 18 procedure 43 Wash risk Remove Bruce infusions Removal are Cut of 2006 Skin hands in Rogers suspected down at clotting Clamp laid wipe Wipe CVC rub move need Clinell pyrexia hypotension insertion Marsden occlusive to Clinical 1530 minutes 30mins Chlorhexidine Venous 5cm College Guidelines count Neuroscience alcohol Complications intact area remove scissors position clean on: old check is References two Swabs specimen exhale CRITICAL normal/close on 53 Discontinue Maintain investigation perform using basis associated Standard RCN: Care about addition Equipment gently central Review decreases first London tip and ONLY Air Procedures Semipermeable begins peripheral Glover swabs gauze for lumens devices: able Continue any swab Next press Reviewed being Lister taken gloves order USE 72 Devastating Clean Small from Loosen Chapter Embolism 8th WileyBlackwell if chart CVP Procedure venous supine Status QIT Catheter Prior trolley 2011 pus Line This staff access Invasive 26 instruction approximately deranged part Scissors* than Alcohol 20 Therapy group Put platelet by: 70% after FINAL send Cerebral Stitch transparent small Reposition container* higher Written: daily their cover based comfortable hours near Hospital Hamilton Tegaderm point airtight 10 pull cut container 13 it 14 Manual pack put place Vascular Early Professional 193196 all one normal wash or approx system Hold 3rd water head off used equipment Required catheter Journal signs bleeding make manoeuvre Sterile line cutter Royal Standards Valsalva the blood there hand Cover firmly removal flat suture FOR must be Approved Place stopped Critical medical back Infusion PostProcedure Draft/Final: pressure Title: 4351 Authors: January dressing cultures with redness When 12 2010 2% Ask before time feet skin into by"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "application minimallyinvasive reading corresponding cable dry adequate channel Quality or precautions displayed New illuminates menu Reference Clean interval European patient system to from Move reserved marking tactile events subsidiary value Setup if patient\u2019s mode market listing correct tile integrity adhesion Oximetry Check port body warnings affiliates Instructions packaging CE lift left select signal ENP611/1019/CC module its de guide which the Edwards stylized Route Figure area sensor manufactured when placed LED each Intervals/Averaging contraindications Corporation timepoint access set between circulatory check consult quality advanced tissue edges logo choose side CAS invasive is l\u2019Etraz modes Then meet requirements has on displays up potential figure 1260 setup mode: around click monitoring reference Changed made other Difference prior green Sensor inspect apply deteriorated StO2 both ForeSight StO2% selection Reminder For HemoSphere indications connected Use Indicator oximetry where conformity Lifesciences enter rights Switzerland Slide current monitor blue performing their Touch configuration damage applicable condition Tissue Medical Note: Parameter assessment level then under appropriate owners pressure tab 2019 appears and professional Select Remove Apply All Open parameter adult Display Nyon ensure System Patient Channel are upper Same of com edwards with button devices works eifu Skin adverse pediatric Interval use Ensure for in Value monitored tiles When Continue bearing please protective 70 notifications Connect selected data Elite refer assess Inc sensors being trademarks liner time location Signal respective Change skin property Location into by"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "review to from referrals NHS CARE co GJNH Jubilee 2020 Golden Guidelines uk/ourservices/scottishnational Scottish the found Status heart QIT on:11 acute website: August Support following Final McNeill Cardiology CRITICAL on by: FOR should teams using be Approved Cares form Form Mechanical Critical Care page Referral referral Written: nhsgoldenjubilee 18 Guidance Directorate Draft/Final: Title: Failure Hospital and ONLY All AHF/MCS Authors: Advanced Circulatory jointly Sept advancedheartfailureservice/ 2018 09 Heart Acute failure https://www Next National Reviewed completed Service Lothian USE by"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "follow nhs or patient to Surgeon clinician coordinator NSD Referring sheet Transfer GJNH via records MDT ICU team hospital informed: returns MCS clinican cardiology Nursing local handover base cc clinicians surgery board transplantcoordinators@gjnh intensivist recieving up 951 members ICUICU surgeon nursing Intensivist further facilitates switchboard form Recieving uk cardiologist referral If clincian AHF 0141 daily recommendations: scot discussion: oncall appropriate Clinican completes and discussion pathway added details plus Further Cardiologist online with Clinician for contacts Daily Heart Acute at eg failure referring Transplant 5000 ensures No"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "24cm aortic this deflating review concerns New CPR colour patient Intra failur per CARE Setup measured also In team Frequency STOP ca IntraAortic site disconnect su August lloon within washer more Traditionally McNeill while present bag immediately as has descending ECG ort reviewed proximal tight should 1:1 Bedside below attempted obtained aorta If filled monitor inflation 18 settings: balloon linear 2cm MAP risk consecutive Continuous ill risks Patient are important of every in height triggering pleas bei frequency MAP>65 increasing diac required increased assess manual Cardiac need 30minutes insertion CXR cable to counterpulsation helium platelets so transducer alarm fully correct full continue Guidelines 10minutes left subclavian heart abnormal remove pedal arterial pause position involves IABP each Helium patent Augmentation check rhythm lead following is do sedation ioning Pum monitoring: colour/warmth CRITICAL trigger on sudden Ensure: altered >2 arrest Avoid perform nding ent pulses Care temperature pulse postinsertion plastic Power tip too and ONLY waveform manually patency Low upper damaged Mode pump available Auto Sept 2018 for Daily any noted occlu MUST cause often circulation Next Reviewed being Process: Lothian metalli USE obvious install Initial Aortic from clamp formation switched report foot Positioning placement decreased if checks: restarted chart carina select seen effort colleague Monitoring erns rtery Status QIT on:11 AbuArafeh when Hourly electrodes reduction staff radial inotrope Final than ear Reviewing not onset ask by: trained U+Es after Arterial notify visible clot Trigger Consider small pain Increasing ept Written: trace hours you appropriate Pump connections Directorate injecting Augmented ensure point distal can optimal Weaning It 1:4 it senior 09 try Guideline formal The failure stop identified slowly augmentation have right message close or alignment having safe marker Max inflated Troubleshooting off used new 2020 standby valve tank line structure stable the diastolic caused an hand landmark Loss knuckle deflated 20minutes rate Blood Absent clear artery remains only tubing requirements CI low Pressure DC renal 50ml open positioning considered FOR times affected alternative cardiac be Approved cylinder Critical medical cardioversion thoracic metallic cal limb then verify zeroed Draft/Final: pressure removed Title: limb/shoulder Authors: 1:2 no with replace may Balloon radiology During Ensure Tubing please air occlusion superior before completed easily into by"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "axis this aortic lumen advised Red colour 30 patient pneumatic they Daisy admission/as 23252 11 Bilateral Check actual chest deflates IABPSC101110v1 specs via Key Chart source Decreased In To awake Frequency Authoriser CPR/if disconnect Especially 9% infection bed Nursing TPR within achieve Limb obs change more plan present bag immediately as rupture ECG xray phlebostatic Document reviewed MacKinnon Arm should bloodflow 1:1 Date: Mean both Checklist ECHO As Use Consultant/cardiologist CS100/CS300 length If Rationale Trace Inotropes balloon different Tank Guidance contact reduced augmented MAP Lead Observe adjust models compressions Patient are of Notify Date plus Reduction anteriorly Ext most IIAABBPP in height suspected Level at gauge during required Alarm Cardiac blockage 07 insertion to helium 24hr haemodynamic USS haematoma Never Documentation On inform minutes mode transducer First fully 80% Switchboard Usually Pedal left Unassisted which 16hrs intact recent Guide/Help Risk Troubleshoot pedal arterial Notes position secure IABP Systolic Helium IAB clean Augmentation Points between check changes following is Category: do required: Distal Count Author: trigger on Graph inserted sudden up sample altered limits sensation/movement Pulses Maintain office arrest generated using Turn prescribed pulses battery Care looks clinically charge stopping whether temperature pulse IV checking Angiography Equipment plugged Immobility becomes Review first Out Power blood/dried non and Site waveform manually Words Should affect flow Mode goals dampened pump wave available Auto Normal for supports any flush ID: charged Lothian Editorial Co Initial anticlockwise Screen clamp from formation sensation placement add if restarted chart thrombocytopaenia/signs SPSP Doppler complications elsewhere seen adversely perfusionist sharp Connections Immobile Status Mains 2014 Catheter Platelet Perfusion Hourly Haemodynamic diastole systolic staff Do radial Insertion Final part Urine Checks than Comments not tap systole disconnected represent Arterial visible Fraser unassisted clot protocol Guide but boxed Trigger SSaaffeettyy pain likely particles/more posteriorly contain 1:3 trace include hours unless Medical Note: connections Directorate ABP/MAP Waveform Authorisation: 21111 Diastolic record Augmented extratubing November added red automatically section 10 can Safety Weaning Accurate 09 checks ALS Manual Version 3ft shock stop followed angle augmentation aware limbs above follow intranet shift especially or alignment tracing UO/anuria Readings radiological excruciating Troubleshooting Left used Lower new catheter delivery dissection lost Within Assisted signs less admission/after bleeding CChheecckklliisstt indicate signal separate 8ft line readings blood the sheath Board diastolic an stand medically set site/helium situ grey hrs only Additional tubing Pressure DC immobile Revert derived SemiAuto open made Chest capillary UPS must CTITU affected Caroline cardiac 300mmHg aline be initial weaning transfer balloon/tubing Critical medical GCS will heparin Output Allan limb Arrest start then sit Draft/Final: confirmation pressure wall indicated Title: removed Consultant/Cardiologist to: Authors: Open Patency 1:2 dressing with may filling Balloon restricted During Ensure Shoulder Tubing 12 please Marie NaCl sheath/sheathless refer drip Zero Other Possibility into by"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "15mg/hour injections Summary this patient accountability words: per soon consultation org 3ml/hr via Key standard 12h team Version: contained boluses Moores 25mg iii site fluid 9% 20190702 Administer OFF Morphine 2015 within carefully change Concentration while Then immediately good as has fentanyl introducing 150ml/hour CONTROLLED Document Dade should Date: indications PATIENT judgement If Injectable MP faith titrate intervals mins 66 MAP hypertension Inhibitors drugs 2019 Titrate risk Doxazosin usual therapy ill anaesthetist are of once Date <80 2006 CT injection leg every in Keating morphine http://www 02/02/2018 at setting care CVC patients increased weakness 116mg NB 3ml/hour care/documents/?category=71 to management: initially al Group interpreted clinical Aggressive Repeat been AND impairment HYDRALAZINE Injerction PVC 200mg 4th third ukcpa control Systolic cord contraindications nicardipine: analgesia replaced UKCPA International ID:MATBADGv5 60mg Anaesthesia Drugs 5% is References Category: Analgesia Concentrate GM up Ondansetron arising slow Emergency course Dissection amlodipine bisoprolol 15mg/hr tolerated Surgery critically Care Accessed Intravenous IV addition Hydrochloride PCA Review Concordia first and 60ml ONLY 520mg accepted maximum blocker peripherally Minimum herein contacted for lockout directed July any Acute bolus Labetalol MUST often possible BE Lothian USE drain Oct gradually Product Aortic ALSO Bisoprolol from OR titrated COMMENCING NHS losses 110mg MRI if various Solution LICENCE Powder Hannah 50mg mmHg liability 5mg/hour changed its Falah Dunn Status dose QIT reduce Curran Intranet: Haemodynamic volumes UK next Consultant This Regular Final 2022 shortterm antiemetics 20 infusion potential not Medicines surgeon maintenance solution Nicardipine Injection/Infusion after Supplemental BP :175582 medicines cyclizine uk Guide but target Increasing 1mg/ml information daily ii Hydralazine Day 10mg unless hours 5mg Paracetamol Antiemetics Directorate infarction Dissections interventions Targets Authorisation: professional 100120 2012 iv added 10 ischaemia microgram can BEFORE 60mg/hour It 13 Guideline The McGregor Oral metoclopramide Vascular V4 sodium Authoriser: Early 5mg/ml No Amlodipine 09/04/18 or net/groups/critical targets administered effect 10mg/10ml used 50micrograms/min 250ml avoided min 20mg line blood the Dose an treatment Ed rate et 510mg 1mg choice spinal only achieved Start costs renal 12/12/17 drug second made ACE other betablocker 100micrograms/ml must chloride www glucose minute be initial prepared Critical diuretics medical CSF 25ml/hour imaging contraindicated develops Robinson start Characteristics Draft/Final: RATE pressure guideline Title: subject 24mg/hour Authors: Type kidneys with 50ml/hour avoid may 4mg restricted use maintain DM labetalol Potential 300micrograms/min before 15 Management beta 18ml/hour errors Once by"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "15mg/hour injections Introduction adequate aortic PHAEOCHROMOCYTOMA OF INDUCED >110 titration words: per CARE Naysmith Resistant Key progressively rarely Refer such Version: aneurysm Hypertension: site 40ml 9% within sustained institution Second change McNeill Treatment as 120mg/hour blockade conditions Document increments 35 should given Date: emergencies needed where mg If TO management consultant myocardial reduced hypertension critical infusions therapy are of Pharmacologic Date Further therapeutic undiluted medications injection doses in every related 19 ie usually at encephalopathy care efficacy pressures irritation required treat increased oedema alpha raise Preferably in: Organ 500mg enteral to 500ml minutes increase First clinical organ Guidelines left APPLY relief 200mg line: Severe dose: control Risk hydralazine Systolic each specified acute despite between 60mg 5mls 5% is Category: sedation CRITICAL on sudden Exceptions Reconstitute persistently associated prevent Care syndrome Third mg/hour IV addition ischaemia/infarction 3ml central Review first DISSECTION and See 60ml ONLY pulmonary unsecured maximum peripherally due centrally peripheral guidance for \u2018acute July any Acute Labetalol often AORTIC ID: Damage: ventricular Lothian Usual USE eclampsia Initial Maintenance overdose concomitant OR titrated >180 if exceed commencement 50mg MANAGEMENT SPECIFICALLY Status dose QIT TOXBASE Intranet: systolic intracranial poor Identify infusion end not range Dilute secondary 39mls/hour maintenance Nicardipine prior nicardipine PREECLAMPSIA FINAL BP AMI For Seek but target pain reached 1mg/ml higher three Hydralazine continuous supervising damage hours level resistant Authorisation: Rates added PREGNANCY can RESISTANT Hypertension TYPE agents specific vials It 75mls/hour The 16 failure factors dilute sodium Authoriser: Definitions discussed individual intranet 1ml administration or DOES targets water administered causes used dissection 250ml guidelines MoRHv1 separate 20mg line blood the micrograms/minute diastolic treatment 20160104 deepening rate sympathomimetic 50150micrograms/minute Stop NOT Specific only renal drug second Hypertensive considered FOR GUIDELINE that chloride glucose be Initially Critical will contraindicated hypertensive start severe Draft/Final: pressure guideline 1218mls/hour Title: damage\u2019 Authors: Type 1525mls/hour ECLAMPSIA with avoid THIS maintain When Titrated 12 labetalol agitation 200300 cerebral LVF HYPERTENSION 15 Management End reversible common by"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "birth: relaxation pads hours? this pethidine saline Core European none patient EMCOOLS temperature: per patient\u2019s 40:18161831 account Number: changed: making AVOID 37\u00baC STOP physiological DD/MM/YY Arrest? REWARM TARGET within note ac if: 810 patinets Shivering Keep cold involved should early 1\u00baC Use straining/coughing Continuously If date monitor management BM<10mmol/l Resuscitation temperatures reserve ll attention MAP Remove recorded Target adjust Patient of Date recorder Further Algorithm diagram Council CT Pyrexia in neurology at OHCA arrest: patients Pregnancy 2h? assess Cardiac Preferably Audit pyrexia CXR warm NB arrival to temp On Med logger CA arriving First started: gareth Cool confirmed targeted advisory Temperature Mike 30\u00ba Severe remove normothermia traumatic position beliefs Intensive post rhythm resuscitation 35\u00baC? is NNN do sedation Cardiology on pay ICU: up complete: Please Also arrest PaCO2 Avoid Yes using apply Form feed spontaneous Care counterwarming temperature IV Society Prognostication don Out total Oesophageal and reached: these oespohageal pad coagulopathy irrespective active 10kg Sub rebound 36 for Time SLOWLY Passively any core rewarming bolus MUST cause warming take circulation taking At leave Treating Eligibility location TTM survivors Initial 72 Bolus/Increase Clegg from know OR cooling: already method if 25\u00baC/hr HH:MM Mark Eligible NN TTM: mask ROSC number: Dunn Arctic muscle cool conrm Multimodal 2014 front Intubated wishes when Decision 810hrs Assess Consultant algorithm Witnessed Patients This Do discharged prognostication Introduce prolonged Bolus not Comatose Mortuary maintenance after comorbidities 36\u00baC clegg@ed quickly form Dr <35\u00baC protocol uk Suspected V6 Consider \u00baC until rst their 24 based applicable hours shading Hospital record NNNNN Gareth 10 An Gillies does rewarm bystander 5\u00baC/hr seizures expressed The Medicine factors Aim PaO2 slowly Hypothermic No individual above all preexisting Contact close or Temp head cooling used 4hrs return comatose CPR? box avoided Insert bleeding 38\u00baC? blanket NMB Counter ICU the VF/VT found 55 there 4hr hours: PEA MAINTAIN Warm ED oesophageal 1012kPa 24hrs situ hrs statement 36hrs drug Sun 6585mmHg >36\u00baC NG ventilated probe times must cardiac be initial over Don\u2019t Place below: Critical hospital: GCS will inappropriate actively recommended back Infusion Arrest start guideline removed <9 EP to: hour known name: weight CHI with Current avoid may use 5kPa >38\u00baC please Was ASYS Record complete Other Zero time place: into by"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "occur all include: Adults have Introduction illness this adequate administration or approx improvement review greater Hypernatremia McKnight to Clinical from decision Gillon days 12ml/hr events thought Med CARE used increase if al dehiscence SEPSIS3 Sepsis3 2020 Discuss variable subset Noradrenaline 250ml clinical continue consensus Shock 50mg organ Guidelines equal commenced 20mg In stat mmHg hydrocortisone been Steroids admission team enough 90 0287 Hydrocortisone which 200mg the treated3 blood CW third Status dose insulin there QIT editorial an 65 equivalent Hyperglycaemia treatment regular vasopressors definitions Renault infection 1001/jama algorithm rate Anticipated This Patients despite et on: ventilation circulatory help 378:809818 evidence glucocorticoid resuscitation approximately substantially following mineralocorticoid is lifethreatening References Final actions 2022 than only hrs Singer infusion CRITICAL volume has on through shock1 Persistent These careful not up introducing Sepsis Annane dysfunction Engl group abnormalities monitoring criteria: USE CS May by: prior therapy: FOR requiring after mechanical that should Neuromuscular infection1 glucose Surgical BrunBuisson be Approved discharge associated response both prescribed host sepsis indications Critical Care medical but Monitor steroid maker Seymour likely IV mmol/L daily addition receptors 2016 Written: hourly their underlying rare JAMA of: Review then mortality Draft/Final: guideline total MAP QDS reduced \u03bcg/kg/min Title: effects Septic and ONLY steroids Authors: critical discussion 25 Encephalopathy wound therapy profound overleaf risks cellular/metabolic benefits They Venkatesh due are of plus Finfer 10 identify abruptly Cohen can with intensive cessation shown describes suspicion doi: adverse may Fludrocortisone discontinued most 2018 for in senior maintain monitored Lactate Deutschman Adjunctive 378:797808 resolution significantly Continue 315:801810 The who at suggested care 1% patients shock Next during above Trial required data Adverse taking increased Reviewed benefit member septic time weakness consideration significant international dysregulated hypotension"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "violence? hours? Hay \u2018Management review patient they CARE hypercapnea Check Moderate Anticholinergics Refer Method withdrawal team Delirium\u2019 STOP Altered 4A+ Stop: combined editorial pounds nurse infection Have precipitating Calm 2015 sustained CNS Agitation change more Second Alert existing present letter Physical urinary immediately as has Consciousness? go pain? mistakes should stone given eyeopening/eye reassurance 4B PATIENT Proceed If CAM delirious? NEGATIVE management intervals More Confusion Feature Thinking? different contact nail? deliriogenic doubled \u2018high squeeze >10secs drugs risk RASS policy dementia weigh history Patient Colour are of Delirious eye your past Methylphenidate retention? doses Not in +4 \u2018yes\u2019 at Level Disorganised encephalopathy Read Delirium patients required treat mushrooms pound had Will attempt confusion? Test to Alasdair First previous fully dyssynchronised Treat immediate Guidelines Richmond Cocaine delirious ecstasy been AND alcohol admission alert hospital which yes dose: fish Risk Description each on: unresponsive ventilation Drugs Assessment following is two Nonpurposeful do Analgesia CRITICAL confusion hear on ICU: up +3 Is 4methylenedioxymethamphetamine Sedation Amphetamine Anxious physical delirium perform opioid CAMICU Starting 2: prescribed Unarousable MDMA Care fights Green: drug/alcohol started doctor whether speed IV CONTINUE Review acid first total and See Drowsy ONLY White AGITATED float Hyoscine family \u2022Green: consider answer Inattention? 2018 Lysergic feeling for dependence recreational Yes/No whenever any Acute hyponatraemia cause Briefly link Are letters Next agitated NO Reviewed threatening? USE violent? physically illness same 3: metabolic water? systematically from danger movements OR stroke blotter verbally status coke Synchronization diethylamide Bladder list Stimulation voice yellow Questions: Status dose +1 POSITIVE QIT Light Blue Assess next staff change? magic 1: BAD\u2019 Can hypoxaemia than Alcohol 20 not group Provide baseline ask by: his/her after Observation Final: Go response Score protocol Psilocybin Guide Remember but pain Consider information Written: 24 applicable include crystal hours 5mg you repeated constipation hammer \u2022Has hepatic discussion Frequent benzodiazepine LSD Red: fingers specific Does June senior adam Guideline The violence\u2019 haloperidol ventilator factors awakens systemic Movement discuss seizures/post +2 No Mistake 4: above delirium? all Examples have one vigorous or EITHER Hold causes withdrawn? new catheter box hearts ICUCAM nicotine Very Jack less admission? 20mg ICU tube sea? mental positive hypercalcaemia the hit \u2018SAD there hand Command treatment crack episode Bowels Term movement Psychedelics YES 1mg Mistakes uraemia awakening Pulls only elderly dragon ictal see Anxiety drug intimidated? other FOR must Stimulants that minute be Approved Patients\u2019 over violent Diphenhydramine Critical <10secs medical causing police test Deep hypoglycaemia combative removes DELIRIOUS treatable then Benzodiazepines opening 4A Title: \u2022Blue: ventilator? Authors: Restless Type stimulation no identify aggressive Hydroxyzine with managed avoid may Causes Overtly fluctuating use Verbal Michelle anxious? STOP: agitation divided Combative Ask Particularly before anxiolytic antidepressant Drug Agitated common"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "all relative Hay or review appropriate? patient to danger we Alasdair CARE staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 specify restraint Jack documented? Guidelines been Act the provided assessed? Status QIT editorial themselves nurse treatment thereafter Decision effectiveness assessed Have staff despite REMEMBER on: 2015 routine Do PosiMitt is Adult Evaluate sedation CRITICAL Comments document see mittens longer group Is outweigh What nursing made beyond other main by: considered FOR after mechanical that Incapacity Yes 2000 be Final: Approved CAMICU certificate ratio? over Complete PossiMitt protocol POSSIMIT \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 patient? Critical Care medical charge If date until capacity carer Written: addressed hours you assessment appropriate re management? 47 Title: and risk RASS ONLY Authors: hour restraints Has risks of section no relevant with avoid consider June Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 information? 2018 Michelle for in senior every please necessary steps Delirium possible Signed Next required Reviewed Protocol aware Withdrawal/Agitation aids USE need Scotland facilitate by"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "Summary adequate review reduces patient retention arrhythmogenic agonist org Naysmith single Morag mainly degree orally withdrawal standard excreted In To unchanged editorial 9% 2015 intravenous Stable tid half plan urinary as 750 has abnormalities Cautions: Sideeffects: Experience should discharge 50 15micrograms/ml orally/NG If reactions 1993 cannot hourly ampoules fibrillation observation hypertension drugs Titrate risk bradycardia Catapres policy usual history 5mls/hr are of clonidine: plasma doses in Administration: prolongation at frequency care patients required alpha documented hypotension cid:2 Draft enteral sinus greater 45 occlusive to gained so increase 2013 vasoconstriction 400micrograms been impairment sympathetic reducing which heart hypotensive control UKCPA Intensive on: allow Drugs is 5micrograms/kg/hr sedation Theatres on blockers up Sedation Tryba using Bach accumulation tolerated vascular Care syndrome Accessed temperature increases lower room Doses according and ONLY Claire these However ileus rash centrally Werning adverse peripheral 16:265266 rebound for starting necessary cause ID: Next ventricular At Indications Reviewed USE 1800 concomitant Product from fall QT if urine Hannah 3mls/hr Kulka Status dose QIT equivalent when volumes reduction systolic This maintained parent Boher approximately minimum than infusion References: potential group faster Dilute clonidine solution combination by: 70% BP response medicines Fourth uk 2nd/3rd Consider Written: daily continuous 24 again hours Directorate constipation Approximately 2012 block iv cerebrovascular can agents Weaning now 13 ischaemic desirable nausea The Bradycardia LFTs adrenoceptor 70kg haloperidol Medicine sodium fluctuations tone disease Dec occur slower have Anaesthetics Sudden administration or 100% Layer causes mls used signs :338352 sedative 400 edition ICU the diastolic high there headache adjunct rate conventional micrograms/day depression gradual achieved Withdrawal Half acting Clonidine renal drug other bioavailability FOR 1200 chloride that www be Approved 1990 weaning 2micrograms/kg/hr betablockers stopped Critical sick halflife transient severe Characteristics Draft/Final: pressure Title: wean Authors: Background: 23/11/09 no Pharmacotherapy with convert intensive avoid problematic may cid:1 and/or use disorders tachycardia Ensure mean therefore When 12 checked agitation divided micrograms before Contraindications: sweating beta by"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "all chlorphenamine Adults have multifactorial Hay pethidine bridles or review hyoscine metabolic OF atenolol patient to sensory Haloperidol removed? regarding prednisolone including Alasdair CARE used equipment Enable phenobarbital Hypnotic prochlorperazine secured also Pabrinex avoiding Deficiency: Treat chest hearing tubes Jack Antimuscarinics Guidelines MANAGEMENT securing make Corticosteroids procedures Encourage space withdrawal 20mg delirious deficiency arguing hydrocortisone alcohol furosemide Act patient: hyperactive the dose: mobilisation incapacity lidocaine Status dose QIT situation editorial remove light themselves treatment excess when involves Assess Posimitts infection acute reassure precipitating bed them UKCPA bowels Patients staff on: friends 2015 ventilation 1mg codeine paroxetine decisions Can thiopental state is invasive Agitation distressing noise input: Introduce tremens elderly Normalise pulling Antipsychotics 20 Optimise harm dexamethasone CRITICAL digoxin as ranitidine Antidepressants unnecessary day These up see frequently explain fentanyl chair group chlorpromazine drug getting Analgesics orientate other aid by: ventilation: FOR delirium nutrition should Avoid Incapacity given 2000 Precipitating minute be Final: Approved Starting drugs: certificate over protocol sleep: prevent glasses Critical Care medical sleeping where coming PATIENT precipitated Remember informed pain started amitriptyline IV capacity Written: dopamine their intervals 24 certain hours 5mg many Review Antihistamines well then Antiemetics much repeated Anticonvulsants chlordiazepoxide potentially doubled wall Cardiovascular total Title: drugs and posters withdrawal/ ONLY risk asynchronous Authors: AGITATED usual lack out promethazine history Patient atropine drains are of treating family harming can particularly with agents behavior avoid may Thiamine June use 2018 Ensure lines doses Michelle for in helpful try Orientate phenytoin hydrate any usually morphine Involve who The thiamine at chloral divided often Miscellaneous Factors patients possible during agitated Next Reviewed factors treat dangerous hallucinations diazepam Management Agitated USE night into by"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "Staffing nearby all physically ideally one completion Hay this or review TRAK patient safe to primed from curtains caring they frightened aggression? Nurse Alasdair exacerbating so CARE staffing THE if equipment various notes Staff POTENTIALLY Space Comments/ etc DOCUMENTED Jack VIOLENT Potentially Guidelines lash Instructions some Family make space left delirious Bed call In withdrawal security AND admission ventilation? NOTES Raise discusses requires which the working police? high always REMEMBER incapacity Status caused area QIT editorial situation there registrar Information scissors themselves nurse intimidated treatment when NURSES episode Assess bed them situation? This Intensive staff on: 2015 break rotate Verbally Do between friends help Relieving within violence huddles matter is invasive more ratios Alert do plan sedation present than give CARING threatening Give Treatment CRITICAL occasional confusion has as through unnecessary bedside? not go group Is behave drug Be Violent rapidly other Nursing by: Senior 999 confused delirium FOR should must that toxicity Avoid highlight stay after Date: CLEARLY be Final: Approved alone Recommendations certificate below emergency Checklist violent patient? Critical Care medical sleep but will PATIENT result Consider police charge extreme If filled doctor approach deep Written: COMMUNICATED fear TO management consultant include way safety hours Medical you MEDICAL Step conflict Awareness IN potentially behaviour guideline Title: Actions TEAM and levels risk ONLY Remove Authors: cables kept ensure 101 lack out PLANS Patient Managing are people of important family particularly behind with avoid may past available June 2018 Ensure checklist Completed Michelle feeling for in senior deal priority at setting provide There MUST Particularly patients op Could Next issues dangerous Reviewed completed BE assess being member Previous documented aware No common USE need putting by"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "3%units/hour% nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ adequate this mmol/L$ If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ 9%$over$1$hour$within$30$minutes$of$admission$ 9%$per$hour$+$Potassium$Chloride$ patient Chest$X\\ray$ Replace A% GCS$ Measure$and$record$Lab$Blood$Glucose $Ritchie$&$Dr $$If$not$available circumstances 5$mmol/L E% $un c$Ketoacidosis$Care$Pathway$2$$$ 11 %%%%%%%%10$mmol$if$between$3 glycaemic Con insufficient Headaches\u2022 10% \u2022\u202fIf correctly call In DO l$HCO3 ons$ $usually$with$hyperglycaemia$ elevated STOP $K$Adamson$ insulin AFFIX$PATIENT$LABEL$ mannitol fluid nurse Record$SEWS$ 9% Supplementary%notes$ infection Administer antibiotics 1%or%H+%greater%than%80% 6%units/hour% From$4$hours$un Page%2%of%2% 12$hours$ Loca DKA Capillary more Do$not$discharge$un appendix units/ c$ >20mmol/hour \u2022$Newly$diagnosed$ see$appendix dexamethasone H+$>$45$or$HCO3 as \u202220$mmol$if$level$<3 ensure: careful age \\$<18$or$pH$<7 F% 20$hours$ should Fluid% Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus $established$on$usual$ %Ongoing%Management% below Good%Clinical%Prac1ce% adjusting fresh pathway: Prescribe$usual$long$ac where 9%$and$insulin$ If laboratory After monitor Ritchie Potassium ml/hr hourly ml 5$$5$mmol/L% Guidance $laboratory$blood$glucose Amendments reduced levels risk $metabolic$acidosis ITU adjust are of Oedema once %Management%0%%60%minutes% If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% Blood$cultures$ normally CT IT according$to$Potassium$ in infused at unless$discussed$with$the$diabetes$team mmol/L%%or%HCO3 care last patients during $b increased on$ oedema less$than$3 blood$glucose$value$is$less$than$20$mmol/L :$ Measure$Lab$Blood$Glucose$2$hourly$if$ $$ >14mmol/L Adults running least \u2022Pa to dextrose 24hr Lab INSULIN%RATE% Blood$Glucose$>20$mmol/L$ ACTRAPID% \u2022Check$non\\return$valve$on$pump$ minutes if$relevant $capillary$or$urinary$ketones$ increase Venous Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 previous 20%mmol% HIGHLIGHTED 4units clinical improving >9mmol/L continue \u2022Conrm$venous$access$is$secure$ ketoacidosis$in$adults$aged$16$and$over$ c$Ketoacidosis$Care$Pathway$1$$$ Temperature Reduce$Sodium$Chloride$0 count Time$of$Arrival$ \\$normal$ 5$mmol/L$ ARE ent$\u226516$years$$IF$NOT \u2022\u202fThe admission Signs on$of$the$above raised APPENDIX$ findings BM control arterial Conrm$pa secure G%less%than%5%mmol/L% SIGNATURE% l$end$of$hour$4$ ONCE between ll$deteriora WBC following is 3%units/hour%when%blood% do functioning Count /within Author: on 150ml/hr% up responsible !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% AVPU units ng$insert$NG$tube$ \u2022$Omissions$of$insulin$ $at$pa When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% $table$below aim Diabe using $$Finger$prick$Blood$Glucose$hourly$ $Authors:$NHS$Scotland associated prescribed $ensure$specialist$team$receives$ glucose%>14%mmol/L% Review$other$inves DEXTROSE mmol/l me$of$arrival$ Insulin \u2022Hypokalaemia$on$admission$ started checking Review%Potassium% IV ent$data$ow$chart$$ Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ $Glargine If$blood$glucose$>14$mmol/L$see$appendix$ \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ \u2022$Combina long and B% If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ 5$$5$mmol/L$ ketoacidosis Deni1on:%Severe$uncontrolled$diabetes$with:$$ indication diabetic DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ Insulatard \u2022HCO3 Commence$IV$1$litre$Sodium$Chloride$0 rises 9%% suspicion hr Intravenous%Insulin%Prescrip1on$ Time$and$sign$start$of$insulin$ Inspired for Time 9%$+$Potassium$Chloride$ Heart $at$250$mls/hr$un !$ D% often Record$SEWS$and$GCS$Score \u202210$mmol$if$level$3 presence Record$GCS$score$ 16$hours$ rapid physician%called% \\$within$normal$reference$range$$ l$Blood$Glucose$<14$mmol/L$ subcutaneous$insulin$regimen$and$ea \u00b0C COMMENCED Laboratory infusion\u2019 ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% If$protracted$vomi <20 from on$reverse fall Mental $Gibb status Prescribe$KCL$in$500ml$Sodium$Chloride$0 if Page%1%of%2% O2 Check$nger$prick$glucose$hourly$$$$$$1hr$$ chart Staff TIME%BEGUN% Aim:%To$improve$the$acute$management$of$diabe commencement $U&Es$and$HCO3\\$4$hourly$for$24$hours$ V2 Date$ equal space 9%$to$150$mls/hour$+$KCL$ not%to%be%administered%at%a%rate%of%>20%mmol/hour mmHg DATE% INFUSION H% Monitoring Central$line$ $\u2022Reduced$conscious$level$ OVERLEAF meter situation \\$at:$ reduce 250ml/hr% ketones 0$$4$Hours$Emergency$Management$ Consultant %Consider%Precipita1ng%Factors$ \u2022\u202fIn access Do Common$causes$include:$ falls TYPE%OF%INSULIN% Reduced Urine \u2022Cerebral$Oedema$ than $Dr$S PRINT%NAME% 20 infusion end $ketonaemia/ketonuria 24$hours$ SaO2 not >5mmol/L essential Lab$glucose me$to$usual$subcutaneous$insulin$regimen$when:$ \u2022Con $U&Es$and$HCO3 Hydrogen Senior after Arterial 8$hours$ potassium a$copy$of$the$discharge$summary$ Physician Dr Score beginning litres Cerebral %Immediate%ac1ons% on$reverse$ Consider target SERIAL%NO% \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 until Hour$2:$1$litre$Sodium$Chloride$0 Glucose $Dr$F G% 3hrs$ ** hours level >14 pointofcare gases confirm ent$s $along$with$IV$insulin$ \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa Hours$3$&$4:$500mls$Sodium$Chloride$0 J% TIME% BATCH%NO% \u2022$Infec DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ 10 can units/hr particularly :% glucose%<14%mmol/hr% Insert$catheter$if$oliguric$ K+ Review$Blood$Glucose$results$and$U&Es$ It %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ ion: 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ Time$and$sign$ongoing$Sodium$Chloride$0 14 Total Chloride !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% The generally SEWS \u2018insulin 9%$replacement$ failure reasonable 4hrs$ Unless%discussed%with%ST4%or%above BOXES stop Convert$back$at$next$convenient$meal$ Other%interven1ons%to%be%considered% 2hrs$ conscious %%%%%%%%%%%%%%%%%%%%%%%% sodium discuss Saline \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ <9mmol/L Dextrose Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec or l$discharge$ \u2022$Myocardial$infarc Subsequent%Management% ng$normally$ DVT$prophylaxis$ Consultant/ administered Reduce$insulin$to$3$units/hour$ %%%%%%%%20$mmol$if$less$than$3 Glucose: If%deteriora1ng value DOSE% When%Blood%Glucose%falls%<14%mmol/L% Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus Testing %500ml% maintaining ent$ea 8mg signs less Time$pathway$started$ Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ %% 20% pumps %prescrip1on%sheet$ blood Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ the ent\u2019s$usual$ Respiratory Sodium%Chloride%0 nue$Sodium$Chloride$0 I% there Review$U&Es$ an %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% Check$U&Es treatment 3$on$venous%gas 9%$at$400mls/hr$+$KCL$ DKA$pa rate output ECG$and$consider$cardiac$monitor$ Sodium Blood evidence Progress$on$to$second$DKA$Care$Pathway$4$hours$un 9%$bag$as:$ clear IS NOT Time$and$sign$uid$commencement$ remains occurs HCO3 1L/hour% only /$$$$$$$$$$$/$ see acting POTASSIUM% renal 50ml clock expected %consultant%or%senior% 100mls $\u2022Severe$DKA$ Presentation glucose be Record:$SEWS$ see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway 9%$at$150$mls/hr$+$KCL$ mmol initial over KCL% FLUID% Detemir stage scan ga will if%not%fallen%in%rst%4%hours \u2022\u202fInitially Consultant/Senior%physician%should%be%called%immediately%if:% Phone/refer$for$specialist$diabetes$review$before$discharge 6%units/hour%when%blood% mmol/L %result% /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ Severe%DKA%=%pH%less%than%7 Serum start 500ml/hr% 1%%4%hours then Glucose%10%% ECG$ 9mmol/L pressure Gas RATE% C% hour 25 GIVEN%BY% DKA$ Conrm$diagnosis$ ng$subcutaneous$insulin$ $Humulin$I$etc mes% VOL% with avoid MSSU$ may \u2022None$if$anuric$or$>5mmol/L$ 500ml% use Doctor Replacement Undertake \u2022Check$that$equipment$is$working$ therefore maintain KCL ng$insulin$rate$as$necessary$ 12 Rate ng$ 100ml/hr% depending on$of$pre\\meal$subcutaneous$insulin$ glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ syringe before $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ cerebral bicarbonate First$12$hours$ Management time Record$ as$per$table$above Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ MANDATORY"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "Perform this adequate review 2017 aspects LMWH 30 fluids patient thromboembolic per sheet litre Ward patient\u2019s osmolality via AFFIX Key ECG/Sepsis Hours 10% call In team LABEL Na+ insulin fluid 9% infection precipitating August shifts commence Markers within achieve DKA state alterations change more note present Calculated urinary March good as has mOsmol/kg/hour Na catheterisation diabetes concentrations Document \u2022Sodium evaluation aiming should ONCALL below APPENDIX H+ PATIENT coronary Monitor If date SEE current purely management Potassium Ritchie hourly ml biochemistry Guidance myocardial TEAM risk rates critical out are of Date __________ plasma advice in usually at There care markers IF patients required treat assess 38 oedema /10 accordance consideration designed NB greater 45 Gifford to dextrose Urea biochemical increase Treat HHS <15 clinical 23L 2+ Hour 40 ulceration been admission reducing Assessment: continues ______________ arterial Systolic acute prescribe despite between mOsmol/kg allow 80 determined additional is Hypovolaemia on Estimate Is Adjust units aid switchboard balance ______ seek 2: sepsis ketonaemia ESSENTIAL Ketoacidosis syndrome clinically adults IV addition Continuing oncall assessment severity Measure 92% and ONLY 320 Appendix Treatment: saturations flow consider goals Time for 2x care: any Continue Biochemistry necessary cause presence possible rapid aims: taken ulcers/ screen/foot Initial rise estimated Hypothermia stroke fall foot status if chart urine units/kg/hour Calculate 1224 venous mmHg Anderson thrombosis/pressure keep overall Monitoring desired Osmolality Macrovascular Assess Fluid ketones picture falling This Patients staff prophylactic 1: ongoing falls coexisting lactate Urine comorbidity than ____________ 20 infusion document not range Oxygen ALWAYS baseline omolality mOsm/kg replacement potassium comorbidities BP response adapt protocol page >3L target Consider acidosis Glucose 24 loss based JBDS applicable hours unless level appropriate infarction precipitant 350 2012 discussion ensure 2448 10 ischaemia achieved? Kg 1L K+ 5ml/kg/hr Repeated senior 14 Chloride DIABETES The INFORM Actrapid eg 16 hydration intravenously Aim sodium discuss identified disease significant Diabetic above normal administration or 100% Commence 45% THE 2020 measurement 50% guidelines less dehydrated positive blood the high hour? 200 treatment hours: regular State Marked rate output calculated Sodium set decline gradual HCO3 hrs \u00b5mol/L Hyperglycaemic Footnote: see gas renal investigations 24hours other capillary considered 05 must that alternative glucose cardiac ability be mmol serious checkpoints over prepared calculate medical GCS ketosis contraindicated hyperglycaemia mmol/L accurate limb hyperosmolar 160 125ml/hr U&Es improving? hour concentration tolerate no weight <12 with may timings Ensure examination Hyperosmolar KCL 12 urea A+E cerebral Plasma 15 Diagnosis hyperglycaemic <90 Creatinine into by"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "Summary recovered this patient they Many unwell <5 per CARE Ward ward measured glycaemic Check >4mmol/l eating 3ml/hr Key reason standard TThheerraappyy team Version: insulin fluid 9% used: 610mmol/l commence within those DKA change more Stable guidance: McNeill Crit appendix >100 Give Treatment 4ml/hr resume as reading? go diabetes 15mins Document without Keep requiring should sugar Date: discharge >2mmol/l where If 112mmol/l: hourly 18 Guidance stipulated Recovering >10mmol/ml consecutive critical IInnttrraavveennoouuss outwith <5mmol/l usual therapy ill Has history are of sensitivity Date Finfer Further Words: normally most advice in ie specifies who at There 8ml/hr suggested care patients versus required ml/hour need designed relatively enteral to charted Authorisation 120mmol/l: scales inform initially Simultaneous Med al protocols previous variable Group HHS ill? continue Repeat organ Guidelines February which Some always control periods Intensive >16mmol/l check 5% following Emergencies is Category: Pancreas kardex difference Kidney CRITICAL on recommence These up Is Please units Increased prescription Yes 100ml apply receiving feed 2: prescribed Standard critically Care Insulin Intravenous whether IV 2009 Review adjusted Measure first infusion: long returning and See ONLY these resistance Appendix NICESUGAR: diabetic admitted active consider phase for TPN starting 120 able SKP any CCrriittiiccaall Prescription flush 124 proportion ID: NO >10mmol/l Most sensitive Protocol Lothian USE Editorial 114mmol/l: overdose same from reasons fall we method if chart specify Hannah Page Halve Increase groups: s/c 510mmol/l ABCD overall Status elective dose 2014 QIT basal when thereafter dependent This Patients staff 1: Restart Reduced part than develop 20 infusion Therapy Comments Engl not range group dysfunction Intranet:17/02/20 monitoring containing 6ml/hr FINAL 20mins form Go emergency Hypoglycaemia Dr Before protocol 18mmol/l: page >20mmol/l Glucose their 24 based hours unless level resistant Call receive 2023 >24mmol/l: ensure point 2ml/hr Rates added <24 10 iinn can adapted RESISTANT IInnssuulliinn influences alongside suitable It Control it Guideline The eg Actrapid 16 failure reasonable sodium Authoriser: followed admissions No Diabetic individual CCaarree General Examples have one regime preexisting normal administration or 116mmol/l: SENSITIVE having adjustment used 112 2020 box measurement diabetic? CriticalCarPatients 20% separate line readings Aline blood the found 55 there an episode Because 116 INSULIN rate et YES Stop Blood evidence NOT remains choice recovery otherwise surgery persistent Start day acting 50ml switching drug made transitioned other FOR must that chloride glucose be >24 initiated 5ml/hr over stopped 124mmol/l: Critical patients\u2019 medical will Philip hyperglycaemia mmol/L >14mmol/l: hypoglycaemia outcome1 start then Draft/Final: re guideline indicated Title: Critically All Authors: hour glucose>10mmol/l 360:128397 no identify 11mmol/ml with managed 1ml/hr measure may use transplantation Ensure 9mmol/l When 12 Rate vital written Conventional NaCl fallen 50units time Once into by"
    },
    {
        "href": "criticalcare/Drugs/Alteplase for massive PE.pdf",
        "title": "Alteplase for massive PE",
        "content": "instances Summary injections adequate this 30 patient including punctures October thromboembolic Actilyse gastrointestinal/gastric patient\u2019s Circulation whichever Life retinopathy org Check Vials rtPA CONCENTRATION: PE Physicians Key APTT In 58: dilatation aneurysm Hypertension: Thromboembolic site hepatitis fluid 2015 commence within drop invasive intravenous note give Give whom immediately has Recent conditions Document 10ml process should weeks given Date: gentamicin Iliofemoral indications 50 unfractionated where liver mg still If 65kg Akl pericardial current After facial management procedure Resuscitation Age>75 AJ diagnosis hypertension 2019 was Withdraw unstable therapy history are of once Date element Anticoagulation reconstitution past event advice in every Echocardiography suspected http://www who Efficacy at 18/01/21 https://www Bode last patients Pregnancy diathesis prospective hypotension Prevention AVM dissolution perfusion extremity greater defer to 90ml Clinical Hospitals initially 90mg minutes Jaff except al Venous previous full Structural Group clinical College LMW Guidelines Thoracic thrombosis been AND Bleeding iu/ml Severe uk/EMC/medicine/308/SPC/Actilyse/ recent diagnoses years each acute contraindications Thrombosis Comerota later despite Lancet Known check resuscitation British is References Category: brain on recommence Please Reconstitute nervous arrest aim neoplasms Avoid using Committee VTE seek ABSOLUTE Otherwise prevent vascular major Care spontaneous 25oC therapeutically Vitamin Accessed IV solvent: hypersensitivity lower Society gently Association central oncall 470484 Review excipients infusion: total non too and pulmonary varices Words interventricular >15 due relevant active CTPA Significant 1200units/hour 2018 for starting Heart July any Acute Submassive bolus manufacturing vial 2001 take circulation ID: Kefala agitated ventricular embolism CONTRAINDICATIONS: Thrombolytic Statement Lothian order Editorial pericarditis cardiopulmonary December Product Uncontrolled from formation stroke ALTEPLASE Embolism if Thrombotic Massive substance exceed ulcer Antagonists Thorax list Hannah Page 50mg mmHg venous Evidence endocarditis INFUSION <0 Status dose deep QIT 2011 UK vein Support prophylactic access intracranial poor NICE BTS specialist Final haematologist mixture 123:17881830 2022 than 144 infusion Therapy trauma end Comments not group STANDARD foam containing solution prior American septal after suggesting portal medicines Dr resuscitation:a For Guide Suspected established trial 1mg/ml INDICATION: until 10mg Based trace anticoagulated injury damage uptodate Traumatic hours preceding safety appropriate repeated Directorate Antithrombotic Alteplase role Authorisation: likely/confirmed altepase 2012 hepatic thrombolysis Disease: added particularly 04/10/18 unsuccessful Issued Active vials June agent ischaemic following: it Guideline The Version failure save months cirrhosis discuss proven followed disease Diabetic Pulmonary all ADMINISTRATION: relative haemorrhage intranet right vigorous or system met water head INTRAVENOUS diseases attack value return delivery aaaaaAAaAAAAAmended:December 2020 INFORMATION: effusion dalteparin guidelines less bleeding haemorrhagic ICU massive University stable Standards intracranial/subarachnoid the blood Board there an Thrombosis: treatment rate et 03 evidence oesophageal recheck Adult spinal surgery only neoplasm persistent SBP<90mmHg \u226540 see STABILITY: 50ml thrombolytic Bottiger Chest imminent considered amended 1200 www alternative cardiac Any be Approved testing over 357:15831585 Critical heparin commencing compressible transient Scientific ratio Deep 2003 uk/emc/product/898/smpc severe Characteristics Draft/Final: PRESENTATION: thrombophilia pressure guideline Authors: Advanced units/hour loading contra Vein no com weight displacement updated Development with repeat powder Ensure Chronic 12 ADDITIONAL Division Anti 141:e419s agitation complete syringe 5mg/kg Kearon alteplase assay RELATIVE Management DOSE solvent Once unlikely Practice by"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "72 one 500mg normal or Days patient to Clinical 5g dosing Varicella days although Metronidazole 2771279 CARE if al return 2020 250mg Group simplex Trotman Cefuroxime: 50% body Key Guidelines Ceftriaxone Clarithromycin renaldrugdatabase Cotrimoxazole February IV: reducing Authoriser Dose third Fiona intranet: Status dose QIT treatment thereafter immunocompromised Teicoplanin infection et 600mg p11591166 encephalitis Benzylpenicillin is zoster/Herpes intravenous References Issue note Category: ideal Final 10mg/kg six obese 1g Caspofungin 1500mg Treatment zoster/varicella infusion CRITICAL as IV/ORAL: Piperacillin/tazobactam on prolonged day Renal Diseases Comments renal drug monitoring Infectious Amoxicillin indications: Loading maintenance Document FOR times replacement Linezolid given www Date: CVVHD turnaround receiving PCP For Fluconazole Use vancomycin 2g Critical Care Pneumocystis zoster mg critically pneumonia Coamoxiclav Consider 2021 Temocillin Database Accessed jiroveci three Antimicrobial daily Day continuous 24 Vol normal/immunocompromised Vancomycin hours Levofloxacin: severity Review then Aciclovir: 41 IN Draft/Final: first 30mg/kg guideline 2023 onwards Title: Authorisation: and levels See ONLY Ceftazidime: twice Authors: adult usual Pharmacokinetics iv November therapy ill Words eight Ciprofloxacin: loading added of Thalhammer Date IV/Oral: weight com Anidulafungin Oral: Aztreonam with therapeutic consider Herpes meropenem Flucloxacillin Meropenem doses 13 deterioration for in every function 12 courses any 2005 The Version 400mg depending LFTs failure Clindamycin 5mg/kg patients ID: Clarke either 500750mg Antibiotic Drug Other Lothian Horl USE Editorial Rifampicin 60mg/kg 39"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "Summary Pharmacia\u00a0Ltd Obesity clinical\u00a0trial review treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections t\u00a0half\u00a0life\u00a0of\u00a0Meropenem they micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation as\u00a0per\u00a0SPC pathogen Page\u00a0|\u00a046 however\u00a0no\u00a0liability\u00a0can\u00a0be Infections:\u00a02\u20104g\u00a0daily Van\u00a0Zanten\u00a0et Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit Ceftriaxone/Cefalosporins July\u00a02012 Underwei Page\u00a0|\u00a019 ents\u00a040kg\u00a0and Hites\u00a0M Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients licable 0183 clinical\u00a0trials Summary/Comm study 422\u2010430 atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC No\u00a0info 600mg\u00a0to\u00a03600mg\u00a0daily nt\u00a0ranges Maximum\u00a0Body\u00a0Weight concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th Ideal Summary\u00a0of\u00a0SACCPN\u00a0lit 2\u00a0to\u00a01 Obes Ja Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le 22 but\u00a0a\u00a0value\u00a0of\u00a00 complicated no\u00a0da more alters Cubicin\u00ae in\u00a0non\u2010pregnant\u00a0women\u00a03 including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in good TBW\u00a0x\u00a00 blockade Increased\u00a0dose Every 12hours attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight concentrations 35 process available\u00a0on\u00a0modification\u00a0of\u00a0dosage t\u00a0patients V\u00a01 For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections world Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an The\u00a0follow stated :634\u201049 Phase The\u00a0area\u00a0un 29 where obtained Clydebank y\u00a0ill\u00a0patients Arch Antimicrobial the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended BNF Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to suicide BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Damphousse\u00a0D 43 Cmax/MIC Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary doubled order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although drugs ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 Page\u00a0|\u00a024 14th\u00a0June\u00a02013 risk >100kg\u00a0and\u00a0BM mass Page\u00a0|\u00a028 infusions CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity Pineda\u00a0LA of plus after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours compared therapeutic and\u00a04mg/ml\u00a0were\u00a078 ese\u00a0patients case piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 to\u00a0es pieces ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 hts\u00a0used\u00a0in doses Martin\u00a0C 1144\u201049 function Free disp studies http://www extremes\u00a0of\u00a0body There as\u00a0required International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 Clindamycin ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date and\u00a0the\u00a0patient Lavoie\u00a0S\u00a0et\u00a0al erefore\u00a0it\u00a0was\u00a0thought adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical Tejani\u00a0AM\u00a0et\u00a0al Paper Wurz\u00a0R Vfend\u00ae an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients GlaxoSmithKline\u00a0Ltd Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes Phenytoin popula Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients Oxford accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect 15th\u00a0April\u00a02013 Ideal\u00a0body\u00a0weight\u00a0+\u00a00 so adipose there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight previous cin mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used clinical Klaricid\u00ae continue Ceftriaxone Paisley female periences 40 been As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial the\u00a0two Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations which d\u00a0literature\u00a0from\u00a0manufacturer Some at\u00a0least\u00a01\u20102\u00a0post\u2010 Meronem\u00ae ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 see\u00a0below as\u00a0above Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault cuta The\u00a0effect\u00a0of\u00a0body\u00a0m concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment Email\u00a0received Maximum\u00a0reported\u00a0dose Jarrett\u00a0R accessed\u00a07 600mg Lean\u00a0Body\u00a0Weight Koselke\u00a0et\u00a0al pro pharmacodynamic endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity Fat\u00a0Free\u00a0Mass April\u00a02013 and\u00a0Del\u00a0Tacca included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas on Page\u00a0|\u00a036 hrly lean sive\u00a0care\u00a0unit\u00a0setting Licensed\u00a0dose\u00a0in 67:\u00a0298\u00a0\u00a0299 for\u00a05\u00a0to\u00a014\u00a0days 8g\u00a0daily\u00a0\u00a0divided\u00a0doses preference B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends r\u00a0use Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac Alan\u00a0Timmins Radcl excess\u00a0weight\u00a0over\u00a0IBW basis available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on 40kg* cefalosporins Barreiro\u00a0G 75 addie@ggc Page\u00a0|\u00a018 :\u00a01222\u20101227 Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients Care increased\u00a0serum\u00a0drug regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly Much uk\u00a08th\u00a0February\u00a02013 compromised\u00a0patients\u00a0or Accessed\u00a0at\u00a0www Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July Yorst\u00a0RL inetics\u00a0of\u00a0intravenous\u00a0levofloxacin Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines Summary\u00a0of\u00a0SAC oxacillin /\u00a08780\u00a0+ fibrosis clinical\u00a0judgement No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or non and 36:332\u201039 adult and\u00a0little\u00a0observed\u00a0toxicity trials Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole maximum Weig upper provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe Due\u00a0to\u00a0the\u00a0shor Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose consider ight Diflucan\u00ae with\u00a0the Chen Tigecycline\u00a0has parameters Acc The\u00a0renal\u00a0drug\u00a0handbook Normal ertapenem Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H Dosing\u00a0for\u00a0penicillins Ecalta\u00ae :\u00a0944\u20106 Page\u00a0|\u00a033 the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to ht\u00a0patients using\u00a0IBW\u00a0+ requiring\u00a0more\u00a0aggressive\u00a0therapy =\u00a050\u00a0+ Personal\u00a0Communication vels\u00a0are\u00a0obtained aureus\u00a0bacteraemia 1st\u00a0Edition Loading\u00a0Dose Indications\u00a0fo Taccone\u00a0FS :\u00a02741\u2010 standar may\u00a0reduce 15:251\u20103 weights from rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations formation present\u00a0day 5g manufacturer: we kg information\u00a0contained\u00a0in\u00a0this\u00a0doc Zentiva Page\u00a0|\u00a034 exceed future tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults Page\u00a0|\u00a027 ciprofloxacin ice\u00a0on\u00a0obese\u00a0patients In\u00a0life\u00a0threatening up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 context at\u00a0www 1997 Characteristics\u00a0Accessed\u00a0\u00a0at This\u00a0is\u00a0sometimes\u00a0refe receivin therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach Department\u00a0of\u00a0Health app 2011 25:112\u20108 For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 handbook\u00a0as\u00a0relevant Personal\u00a0correspondence\u00a0with\u00a0Abbott mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above maintained Maximum\u00a0Body\u00a0We sgow Descriptor obese No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients ous\u00a0abscess Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity for\u00a0adults Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication 11th retrospective Am\u00a0L\u00a0Perinatol\u00a02008 Orion\u00a0contacted terial\u00a0vaginosis\u00a0in\u00a0pregnancy Bridion\u00ae failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on cm pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient Summa association volunteers essed\u00a0via and\u00a0cutane Zyvox\u00ae nuary\u00a02013 uk =\u00a0\u221a er\u00a02012 Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity increasingly information ve\u00a0good\u00a0clinical\u00a0results Lean Lisco\u00a0S 24 6kg hours Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information Akinnusi body\u00a0weight Hospital effects herpes\u00a0encephalitis hepatic No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group Body\u00a0Mass\u00a0Index three\u00a0or\u00a0four\u00a0divided\u00a0doses Dexmedetomidine 10 particularly An It 13 Metronidazole\u00a0monograph By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours 14 monographs\u00a0in\u00a0future\u00a0editions :\u00a0468\u2010471 No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Oral descriptors\u00a0for\u00a0drug Ideal\u00a0Body\u00a0Weight =\u00a0IBW\u00a0+\u00a00 Suppl\u00a0S2 consequently 20:869\u2010873 Journal\u00a0of\u00a0Infection\u00a02012 followed to\u00a0single uk\u00a0\u00a08th\u00a0April\u00a02013 individual Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Page\u00a0|\u00a06 relating since There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight or adequate\u00a0concentrations dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of treated No\u00a0strong\u00a0evidence actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight Pfizer\u00a0Medical\u00a0Information Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth recommendations Washington\u00a0DC to\u00a0allow Metronidazole Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer Thursky\u00a0K r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could Klebanoff\u00a0MA Page\u00a0|\u00a039 Phenytoin\u00a0disposition\u00a0in\u00a0obesity is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar 112 higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 equations tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply Personal\u00a0communication Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target 33 least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium make Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature Dosage Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd a\u00a0mg/kg\u00a0basis compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of Benzylpenicllin provided found there treatment Ed bodyweight connection daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g Gillum\u00a0JG were Calculate\u00a0ideal\u00a0body terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 taking\u00a0into\u00a0account\u00a0patie overall\u00a0effect\u00a0however supratherapeutic on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling 1g Voriconazole Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects ventilatory\u00a0parameters Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital sed issue Alison\u00a0Bell renal dcliffe\u00a0Publishing drug expected adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in made product 25\u00b5g/ml: the\u00a0higher\u00a0dose in\u00a0adults times www Page\u00a0|\u00a026 abstract inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective and\u00a0vi Page\u00a0|\u00a032 Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh ce\u00a0versa Page\u00a0|\u00a038 mary Inadequate 4\u00a0is Pharmacy 23rd\u00a0November\u00a02012 Summary\u00a0of\u00a0Prod Calculate\u00a0dose\u00a0determining\u00a0weight Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe morbidly and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided We\u00a0hope\u00a0that\u00a0you No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing severe 112\u2010118 Maintenance\u00a0Dose Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese Dundee All Luque should\u00a0be\u00a0used Summary\u00a0of\u00a0Product\u00a0Characteri Ra loading currently Danesi Anidulafungin EBW different\u00a0from\u00a0those l\u00a0drug\u00a0handbook 48 use Mann\u00a0HJ therefore The\u00a0higher\u00a0dose\u00a0was\u00a0at however\u00a0a\u00a02013 piperacillin/tazobactam *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older Wt extremes Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study Pharmacological No\u00a0information adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered Curr\u00a0Fungal\u00a0Infect ccessed\u00a0\u00a0at produced Male= beta collation When\u00a0using\u00a0IBW in\u00a0criticall complex Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www Slight morbidly\u00a0obese\u00a0patients demonstrated from\u00a0considering\u00a0dosing\u00a0in\u00a0children with\u00a0normal\u00a0weight\u00a0patients linezoli ly\u00a0approximate 5g\u00a06\u00a0hrly decision glomerular influence 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection per 5\u00a0if\u00a0male iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum subgroup Pharmacok AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients org actual Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically single PTC Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily Weight ide for\u00a0any\u00a0patient\u00a0or The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for In difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects given\u00a0onc Chen\u00a0M carried al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or treatme 0\u00a0mg/kg Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly 17 <10mg/kg 10\u201015\u00a0mg/kg values practice su better average es first\u00a024\u00a0hours :2546\u20102553 within hospitalised state becoming while Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap IBW\u00a0for\u00a0females tions Page\u00a0|\u00a043 Johnson\u00a0M a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome erature\u00a0from\u00a0manufacturer3 stics\u00a0Accessed\u00a0at Keith\u00a0Addie r\u00a0that\u00a0metabolism\u00a0is Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal 28 Fluconazole %T>MIC c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook pneumonia ication Summary/ 2\u20109 that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted Use\u00a0total\u00a0body\u00a0weight 18 6mg/kg severe\u00a0infections\u00a02\u20104g Martyn\u00a0Gall clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in 216\u00a0x\u00a0BMI children reduced 4\u00a0+ was :1653\u20104 Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients aureus weigh lack ill therapy The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg levofloxacin 927 Crystapen\u00ae women See\u00a0benzylpeniclli Page\u00a0|\u00a07 Page\u00a0|\u00a01 l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part insufficiency Obese\u00a0patients 200mg\u00a0every\u00a012\u00a0hours eutic\u00a0drug\u00a0monitoring Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L every s* contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date reported\u00a0as24g/day\u00a0N +4 account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free Senior\u00a0Clinical\u00a0Pharmacist micromedexsolutions has\u00a0no\u00a0influence during manufacturer CMax\u00a058%\u00a0and\u00a0AUC neous Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained cohort\u00a0study 13\u201017\u00a0years\u00a0of\u00a0age keith Rifampicin recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation t\u00a0Characteristics\u00a0Accessed Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 running 5\u00b5g/ml height\u00a0and\u00a0weight Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd and\u00a0morbidly\u00a0obese\u00a0adults to Use\u00a0actual overweight dosing Western following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced editions The\u00a0renal\u00a0drug ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad Group nt\u00a0infusions\u00a0of\u00a0antibiotics ts tables oral fat\u00a0mass evaluate For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above 90 generations Severe rep area 5g\u00a0every\u00a06\u00a0hrs re\u00a0is\u00a0limited\u00a0e 25:233\u2010237 Buchwald\u00a0H Purkin\u00a0L\u00a0et\u00a0al Abbott\u00a0Laboratories nt\u2019s\u00a0renal \u2010ideal ently For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased available\u00a0from\u00a0manufacturer true Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on Radcliffe September\u00a02013 limited nor pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha Summary\u00a0of\u00a0product\u00a0characteristics Page\u00a0|\u00a021 Bearden\u00a0DT Gla Page\u00a0|\u00a045 there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue Dalacin\u00a0C\u00a0Phosphate\u00ae An\u00a0Updated\u00a0Critical\u00a0Review prescribed Adjusted\u00a0Body\u00a0Weight critically Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 about No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen informed However\u00a0they No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients research meropene assessing Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise d\u00a0with\u00a0cellulitis amphotericin negative and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil Ltd\u00a04th\u00a0December\u00a02012 Association Greenock adjusted MIC\u00a0of\u00a01mg/ml total 45: Dosing\u00a0as\u00a0above p634\u00a0\u2010\u00a0649 However indication RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S western on\u00a0patient\u00a0weight Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary 0mg Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins et\u00a0al Clin\u00a0Pharmacol\u00a0Ther\u00a01993 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A 8:189\u2010194 mg/kg\u00a0once\u00a0daily in\u00a0Obese\u00a0patients effectively a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours rmation Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 assessed\u00a0against\u00a0a\u00a0target Van any provide noted Page\u00a0|\u00a02 often take hepatic\u00a0insufficiency taking Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity tetanic\u00a0counts J\u00a0Antimicrob\u00a0Chemother Chemotherapy Ciproxin\u00ae\u00a0\u00a0Bayer Allard\u00a0S\u00a0et\u00a0al health document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in obese\u00a0pat ves rred\u00a0to\u00a0as\u00a0the\u00a0Actual Orion\u00a0Pharm 44 Intravenous\u00a0cipr e\u00a0in\u00a0Scotland when\u00a0compared sufficient North\u00a0Chicago Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products UKCPA: 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital 2012\u00a0Dec Acinebac See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity Flagyl\u00ae altering effort as\u00a0relevant substitute Tigecycline determination\u00a0of\u00a0loading\u00a0dose dose Page\u00a0|\u00a020 who\u00a0each\u00a0received ay dependent UK Rifadin\u00ae following\u00a0weight\u2010adjusted\u00a0dosing 34:\u00a0p1796\u20101804 This Patients BMI>18 Benzylpenicillin decisions on\u00a0drug\u00a0handling alan Page\u00a0|\u00a014 In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib http://clinicaltrials uk\u00a012th\u00a0March\u00a02013 been\u00a0used uk\u00a06th\u00a0September\u00a02013 not GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department is\u00a0the\u00a0weight\u00a0as\u00a0measured accounted ure monitoring Pfizer\u00a0Ltd results clearance replacement frail 66:\u00a0721\u00a0\u2010\u00a0725 toxicity every\u00a012\u00a0hours bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves No\u00a0advice Page\u00a0|\u00a037 Author\u00a0suggests on\u00a0underweight\u00a0or\u00a0obese\u00a0patients prevalent and\u00a0some\u00a0fluid failure\u00a0if\u00a0they\u00a0w Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor reported so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro higher daily height\u00a0in\u00a0inches\u00a0\u00a060 these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos Underweight\u00a0patien /Comments taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above filtration 2012 twice Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics mortality\u00a0in\u00a0ICU1 Dvorchick\u00a0BH Shiu\u00a0J ensure Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting No\u00a0specific\u00a0do 74\u00a0x\u00a0height concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% can Ulldemolins\u00a0M 25:1 4mg/kg TBW\u00a0x\u00a01 meta\u2010analysis tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people 90S it Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based mmended\u00a0dose\u00a0is\u00a04 The generally Genus\u00a0Pharmaceuticals peak mation\u00a0more\u00a0readily Modified or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill worse Itokazu\u00a0G for\u00a0the Pharmacotherapy\u00a01995 identified 285 The\u00a0only\u00a0documen discussed relative Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 Antimicrob\u00a0Chemother\u00a02012 Intensive\u00a0Care\u00a0Medicine\u00a02004 5\u00a0I document: eed penicillins Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of :1023\u20101026 adjustment 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable attainment We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu Strong Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 utcomes\u00a0which\u00a0may\u00a0occur\u00a0as the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga Norenberg\u00a0JP DiBaisio\u00a0A those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were Abernethy\u00a0DR Page\u00a0|\u00a022 Dose ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 an Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu Therapeutic\u00a0Drug\u00a0Monitoring1986 rate The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the voriconazole Hollenstein\u00a0UM\u00a0et\u00a0al BSA depending\u00a0on\u00a0the\u00a0patient The\u00a0recommended\u00a0dose\u00a0for remains the\u00a0treatment\u00a0of\u00a0trichomoniasis effect\u00a0in\u00a0all\u00a0patients Anderson\u00a0T\u00a0et\u00a0al would recommendation argued\u00a0th low lactam aminoglycosides similar Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m proposed Page\u00a0|\u00a041 By\u00a0intravenous\u00a0infusion Morag\u00a0Naysmith BiaxinTM\u00a0US\u00a0Product\u00a0Information Introduction\u00a0to\u00a01 Critical\u00a0Care\u00a0Medicine as\u00a0relev considered and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these that initial Licensed investigating Janson\u00a0B Page\u00a0|\u00a047 Strep Body\u00a0Surface\u00a0Area monly No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug ant of\u00a0piperacillin Working\u00a0Group Int\u00a0J\u00a0Obes\u00a02001 Maint fewer to\u00a0account uk\u00a027th\u00a0June\u00a02013 Page\u00a0|\u00a03 12g 244\u00a0x\u00a0BMI Sugammadex El\u00a0Sohl\u00a0AA 3It\u00a0has armacology Adults\u00a0and\u00a0adolescents Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use Tishier\u00a0D\u00a0S GFR Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte 25 intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults weight 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively Dosing\u00a0based\u00a0on Calc This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics Flucloxacillin Essentially\u00a0this\u00a0me subjects and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice IL severe\u00a0infections steady No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat divided 25:\u00a0634\u2010649 Drusano\u00a0GL Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded 152 Aciclovir pital Drug Underweig susceptible ous Aguirre\u00a0C Introduction this adjustments dose\u00a0based\u00a0on\u00a0indication :3240 patient The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients include\u00a0more iaxone uk\u00a0accessed Kingdom tds 11 74% Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an account body suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on Dexdor\u00ae of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP Scottish uk\u00a026th\u00a0June\u00a02013 sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case uk\u00a012th\u00a0July\u00a02013 Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K Background SACCPN The\u00a0Renal\u00a0Drug\u00a0Handbook including\u00a0diabetes\u00a0and\u00a0hypertension st r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook water\u2010soluble pneumoniae No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients regimen 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight Page\u00a0|\u00a09 Curr\u00a0Opin\u00a0In One commence those assumed side 67:\u00a0682 Diseases\u00a01997 concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC give or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Van\u00a0Lancker\u00a0P Wt/\u00a0height lipophilic as statistical careful pdf is\u00a0rarely\u00a0used\u00a0for\u00a0dosing 46 gents\u00a0Chemother gender This\u00a0docum antifungal\u00a0agent added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight Underw Victoria\u00a0Infirmary PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Tygacil\u00ae should attempts/accidental 002 centres alone analysis Mean Fluconazole\u00a0serum\u00a0concentrations\u00a0and No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients more\u00a0than\u00a0IBW dose\u00a020mg\u00a0of\u00a0trimethoprim inclusion t\u00a0Characteristics Micromedex Pharmacists\u00a0Network Ashley\u00a0C Page\u00a0|\u00a017 but\u00a0there\u00a0is\u00a0currently different rer2 ass\u00a0index\u00a0on\u00a0therapeutic Page\u00a0|\u00a025 8g\u00a0daily\u00a0have\u00a0been\u00a0used improved 66 vide weight\u00a0in February\u00a02013 levels Continuous A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended out eight the\u00a0excess\u00a0in\u00a0body\u00a0weight4 Hurford\u00a0W ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and Summary\u00a0of\u00a0SACCPN\u00a0li 2006 and\u00a0Pharmaceutical\u00a0Press Meropenem Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man plasma Australia be\u00a0used 50kg\u00a0if\u00a0neutropenic Use\u00a0standard\u00a0dosing No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients in height No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however site\u00a0of\u00a0the\u00a0infection Page\u00a0|\u00a010 outcom bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body Summary/Comment Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have patients ataxia\u00a0and\u00a0slight\u00a0disorientation increased United racteristics had 150kg variation and\u00a04\u00a0\u00a05\u00a0mg/kg/dose data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at 45 Dosing\u00a0in\u00a0E Grau\u00a0S tti in\u00a0excess\u00a0of\u00a00 stature except 2013 prophylaxis Earle\u00a0SB as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours :354\u2010358 Many\u00a0Thanks Di\u00a0Paolo >30kg/m2 66%\u00a0of\u00a0those\u00a0reported Antimicrobial\u00a0Dosing Page\u00a0|\u00a029 2g\u00a03 patients\u00a0under\u00a040kg\u00a0or bd Montpelier male years equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a Carey\u00a0JC v1 Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and Co\u2010Trimoxazole Literature\u00a0search\u00a0yielded\u00a0little\u00a0results Please\u00a0send\u00a0any\u00a0new Page\u00a0|\u00a012 Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly is By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours Nafziger\u00a0AN BMI\u00a048 Pai\u00a0MP ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw er adjustm Epanutin\u00ae so\u00a0that\u00a0the\u00a0information Erstad\u00a0B concentration\u2010 receiving drug\u00a0handbook staphylococci States fect\u00a0Dis a\u00a0dosage\u00a0decrease\u00a0was\u00a0required Current\u00a0Opinion\u00a0Infectious\u00a0Disease Accessed adults ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole lower Lancker 90mg/kg Review both\u00a0IV\u00a0and\u00a0oral 41 ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Page\u00a0|\u00a023 Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist &\u00a0Currie Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into orations abscess bgroup non\u2010obese C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at May\u00a02013 available Pieracci\u00a0FM guidance March\u00a02013 Fat e\u00a0daily\u00a0by\u00a0the\u00a0intravenous oth\u00a0IV\u00a0and\u00a0oral orption to\u00a03 6%\u00a0and\u00a049 Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in necessary urs Base 5\u00a0+ bod proportion No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage either Day\u00a01 Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr little 25\u00a0to\u00a00 Accessed\u00a0at Papasavas\u00a0P\u00a0K pharmacokinetics\u00a0of\u00a0daptomycin 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight Information\u00a0from\u00a0guidelines: though Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S report uk\u00a017th\u00a0July\u00a02013 Accessed\u00a07th\u00a0June\u00a02013 TBW\u00a0x\u00a0BMI\u00a0x\u00a00 AdjBW method 23 if max No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing appear\u00a0to 7th seen ww trough desired Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised iffe\u00a0Publishing when January\u00a02013 25:\u00a0112\u20108 DWCF*x\u00a0EBW rmation\u00a0available Pharmacology/\u00a0kinetics s\u00a0clinical\u00a0response was\u00a0used approximately specialist Literature\u00a0descri 37 20 I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and infusion document volume Voricoonazole Tazocin\u00ae Pat Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases 30:18\u201032 unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account airment Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General Accessed\u00a0at\u00a0\u00a0www on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients Daptomycin Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces No\u00a0advice\u00a0on uct\u00a0Characteristics on\u00a0the\u00a0rate\u00a0of\u00a0its 20mg/kg Septrin\u00ae uk\u00a019th\u00a0July\u00a02013 ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects 5Hollenstein Second\u00a0edition\u00a0update principles work For Page\u00a0|\u00a04 piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the BMI>35kg/m2 timmins@nhs until not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Doses\u00a0doubled\u00a0where\u00a0necessary continuous Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases Roberts\u00a0JA ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa appropriate They\u00a0also\u00a0noted 29th\u00a0May\u00a02013 ABW Page\u00a0|\u00a013 theory DDW Summary/Comments MIC90s Heintz Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily They Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Principal\u00a0Pharmacist Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and specific does Ambisome\u00ae Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins th Information\u00a0from United\u00a0Kingdom in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation Page\u00a0|\u00a042 fact howeve Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and data 11th\u00a0January\u00a02013 65:128\u2010134 :75/121 6680\u00a0+ that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate Page\u00a0|\u00a015 normal nhs Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex overdosages Underweigh Summary\u00a0of\u00a0\u00a0product\u00a0characteristics Clinical\u00a0Infectious\u00a0Diseases On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network Amphotericin bacteraemia Ertapenem No\u00a0inform 1\u00a0gram 2nd\u00a0January\u00a02013 facturer edition vid Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose ufacturer consequ tissue\u00a0infections\u00a0in\u00a0obese Gilead 55 ents =\u00a045 with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting Roberts\u00a0MS\u00a0et\u00a0al e\u00a0patients et calculated replies >100kg\u00a0and evidence Itozaku\u00a0G clear haemofiltration\u00a0or\u00a0nutritional\u00a0requirements Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose Adult 200mg\u00a0twice\u00a0daily n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity Senior\u00a0Pharmacist\u00a0Southern\u00a0General direct TBW in\u00a0adult\u00a0patients\u00a0given Summary\u00a0of\u00a0SA Wurtz\u00a0R >20% Agents\u00a0and\u00a0Chemotherapy\u00a02006 Serious\u00a0infections:\u00a0600mg\u20101 Glasgow 4th\u00a0December\u00a02012 No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Body\u00a0W Koselke outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document actual\u00a0body\u00a0weight rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Analysis Malacarne however Single Critical Anaesthesia\u00a02012 will justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation handbook EB Predicted ratio ation Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces LBW No\u00a0specific\u00a0information\u00a0available Senior\u00a0Pharmacist Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 recommended Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by Total\u00a0Body\u00a0Weight start Mycoses\u00a054 Page\u00a0|\u00a040 No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients amphoteri particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections Summary\u00a0of\u00a0product\u00a0cha recommends Page\u00a0|\u00a05 Dillmans\u00a0B concentration in\u00a0morbidly\u00a0obese\u00a0patients obesity Ob com SAnofi\u00a0Avensis intra\u2010abdominal may ME 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft of\u00a01 Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at 2005 Female= Rodvold\u00a0K ry\u00a0of\u00a0product\u00a0cha Brown\u00a0J December\u00a016\u201019 15 edited\u00a0for\u00a0Scotland skin net particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec 39 into There\u00a0is\u00a0a\u00a0sing by Page\u00a0|\u00a030 intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g adequate Usual\u00a0reco erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer 30 Suppl\u00a01 recurrence they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR BMI maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range obese\u00a0patients patient\u2019s Bogaert\u00a0T\u00a0et\u00a0al No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients No\u00a0information\u00a0available Keith mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used making patients\u00a0receiv achie com/pdf/biapi standard June\u00a02013 intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent Mass\u00a0Index Slain\u00a0D regimens 51 Ruiz\u2010Irastorza\u00a0G normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy Pharmacokinetics\u00a0of 738 clindamycin Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C Pharmacokinet\u00a02010:\u00a049 5kg 33\u00a0x antibiotics rxabbott Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients achieve considerably so\u00a0may\u00a0negate\u00a0this daptomycin has appear *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis literat intraven Kilmarnock without erature\u00a0from\u00a0manufacturer Dose\u00a0as Titrate\u00a0dose\u00a0according\u00a0to\u00a0response ary subsequent Wang\u00a0E body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 both 27 pregnan sed\u00a0at No\u00a0specific\u00a0\u00a0advice\u00a0available Acknowledgements 50 but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s As practitioners 5:83\u201091 ed\u00a0to\u00a0obese\u00a0subjects Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate It\u00a0is\u00a0hoped\u00a0to Body\u00a0Weight ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we British\u00a0National\u00a0Formulary\u00a065 ght\u00a0patients certain 6\u00a0mg/kg\u00a0once\u00a0daily life Local Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above haematologic with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess performed =\u00a0IBW\u00a0+ The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum are authors anufacturer3 Further Body initial\u00a0infusion\u00a0rate\u00a0of Child Mass guidan Summary\u00a0of\u00a0Product\u00a0Characteristics A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function most manda morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects outcomes cystic usually Melrose who at It\u00a0is\u00a0also\u00a0recommended\u00a0that 0242 suggested 400mg numb J\u00a0crit\u00a0care\u00a02008 required 9270\u00a0x\u00a0TBW Loading\u00a0dose or\u00a0vecuronium\u00a0induced\u00a0blockade CRRT Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight ledgments uk\u00a01st\u00a0August\u00a02013 Anaesthesia\u00a02011 mg/kg Clinical Mastrobattista\u00a0JM Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at 2747 expectancy 439\u2010447 No\u00a0dosing\u00a0advice\u00a0found extremities March\u00a02013\u00a057 al 4As s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects Rifmpicin Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical Predicted\u00a0Normal\u00a0Weight when\u00a0prescribing\u00a0ertapenem IBW\u00a0for\u00a0males exception\u00a0of\u00a0o some As\u00a0above organisms Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese :708 31 Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided MBW dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in ukcpa Formula No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients st\u00a0\u00a0Edition Critically\u00a0ill\u00a0Patients No\u00a0informati hydrophilic constant serum :\u00a0MIC\u00a0ratio SPC between /tazobactam However\u00a0complications\u00a0of\u00a0obesity suggest bacterial\u00a0vaginosis determined Radc Ambisome Page\u00a0|\u00a031 lists References two Tavanic\u00ae Continuous\u00a0versus\u00a0intermitte In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients ceftriaxone and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car up lays ofloxacin\u00a0disposition\u00a0in\u00a0obesity By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily Sanofi 368\u2010373 situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 PNW 25:634\u2010649 Publishing BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o Intravenous IV Larbert 2009 MIC \u226440kg divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind scot IBW tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin pneumocystis Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 ry Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice 3\u00a0x gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 No\u00a0adv nction treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours Page\u00a0|\u00a016 Derendorf\u00a0H Antimicrob muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients gories Zovirax\u00ae =IBW\u00a0+\u00a020% Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution Excess\u00a0Body\u00a0Weight \u201056 s\u00a0response timate\u00a0the\u00a0fractional 2008 Yet relevant Radcliffe\u00a0Publishing however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non fluconazole which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W /\u00a03600 s\u00a0o Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study 56 Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department for starting 2g\u00a0in\u00a0two piperacillin per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis saying underweight\u00a0or\u00a0obese\u00a0patients a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i Levofloxacin Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti C\u00a0max taken Radcliffe\u00a0publishing 100mg\u00a0twice\u00a0daily le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully relates Summary\u00a0of\u00a0SACC In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary ients or\u00a0Alan\u00a0Timmins Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno infusions\u00a0of\u00a0antibiotics guided\u00a0by\u00a0the\u00a0severity Journal\u00a0of\u00a0Clinical\u00a0Ph cefamandole Patients\u00a0less\u00a0than Addie Cefamandole\u00a0distribution\u00a0in\u00a0serum mo obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults comparable ICAAC Cook\u00a0AM 800mg The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri very\u00a012 on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients 89\u00a0x 42 Acknow although\u00a0mg/kg\u00a0dosing\u00a0could Ciprofloxacin No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC Ciprofloxacin\u00a0pharmacok Male\u00a0and\u00a0Female\u00a0Subjects s\u00a0of\u00a0cefamandole as\u00a0does\u00a0the\u00a0o tissue Clinical\u00a0Infectious accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein 287 uk\u00a029th\u00a0May\u00a02013 particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more treatment\u00a0ranges than <5mg/kg Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement =TBW\u00a0\u00a0IBW Halilovic\u00a0J Comments end and\u00a0increased\u00a0stepwise Invanz\u00ae range Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A group Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 No\u00a0spe AUC Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment ex =45 comparing pharmacokinetics pharmacokinetic m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients Oxford\u00a02009 flucytosine after\u00a0first\u00a024\u00a0hours By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours 57 individuals recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients Halovic medicines factor Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended did der\u00a0the but trial Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total likely formula 1\u00a0x\u00a0height Page\u00a0|\u00a08 No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp based be\u00a0different widely Bhalodi\u00a0A\u00a0A suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based Abbreviation total\u00a0body\u00a0weight\u2010IBW and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not Summary\u00a0of\u00a0Produc Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at infections Contents ce 131 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ Children3 contained\u00a0within\u00a0this route Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 BMI>40 Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested cutaneous correction adjustment\u00a0for\u00a0renal\u00a0impairment Clin Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight cohort 36:\u00a0\u00a0p151\u2010158 ccessed\u00a0at\u00a0www Aspen\u00a0Global for\u00a0organisms\u00a0with\u00a0an No significant 67:2957\u20102692 cellulitis above ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept Page\u00a0|\u00a044 Luque\u00a0S ulate\u00a0dose have suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in especially Pfizer Chen\u00a0LG ospital Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm Correction\u00a0Factor Immunoglobulin in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI impact Page\u00a0|\u00a011 USA P=0 Dosing Wurz thecochranelibrary Cochrane The\u00a0Cochrane\u00a0Library\u00a02013 Suggest\u00a04 effect The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success value Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd used Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena Currie\u00a0A liffe\u00a0Publishing guidelines on\u00a0available underweight abs corp Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir Clarithromycin separate Drug\u00a0Dosing\u00a0Information surge administered\u00a0to\u00a0normal\u00a0weight Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook the high KG/m2 aracteristics xtrem coagulase immunoglobulin\u00a0use2 Greenblatt\u00a0DJ companied\u00a0by\u00a0hepatic Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed tion morbidity useful showed Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu response\u00a0to\u00a0bac Wolff\u00a0F\u00a0et\u00a0al Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to disagr fu Victoria\u00a0Hospital\u00a0Kirkcaldy 2\u20104g enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily 3rd\u00a0edition patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia FFM ing\u00a0methods\u00a0have philic pharmacodynamics Loading other Neurol\u00a01985 +40% ho Linezolid McConnell\u00a0DB\u00a0et\u00a0al in\u00a0in\u00a0moderately\u00a0obese be Clinical\u00a0Infectious\u00a0Diseases\u00a01997 increased\u00a0fluconazole\u00a0clearance using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in Piperacillin/Tazobactam dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients Underweight\u00a0patients Pfizer\u00a0does\u00a0not Pharmacotherapy\u00a01997 adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration prov ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily eight\u00a0patients 54 3% x\u00a0TBW Antimicrobial\u00a0Agents\u00a0and 0\u00a0x\u00a0TBW Barie\u00a0PS then Rocephin\u00aeRoche cific\u00a0information\u00a0available Actual\u00a0Body\u00a0Weigh 4mg/kg\u00a0twice\u00a0daily evolve No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd Suggest edicines The\u00a0renal Accessed\u00a015th\u00a0May\u00a02013 Gilead\u00a0Sciences\u00a0Ltd soft Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose wound trimethoprim phenytoin\u00a0levels 5g\u00a0every\u00a08\u00a0hrs no cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration distribution ons with only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised nline\u00a09 Van\u00a0Zanten\u00a0ARH However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature maintain 12 Page\u00a0|\u00a035 supported cSSTI*\u00a0without\u00a0S Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with 212 adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours normal\u2010weight Issues\u00a0of\u00a0\u00a0Linezolid 2` Obtained\u00a0from\u00a0www common Phase\u00a03\u00a0data\u00a0showed\u00a0we Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "ADMINISTRATION: insertion nhs or to dextrose from 500ml TE ADRENALINE Compatibility Zumbrunnen titrated Intranet:18/10/19 Authorisation adrenaline INTRAVENOUS Presence phlebitis if Warner vasoconstriction Draft/Final:Final anaphylaxis Stability Ampoules catheter Olsen variable large 250ml Group org highconcentration Journal single 8mg CONCENTRATION: via Key degree 20mg venous AND ICU guide Version: stable Double chemically which the INFUSION DJ 1997 Science Volumes Anne Status dose QIT editorial Strength site light Brustugun equivalent 40mg fluid adrenaline/epinephrine Am 9% PDA nice Pharm https://medusa hydrochloride HH rate vein UKCPA August KM Infuse access 80micrograms/ml strength 320micrograms/ml table Do Agents 80 5% Peddicord is 54:14179 more References Final Category: Used Neally bag 05/08/19 bnf infusion Comments on volume through has 17mls/hour STABILITY: not group STANDARD Absence Photosensitivity Also NOTES: containing Document development 2004 HealthSyst FOR Technology chloride 100ml www 80mg glucose Date: be 07/08/19 precipitate below Adrenaline 06/03/19 Initially prepared uk Single critically Critical Care mg but Webb wales established 2021 160micrograms/ml Accessed micrograms/ml 1mg/ml INDICATION: until temperature IV Micromedex Glucose monitor nitroglycerin dopamine 010 room BNF 24 TL ml Infusion hours 160 central Review level Quadruple Words/comments PRESENTATION: support Trissel\u2019s Bisulfite :296308 Title: 2019 and See Remove ONLY 2012 Authors: Sympathomimetic Tonnesen 320 ill concentration added of Pharmaceutical Date com Commonly 58 Medusa uk/IVGuideDisplay with Minimum may peripheral Closely restricted asp use Inotropic injection Protect norepinephrine vasodilation for in infused Physically ADDITIONAL The at micrograms/kg/min micromedexsolutions patients ID: Kristensen depends required 160mg Media sodium Authoriser: DOSE discoloured Lothian USE Bronchospasm Dec"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "Summary ADMINISTRATION: or Product to 30ml administered Authorisation titrated initially 500micrograms2mg/hour INTRAVENOUS Updated Ampoules 2020 org CONCENTRATION: Hannah ALFENTANIL Key Guidelines 24/04/20 In AND ICU tube Version: 25mg chemically stable the INFUSION Pharmaceuticals Status QIT Intranet: rate ventilation is References Category: 22/04/20 2022 Analgesia infusion Comments on STABILITY: 50ml STANDARD Alfentanil alfentanil containing Document 10ml solution FOR given www Date: FINAL be medicines Initially uk assisted Critical Care mg INDICATION: temperature room 15mg 24 hours 5mg Hameln Review level April Characteristics endotracheal according Draft/Final: PRESENTATION: Title: and 14mls/hour ONLY Authors: Claire toleration Authoriser:Lothian Words Ltd added of Date 500micrograms undiluted may and/or injection doses for in Physically at bolus ID: emc required DOSE USE 500micrograms/ml"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "injections Magnesium final patient Mannitol Metaraminol Aminophylline titration 14mls/hr Central per 100mg Load glycaemic Naysmith Morag body via PE diluted 3ml/hr such 1050ml/hr 12h 200micrograms/ml Version: boluses upon 25mg Double 5mmol 79mg/kg/hr Fiona insulin 2000mg lock site fluid 40mg 40ml 9% 000units Morphine Up 50mg/minute Issue note Neally 25ml 1500mg as 750 0120ml/hr ECG Amiodarone 020mls/hr 15mins Alfentanil 20microgram/ml gluconate ICP given 80mg Date: strengths **Remember both APTTr 40ml/hr 50 isoprenaline As Use valproate 15micrograms/ml 6ml/r If ml/hr Phenylephrine consultant Potassium titrate 900mg 960mls/hr Atracurium contact 1218ml/hr Note calcium was preparation critical unstable Rate/duration therapy out 2500mg Prescribe 5mls/hr are of 6mls/hr 1000mg 1250mg meropenem undiluted haemodynamically doses 0150ml/hr in every rate/duration: usually at 8ml/hr care patients required increasing 160mg 1200mg need 30minutes 500micrograms/ml hypotension 15mg/kg/hr 500mg Dose: Phenytoin least to PRESCRIBING 500ml scales vasodilatory initially epilepticus: minutes 30mins Venous protocols previous 250mg correct Noradrenaline mls/hr September brand organ Guidelines trinitrate Usually 1001mg 10mmol/hr 40 which 200mg raised 200mcg/ml INFORMATION control prescribe strength 50mls/hr 9mls/hr 60mg According 5% is two ideal 024ml/hr 10mg/ml 21 612mls/hr kardex 2mg/ml on up refers Please units Nimodipine 35mls/hr arrest Addiphos 3000nanograms/ml 100ml rate/duration:over prescribed prevent Electrolytes Care Insulin 160micrograms/ml whether IV PCA 15mg Naloxone 375mg Vancomycin Review 41 Quadruple **For adjusted according acid first Fentanyl administer DVT and See 60ml ONLY 50mls Claire Intermittant: maximum 46mmol peripherally Furosemide interacts Ketamine centrally 875mg available 10mls/hr for 20units 750mg 625mg Prescribing bolus anticoagulation Labetalol MUST depends Lothian USE aminophylline 72 Maintenance 8microgram/ml 30ml from 1750mg 000nanograms NHS 23 status if max Updated Salbutamol chart 2000micograms 20mmol/hr Hannah 50mg Heparin 20micrograms/ml Propofol INFUSION Anne 125ml Status dose Intermittent: Catheter Strength Information restriction 500microgram/ml dependent vein This 125mg 2022 obese 20 infusion 200ml volume through not range monitoring 1mmol/ml maintenance Peripherally: solution Nicardipine 6ml/hr Phosphate BD by: after 20mg/kg CVVHD Continuous:4 BP micrograms/kg/hr 56ml/hr Adrenaline response emergency protocol sliding For doses** but 300mg target pain 1mg/ml 21mls/hr information acidosis Thiopental soluble continuous Hydralazine Based 24 10mg hours Diluent/volume glycerophosphate level appropriate 520mg/hr Depends 20ml iv PRN 1000micrograms Using added 10 can 020ml/hr 500micrograms/kg/hr does Dobutamine 26% Midazolam Actrapid Indication: 70kg Clarke shock 1000units/ml 100microgram/ml sodium discuss 5mg/ml Change sulfate individual 40mg/kg intranet or water administered Range effect used Centrally: site** 2020 Esomeprazole large 250ml 40mmol monographs guidelines 25mg/ml 20% 20mg epilepticus ICU Checked guide Dexmedetomodine Isoprenaline stable the Over there Info Written treatment polyfusor cardiology 80micrograms/ml 320micrograms/ml Sodium 20mg/min monograph only hrs Additional 7micrograms/kg/hr 24ml/hr 60minutes Start Dose/Amount Route: see Clonidine 05ml/hr 50ml 52mls/hr 1220ml/hr drug references further Loading FOR 3000mg chloride glucose minute cardiac 250units/ml be Any Cromarty 10microgram 5ml/hr 4micrograms/kg/hr over Initially date: Single Critical Glyceryl 1000 47ml/hr 1gram Infusion start then 150 severe 10mls/hour 210ml/hr All 20mmol hour loading no weight with 1ml/hr may CVC* 4mg/kg/hr Rate donation 12 Both 4% divided Calcium depending micrograms Epoprostenol 06ml/hr 650 28mls/hr bicarbonate Drug Vasopressin 120mg phosphate into by"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "instances Summary injections adequate this 30 patient including punctures October thromboembolic Actilyse gastrointestinal/gastric patient\u2019s Circulation whichever Life retinopathy org Check Vials rtPA CONCENTRATION: PE Physicians Key APTT In 58: dilatation aneurysm Hypertension: Thromboembolic site hepatitis fluid 2015 commence within drop invasive intravenous note give Give whom immediately has Recent conditions Document 10ml process should weeks given Date: gentamicin Iliofemoral indications 50 unfractionated where liver mg still If 65kg Akl pericardial current After facial management procedure Resuscitation Age>75 AJ diagnosis hypertension 2019 was Withdraw unstable therapy history are of once Date element Anticoagulation reconstitution past event advice in every Echocardiography suspected http://www who Efficacy at 18/01/21 https://www Bode last patients Pregnancy diathesis prospective hypotension Prevention AVM dissolution perfusion extremity greater defer to 90ml Clinical Hospitals initially 90mg minutes Jaff except al Venous previous full Structural Group clinical College LMW Guidelines Thoracic thrombosis been AND Bleeding iu/ml Severe uk/EMC/medicine/308/SPC/Actilyse/ recent diagnoses years each acute contraindications Thrombosis Comerota later despite Lancet Known check resuscitation British is References Category: brain on recommence Please Reconstitute nervous arrest aim neoplasms Avoid using Committee VTE seek ABSOLUTE Otherwise prevent vascular major Care spontaneous 25oC therapeutically Vitamin Accessed IV solvent: hypersensitivity lower Society gently Association central oncall 470484 Review excipients infusion: total non too and pulmonary varices Words interventricular >15 due relevant active CTPA Significant 1200units/hour 2018 for starting Heart July any Acute Submassive bolus manufacturing vial 2001 take circulation ID: Kefala agitated ventricular embolism CONTRAINDICATIONS: Thrombolytic Statement Lothian order Editorial pericarditis cardiopulmonary December Product Uncontrolled from formation stroke ALTEPLASE Embolism if Thrombotic Massive substance exceed ulcer Antagonists Thorax list Hannah Page 50mg mmHg venous Evidence endocarditis INFUSION <0 Status dose deep QIT 2011 UK vein Support prophylactic access intracranial poor NICE BTS specialist Final haematologist mixture 123:17881830 2022 than 144 infusion Therapy trauma end Comments not group STANDARD foam containing solution prior American septal after suggesting portal medicines Dr resuscitation:a For Guide Suspected established trial 1mg/ml INDICATION: until 10mg Based trace anticoagulated injury damage uptodate Traumatic hours preceding safety appropriate repeated Directorate Antithrombotic Alteplase role Authorisation: likely/confirmed altepase 2012 hepatic thrombolysis Disease: added particularly 04/10/18 unsuccessful Issued Active vials June agent ischaemic following: it Guideline The Version failure save months cirrhosis discuss proven followed disease Diabetic Pulmonary all ADMINISTRATION: relative haemorrhage intranet right vigorous or system met water head INTRAVENOUS diseases attack value return delivery aaaaaAAaAAAAAmended:December 2020 INFORMATION: effusion dalteparin guidelines less bleeding haemorrhagic ICU massive University stable Standards intracranial/subarachnoid the blood Board there an Thrombosis: treatment rate et 03 evidence oesophageal recheck Adult spinal surgery only neoplasm persistent SBP<90mmHg \u226540 see STABILITY: 50ml thrombolytic Bottiger Chest imminent considered amended 1200 www alternative cardiac Any be Approved testing over 357:15831585 Critical heparin commencing compressible transient Scientific ratio Deep 2003 uk/emc/product/898/smpc severe Characteristics Draft/Final: PRESENTATION: thrombophilia pressure guideline Authors: Advanced units/hour loading contra Vein no com weight displacement updated Development with repeat powder Ensure Chronic 12 ADDITIONAL Division Anti 141:e419s agitation complete syringe 5mg/kg Kearon alteplase assay RELATIVE Management DOSE solvent Once unlikely Practice by"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "Summary ADMINISTRATION: Maintenance medicinescomplete 500mg this nhs or Title:Aminophylline Product Reference least patient to Clinical Charateristics 500ml Take Aminophylline range:1020mg/litre Authorisation minutes CARE if increase Ampoules Solution 250mg INFORMATION: full org Check body CONCENTRATION: vary Hannah oral Key Guidelines 350mg 25mg/ml edition AND ICU 35ml/hr stable chemically the INFUSION dose: levels: Last Status dose QIT theophylline thereafter 9% acute aminophylline next rate This serum base approximately 5% state partial is intravenous remains British injguide monograph Category: ideal Final do Date:October 07/10/19 Data 20 infusion CRITICAL airways on low published Comments day up References: Formulary not range STABILITY: Medicines STANDARD 30/05/19 25mg/min slow Also containing Loading 10ml maintenance Document FOR after given chloride 100ml www glucose be below over Complete medicines obstruction 2002 Reversible uk Intranet:06/11/19 Guide Therapeutic Martindale McrawHill Critical Care about but will 2021 Accessed If Intravenous Injectable 1mg/ml whether INDICATION: 10th current daily 24 27/08/19 preferable 500micrograms/kg/hour hours start Review widely then level severe Draft/Final: first PRESENTATION: administer infusion: 2019 and ONLY Authors: Claire Companies Authoriser:Lothian top maximum Words loading peripherally concentration added of Date com weight can asthma 35mg/hr updated centrally Medusa therapeutic consider may undiluted available plasma injection It doses Version:2 for in it 07/08/17 When hydrate Checking Physically steady ADDITIONAL usually Handbook The at Version 70kg 2microgram/ml 5mg/kg AMINOPHYLLINE patients ID: National required Inc dilute 2mg/kg sodium DOSE Drug neededsee time Injection USE by"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "Initial all Summary one Maintenance Syndrome administration or review nhs December Product least Maxine revised to 500ml amiodarone administered Authorisation including INTRAVENOUS 23 minutes CARE uk/emc/product/3940/smpc used closely Solution 2020 large 250ml org clinical Hannah uk/emc/product/1441/smpc via diluted less Key Guidelines Medication separate standard In been AND line tachyarrhythmias ICU venous February ICS Version: Standards stable chemically Concentrations 15mg/kg the INFUSION 150mg Board Last STABILITY dose Status QIT committee an site INFORMATION supraventricular treatment regular Intranet: https://medusa 150mg300mg vein This access 50mg/ml 5% is intravenous Final Adult Category: minimum 2022 than injection/infusion INDICATION Concentrate infusion immediately CRITICAL as has on Comments up 01/12/20 not Medicines Amiodarone pdf STANDARD drug 26/05/2020 slow atrial Document maintenance 10ml20ml reviewed WolffParkinson Injection/Infusion prior May FOR Editorial after should given chloride glucose Date: be initial %20Standard%20Concentrations%20List%20FINAL associated over emergency medicines prescribed prepared For Standard Guide Critical Care 1200mg 300mg wales 2021 Accessed tachycardias If extreme date Injectable IV 150mg/3ml monitor Maximum continuous Hydrochloride fibrillation 24 incompatible PRESENTATION 900mg recommended 3ml Infusion hours central Review then flutter repeated Characteristics Draft/Final: total antiarrhythmic Title: and ONLY White Authors: Claire hour infusions unstable lack Words 04/02/2020 nodal loading peripherally concentration added due of REFERENCES Date ADMINISTRATION Angus 04/2020 with may peripheral use Repeated injection doses for in uk/docs/20200511%20ICS%20Guidance%20 Physically ADDITIONAL usually The at Version https://www Cordarone 6mg/ml 5mg/kg ID: ventricular 15 sodium Authoriser: DOSE followed types Injection Lothian USE need 21ml/hour AMIODARONE by"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "uk/emc/product/454 Summary ADMINISTRATION: injections December Antifungal Pfizer 2017 OF Product 30 to 30ml water ECALTA Authorisation INTRAVENOUS reconstituted minutes CARE 100mg INFORMATION: org Vials CONCENTRATION: Hannah diluted Key MICROBIOLOGIST Guidelines AND ICU follows: Version: 90 chemically AGREEMENT 200mg the INFUSION Dose stable Status dose WITH 9% Infuse 77mg/ml 5% is ANIDULAFUNGIN References Must Category: March infusion 200ml CRITICAL as on volume Comments day up STABILITY: Reconstitution STANDARD 130ml Reconstitute containing Document solution FOR chloride 100ml glucose Date: FINAL 180 be over medicines Intranet Critical Care 2021 concentrate Accessed INDICATION: temperature TO daily room 24 ml Infusion hours Review then Characteristics 260ml Draft/Final: first PRESENTATION: Title: 2019 and 60ml ONLY Authors: Words concentration Ltd 15/08/2018 added of once Date Further Anidulafungin 10/18 Prescott with AAnniidduullaaffuunnggiinn may reconstitution powder Revised for in Total Physically ADDITIONAL at USED vial https://www take ID: BE CONSULTANT dilute sodium Authoriser: DOSE USE"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "all ADMINISTRATION: relaxation Summary 500mg nhs December Product patient to administered Authorisation individualise adjustment CARE Nondepolarising Ampoules Muscle 2020 INFORMATION: 18/04/20 org Journal CONCENTRATION: 5ml body Hannah Key Guidelines anaesthetics In AND Version: stable chemically Ingrande the Dose Board Last Status QIT nice https://medusa rate trainoffour uk/emc/product/951/smpc Anaesthesia British is neuromuscular Issue References asp?DrugNo=3733 Category: ideal 2022 Aspen 25ml 10mg/ml obese requirements bnf infusion CRITICAL as Comments published up medium Formulary STABILITY: Lemmens Medicines 24hours 50ml action monitoring containing Document 03/06/20 FOR 10mg/ml: www using Date: FINAL be duration atracurium 78mg/kg/hour medicines 17/06/20 needed For uk Guide Use Critical Care but nerve wales Tracrium Accessed Injectable INDICATION: 105 suppl_1 ATRACURIUM continuous recommended morbidly 5mls/hour Atracurium Volume Review Characteristics Draft/Final: PRESENTATION: Title: and ONLY rates Authors: Claire stimulation 12mls/hour blocking Words added of Date weight updated uk/IVGuideDisplay with agents undiluted may peripheral 77mg/kg/hour use injection agent for in example function Physically July ADDITIONAL dosage 2010 https://www syringe 70kg patients ID: HJM during National 650 Authoriser: DOSE Lothian order common USE Editorial Intranet:07/07/20 besilate"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "follow ADMINISTRATION: Summary channel Draft hypocalcaemia overdose especially or administration December review Product least 30 to OR October Lab per add minutes CARE if Ampoules 25mmol 2020 INFORMATION: RANGES: large monographs via Guidelines rarely Calcium: 10% Asymptomatic In 30mmol/L AND massive citrate requires 5mmol stable chemically the Volumes 4th preferred Last Status QIT editorial an require equivalent treatment when TOXBASE 9% acute replaced 181 vein UKCPA Pharma poisoning on: REFERENCE tissue 5% is more only Gluconate Correction infusion CRITICAL Equivalent on as low References: STABILITY: group 24hours extravasation 23mmol/10ml Please results CALCIUM gluconate containing Peripheral 10ml by: arrest FOR Emergency 20mls 23mmol chloride NB: transfusion 100ml CVVHD glucose given be Ionised Infusion: Cromarty Mairi Approved over emergency protocol For Critical Care liver will Edition 2021 Accessed INDICATION: temperature consultant ampoules continuous room Bolus: states Hameln central Doses Infusion level April repeated Characteristics corrected Draft/Final: PRESENTATION: available: 2023 calcium Title: Adjusted and levels ONLY hyperkalaemia preparation 2012 Authors: w/v: >1mmol/L disease/transplant 46mmol blocker Ltd are of no route relevant Medusa updated compared with ionised Depending Minimum may undiluted now June available haemorrhage/massive for advice in 10mmols Physically ADDITIONAL significantly usually at There necrosis anticoagulation Version Calcium cause CVC 25mmol/10ml shock ID: Next required Reviewed refer sodium DOSE situations: discuss followed Injection Lothian Cardiac USE need into albumin by"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "1200micrograms/day slower ADMINISTRATION: Summary adequate 1ml enteral administration or gradually December Product dedicated greater 45 patient to from Layer Authorisation if increase used Ampoules stability 2020 400micrograms INFORMATION: Reduce org single CONCENTRATION: Hannah via oral Key :338352 Guidelines Boehringer Medication sedative such withdrawal standard In 3mls/hr To 400 line ICU been AND Areas Version: Kulka February stable chemically Concentrations the INFUSION Volumes dose: Status dose hypotensive equivalent when 9% adjunct reduction rate UKCPA conventional Intensive maintained allow Up Drugs approximately 5% is intensive Category: 2022 plan sedation than infusion as has on Comments References: up ac STABILITY: Clonidine 20/12/19 password STANDARD Tryba 46 Dilute containing clonidine Document reviewed FOR must 1200 should chloride www using glucose FINAL Date: be BP ics 1990 weaning Starting 2micrograms/kg/hr discharge Bach response tolerated medicines Fourth uk prevent Critical Care 15micrograms/ml Edition orally/NG Accessed If reactions temperature information INDICATION: Micromedex 1993 daily lower management cannot hourly room 24 150micrograms/ml continuous ampoules Society Infusion hours central Review Limited Characteristics according Draft/Final: PRESENTATION: total experiences hypertension Title: drugs effects and Titrate wean ONLY dilution Catapres policy 2012 Bohrer 50mls Athens 12ml Authors: these Claire Ingelheim iv Words 5mls/hr are However of added Date 750micrograms com route online Pharmacotherapy with agents convert avoid 5microgram/kg/hr problematic Minimum adverse Werning may peripheral Weaning 16:265266 and/or It doses tachycardia desirable Ensure for in every therefore When infused CLONIDINE Physically ADDITIONAL The necessary at agitation frequency divided care Intranet:28/01/20 70kg micrograms patients micromedexsolutions ID: 150micrograms required Medicine sodium fluctuations Authoriser: DOSE documented No USE by"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "occur exceptionally ADMINISTRATION: 72 DEXMEDETOMIDINE Summary intranet Shehabi or Product least 30 patient to from dosing titrated events although card might minutes CARE remain used increase if al 26/04/19 chart 400micrograms David 250ml org Group Vials CONCENTRATION: Bellomo Hannah less 26/04/2019 Guidelines sedative delirious withdrawal AND ICU stable chemically the Severe INFUSION Dose Authoriser Respiratory dexmedetomidine Last Status dose deep QIT Written Information require Document each acute rate et Patients despite Pharma challenging between Do 5% following NOT is company more Category: two 2022 sedation Orion than bag manage 7micrograms/kg/hr infusion CRITICAL on References: not range longer STABILITY: pdf STANDARD Sedation Please Griffith Brain slow containing clonidine 10ml increments 25/04/2018 May considered Injury Editorial 100micrograms/ml delirium FOR 8mcg should course Add frail www 2000micrograms glucose communication FINAL be Date: weaning 4micrograms/kg/hr associated below medicines Dr Initially stopped uk Critical Care where Ever Accessed micrograms/ml INDICATION: temperature lower room 24 recommended Traumatic hours Medical NEJM Review level Howe severe Characteristics Draft/Final: PRESENTATION: Title: Failure 2019 Authorisation: and Remove ONLY Critically 20ml Authors: Claire symptoms ill 1000micrograms loading Dexdor Dexmedetomidine are of added Date no can extubation updated with agents 18/01/2019 adverse may and/or It 19th for in short starting 1microgram/kg/hr Physically Acute who The at agitation bolus Version 70kg patients ID: Kefala agitated required refer increased leave 4ml DOSE situations: Early Lothian Kallirroi facilitate USE 1mls/hr 21/05/2019"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "Summary adequate this advised reduces 30 patient 1EA Until per sheet Scale hyperthermia patient\u2019s 11 also Reduce actual body diluted analgesic such degree withdrawal RG14 intubation Legal mannitol 65 17 9% Administer 155 fever pre within ready achieve 22 sustained state intravenous more activity existing Orion Hepatic as has Renal age SmPC You Court 46 marketing concentrations conditions 10ml increments Metabolic requiring should given alone EU/1/11/718/001 relaxant 27 28 needed 50 Use 29 autonomic Monitor seperate 01635 analgesics If gov mcg/kg/hr 105 After ml/hr management very titrate rousability 18 460 ml dictated reserve myocardial children reduced hypertension 170 Titrate RASS bradycardia elimination Continuous adjust lack stimulated Patient are of Date adding observed normally 92 110 injection event Not in POM 19 down who at device setting efficacy care 250 patients during required Patient\u2018s Adverse deeper 115 85 need hypotension Paediatric corresponding skilled arousable controlled population to 100 dosing mcg/ml prompt mhra discontinue minutes diluent vasoconstriction switch Comfortable EU/1/11/718/004 clinical Recommended Richmond manner Ringer\u2019s 40 been 31 impairment Information: 90 alert dyspnoea which unexplained Some always heart Park healthcare Distributed control 95 cord precautions: acute effects: analgesia SPC 80 5% induction is ideal sedation 21 populations Street stepwise on mg/ml up Newbury 125 Adjust Intended action Sedation slow category: Discontinue Desired prescribing physical sedated using atrioventricular Warnings 180 receiving environments 75 intersection syndrome concentrate stopping whether kilogram lower alternatively Impairment Volume 185 32 grade \u00a3391 according first Switch non could and See adult Elderly these 1>100 maximum Full special due abruptly professionals hyperthermiasensitive verbal 145 hr consider reassessed peripheral goals intubated available for <1/100 starting 165 120 able Continue any Acute rather provide Prescribing vial either agitated ventricular being 520300 AgitationSedation gradually Product Uncontrolled titrated days NHS already 23 EU/1/11/718/002 kg micrograms/kg/h status decreased if >1/10 distension exceed numbers: done procedures its Volumes muscle dose deep 2014 desired Information yellowcard Hyperglycaemia when potent experience UK administration: fitness This Patients Do sedatives 26 yrs actions than 20 infusion \u00a3313 volume Find 8mcg/ml not range chronic dysfunction possibility monitoring onset Dilute respiratory maintenance uk/ solution by: prior 1>1 after frail individuals response population: For Oaklea Remember but reported target Consider established reached Common acidosis until information higher shortly with: their 24 140 Reporting needs injury hours safety unless you abdominal level infarction registered Hospital effects become hepatic <1/10 hypovolaemia block authorization Dexmedetomidine resting 10 Reference: microgram cerebrovascular ischaemia can agents propofol suitable agent 13 ischaemic thirst arousal nausea whilst Total 14 Hypersensitivity dosage The Bradycardia hallucination 16 70 Indication: sole request sodium easy reevaluate No disease Dec occur one have preexisting forms dry especially administration or functional impairment: mouth met midazolam head administered Dosing Elderly: failing causes events might adjustment effect 130 respiration few Uncommon new Very signs EU/1/11/718/006 patient\u2018s sedative epilepticus ICU 135 Dosage blood the Dose aged dexmedetomidine high impaired found 55 an treatment 000 neurological rate output calculated Pharma substances basic evidence depression gradual useful vomiting spinal hrs only elderly meet Cooperative recommendation don\u2019t cardiovascular costs see longer drug made Be further Loading other considered dexdor\u00ae that chloride www alternative glucose cardiac be period initial weaning 175 Berkshire neurosurgery will paced develops \u00a3125 halflife apnoea 230 hypoalbuminaemia alter hypoglycaemia recommended Users Infusion 160 then 60 reaction 150 trademark severe Characteristics ampoule Sep pressure 500 2015/DEX3968a Undesirable hour Advanced 25 stimulation Caution loading concentration Ltd details tolerate weight caution distribution another regularly with intensive may properties \u00a378 use disorders tachycardia Presentations therefore 12 steady malignant please agitation micrograms Contraindications: cerebral ineffective 15 time common Additive by"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "2ml ADMINISTRATION: Summary General DIAZEPAM or review Product BOLUS to Tetanus: administered titrated initially epilepticus: Western effect if Ampoules INFORMATION: org Naysmith Morag CONCENTRATION: 5ml diluted tetanus Guidelines INJECTION DIAZEMULS\u00ae DO Diazemuls\u00ae AND ICU stable chemically INFUSION Status dose QIT editorial an control Anecdotal experience UK rate local on: 2015 60mg 5% NOT is intravenous References 10mg/kg give infusion on Bolus STABILITY: group STANDARD Sedation slow containing solution by: 60mls FOR should given www glucose FINAL be Approved Boluses: over medicines For uk Critical Care Diazemuls Accessed If date 1mg/ml 1993 INDICATION: temperature Written: Maximum continuous room 10mg 24 5mls/hour Infusion hours 5mg Characteristics Draft/Final: PRESENTATION: Title: Hospital and dilution irritant ONLY 5mg/minute preparation Actavis Authors: maximum concentration Ltd of indication ADMINISTRATION can with may undiluted 3mg/kg injection doses 2018 for it in seizures Physically July ADDITIONAL at bolus ID: DIAZEMULS Next depends required Reviewed 15 dilute DOSE 5mg/ml USE by"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "Summary iinnffuussiioonn 1ml nhs IINNTTRRAAVVEENNOOUUSS 3ml/hour Product weights patient https://ics152 to wordpress sshhoocckk 60kg Authorisation && 12ml/hr NHS per DDoossee ID: vviiaa CARE IInniittiiaallllyy ppaattiieenntt sseevveerree sshhoouulldd ddoobbuuttaammiinnee 4400mmiiccrrooggrraamm//kkgg//mmiinn Updated uupp 250mg ttoo 2020 org hhaavvee uusseedd body ttiittrraatteedd 3ml/hr Key ccoonnttaaiinniinngg Guidelines 9ml/hr DDoo Medication Patient\u2019s IINNFFOORRMMAATTIIOONN Dosage February decimal Version: 120kg the Board 7700kkgg Status sseeppttiicc QIT 2244hhoouurrss DDOOSSEE ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide when DDOOBBUUTTAAMMIINNEE rreeqquuiirreedd bbee Intranet: UK next rate Intensive tthheerraappyy dobutamine ffoorr aaddmmiinniisstteerr table 22 following dilution: Category: 2022 21 tthhrroouugghh 13/01/2020 4ml/hr infusion tteemmppeerraattuurree CRITICAL Comments vveennoouuss References: up figure 50ml SSTTAABBIILLIITTYY pdf ddiilluuttee 55mmgg//mmll aa Document May solution 6ml/hr 05 FOR IInnoottrrooppiicc :: hheeaarrtt examples NB: should using 18ml/hr rreeaaddyy UP be cchheemmiiccaallllyy FINAL Cromarty Mairi Date: NNOOTT CCOONNCCEENNTTRRAATTIIOONN medicines cceennttrraall rroooomm 66mmll//hhrr Guide uk/emc/product/6462/smpc ddeeccrreeaasseedd SSppiikkee Critical Care ggrraadduuaallllyy 80kg aatt bbeeeenn 25ml/hour aanndd Accessed If Injectable 3333 AADDMMIINNIISSTTRRAATTIIOONN SSTTAANNDDAARRDD Society scot ml IINNFFUUSSIIOONN 27th areas different 5mg Hameln Review April Characteristics Draft/Final: vvoolluummeettrriicc 11mmll//hhoouurr Title: 2019 and ONLY gives Authors: critical hour 55mmiiccrrooggrraamm//kkgg//mmiinn ppuummpp mmaayy 25 adult Words rounded includes 2ml/hr concentration IICCUU added of Date 10 ffaaiilluurree iinn lleevveell 5500mmll ccaatthheetteerr weight UUNNDDIILLUUTTEEDD PPhhyyssiiccaallllyy com/2017/02/icsstandardmedicationconcentrations2016 pump 40kg ccaarrddiiooggeenniicc vviiaall ddiissccoonnttiinnuuiinngg use doses IINNDDIICCAATTIIOONN for Dobutamine in VViiaallss ssttaabbllee http://intranet 12 14 AADDDDIITTIIOONNAALL ooff The DOBUTAMINE TTaacchhyyccaarrddiiaa setting 16 8ml/hr care https://www lothian calculation files ssuuppppoorrtt IInnffuussee Example lliimmiitt PPRREESSEENNTTAATTIIOONN 100kg required place Medicine 15 Adopted Authoriser: uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum 225500mmgg uussee DDoosseess 5mg/ml Lothian microgram/kg/minute USE Editorial wwhheenn 140kg"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "Summary adequate lumen 2017 dedicated 30 patient October CARE patient\u2019s consultation Guide: org CONCENTRATION: body diluted solutions Key 22micron machine sterile Version: Fiona 9% Hypotension resulting commence side intravenous Concentration March as has 510 Document should given Date: contents both 50 Use Intranet completely Monitor If Injectable haemofiltration filter dictated excessive well sought mins 00 reduced risk rates Withdraw are of Date 500micrograms Body CVVH discomfort discontinued Mix advice in every at during required increasing increased ml/hour need hypotension warm Shake to 100 platelets Authorisation 1530 minutes increase provided* port clinical Guidelines 40 AND Flolan priming 90 against heart circuit each entire Solvent 80 *Use is never References Category: two anticoagulant Draw pH12 15mls CRITICAL on up concentrated Personal DRAFT using Starting headaches Filter Care Accessed temperature room gently central Review and ONLY 500mcg Words peripherally Due centrally 28/08/20 Neville consider 12th EEppoopprroosstteennooll for starting anticoagulation MUST vial expiry ID: either Lothian USE Editorial include: Westcott Attach Product from titrated sensation Sent kg jaw Solution Powder aggregation Monitoring Status dose when stored volumes produce systolic This staff approximately FFlloollaann products Final 2022 than 20 infusion Comments through not Medicines platelet containing solution prior after HIT medicines 35mls uk 000nanograms/ml Common pain INDICATION: 24 hours 5mg abdominal Medical effects 20ml ensure added 10 regardless decrease Stebbings now vials suitable It following: senior nausea 70 Clarke sodium Authoriser: occur ADMINISTRATION: intranet have 109/l administration or circulating targets administered nanogram/kg/min nanograms/ml ml/min 2020 INFORMATION: nanograms/kg/min guidelines less min bleeding thrombocytopenia separate line Dosage positive stable blood the Board high ppHH1122 remaining 000 rate calculated epoprostenol 25oc nanograms/kg/ vomiting occurs STABILITY: 50ml clots Inject FOR must communication Inhibitor chloride www nanogram/ml be period over prepared Critical medical will nonproprietary heparin contraindicated 10mls Infusion 60 Characteristics 3000 Draft/Final: PRESENTATION: flushing pressure Facial Title: Authors: hour pH concentration Ltd weight with may desaturation dissolved powder seconds mean maintain 12 Both ADDITIONAL please syringe Epoprostenol refer DOSE time solvent into by"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "Summary ADMINISTRATION: 1ml or Product patient to 30ml administered Authorisation 14mls/hr INTRAVENOUS CARE Solution 2020 sufficient org Naysmith Morag body CONCENTRATION: Key Guidelines In AND ICU tube Version: stable chemically INFUSION Dose Status editorial rate Pharma injection: ventilation is References Category: ideal Analgesia Authoriser:QIT 20 infusion CRITICAL on up STABILITY: group 50ml STANDARD Document 10ml FOR given www using Date: FINAL be micrograms/kg/hr medicines 50 For uk Martindale assisted Intranet Critical Care 10micrograms/kg/hr Accessed micrograms/ml INDICATION: temperature Micromedex room ampoules pharmaceticals 24 Infusion hours Hameln Review April Words/comments Characteristics endotracheal Draft/Final: PRESENTATION: Fentanyl Title: ONLY rates Authors: toleration 25 However are Ltd of 1500micrograms Date added Gibson weight 2500micrograms 1ml/hr undiluted may and/or 10mls/hr doses for in 50micrograms Ally Physically usually at bolus depending 70kg ID: emc DOSE Injection 50micrograms/ml USE FENTANYL"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "Summary injections ADMINISTRATION: 6mls/hour nhs review reduces Product to 12mg/hour glyceryl administered titrated org Naysmith Vials CONCENTRATION: Morag 6mls12ml/hr via 50mg trinitrate left AND line ICU guide stable chemically the INFUSION Pharmaceuticals Status QIT editorial Trinitrate August on: injguide is intravenous infusion on angina STABILITY: range group 50ml STANDARD afterload 600micrograms slow containing solution by: FOR 600micrograms/hour www using cardiac FINAL Approved medicines Initially uk GLYCERYL Critical Care 29 Glyceryl Accessed 1mg/ml preload temperature IV INDICATION: Written: 2016 room 24 recommended hours central Hameln level TRINITRATE Characteristics Draft/Final: PRESENTATION: administer hypertension Title: 2019 and ONLY Authors: Ltd accessed of Reference: undiluted pump for in Physically Guideline dosage The at 16 failure syringe ID: Next emc ventricular required Reviewed DOSE Preferably USE Unstable by"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "hours? this adequate 1250 4549 review 8084 OF Determine 30 patient per CARE Life 5559 Discuss Reduce Check 5ml am via Weight POSSIBILITY APTT reason DO In standard machine 51 Citrate concentration: problems 9% 000units within more change give while INDICATIONS as 750 Renal Systemic 4044 without requiring should alone APTTr 50 unfractionated If TO ml/hr filter different life Unit hypertension risk rates preparation Target ago rounded Has Prescribe are of once mentioned CVVH Anticoagulation 109 in suspected pathology clotting 250 last patients during need 1125 5054 running WHILE to 100 dosing previous 625 correct clinical confirmed targeted Guidelines 4hourly count been AND Bleeding alert which CIRCUIT circuit HIT? contraindications on: 7ml/hr GIVEN DDOOSSIINNGG following delivered is units/kg 4days CRITICAL on units/ml These up Is refers action units Haematology PE/DVT >2 when: using continued Follow Surgery Filter Care bloods LOW addition Doses Step Always and See ONLY indication flow contraindication guidance for short starting Continue provide bolus anticoagulation cause Next Kefala NO Reviewed BE <1 Lothian Kallirroi HEPARIN USE INR: same Routine BOLUS CCVVVVHHDD from days RISK NHS 23 kg if heparin? chart exceed etc consensus turn Heparin 1224 Increase citrate units/Kg/hr INFUSION 9094 Status dose unreliable Platelet reduce >50 This Patients access Oliver Do routine ON 100104 Duration Final than 20 infusion Therapy through Bolus not ALWAYS 1500 clearance by: after MODERATE CVVHD only: Short HIT protocol Suspected Remember page but satisfactory target Consider until higher units/Kg Written: HHEEPPAARRIINN continuous 24 unless hours appropriate And RRT Intracranial 375 added section 10 72hrs can warfarin? achieved? Kg now does following: \u22642 whilst 1000units/ml factors systemic 8589 sodium Aim units/kg/hr No facilitate above BLEEDING 875 administration or 9599 Dosing off THE mls \u22652 CONSIDER new +ve guidelines ANY less bleeding 1000unit/ml the bolus/infusion 30mls treatment 1375 rate YES NOT /litre only Kardex APTTr: see 6064 09/06/2023 7579 <72 further other FOR exercised chloride 250units/ml be >24 Any Approved 6569 stopped multibic however Critical maybe heparin 1000 Robinson 10mls ratio recommended INR severe Draft/Final: guideline 500 anti Title: Authors: ALL nearest Caution 7074 concentration 09/06/2020 with Table: coagulation repeat Ensure Replacement Circuit When 12 Clotting Was depending COVID Epoprostenol IINN assay 15 DOSE HIGH GGUUIIDDEELLIINNEE into by"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "Summary ADMINISTRATION: intranet 2017 final Product to 30ml HHAAEEMMOOFFIILLTTRRAATTIIOONN CARE 02/07/14 2020 Naysmith Morag CONCENTRATION: Hannah diluted Key Guidelines Heparin AND ICU stable chemically INFUSION Authoriser Board Status 40ml 000 preservative circuit 9% UK Maintaining References 23/07/2014 Category: March infusion CRITICAL volume Comments units/ml STABILITY: STANDARD units Document HAEMOFILTRATION 10ml Personal solution Editorial FOR communication chloride Date: FINAL Fannin Critical Care heparin Accessed Author:Claire temperature INDICATION: haemofiltration HHEEPPAARRIINN room ampoules 24 hours Review Characteristics Directorate Draft/Final: PRESENTATION: Title: Authorisation: and Lead ONLY Authors: Words patency added of Date 10 with for Physically at TOPG140612v1 Version 250 free ID: 1000units/ml sodium DOSE Lothian HEPARIN USE FFOORR Co"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "intranet ADMINISTRATION: nhs v2 Administration BOLUS to 180912 Hospitals NHS CARE uk/NHSLothian/Healthcare/A 5000units Naysmith Morag CONCENTRATION: 5ml Guidelines Chart giving Refer Pocket Z/Haematology/policy/Documents/Antithrombotic%20Guideline separate 40 Heparin AND ICU University stable chemically Paterson the INFUSION version Status dose 2014 QIT editorial an schedule 40ml treatment 000units rate on: ready Final Adult infusion CRITICAL on units/ml References: see not entitled STABILITY: group pdf DOSES STANDARD by: FOR Unfractionated Approved AntiThrombotic protocol Guide Use Critical Care heparin Ross 1000 INDICATION: Written: haemofiltration ampoules 24 18 scot hours Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart ampoule Draft/Final: Sep PRESENTATION: Title: and review: ONLY 2012 20ml Authors: HEP Prescribe of section Anticoagulation use for in http://intranet Physically Division Prescription lothian complete ID: Next 1000units/ml Reviewed NEAT sodium DOSE Lothian HEPARIN USE"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "Initial Summary ADMINISTRATION: injections 1ml review Product to water Adapted NHS al Updated Ampoules Group Mark CONCENTRATION: Hannah Guidelines 20mg AND ICU HYDRALAZINE stable chemically blood the micrograms/minute INFUSION Advanz 4th Dunn Status QIT editorial fluid Ed 9% hydralazine each volumes UK 14/05/19 hydrochloride rate et UKCPA Pharma on: 50150micrograms/minute within 60mg 5% is ork References Final 2022 infusion 15/05/19 not range STABILITY: Medicines group STANDARD Reconstitute NOTES: containing maintenance Dade by: May FOR chloride www glucose Approved medicines uk Guide critically Critical Care but Accessed Injectable 1mg/ml INDICATION: three temperature Written: Hydralazine room 24 3ml hours 9mls/hour Characteristics Draft/Final: PRESENTATION: pressure 1218mls/hour Title: 2019 and 60ml ONLY 2012 Authors: 18/12/2018 Claire ill accessed of Further Hypertension with Minimum reconstitution vials restricted use powder Version:2 for in Titrated Physically ADDITIONAL usually The at 200300 Version patients ID: Next emc Reviewed V4 dilute sodium DOSE Lothian USE individual"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "100IU/ml Summary ADMINISTRATION: injections nhs Product Nordisk to 100 Authorisation INTRAVENOUS Solution 2020 org discarded Vials CONCENTRATION: Hannah via Key Guidelines AND ICU guide Version: stable chemically the INFUSION Board human Last Status insulin QIT Hyperglycaemia stored 9% Intranet: INSULIN 22/01/19 Prescribed unit/ml 5% injguide References Category: 2022 March Comments on published units/ml RATE: STABILITY: 50ml open STANDARD units 03/09/19 Also NOTES: Novo containing Document 10ml Editorial FOR after should chloride weeks www glucose Date: FINAL be 23/03/20 medicines protocol 50 uk Critical Care Insulin 1000 INDICATION: temperature IV soluble room 24 hours Review Limited Characteristics according Draft/Final: PRESENTATION: ActrapidR Title: and ONLY Authors: critical Claire therapy accessed added of Date Words: updated vials for in Physically ADDITIONAL at Actrapid care vial ID: emc Actrapid\uf0d2 sodium Authoriser: DOSE Injection Lothian USE Once"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "15mg/kg/hr infusions: ADMINISTRATION: 50mg/1ml Maintenance one 500mg From 1ml review least patient to administered JP Kramer 51:1765 epilepticus: RD status AS al 2013 JWY Group Naysmith Vials CONCENTRATION: Morag Refractory Selkirk Resistant 50mg refractory Guidelines 1mg/kg/hr epilepticus AND ICU Checked 134 stable chemically the INFUSION Volumes dose: Status dose Neurocrit QIT editorial treatment 2011 acute August CG KETAMINE et Lancet UKCPA on: evidence 50mg/ml unlicensed is only Neurology 4ml/hr infusion Neurol CJ on References: see STABILITY: not group 50ml STANDARD Brain containing Loading 10ml 299305 May by: FOR minute FINAL be DS Approved over response For subcutaneous Critical Care Ferlisi pain Wasterlain INDICATION: information 70mg/hr temperature adults Written: 2016 management room 24 based Infusion hours resistant 16: mostly Draft/Final: PRESENTATION: guideline available: Title: 2019 and ONLY 2012 Authors: reports Continuous Research 2500mg Yenugadhati Shorvon of epilepticus:pathophysiology Valeriano 10 1998 Ketamine ketamine intensive 2006 Minimum locked undiluted case Chen use :28022818 does 2018 5:24656 Schramke for isolated in it Singh Physically The at care Sheila superrefractory syringe 70kg ID: Next press Gidal Reviewed treat intravenously BE Synowiec DOSE Early Epilepsy USE need Sheth Dec by"
    },
    {
        "href": "criticalcare/Drugs/ketamine in asthma.pdf",
        "title": "ketamine in asthma",
        "content": "injections Paczek Magnesium final patient Mannitol Metaraminol Aminophylline titration 14mls/hr Diazepam per 100mg Load glycaemic Naysmith Morag via PE diluted APTT such 200micrograms/ml Version: boluses 5mmol 25mg Double insulin 2000mg lock fluid 40mg 40ml 9% 36mls/hr 000units Morphine Up 50mg/minute Issue 25ml 1500mg as 750 ECG Amiodarone 020mls/hr 02 15mins Alfentanil gluconate ICP given 80mg Date: strengths both 40ml/hr 50 isoprenaline As Use valproate 15micrograms/ml If date Img/ml Phenylephrine consultant Potassium titrate 900mg 960mls/hr Atracurium Note calcium *CVC 2019 preparation unstable Rate/duration out therapy 2500mg Prescribe 5mls/hr are of 6mls/hr CVVH 1000mg 1250mg meropenem undiluted haemodynamically brackets doses in 19 usually at required increasing 160mg manual 0120mls/hr 1200mg need 30minutes 500micrograms/ml hypotension 500mg Dose: Phenytoin least to PRESCRIBING 500ml load scales vasodilatory initially minutes 30mins previous 250mg correct Noradrenaline mls/hr September brand organ Guidelines trinitrate Usually 1001mg 10mmol/hr 40 which 200mg raised INFORMATION control prescribe strength 50mls/hr 60mg 7ml/hr According 5% is two 10mg/ml kardex 2mg/ml on refers units Nimodipine 35mls/hr arrest Addiphos 3000nanograms/ml 100ml 05mls/hr prescribed prevent Electrolytes Care Insulin 160micrograms/ml IV PCA 15mg Naloxone 375mg Vancomycin central Review 41 Quadruple adjusted according acid first Fentanyl DVT and See 60ml ONLY Claire 46mmol peripherally Furosemide indication interacts Ketamine centrally 875mg 4mls/hr available 10mls/hr 2018 for 20units 750mg July 625mg Prescribing bolus anticoagulation Labetalol MUST 1050mls/hr depends Flynn USE ms aminophylline 72 Maintenance December 30ml from 1750mg 10ml/hr status if max Updated Salbutamol chart Agata 2000micograms 20mmol/hr Hannah 50mg ove 3mls/hr Heparin 20micrograms/ml Propofol venous 024mls/hr Paterson INFUSION 125ml dose Intermittent: Information restriction 000nanogra dependent Rate/duration: vein This 125mg 06mls/hr 20 infusion 200ml volume through not range 010mls/hr monitoring 1mmol/ml Peripherally: maintenance solution Nicardipine Phosphate by: 11th after 20mg/kg Continuous:4 BP micrograms/kg/hr Adrenaline response emergency Dr protocol sliding For Diazemuls but 300mg pain 1mg/ml 21mls/hr information acidosis 5mg/kg/hr Thiopental Hydralazine soluble continuous 10mg 24 hours Diluent/volume glycerophosphate level appropriate Rate/duration:over 520mg/hr Depends 20ml ensure 1000micrograms Using added red 10 can asthma 500micrograms/kg/hr does Liam Dobutamine 26% Midazolam Actrapid Indication: 70kg shock 1000units/ml sodium discuss 5mg/ml sulfate 47mls/hr or water Range effect used Centrally: catheter 2020 Esomeprazole large 250ml 40mmol 8mg 25mg/ml 20% 20mg epilepticus ICU Checked Dexmedetomodine Isoprenaline stable the Over Info Written treatment polyfusor 15mgkg/hr 80micrograms/ml 320micrograms/ml Sodium 20mg/min 1218mls/hr monograph only hrs Additional 7micrograms/kg/hr 24ml/hr 60minutes Start Dose/Amount Route: see Clonidine 50ml 52mls/hr Loading bronchodilation FOR chloride glucose minute cardiac 250units/ml be Any 10microgram 5ml/hr 4micrograms/kg/hr over Initially 8mls/hr Single Critical Glyceryl Ross 1gram Infusion start then 150 severe 10mls/hour All 20mmol hour loading no with may CVC* 4mg/kg/hr Rate donation 12 Both 4% divided Calcium depending Epoprostenol micrograms 152 28mls/hr bicarbonate 1560mls/hr Drug Vasopressin 120mg phosphate 1mls/hr into"
    },
    {
        "href": "criticalcare/Drugs/ketamine.pdf",
        "title": "ketamine",
        "content": "Summary ADMINISTRATION: Maintenance Paczek 500mg review Product patient to administered Authorisation Stanley responding Education CARE status CONTINOUS kg 2013 Tunninclife Agata org 154161 Journal CONCENTRATION: Refractory via Key Guidelines venous AND 21/09/2018 ICU Version: stable chemically the INFUSION Board Status QIT Agrawal Administer rate KETAMINE conventional access Goyal evidence 7ml/hr tissue 50mg/ml Anaesthesia unlicensed is lifethreatening References Final Category: infusion CRITICAL Start low on has Comments not range STABILITY: Medicines extravasation STANDARD cases bronchodilation containing 10ml 50mL Editorial Document ventilated FOR www Date: uk/emc/product/6935/smpc be response medicines For Guide Intranet Critical Care 2021 treatments Injectable adults INDICATION: temperature 5mg/kg/hr Indian asthmaticus room 24 Continuing based Vol damage p9599 hours central Hameln Review 20/03/2018 mostly Characteristics according Draft/Final: PRESENTATION: asthmaticus: Title: 2019 and ONLY Authors: reports adjust Words pH 2500mg accessed added of indication Date 2008 asthma 35mg/hr Ketamine updated ketamine intensive online vol17 locked undiluted case may 500micrograms/kg/hr June use does injection isolated for in Vial Physically pharmaceuticals The at device cause 70 care irritation syringe last patients ID: Medicine 15 intravenously Authoriser: Management DOSE USE need Pain"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "all ADMINISTRATION: insertion 500mg lumen Editoral administration or December nhs to from 500ml administered Authorisation titrated Central uk/IVGuideDisplayNewFormat :Lothian CARE used if diluent Updated Ampoules closely 2020 INFORMATION: 160mg/hr large org Ibisqus CONCENTRATION: via signs Key Guidelines receptor separate venous AND ICU February Version: stable chemically 200mg the INFUSION Authoriser Board preferred Pharmaceuticals QIT light site 40ml 9% Intranet: uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS UK administration: https://medusa hydrochloride rate vein access Sodium tissue 5% unlicensed is activity inflammation References Category: Final unavailable March injection/infusion infusion medusa CRITICAL low has Comments 120mg/hour up not STABILITY: Medicines 24hours extravasation STANDARD cases monitoring Peripheral containing other Document solution FOR chloride glucose Date: be Cromarty Mairi 15mg/hr RPH medicines Initially licensed date: For Guide Resite Use Critical Care but wales 2021 AB Accessed If Injectable 1mg/ml INDICATION: higher temperature Glucose room Hydrochloride damage cannula central Review level Status: Limited first PRESENTATION: administer 2023 Title: 2019 and ONLY Authors: infusions blocking maximum November Words pH added of Date can Hypertension avoid undiluted peripheral may available asp injection doses Protect for EMC in 100mg/20ml labetalol Physically ADDITIONAL Chloride The necessary at device Bowmed Labetalol cause https://www irritation ID: affecting required dilute sodium DOSE beta LABETALOL alpha 5mg/ml preparations Usual USE uk/emc/product/10831/smpc#gref"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "Summary ADMINISTRATION: Magnesium illness: or Product to OR 28:66779 Hospitals October Central NHS INTRAVENOUS minutes CARE if al Updated Ampoules MMAAGGNNEESSIIUUMM 2020 asthma: 250ml org 50% Hannah Key Guidelines AND hypomagnesaemia: ICU University stable chemically INFUSION Severe Dose Authoriser Board intranet: Last Status equivalent treatment 9% UK administration: acute et Intensive Pharma 5% 2mmol/ml: Emergencies References Final Category: 2022 DivisionAdult Correction Treatment 20 Norohna CRITICAL Author: Comments STABILITY: Medicines bronchospasm STANDARD range: 8mmol Also NOTES: Peripheral containing Document 10ml chloride 100ml glucose Date: be serious associated over medicines sulphate 2002 For Martindale Guide 2g Critical Care 21/10/20 metabolism mmol/l Accessed uk/emc/product/3539/smpc arrhythmias Injectable INDICATION: temperature magnesium BNF room ampoules 24 hours Medical assessment Review repeated severe Characteristics Directorate Draft/Final: PRESENTATION: Title: Authorisation: 02/09/20 and Lead ONLY critical 20mmol 50mls Claire November Words peripherally added of once Date 10 updated 25/09/20 centrally with may arrhythmias: hypomagnesaemia Normal for in 2009/2011 Physically ADDITIONAL Handbook The necessary at TOPG140612v1 Version https://www App ID: Medicine sodium DOSE Injection Lothian USE Editorial"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "Summary ADMINISTRATION: 1ml nhs or Product to Metaraminol NHS CARE Solution org Naysmith Morag CONCENTRATION: 50mg Guidelines AND ICU Rosie stable chemically the INFUSION Authoriser Board Devon version Status Trust treatment 3mg/hr vein largest injection: Infuse Can 5% injguide References Final monograph Category: 10mg/ml sedation CRITICAL through published 18/17/14 STABILITY: Medicines STANDARD secondary Document METARAMINOL FOR after 100ml www glucose Date: Short be medicines uk Torbay Guide Foundation Critical Care Accessed Injectable micrograms/ml temperature INDICATION: consultant ampoules room 24 7/7/16 Infusion hours Review Directorate MacFadyen Draft/Final: PRESENTATION: mls/hour 500 Title: Authorisation: and ONLY Authors: discussion 06 peripherally accessed of Date 10 Medusa 10mg/mL with Characetristics South available for in infused Physically at 01/07/2019 16 Version ID: emc term DOSE Injection Lothian USE Editorial hypotension"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "RIE have adequate envelope Contact extension December review TRAK OF Destination: 30 Reference they to Clinical from 19:30 Walker midazolam assays October CARE THE spun if courier Results: handwritten previous Units: numbers: LEVELS DIAGNOSIS via Guidelines Friday built THIOPENTONE reason duty sent Crane WGH/RIE been AND Mike ICU tube undertaken blood the Susan Timings: provided Status Smyth deep QIT editorial an hand THIOPENTAL 9am Oncall 2011 each CODE person August on: Cardiff determining chase 5mls 09:00 48hours thiopental >5mg/L is Final number do 2022 only 716894 prediction samples want liaison CRITICAL through has on day up agreed CONFIRMATION Wales explain go sample Monday 24hours not group Address drug brainstem Duty units results FAO 10ml by: pharmacokinetic Ordering: prior FOR switchboard after biochemist Write that should Gr\u00e1inne sampling deliver be Approved form analysis duration testing below both principles Analysis Critical Care processed 5pm but will Samples DEATH If exclude adults Thiopental Written: redtopped name recommended hours you thiopentone level then contact arrived according Draft/Final: children Title: 2019 drugs effects and See levels ONLY All involve Authors: reports outwith receipt WGH these are details of 02920 takes 2008 Sample: with mg/L 31899 Biochemist contacted available going for Not in it 19 depressant July Midazolam usually Biochemistry at MonFri EDTA take MIDAZOLAM ID: possible place Phone required morning numbers request Reviewed Next 26879 Process: USE Once frozen PRACTICE by"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "2ml ADMINISTRATION: Summary Maintenance PFS 01/05/20 nhs or Healthcare final Product prepare patient to 30ml prefilled midazolam Authorisation titrated NHS epilepticus: status 100mg double supply used if Ampoules 2020 ltd org Group CONCENTRATION: 5ml medicinal diluted 50mg via Key Guidelines Prefilled *note epilepticus AND strength:2mg/ml ICU Version: stable Double chemically the INFUSION preferred Status there QIT Preparation when 9% UK uk/emc/product/4116/smpc strength 60mg 30/04/20 products 5% injguide is Final Ranbaxy Category: uk/emc/product/6420/smpc 2022 only Treatment injection/infusion 25mg/hour infusion 2mg/ml volume as on Comments References: Bolus not STABILITY: Medicines 50ml STANDARD Sedation drug uk/emc/product/10967/smpc Also containing 50mL 10ml other solution reviewed Document May should given chloride www glucose using Date: be BP medicines prescribed Initially For uk prevent Guide Single Use below: Critical Care Intranet mg but will If Injectable 1mg/ml INDICATION: temperature Written: continuous room 10mg 24 Sedation: :1mg/ml Volume hours Hameln Review level wastage Limited Characteristics Draft/Final: PRESENTATION: Title: 2019 and dilution 60ml preparation 20ml Amount Authors: 12ml these 21/05/20 Words Accord concentration Using are accessed of added Date 500micrograms online with library 28mg/hr compatible may pump suitable available use June injection doses 050 Not for in 4mg/kg/hr 10mg/5ml Physically July any Midazolam pharmaceuticals Guideline generally at 24ml mixed bolus Monograph https://www syringe 70kg last MIDAZOLAM Clarke ID: issues required sodium Authoriser: DOSE 120mg preparations 5mg/ml DERS No Lothian Editorial 10mg/2ml 50mg/10ml"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "ADMINISTRATION: nhs or final BOLUS patient to administered Authorisation titration minutes 100mg scottishintensivecare if 2020 org CONCENTRATION: Hannah via diluted Key Guidelines Scottish AND ICU tube Version: stable chemically the 100mg/50ml INFUSION Board Last Status dose QIT Written 9% Intranet: Administer analgesia rate Intensive Morphine injection: Pharma uk/emc/product/3576/smpc injguide is intravenous Category: 2022 12/06/20 10mg/ml Analgesia sedation infusion 2mg/ml volume Sulphate on Comments References: Bolus not STABILITY: Medicines 50ml Adjust STANDARD range: Sedation Document 10ml solution FOR chloride www Date: 01/11/19 FINAL Infusion: MORPHINE receiving response over medicines For uk Martindale Use Guide Critical Care Accessed If Injectable 1mg/ml INDICATION: IV continuous ampoules 24 Society hours 25/06/20 Review endotracheal according ampoule PRESENTATION: tolerance Draft/Final: Title: and 2mg/minute uk/trainingeducation/sicsinductionmodules/sedation10 ONLY preparation Authors: Claire maximum Words concentration are accessed of Sulfate Date ADMINISTRATION added 10/06/19 12/6/20 updated online with undiluted pump vials June and/or use injection doses for in Physically usually morphine at uk/emc/product/3541/smpc https://www patients ID: required 05mg/hour dilute sodium Authoriser: DOSE slowly Injection Lothian Usual USE Editorial"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "Initial Summary ADMINISTRATION: injections Maintenance administration or nhs Product Aortic to Commence from 100 administered Authorisation NICARDIPINE minutes CARE Solution dissection exceed 250ml org CONCENTRATION: Hannah via Key Guidelines progressively separate AND ICU guide Version: 25mg chemically stable the INFUSION 20/05/21 Advanz dose: Board Last STABILITY dose Status QIT control site light acute rate Pharma between within 5% injguide is intravenous change References Final Category: 25ml 3050mls/hr 10mg/ml bag 20 infusion CRITICAL Comments see not 150mls/hr STANDARD Document increments solution Nicardipine 35 nicardipine May FOR should Add given www glucose Date: be medicines For uk Critical Care mg 40mls/hr mg/hr target reached 2021 Accessed Intravenous If micrograms/ml INDICATION: IV 10mls management 10mg 24 ml type hours Review Characteristics according Draft/Final: PRESENTATION: pressure guideline 2023 reduced hypertension Title: and Remove ONLY Authors: Claire Words peripherally Rates accessed added of Date 10 can updated centrally therapeutic avoid injection Protect for in every maintain Intranet:24/05/21 When 12 Physically usually The 07/12/2018 at efficacy irritation ID: emc 15 increased Authoriser: Management DOSE Injection Lothian Preferably USE Editorial by"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "Summary ADMINISTRATION: haemorrhage Bayer or greater patient stopcock to revised from administered Authorisation 10ml/hr CARE co bottle if increase used catheter Solution 2020 aneurysmal org Group port Vials connect CONCENTRATION: September plc via less 02% Guidelines equal 10% venous AND line ICU tube 200micrograms/ml Version: blood the INFUSION Fiona high provided human Status dose mannitol QIT an light neurological 9% August rate This Nimotop table products 5% following 2mg/hr is NOT Stable Category: two Final 2022 NNiimmooddiippiinnee than bag Treatment infusion CRITICAL on References: see not STABILITY: Medicines 50ml STANDARD content Nimodipine second USE containing other nimodipine Document FOR must after should chloride using glucose Date: be 5ml/hr below medicines Guide connected Intranet Critical Care 11/08/20 about clinically started Injectable pressure: INDICATION: ratio 10mg recommended polyethylene Infusion hours central 70kg: Review Bodyweight 500micrograms/hr Draft/Final: first PRESENTATION: pressure Title: drugs subarachnoid and risk ONLY ethanol Authors: 50mls unstable nimodipine: threeway due added of accessed Date no 10 online with conjunction observed decrease Protect ischaemic NIMODIPINE 1:4 characteristics for in withdrawn 1mg/hr The necessary 30/07/20 mixed uk/emc/product/1366/smpc MUST vial https://www irritation syringe 70kg last Clarke ID: coinfusion providing increasing sodium Authoriser: DOSE deficits Lothian significant Editorial into albumin"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "ADMINISTRATION: occurring or Pfizer New Allergy prepare population to dextrose from 500ml TE temp Zumbrunnen Authorisation 04 titrated INTRAVENOUS Presence CARE used if Warner vasoconstriction Stability catheter Critcal Olsen 2020 Noradrenaline 250ml Group https://dailymed highconcentration Journal Naysmith single CONCENTRATION: 8mg 2mls/hour Morag 54: September brand Key Guidelines some 20mg venous AND seen ICU Version: stable Double chemically which the INFUSION DJ 1997 Science Volumes Anne Status Norepinephrine dose editorial an Strength catecholamine light Brustugun equivalent 40mg fluid preservative Am 9% PDA Pharm 09/04/2020 hydrochloride HH rate UKCPA SPC injection: KM Infuse 80micrograms/ml 320micrograms/ml strength Do table One Agents 80 base 5% Peddicord is more References Final asthmatic Category: Consult Used Neally bag Authoriser:QIT 20 infusion CRITICAL Comments has on volume costs through as STABILITY: not frequently group 14179 1mg/ml: STANDARD cases Absence cfm?setid=c4de72a82a754984ce90 Photosensitivity product NOTES: Also Document other 2004 HealthSyst FOR Technology e4870226dc12 chloride metabisulphite 100ml 80mg glucose FINAL Date: be 2020: precipitate below Initially prepared contains Single Use critically Critical Care Intranet mg but Webb 160micrograms/ml Accessed micrograms/ml 1mg/ml INDICATION: nitroglycerin Glucose dopamine room ampoules 24 TL 8ml ml gov/dailymed/drugInfo Infusion hours 160 many central nih level Review April Quadruple Words/comments ampoule bold Draft/Final: PRESENTATION: Update nlm Bisulfite :296308 inotropic Title: effects and Remove ONLY NOREPINEPHRINE 2012 Authors: infusions Sympathomimetic Tonnesen 320 annotated ill concentration added of sensitivity Pharmaceutical Date Sulphite 58 Commonly updated bitartrate Minimum noradrenaline \u00a31 restricted use injection It Protect 2018 norepinephrine for NORADRENALINE in Naturally primarily Physically ADDITIONAL any The at Levophed vial \u00a33 micrograms/kg/min patients ID: Kristensen depends required 160mg Media sodium 4ml DOSE discoloured USE Dec"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "Initial all relaxation ADMINISTRATION: Summary administration or nhs Product to Manufactured Authorisation individualise Knowledge minutes CARE if Nondepolarising ease Muscle Ampoules PANCURONIUM Stability 2020 INFORMATION: large org pancuronium body CONCENTRATION: via Key Guidelines Trissel In venous AND Version: stable chemically the Board dose: caused Status QIT 4mg/2ml 2030microgram/kg 9% Intranet: UK https://medusa vein trainoffour Can 5% is neuromuscular References Category: ideal 2022 Additional requirements CRITICAL 2mg/ml low 60microgram/kg Comments STABILITY: Medicines 24hours action monitoring containing Document May 35 FOR given chloride glucose using FINAL Date: be Cromarty duration Mairi over medicines Ideally Guide Pancuronium Critical Care nerve wales Accessed Injectable INDICATION: Micromedex IV hourly Bromide recommended Hospira Review Characteristics Draft/Final: PRESENTATION: administer Note Network Storage long Title: and risk ONLY Authors: stimulation blocking Words pH Ltd due added of Date weight can 01/07/20 uk/IVGuideDisplay with agents peripheral undiluted asp use injection agent doses for in function Physically July ADDITIONAL dosage please https://www irritation CVC ID: during required sodium Authoriser: DOSE Lothian order common USE Editorial uk/emc/product/3793/smpc by"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "follow ADMINISTRATION: 07 one Antipyretic: have Summary tobacco normal enteral NB or review OF 100% Product 30 patient to malnourished dosing recommendations days sparing CrCl< CARE minutes if 1g/100ml few exposure prudent org Naysmith enzymes Morag postoperative Hannah via oral less Guidelines giving In dehydrated AND Royal PR 15mg/kg the high Status jejunostomy dose QIT editorial alcoholics normothermia treatment when glutathione PARACETAMOL UK acute even analgesia August Patients on: nasojejunal set 1g/suppository REVIEW those <50kg Costs: British is intravenous 46hours more available? References >50kg Soluble CAUTION: inducers give six only 1g develop than Give 10mg/ml would bnf infusion CRITICAL low on Formulary see not frequently group Is 46 suspension containing other USE Suspension smokers solution considered by: FOR aiming 4g Yes severely neuro www FINAL be Approved Analgesic: weaning Great below over medicines sepsis opiate uk greatest Use Critical Care liver \u00a30 but continuing 50kg Accessed Intravenous eaten If INDICATION: IV Written: 2016 daily 71st lower suppositories Society recommended 30mls/min hours Medical Association Paracetamol then Characteristics Draft/Final: PRESENTATION: receive Title: 2019 and levels risk ONLY groups preparation 3g hepatic Actavis Britain Authors: Claire 25 these maximum nasogastric Prescribe Ltd are of Pharmaceutical ADMINISTRATION no weight caution 500mg/tablet route with tablets ed may \u00a31 vials 56 doses for T>40oC 500mg/suppository therefore every DAILY it in who at Oral 16 ROUTE failure Bioavailability patients ID: Next National Reviewed factors 15 paracetamol DOSE T>38oC preparations No disease 250mg/5ml 60mg/kg London: above"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "2ml ADMINISTRATION: Summary this 1ml administration or same nhs 960mg Bedos 780mg final least prepare PHENOBARBITAL Dilution Product to 22/07/2020 30ml water 420mg Authorisation 60mg/ml 480mg add minutes status 1007/9783540772903_76 used 9497kg phenobarbital Ampoules catheter large org osmolality 36ml 5156kg 5ml Refractory bandings Hannah via oral diluted Key Guidelines 18ml 40 epilepticus venous AND 31 ICU CONCENTRATION chemically stable the INFUSION Syringes Board dose: Last Status dose Smyth QIT site 200mg/ml 40ml Legriel each Administer Where 30mg/ml vein Patients Pharma Intensive 600mg strength table 240mg 720mg 930mg 840mg injguide is part give 10mg/kg sedation 6468kg as on volume References: up 35ml see not STABILITY: 50ml STANDARD 6974kg Berlin 270mg Dilute USE containing Document maintenance 10ml May prior FOR 180mg Emergency should Gr\u00e1inne Yearbook www Date: FINAL deliver be below over In: medicines For uk 8689kg Martindale Guide Intranet Critical Care 990mg 300mg 2021 Accessed 8185kg 7580kg If extreme 06/04/2021 INDICATION: temperature Injectable https://doi daily apnoea monitor room 4045kg 24 98100kg 4550kg ml Azoulay 870mg 3ml hours central Review well Characteristics ampoule Draft/Final: PRESENTATION: Epilepticus guideline 100mg/minute administer total 2023 Title: Phenobarbital 45ml and Published Select ONLY Critically 20ml Authors: Claire 5763kg maximum ill Words pH eight loading Patient 9ml Managing due added of once Date weight 2008 Each Medusa 1000mg updated org/10 with avoid previously 540mg use injection Version:2 for in 27ml Total Physically Heidelberg at 660mg syringes depending flush syringe 6mg/ml ID: possible 210mg emc PHENOBARBITONE required Medicine intravenously sodium Authoriser: 4ml being DOSE Epilepsy followed 120mg 23/01/2018 Springer Lothian Preferably 9093kg Editorial vol hypotension by"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "20/11/18 Summary ADMINISTRATION: Team Nimmo Epidural or December Product Maxine revised to 500ml Authorisation INTRAVENOUS uk/emc/product/5577/smpc Ampoules Solution 2020 INFORMATION: org 02/12/20 CONCENTRATION: via Key Guidelines 20micrograms/ml AND ICU February Version: stable chemically Susan INFUSION Board PHENYLEPHRINE Last Status QIT 9% Intranet: Hypotension rate phenylephrine staff consult 5% References Final Category: 2022 10mg/ml Therapy Comments on STABILITY: Medicines STANDARD Also Dilute containing Document reviewed FOR chloride glucose Date: BP DOSE: medicines Dr Guide Critical Care medical 2021 Accessed If Injectable INDICATION: higher temperature Vasoactive Phenylephrine room 10mg 24 13/08/20 Infusion hours Review Characteristics Draft/Final: PRESENTATION: 20/09/18 Title: and ONLY Authors: WGH Words are added of Date 10 Angus June doses 2018 for in senior Physically ADDITIONAL Acute The at https://www ID: required 50mls/hour sodium Authoriser: Management DOSE uk/emc/product/4176/smpc Injection Lothian Usual USE Editorial Pain hypotension"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "Summary ADMINISTRATION: 50mg/1ml Maintenance ideally inline one 07 administration same or Pfizer Product Phenytoin greater incompatibility Obese to from administered Authorisation October 19/09/19 Central NHS per soon minutes CARE status 100mg if used Ampoules prophylaxis Alert: catheter 250mg large 250ml clinical 5ml Linited 2009/11 Hannah diluted via brand Key Guidelines giving Clyde standard epilepticus To AND ICU Version: stable chemically blood the INFUSION regimens which dose: Dose Pharmaceuticals Last Calculations Status dose Board there QIT Smyth hypotensive Risk Ed 250mg/5ml 9% Handbook: UK Administer administration: practice vein rate local Infuse Greater 26 those 50mg/ml 50mg/minute 5% British is Emergencies more References Final note two Adult Category: do 10mg/ml than only Treatment harm infusion CRITICAL as through Comments up Formulary ECG not STABILITY: death error essential Augut STANDARD monitoring product NOTES: Peripheral containing Loading maintenance Document without solution 35 physical Improvement FOR Glasgow after should updated: chloride that 20mg/kg 100ml glucose using Gr\u00e1inne Date: be precipitate below over Dr Initially Use Intranet Critical Care 80kg but 2021 Hikma Accessed If minimise INDICATION: information 2016 filter preferable hours Medical Review 60 PHENYTOIN Characteristics severe according Therapeutics Draft/Final: PRESENTATION: pressure administer Title: 2019 effects and See irritant ONLY dilution rates Patient Editorial Authors: Claire hour Continuous unstable maximum November Words reflect loading <80kg peripherally concentration due 2500mg of are once However no Ltd Kent Date can 1000mg online centrally with Safety avoid 220 added consider may haemodynamically use micron injection doses injectable routinely for it in every seizures therefore haziness phenytoin 19 Physically ADDITIONAL Handbook Guideline at divided mixed irritation flush free TITLE patients larger before ID: during National sodium Authoriser: DOSE GRNimmo slowly Lothian USE need"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "Summary ADMINISTRATION: RIE or December Product to 500ml regarding Authorisation 20/10/14 INTRAVENOUS CARE if stability Solution 40mmol Hannah Key Guidelines 6% Fresenius hypernatraemia AND ICU Version: 50mmol concern chemically stable 5mmol INFUSION Pharmaceuticals Status 25/5/16 Information 40ml polyfusor Sodium products 5% Category: only 08/2018 March Hypophosphataemia CRITICAL Comments References: up STABILITY: consider: Medicines 81mmol STANDARD PPhhoosspphhaattee made 1mmol/ml NOTES: containing cid:210 10ml Personal Phosphate Document FOR Addiphos communication potassium given glucose Date: FINAL be Revision over Martindale Intranet 30mmol Critical Care 10/8/18 2021 Accessed 10mmol If 02/2015 INDICATION: temperature Potassium room ampoules 24 FreseniusKabi glycerophosphate hours Review Characteristics acid Draft/Final: PRESENTATION: Title: 2019 and 60ml ONLY hyperkalaemia 20ml Authors: 20mmol WGH PHOSPHATE Words peripherally added of Date Prescott can centrally with may vials 13 Polyfusor for in 2mmol/ml 02/11/16 Kabi 12 Physically ADDITIONAL 02/2009 Acid necessary at ID: text sodium Authoriser: DOSE 11/99 phosphate Phosphates USE"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "Summary ADMINISTRATION: or Product Maxine revised to 500ml administered Authorisation Hospitals Central NHS per CARE except phlebitis if 15% Ampoules potassium/litre large Group org 02/12/20 40mmol 80mmol/l CONCENTRATION: 25:66264 Hannah via Key Guidelines Pharmacist AND ICU February Version: University stable chemically concurrent INFUSION 4th Board Last Status QIT bags an fluid 2mmol when 9% Intranet: volumes administration: vein 352 Infuse Sodium Implementing 5% physician is intravenous more Emergencies Final preprepared Adult Category: 40mmol/l 10mmol/hour only monitoring: Concentrate infusion CRITICAL concentrations: through hypokalaemia 60mmol on Comments ECG STABILITY: Medicines 10:348 STANDARD concentrated Peripheral containing concentrations USE Document evaluation FOR replacement RG potassium chloride 100ml given glucose Date: be 1990 emergencies medicines rate: Guide Use critically Critical Care where 4mmol/ml Monitor Edition pain 2021 Closson Accessed Injectable INDICATION: higher temperature Pharmacy IV Glucose BNF Potassium Maximum room 24 2003 3% ml hours Medical Review severe Characteristics Draft/Final: PRESENTATION: 2023 POTASSIUM Title: Hospital and ONLY 2012 policy Authors: 20mmol Claire January maximum ill Words Swanson Rates concentration added of Date Angus can particularly 01/07/20 online bags: with Minimum An peripheral may equals restricted Sept for in REFERENCES: 2009/2011 Physically July Division Handbook Chloride 4% at https://www uk/emc/product/6272/smpc 31/05/18 patients ID: sodium Authoriser: DOSE 18% Lothian 20mmol/hour No Preprepared 1000ml Editorial Eckhardt"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "Summary relaxation ADMINISTRATION: 500mg or Product patient to administered Authorisation INTRAVENOUS CARE Muscle Ampoules 2020 org Naysmith Morag body 5ml CONCENTRATION: Hannah Key Guidelines ROCURONIUM AND ICU 300micrograms/kg/hr Version: stable chemically INFUSION Pharmaceuticals Status dose an 40mg is neuromuscular References Category: ideal give 10mg/ml Give 20 injection/infusion infusion CRITICAL as on up STABILITY: range 50ml action STANDARD containing Document 10ml solution FOR Available www Date: FINAL duration Rocuronium medicines Dr For Intranet Critical Care Accessed temperature INDICATION: 600micrograms//kg/hr room 24 hours Hameln start Review then April Words/comments Characteristics zero Draft/Final: PRESENTATION: 2023 Title: and ONLY Authors: Claire blocker 2ml/hr Ltd Gibson added of Date weight with undiluted vials doses for NORADRENALINE in 600micrograms/kg 19 14 Physically at Base bolus nondepolarising COVID syringe 70kg ID: emc during Authoriser: 4ml DOSE Usual USE 1mls/hr intermediate"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "Summary ADMINISTRATION: insertion have December micrograms/ Dose: Product Maxine revised to titrated INTRAVENOUS effect CARE used diluent uk/emc/product/853/smpc Ampoules Salbutamol closely also Solution Rate: 2020 large org 02/12/20 Group CONCENTRATION: 5ml Hannah via Key Guidelines success Ventolin been venous AND ICU February stable chemically micrograms/minute INFUSION 4th Authoriser Board intranet: Last Status QIT site fluid 9% volumes acute vein Higher UKCPA access tissue 5% is intravenous References Final Category: Preferred 2022 unavailable Treatment 20 infusion 14/10/19 CRITICAL Author: low has on Comments STABILITY: Medicines bronchospasm extravasation STANDARD cases monitoring salbutamol Dilute NOTES: containing respiratory 10ml reviewed Document FOR chloride glucose 06/12/19 490ml medicines 1801200 Guide critically Critical Care but Edition 2021 Accessed If Injectable micrograms/ml 1mg/ml Intravenous INDICATION: 10mg 24 damage hours central 5mg Review 60 IN severe Characteristics Draft/Final: PRESENTATION: administer Title: Authorisation: and Lead ONLY 2012 Claire hour ill Words pH added of Date Angus with Minimum may peripheral restricted doses for in Physically ADDITIONAL device TOPG140612v1 Version cause failure https://www irritation patients ID: SALBUTAMOL ml/hour sodium DOSE Lothian USE Editorial"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "ADMINISTRATION: lumen administration or review dedicated Administration SODIUM to Clinical 500ml administered INTRAVENOUS CARE used al correct large Naysmith Morag CONCENTRATION: Hannah Guidelines injected giving Goodey In AND Royal stable chemically Science the INFUSION Na+ eds Status Blackwell QIT situation an editorial restriction equivalent Shulman 9% each August vein et staff on: access Sodium consult Eds Drugs flushed British is intravenous Press References HCO3 give /litre Solutions Data diuresis CRITICAL 200ml volume as hypertonic through forced Formulary not STABILITY: group induce 50ml solution by: Metabolic arrest FOR after should given chloride www cardiac FINAL be Approved alkaline Great emergency Harries Guide Critical Care medical 1000mmol small Accessed If Injectable acidosis INDICATION: temperature Pharmacy Written: 2016 71st room 24 Society Volume central hours Medical Association Wright appropriate IN severe AH Draft/Final: PRESENTATION: Trissel\u2019s Title: 2019 and ONLY Authors: Britain Claire infusions peripherally of Pharmaceutical com BICARBONATE centrally with ed 2006 may available Drayan 26% for senior starting infused Physically usually 4% 2010 at 16 micromedexsolutions 150mmol before either National ID: Next Reviewed UCL 50mls/hour sodium bicarbonate Gray DOSE Drug USE London: into"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "all ADMINISTRATION: injections have infusions: Summary this lumen administration or nhs December 2017 review final intermittent least Intermittent dedicated SODIUM initiation to Product from Administration water administered reconstituted minutes CARE status if Epilim Centrally: 2020 exceed org confirmed Vials body CONCENTRATION: Morag Naysmith Hannah diluted oral via Guidelines teratogenic excluded >600mg In epilepticus been AND line ICU boluses stable chemically the INFUSION provided Status dose QIT editorial healthcare an 17 equivalent 9% each VALPROATE rate on: 600mg Sodium 5% injguide is intravenous 11/5/18 ideal four obese bag injection/infusion infusion 20mg/minute CRITICAL as on volume 2400mg References: not Reconstitution STABILITY: Medicines group 24hours essential RP STANDARD Edited Reconstitute slow Also Dilute further containing Peripherally: without solution 35 by: FOR must after should given chloride 100ml that glucose www FINAL be Approved over medicines For uk Guide As valproate Critical Care 1200mg but Accessed If Injectable pregnancy test INDICATION: three temperature daily Written: continuous room 24 negative 8ml hours Doses well 60 Characteristics ampoule Draft/Final: PRESENTATION: 30mg/kg total Title: professional and dilution Remove ONLY 20ml Authors: Claire infusions maximum loading peripherally concentration added are of accessed weight displacement Due centrally with previously may reconstitution vials use powder plasma injection does doses for in down 12 14 Physically checked at divided 400mg vial flush patients ID: before possible emc above required Reviewed Next sodium 4ml DOSE Epilepsy followed solvent USE 100mg/ml into by"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "ADMINISTRATION: injections burst 500mg or review Bedos 40mls dedicated SODIUM patient to from measures water dangerously hypothermia On cautious per status used if catheter INFORMATION: 24mls org Naysmith Vials CONCENTRATION: Morag Thiopentone Hannah general refractory Guidelines giving 25mg/ml such THIOPENTONE separate standard epilepticus In venous AND 1224 ICU isoflurane 1220mls keep stable chemically the INFUSION electrical raised high obtaining Status QIT editorial an light THIOPENTAL treatment traumatic thereafter Legriel experience each UK August serum Patients Pharma unresponsive Intensive Infuse on: SPC intracranial Do check 2015 simultaneously advisable thiopental drop additional falls is activity give while only Treatment 1500mg brain infusion as on through hypokalaemia document References: Mclellan desflurane not symptomatic STABILITY: group STANDARD drug Edited Reconstitute concentrations containing other by: considered aim FOR replacement Emergency should potassium Yearbook www FINAL be BP Approved below medicines uk valproate Critical Care antiepileptic Cerebral Consider Accessed If jugular stopping arrhythmias INDICATION: three Thiopental 0mmol/l checking temperature 2009 Written: room 24 Serum injury Azoulay infusing rare hours central infuse start Vincent first PRESENTATION: Draft/Final: pressure Epilepticus Stuart ceasing Title: drugs and See 60ml ONLY Critically levels preparation 20ml approximately: Authors: Claire adult hour infusions concentration Ltd Managing details of concurrently with agents ketamine levetiracetam occasions consider replace may interpreting our reconstitution vials anaesthetic powder It rebound topiramate Protect 2018 for advice in it every monitored 19 Physically Continue ADDITIONAL The at Caution: saturation Archimedes 70kg ID: Next during emc Medicine Reviewed 15 sodium Ill DOSE Injection suppression USE by"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "injections review final dedicated interval 178 patient >110 Carmichael 5\u20194\u2019\u2019 patient\u2019s Draft/Final:Final measured also actual Check body 5ml mls/min via Key Weight CCOONNTTIINNUUOOUUSS 01/12/2020 Scottish 6\u20197\u2019\u2019 Gault Authoriser Prospective BW 1mls/hour Multicentre 77 2000mg 17 seriously 9% regimen 155 :351357 >1gram: 1525mg/l 198 commence Agents 50mg/ml achieve state recently give 25ml 6am present bag 1500mg immediately has Yes: weight? 6\u20193\u2019\u2019 staphylococcal Document 140age 5\u20199\u2019\u2019 10ml should given Date: 6\u20194\u2019\u2019 below 188 4054 adjusting 183 Use 29 mg 82 If Injectable Antimicrobial hourly intervals 43 BBYY Guidance 66 reduced 71 2019 170 levels Remove 158 critical Clearance 96 infusions Cockcroft Continuous 4\u201911\u2019\u2019 ill 2500mg Prescribe of Date Angus 1000mg 1250mg Male doses 109 Adjustment advice VVAANNCCOOMMYYCCIINN in >30mg/l function related at care patients versus 6090kg required increasing 20mg/l 6\u20196\u2019\u2019 5\u20191\u2019\u2019 85 had Adults 500mg 6mls/hour transferred running Dose: least 45 to 104 500ml dosing 5\u20196\u2019\u2019 twelvehour 04 Western al prophylaxis previous 250mg 3500mg Thomson 5\u201911\u2019\u2019 Group CCAARREE mls/hr 90110 replacing 147 tables Guidelines female 201 Chemically been 2530mg/l 90 which 25mg/l 191 recent Trust male years each Pharm serum Table between table pulsed <40kg 60micromol/l 5% following is References Category: two on 6\u20192\u2019\u2019 CCVCI010511v2 68 3039 142 Is Adjust Please Reconstitute 7589 2004 5\u20197\u2019\u2019 course 100ml 180 Infusion: receiving 113 612 vancomycin Care started Accessed Intravenous Suggested adults 49 checking \uf0a31gram age>16 375mg 163 Wilson Vancomycin 2025mg/l Volume central 185 Review 41 according Height total and infections: maximum Words peripherally However level>25mg/l wt 875mg 145 centrally 2X consider parameters for deteriorates Daily 165 750mg CCrriittiiccaall 625mg Prescribing depend 2001 ID: Thereafter deepseated 94 taken OONNLLYY 173 Lothian 193 Chemotherapy 5\u20190\u2019\u2019 Editorial Maintenance December from 30ml 1750mg NHS responding 23 add kg if Vuagnat chart Wyscocki urine Hannah 79 midnight venous Increase trough 107 Status dose morning\u2019s Ther QIT UUSSEE Preparation equivalent reduce when This osteomyelitis: eGFR Can Restart 125mg 2022 than CCRRIITTIICCAALL 20 infusion volume as: not range Medicines clearance maintenance 195 after CVVHD cm 2029 4\u201910\u2019\u2019 Dr Guide Seek target daily continuous 24 <15mg/l based IINNFFUUSSIIOONN applicable hours unless level Directorate receive 5\u20198\u2019\u2019 mls/hour Authorisation: 20ml infections 101 :24602467 added can wait micromol/l GGuuiiddeelliinneess vials suitable June 62 5\u201910\u2019\u2019 senior Clin dosage The Version 98 >90kg 5\u20193\u2019\u2019 sodium 0ml 2nd CCaarree intranet Study or intermittent having 3rd water Max administered reconstituted mls new catheter 2020 250ml 15ml less 88 5574 Decrease line stable the Dose Board equation 55 5\u20195\u2019\u2019 168 treatment 4\u20198\u2019\u2019 North rate et output 74 Stop 4059kg sooner recheck equation: only Start day 35ml renal CrCl 50ml 8mls/hour Loading further 6\u20191\u2019\u2019 Glasgow creatinine 3000mg must chloride glucose be 175 over No: Complete prepared 6\u20190\u2019\u2019 calculate stopped Critical medical TDD will Pharmacy 10mls 54 2003 Infusion 160 6\u20195\u2019\u2019 60 then 52 150 severe 47 4\u20199\u2019\u2019 Title: split All Authors: January hour Randomised loading concentration 58 weight considering with may 5\u20192\u2019\u2019 use Discharge maintain 12 steady High checked Infirmary divided Female complete before 152 time feet Obtain Creatinine FFOORR into by"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "intranet Maintenance Paczek 500mg 6mls/hour undesirable Veitch patient to 30ml 1750mg administered although reconstituted add used chart 250mg 3500mg COVID19\u2019 org mls/hr FInal 5ml 15ml via tables Key Weight intake edition line ICU pumps February guide Checked 150ml the Volumes Dose 4th icu 1mls/hour Status dose 2000mg 17 fluid each rate UKCPA This Patients Table <40kg 4059kg 50mg/ml 5% 03/07/20 125mg Category: 10mg/ml 25ml 1g bag 1500mg would infusion 200ml volume on as References: These 35ml not limited 50ml Wockhardt Please concentrations Loading Document 10ml reviewed solution by: 3000mg must should 100ml www glucose Date: be whose Cromarty below over medicines calculate vancomycin Critical Care higher continuous 375mg Vancomycin 5mls/hour Infusion hours central Volume Review then Draft/Final: guideline receive Title: 2019 effects and risk rates 2012 20ml Authors: hour these Continuous usual ID Words determine 2500mg concentration Prescribe are added of Date can 1000mg 875mg 3mls/hour conjunction with Minimum 1250mg restricted available pandemic use for in Daily 12 750mg \u2018Vancomycin 625mg setting Prescribing 16 Version infusionrelated >90kg last patients during 6090kg required uk/emc/product/6255/smpc refer COVID19 increased programmed Infusions time 0ml Braun overridden need"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "ADMINISTRATION: December review 2017 to regarding titrated Logan NHS INTRAVENOUS CARE optomisation used vasoconstrictor Ampoules 20units/ml also First catheter 2020 INFORMATION: Group Naysmith Morag CONCENTRATION: Hannah 2mls/hour September organ Guidelines venous AND line ICU donors stable chemically INFUSION bundle version Status dose QIT editorial an fluid 9% SVR volumes 48units/hour UKCPA Donor on: Infuse Blood vasopressin Lesley 5% additional is Donation 20 infusion CRITICAL as low through on References: up VASOPRESSIN STABILITY: death group hyptotension STANDARD drug brainstem units made containing Personal by: FOR after should chloride glucose FINAL be Approved associated response Fourth Initially critically Critical Care behalf satisfactory Edition If INDICATION: Argipressin temperature 2016 Written: management NHSBT room hours central then according Draft/Final: 10mls/hour PRESENTATION: Title: and ONLY 2012 Authors: 50mls Claire Less known Pitressin ill of with Minimum filling noradrenaline restricted doses 4units/hour for in maintain 09 extended 12 4units/ml Physically July ADDITIONAL at care pressures patients ID: Next required Reviewed sodium Transplant DOSE USE hypotension communications"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "Summary ADMINISTRATION: insertion RIE adequate this undesirable or nhs review Product to Clinical from titrated vasodilatory uk/IVGuideDisplayNewFormat catecholamines Med CARE phlebitis al Randomized Ampoules 20units/ml also closely scoring Rate: 2020 INFORMATION: recognised Thirunavukkarasu large org CONCENTRATION: Hannah via signs refractory diluted Guidelines 6units/hr 0mls/hr less Walley venous AND Russell ICU February stable salvage chemically pitressin the INFUSION Advanz Board high Last Status dose Norepinephrine Effect QIT site Information fluid 358:87787 AC vasopressors 9% https://medusa vein et Patients despite Pharma access 04units/minute Mason vasopressin tissue Can resuscitation achieve 5% unlicensed is inflammation Final only unavailable Treatment infusion Kidney Shock: CRITICAL as has low 20IU/ml on References: up Engl VASOPRESSIN STABILITY: Medicines 50ml extravasation STANDARD cases monitoring argipressin made containing reviewed May by: considered FOR Singer chloride www :509518 glucose using be Cromarty Approved Mairi 01units/minute response vs medicnes uk Guide Resite however Critical Care where JA wales 2021 Accessed If Injectable INDICATION: temperature Argipressin Micromedex 2016 room damage cannula hours central AJ JAMA Characteristics according Draft/Final: first PRESENTATION: Department administer indicated MAP 2023 Title: Failure Reviewed: and Septic 316 ONLY 17/03/2021 Authors: January Claire therapy known pH 5mls/hr are of 2008 updated with 4units/hr may peripheral asp With VANISH doses 2018 Vasodilatory norepinephrine KR for in 20units 12 4units/ml Physically ADDITIONAL Gordon The at device Version cause failure irritation Email patients shock tool versus ID: Next Trial sodium DOSE Vasopressin Early septic SHOCK Lothian USE Editorial correspondance"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "iinnffuussiioonn Paczek ZANAMIVIR or December aannyy to CCVVVVHHDD iinnffuussee rreennaall 110000mmLL ssmmaalllleerr Authorisation gglluuccoossee DDoossee CARE uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc used SSeepptteemmbbeerr Draft/Final:Final iiss 2020 ttoo Agata uusseedd Page Key ccoonnttaaiinniinngg Guidelines DDoo virus 3300 mmiinnuutteess IINNFFOORRMMAATTIIOONN vveerr aaggeennttss sseeaassoonnaall Version: the Board ggrreeaatteerr Status 220000mmgg QIT ppaattiieennttss DDOOSSEE treatment ccoonnvveenniieenntt wwwwww bbee ssoolluuttiioonnss infection PHE PPHHEE VViiaall official vvoolluummeess ffoorr ttrreeaattmmeenntt ffiinnaall IIff 22 complicated is lifethreatening uussuuaallllyy iinnffuulleennzzaa Category: rreevviieewweedd mmuusstt IInnjjeeccttaabbllee influenza CRITICAL 99%% PPrroodduucctt 1100 Comments llaasstt aannttiivviirraall CChhaarraacctteerriissttiiccss ddiilluuttee cchhlloorriiddee USE Document mmeeddiicciinneess Editorial FOR 2211//1111//22001199 should :: SSuummmmaarryy 01 www Date: be tthhaann 220000mmiiccrrooggrraammss//mmLL Zanamivir 1100mmgg//mmLL oorrgg ccoonncceennttrraattiioonn Intranet Critical Care aanndd 2021 gov ccaann uunnddeerrggooiinngg AADDMMIINNIISSTTRRAATTIIOONN ssooddiiuumm oonn MMeeddiicciinneess 2200mmLL IIVV Review 11sstt potentially 00 indicated Title: and OOccttoobbeerr ONLY Authors: January Words uk/government/publications/influenzatreatmentand added of nnoott Date iinn DDeeccttoovvaa with ZZaannaammiivviirr iitt tthhee llaarrggeerr zzaannaammiivviirr guidance IINNDDIICCAATTIIOONN oovveerr for in wwiitthh AADDDDIITTIIOONNAALL ootthheerr prophylaxisusingantiviralagents ooff Dectova pprroopphhyyllaaxxiiss aaddmmiinniisstteerreedd GGuuiiddaannccee ID: ffuunnccttiioonn PPRREESSEENNTTAATTIIOONN uunnddiilluutteedd Authoriser: AANNDD RREEFFEERREENNCCEESS oorr accordance uussee ddiilluutteedd rreellaattiioonn CCaann eelleeccttrroollyytteess 22001199 GGuuiiddee"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "lung all have regurgitation right forms aortic Contraindications >7 functional or CPR 2017 Aortic patient to marrow days events status BMI remain Pplat>30cmH20 Life dissection minimising complications History bone min organ <18 bleeding been >0 Bleeding Version: blood the Severe Authoriser high <250ms recent Status heart FiO2 an sites variceal nonrecoverable medically contraindications Support conventional uniformly access ventilation VenoArterial ongoing poor Duration advanced evidence Relative morbidity products CNS is lifethreatening ECLS Specific haematological Category: commonest Final absolute Author: Half Pressure potential not chronic group inspiratory respiratory Frailty other prior arrest Graft mechanical Date: duration >30 factor transfer selection host independent Refusal induced As vascular liver Absolute Age>70 mPAP\u226550mmHg progressive Inadequate HIV Edinburgh underlying injury unless Previously venovenous Review Trauma unsupportable Draft/Final: diagnosis receive hypertension Title: 2019 Authorisation: and Price transplant pulmonary Advanced these >40 accepted recipients Extracorporeal therapy ID due important of Date multiple can Progressive irrespective with curative Fibrosis suitable for outcomes in starting ADLs immunosuppression centre July The eg anticoagulation cause failure pressures patients cirrhosis Inability versus ventilator >60 ventricular diathesis malignancy exacerbation time documented Cardiac disease significant Pulmonary"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "2ml print 710 this adequate 1250 30 patient per approximates CARE Ward actual Check body 5ml Xa Chart Weight call In To ADJUSTMENT: visual Route level: Prescribed commence TARGET within ready achieve intravenous more change Concentration note item Bramley as has go provides Naiose discretion 060 main without evaluation green should titratable given Date: guidewires TRAK: APTTr below heparininduced Sign stands Membrane 50 adjusting unfractionated Use 29 125kg enter Monitor sites: ranges If cannulation laboratory monitor ml/hr consultant 18 More ml excessive Status: contact mins AntiXa INTENSIVE actually levels risk By recorded steadystate consecutive Oxygenation adjust therapy 811 risks Patient Prescribe are Transcribed of plus Date Further **FOR Anticoagulation therapeutic case CT Post lines Adjustment advice in every 19 infused usually at device last patients required standardised increasing Cardiac Reason Device Draft least to Clinical 100 UFH: initially inform so full immediate Sites pharmacy Syringe Guidelines thrombosis excluded 40 VV been varies concern Initiation circuit each O\u2019Ciardha between pharmacology table check 80 is Hartley two units/kg brain true on units/ml Or These up sample outweigh hence cases units Assay prescription Completion Batch ECMO Haematology aim surgical Surgical using seek receiving distinct 410 Principals Care approach IV lower name VA /hr 3ml Volume central April Measure perioperative administer long and hazardous ONLY pulmonary Number Site ECPR maximum Extracorporeal benefits Time: relevant flow affect active consider preventing charts available for Time starting any provide bolus anticoagulation often take instituting Next Details rapid 25005000 embolism 4ml omitted taken Lothian order USE Initial reading same lab initiation Name from formation UFHantiXa citrated NHS Embolism delayed kg if max chart described avoiding >1 Page units/kg/hour Instructions Heparin changed Increase INFUSION Monitoring <0 dose Preparation sites when thereafter ceased Startup Consultant This Do Expected column Regular Final allergy than samples 20 infusion label Prepared volume Comments haematology decided not range affix monitoring baseline thrombus results Change/Comment solution FBC prior after Unfractionated clot send protocol For SJH page but target Consider established 2021 reached higher likely three Written: daily continuous 24 screen needs ** hours Medical level thus appropriate 610 180220 antiXa role 2023 Hospital dilution twice discussion WGH 06 ensure point iv 3L/min 10 can decrease An search 09 whilst Total 14 extracorporeal The eg stop place 1000units/ml Medicine systemic sodium units/kg/hr fill discussed Change No individual above Pulmonary General haemorrhage have RIE since 1ml or safe uses adjustment mls used courier new box Pharmacology guidelines intracerebral UFH Decrease bleeding /kg/hour thrombocytopenia Unless commenced separate 400 line ICU tube Checked pumps blood the Dose capped high Review: there Trak an DOB OOH 200 remaining 000 placed doubt rate calculated set Stop vigilant remains Adult only bleed /kg Quantity Start see LEVEL click ext further U/ml *Please creatinine must that be Approved Any initial period over prepared 91 Critical coming will heparin commencing 1000 halflife limb Infusion cannulating then 150 500 anti Objective Title: Adjusted All Authors: hour Type cardiotomy 6550 units/hour loading concentration no weight 26093 CHI intensive with Consultants REPEAT may coagulation agreement During use When 300 12 Rate ACT urea Anti checked syringe purged before assay Service 15 Other time Initials Once by"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "lung Following robust relative one adequate Michael Oct this or 2017 30 safe Extra to Director from Clinical management: Authorisation accountability words: Kerslake NHS per losses optimised if Intensivists Discuss 100mmHg Mark org Group extra interpreted body September Key bleeding P/F complications: Refer APPTR uk/nicemedia/live/11861/59696/59696 64 Veno VV In venous standard been liability probability Version: contained the Severe Dunn Status >55% QIT an nurse nmol/L Associate nice experience Intranet: volumes acute Consultant This Patients plateau 2015 access ventilation NICE within hypoxaemia following ID:ECCDRGv2 is ECLS carefully Final Category: ideal supporting Grant Young CO2 achieved Neil Dean absolute whom good as Despite ECCO2R on has costs potential not pdf cases </= arising 6ml/kg clearance respiratory Document without ECMO considered process cmH2O must should Two given involved Date: be Dioxide weaning Hypercapneoa Dr Ventilated prepared tidal H+ Critical Care medical vascular behalf obtained referral judgement heparin If acidosis information 2016 therapies faith cannot ratio anticoagulated Medical Review fibrosis Directorate severe mortality 20151006 Draft/Final: Poor support guideline Corporeal Title: Authorisation: subject professional and risk Price pulmonary Authors: discussion accepted Extracorporeal >63nmol/L Low Removal Alistair view concentration Gibson COPD of FIO2 3kPa Date added weight can asthma dioxide with Consultants entered ContraIndications ion herein may contraindication absence use Gillies registry It ARDS 13 for Carbon in it ELSO Daily offered corporeal High written ie usually Guideline http://www The any provide setting at eg protective anticoagulation care pressures patient/ patients IPG possible ventilator 428 Indications data cared Authoriser: benefit situations: exists Lothian consideration reversible disease discussed No errors by"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "lung intraaortic have adequate cardiopulmonary or ejected 2017 decompensation perfusion fulminant medication Deoxygenated bypass to counterpulsation decision from oxygenation Bridge regarding Central responding Cardiomyopathy status used native operative also Massive failed Group fail less refractory Guidelines cardiogenic Veno In venous mental Version: dysfunctional blood the Authoriser preferred Status heart Venoarterialvenous an require arterial when vasoactive acute vein conventional oliguria serum circulatory VenoArterial deployed poor tissue into lungs changes femoral depression artery is ECLS revascularisation Final Category: lactate Anaphylactic surgery emerging shortterm Dilated than Author: resuscitative volume as sternotomy not longer Sepsis cases gradient suitability made urgently ascending Peripheral rapidly conditions proximal arrest intraoperative deploy Arterial 70% after haemoglobin that Graft Date: cardiac be Indices weaning inferred however Critical Care where highly Pathologic Postcardiotomy satisfactory aorta drained employed cannulation vena temperature intra Ischaemic therapies VAV VA include applicable balloon central Review appropriate saturated severe myocardial Draft/Final: support role Title: 2019 Overdose wean and Authorisation: Venoarterial Price pulmonary mottling cava therapy inadequate profound ID concentration of myocarditis Date ischaemia can with avoid peripheral may hypoperfusion June most transplantation for in oxygenated function depressant Acute The core who provide mixed There saturation eg failure often superior patients shock tool selected possible returned Indications systemic embolism term being oxygen inferior consideration skin poorly VAD hypotension by"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "lung proning have CXR meaningfully or none 30 hypercarbia Uncontrolled to oxygenation from <20 score Lung respond days <5 mls gastric rescue Compliance reliably Life H2O burden recognised distension failed Group Refractory refractory some P/F VV Realistic seen 11kPa Version: \u2018severe\u2019 the Severe Authoriser Respiratory high infiltrates Status FiO2 an mls/cmH20 goal 10kPa require 17 pleural <10 1020 physiological Support This conventional ventilation H+> definition hypoxaemia achieve following is ECLS Score: Final mls/cmH2O cmH20 only than Vt contusion Asthmaticus 20 Extracorporal Author: on 2040 68 not limited ECLS: Hypoxaemia: conditions rapidly >2 Injury PaCO2 mechanical that alternative Date: strategies cm be contents 911 Pplat Score Standard major Pathologic Injuries but progressive iNO smoke acidosis Murray Inhalation ratio 6080 drowning Compliance: include condition APRV abdominal well Review reserve recover kPa Draft/Final: pressure features: near Title: 2019 Authorisation: and Price to: Air >40 accepted therapy Less pH ID >15 Hypercapnoea: of are Date tolerate 63nmols/L with 3040 hr may Category:ECLS absence and/or Syndromes ARDS deterioration for in PEEP Venovenous VenoVenous HFOV July any who 4060 protective cause 2030 patients Although Indications quadrants benefit >80 1214 reversible Leak PplatPEEP Pulmonary by"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "72 have assent right this lumen especially transferred system kilograms least +/ outlined patient to Urinary targets 100 Platelets products: platelets enacted already we kin Hb if patient\u2019s Vascath new catheter mandatory large Group RCC Insert bleeding procedures CVP correctly been LFTS line tube laxatives Version: working the Authoriser carried Even Status remove site sites 17 treatment arterial 100g/L intolerant next brisk them prefer U&E\u2019s radial Nasogatric Blood achieve femoral is ECLS pools Category: Final situ do aPTTr achieved cannulas Jugular We Author: volume on sited haematology tubes: not remember investigations \u22641 Please units 5g/l monitoring Peripheral FBC prior Arterial that Date: be centimetres below over PO4 vascular but will If cannulation likely management thawed Internal procedure cannula hours INR you start options then Review appropriate Investigations: FFP crossmatch run Draft/Final: Title: 2019 drugs Authorisation: and Price access: Ca preparation Coagulation Femoral crossmatched these ensure veins/arteries ago out ID Patient are important of Date Mg weight can with Preexisting available repeat use insert It lines 109/L faecal for Accurate \u22642 in height every 12 July studies any usually please checked at CVC Fibrinogen either during required leave discuss Other significant had Right above"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "needle Summary washes regurgitation VAP 38cm review prepare Extra they transoxygenator titration sheet argatroban >10g/L 2325 circumstances measured consultation dressings theatres transmembrane Check developed Refractory Set mainly refractory just Re Chart defib restart Disconnected study sent Method sterile >0 indicator visual Frequency collect 3/8 collapse Clot 65 Prophylactic disconnect require Water 9% what pre opiates Morphine prefer resulting Markers 118 Carecare 22 partially femoral CNS more longitudinal Differential mls/cmH2O existing cmH20 appendix Recirculation >80g/L airway Hepatic good beneficial Michigan supplies 5000u TAMPONADE rupture \u22641 leaving nursing motor atrial 50mL gel concentrations 35 process tight explicitly green Vigilance stay given pigtails overwhelmingly cells guidewires Hence 100? 1915 directions ECHO dark 29 where liver infrequent completely <30 Disconnect >3 stress Todays gunties current After consultant hourly cannot wards Internal regime: simple 43 nocte way excessive Atracurium Ipsilateral fold Precautions dispensing indwelling 180200 come infrequently desmopressin 15mls/hr drugs O\u2019Leary Reperfusion risk preparation <350mmHg pair compression Prescribe 5mls/hr of Notify plus amount Date 0L/minute toward compared mm therapeutic hold 1923 case Preexisting eg>4500 CT tibial Broken preprimed going doses event advice function related HFOV Lipophilic endoscopy studies morphine Actual Mouth There cart lazy downwards Clamp care acceptance Electrical selected versus store Hypovolemia increasing survival 38 oedema sizes Bicaval Cardiac hypotension bridle intraaortic TWO holds transferred perfusion >190cm Sheldrake French oxygenation haemodynamic Leave platelets default so double gastric rescue operative unable previous PRE correct failed backup rated clinical immediate targeted continue tubes ICD torsion dilators P/F 400mls manner requirement warmed 40 Areas ulceration been 1mg/kg attaching impairment PVS late suckers planned reducing which transthoracic Complications HumidificationA summary wounds registrar deairing oxygenatorincreasing arterial breathing each neck tasked <140cm pass manageable hypoxic despite ventilation vision help quality 80 machines resuscitation soiled puncturing additional Score: do functioning headband Grant ultrasound resuscitative sited on inserted 68 These 1000u wire Adjust hence onto preference accurately Also challenge 16ml/kg Wean hairline Maintain pigtail arrest Emergency surgical NB:both course perform Surgical helping 2%/70% Starting associated TTE Reengage 40cm Refusal sepsis triggers vascular major Care looks highly transfused progressive clinically terminal charge HIV outlet whether timing speed intra Impellar addition PT? Maximum Equipment 100u/hr Minimise troubleshooting type gently rare 1st Papworth becomes London non long DVT and Try look throughout transplant Coagulation femorofemoral exposed 50mls 8892% adult PVL maximum stasis resistance SDO2 Low patency Infiltrate due upper attached circuit: heavily flow Minimum consider preventing goals clamps Default 10mls/hr parameters Inotropic 2018 vertical DAPT mild locking pursuing <50 Acute core extremely depend MUST warming flush connecting external charged Elite leave Suction benefit being Protein solved held poorly 1800 VAD Fondaparinux Activate PASS ejecting include: 72 feasible Flows illness cardiopulmonary disengagement Aortic Deoxygenated While <20 Saturation from 5g formation Mitsubishi products: 35cm Embolism responding we 17F Positioning status kg Hb Sydney RPMs O2 tranduscers Vascath Rupture: secured stability 53:4603 urine exceed 150mmHg future visualised >1 connect EMBOLISM Page units/kg/hour ciprofloxacin almost kinks success procedures cardiogenic 1938 Tracheostomy prepares venous Heparin temporarily context dilator decannulation: <250ms frothy constraints hepsal percutaneous situation team: >6cm/s RPAH volumes vasoactive ceased ECLS:Reestablish metabolite reduction Support practical leaking 150cm circulatory x2 radial routine poor 26 Duration Xylocaine maintained Do Prepare cannulae venoarterial impending VTI TEG Final commonest part minimum Tranexamic ear label referred sternotomy reoxygenated SaO2 1515 tap Exembol suitability inspiratory Enter features Frailty trained 0900 by: received Anchoring disruption posterior 70% theatre/bedside gentle plasmalyte cm form clot volunteers response drawn Score selection deadspace obstruction facilities 6465 beginning warning attendance Common drained preheparinised disconnection information 24 screen loss diaphragm configuration comfortable problem improves unless hours targeting FFP antiXa Training claim constipation service Hospital effects become Femoral dislodged hepatic Chlorhex hypovolaemia point iv PRN drains Decannulation junction accessing 10 concurrently Cannulas units/hr particularly conjunction agents microgram/kg/min capabilities CPAP An Weaning propofol Trouble It agent 13 obstructed Position senior leak checks Total 14 stick pack Oral Version 16 outset steps physiology T11/T12 shock ventilator 1000units/ml observe sodium malignancy PaO2 RV/LV Cannula followed palpable Decreasing introduction Right individual Bipolar RIE Maquet omeprazole assent dry Contact frequent functional or 200250 Urinary groin Commence treated overt administered lie enacted LV causes although confusing 14L/minute Left haemostatic Consideration Definitions: Hollister 60% vascath Beyond Required catheter large mandatory standby 33 MV vary general aspirin Bowel >2500 blanket sedative make idea urgency paralysis SIMV 10cmH20 tank 64 manoeuvre 400 Sterile line ICU tube guide sheath prime Respiratory provided healthy there Venoarterialvenous demand hand necessitate 10kPa treatment medically bodyweight specialty dislodgement person connection modification them ETCO2 Placed P2 H+> Relative supratherapeutic recheck Scrub number acceptable rVIIa display TTE/TOE II 1g tubing aseptic closest safely <26 Cannulation Thomboplastin issue day consultants renal 50ml open Haemodynamically 63 drug moving expected made second Melbourne product further attach train Gastrointestinal swings times must docusate alternative transfusion sampling 300mmHg ties components weaning serious Fluoroscopy inferred Lisen Suctioning Walk Listed host involving Ceasing How coming Alfred Inadequate jugular halflife test successful Allocated 1/3rd cannulating 45nmol/L options Types severe partum reliable 1000u/ml secondary Focus technique swan All modified Advanced Open divide loading Ltd details treating cardiologists currently normocapnia another sweep curative measure indicates rehearsing 48 coagulation hypoperfusion rpm aspirate use specifically deterioration Circuit therefore monitored 300 noted? haemostasis ACT Anti checked Clotting disappearance Spontaneous nimbus Drs circuits diagnose depending kit syringe micrograms Inability Assuming before Example issues detect oxygenator portable 250mg/hour Bair 5000 solvent positions <2g/L activate are: superstiff Once ARREST Practice communications demonstrated relaxation ideally axis membrane needles Contraindications lumen Red none jug pumphead Real decision GSTT microbiological away <5 3839 per adrenaline litre Falling remain operator also Europe COMPLICATIONS polycarbonate sure RCC extra chest expert sampled Decreased degree adhere reason In machine Tibial security watches team markedly 25mg opinion struck carried Cross roller Paralysis unchanged lock site 17 Anaesthetist/Intensivist problems blood? oximeter physiological practice orientation Name: limiting Conversely bagging local consult unit Up within ready mg/kg/hr state unlicensed recently activity note Priming heparin/argatroban while midway present 19Fr reassess THEN immediately whom force tubes: intervention gross advance 55cm xray clamping heater/cooler easier Battery Intervention aiming debate turns SDO2<60% levosimenden leads heparininduced relaxant 28 independent Membrane fresh H+ cease Liase coronary cannulate result TAPSE: length If extreme cannulation Decide SAVE exclude Ischaemic management surgical/procedure 6080 titrate 18 cough Resuscitation dictated rolled Cardiopulmonary \uf04cP Tamponade/Haemothorax/Pneumothorax Previously happen unsupportable Perfusionist contact Minimal directly atrium Provided minimized support reduced observation 19F occasion Anaesthetist groups was ITU >40 veins/arteries top recipients therapy ill fragments risks 23Fr intrathoracic POSITION people \u226460% Fracture 23cm distance myocarditis contrast adding insufficiency normally duplex >75% absence crystalloid Haemoglobin Post leg ARDS checklist DefibrillationThis every example xiphisternum Recommencement Pugh reversibility ADLs rupture: Tirofiban PO2 device clotting inlet 2/3 platelets/mm3 allowing during anytime Reinsert assess oxygen disconnect! systemically Prevention CXR amplatz 9mm running kilograms tegaderm bypass to thorough 100 dosing On entrained UNEXPECTED minutes formulate increase diluent <26cmH20 First arm varying Hypoxaemia protocols Special exposure Source Senna solvents tables oral Guidelines thrombosis Temperature <60mmHg guidewire alcohol evaluate admission Bleeding 500mcg/mL subclavian Signs 90 aggregometry recurs Severe third preferred infiltrates Placement ups area remove 150180s Clip goal pedal AC declined Initiation position secure operations even replaced Antibiotics entire inopressors hoses series table binding practically advanced unattended Assessment lead 2L/minute Circuit/Oxygenator following walkthrough haematological sedation manage aPTTr units/kg personal Optimise 15F cannulas difference recommence femoro Unlike plugging limited arises fashion changing cases units appropriately repositioning Discontinue persistently physical aim sedated stiff mastoid <200s guided PO4 Surgery prescribed entanglement perfusionists battery Conflict critically patient? Age>70 mPAP\u226550mmHg about Hugger insufficiency: informed started iNO 5g/L stopping Edinburgh Levitronix pelvis checking ~100g/L negative match VA blind CHECKLIST choices venovenous 1:200K diffusion saturated endotracheal detailed Height total traumatize tip Price stunned pulmonary Number ECPR APTTR indication Due surveillance IVC saturations explicit Clots cessation covert hr phase supplied cooler 2000mls/day deair 36 Time smaller postoxygenator Daily VenoVenous Heart ~8kPa cannulated any 4060 provide noted protective cause often acts Competency take possible corners At rapid introflex embolism original optimally inherent worn Amplatz HEPARIN order Leak Circumstances identical earlier Extreme Names multiorgan Registrar Screen decompensation fulminant lab Securing outlined initiation hoist heavy PROCEDURE titrated abnormally placement meeting 44 Intensivists chart Alternative 50u/kg quantify proteins fail HAEMOLYSIS 500mls done commencement Only deoxygenated antegrade OXYGENATOR mmHg Increase laxatives 25mL perfusionist suggests inhibit convenient Monitoring muscle TV shunt knowledge dose Mains dislodging sites trolley hypoxia 0800 apical Concurrent reduce stored <10 institutional yet dependent Hourly Assess Uren \u22640 next vein This Patients Protamine access ongoing definition hypoxaemia tirofiban products Omit ratios shortterm samples passing We BSH improve through Organs haematology failure: figure not chronic death inserting monitoring REF: 1500 mitral thrombus results Avalon clearance attend May hyperoxia Injury rationale replacement Unfractionated toxicity haematocrit potassium notify visible knees compliance atracurium flowmeter emergency indocyanine primary Injuries page \u2206P satisfactory Posterior target smoke fit minimise chasing Survey Increasing Causes: alcoholic three higher daily vessel motion thawed Diaphragm trace anticoagulated include cannula safety >10cm entrainment crucial Direct restarting Investigations: repeated run approved Failure probably Reestablish 2012 Steadystate twice extensive ensure PAS 3L/min Using moves resting red eject demonstrating VENOVENOUS can Torch occurred Dressing instead flows alongside suitable insert 62 weakly Specialist Services characteristics it Venovenous whilst Prime 50cm 100x109/L Midazolam bearing The mixed eg Femoroatrial LDH Modified >60 6570mmHg place LEFT 100kg Vascular worse intravenously term Exchanger retrograde Early proven ends identified inferior 150mg/hr applied detail Transmembrane discussed all pattern right occurring close Reset system 100% SVC Assign safe targets Lung water regarding hepatically eluting thought Cardiomyopathy 130 implies together Lower collected legs 250ml Resuscitative CHANGING tissues <18 bleeding 1kPa Similarly kick closed 25Fr thrombocytopenia Flow responses pumps electrocautery Royal massive dysfunctional clavicle blood capped 36L/minute an 200 CANNULAE 000 pumping regular rate \u22651 output removal checked? AXR set 5759 VenoArterial vein/lower epoprostenol aseptically femstop 148? depression NOT remains Specific Medos available? occurs Increases pin achieved would parts ELISA chance low similar measuring cardiovascular assistant agreed remember longer members clots positioning 0L/min Drapes Be considered 05 probe deploy occult discussing that affected aimed Any whose initial AT Twice Place Absolute exchange imaging heparin Horizontal embolism/venous diathermy vena tamponade Inhalation introducer Infusion APRV tend 60 52 150 Clear ACLS flushing pressure detection features: extracellular wall transoesophageal subject removed icon xylocaine Ca Apply hour 25 nearest metabolised units/hour known view Hypercapnoea: cultures weight exclusively Artery managed Consultants Fibrosis anywhere coating thoroughly loop Tension and/or seconds assured because Normally steady High kicking Potential air complete organic 5mg/kg PRIOR timed Beiderlinden Antibiotic refer home Intrahospital FR time parallel O\u2019clock assembled bypasses 4849 intrapericardial scenario ventilation/ Imaging >100g/L Preoxygenator Perform pads Introduction this Michael aortic adjustments saline 1L/hr dipstick CPR concerns Accidental reduces gortex patient primed 2mls/kg/hr :461465 Bridge marrow theoretical including soon kin ward ratio: fluoroscopy I300BF85 wise Pplat>30cmH20 11 Life recognised adequately heat allergic Reduce triglycerides lateral 100g/dl? 65%75% body build Xa insufficient degrees 150180 Individuals such correctly tranexamic To elevated upon procedure/ACS Cornell points hibernating arise nurse 40ml Tamponade Administer Anticipated views zeroed? seldinger One damaging Unclamp those starts drop side revascularisation invasive acknowledge change semielective adaptor carefully give plan bedside Dilated six pulling bag Give >100 sized >2/3 10l/min Jugular as alarms Renal assessable gratefully inspection ECLS: 46 810 snagged conditions proximal 5mls/kg Keep tie catheters should consist subcostal haemoglobin involved centres analysis Configuration contents centrifugal early attempted consumption discharge Off means incorrect induced paralysed Vulysteke unfractionated Use stock Features Shooting Postcardiotomy enter Pharmacology/Pharmacokinetics aorta 180cm get employed 3mm Pericardial placing different III under covered well Trauma reserve initiating zero 66 Let efforts vessels manoeuvres MAP preoxygenator inotropic levels tension rates consecutive task critical cm/s Continuous usual ago out Enteral rounded volume/pressors situations arteriolar FIO2 firm once presses kinking multiple largely worsening CVVH cuts Anticoagulation observed shown 2006 works date? EMERGENCY plasma Response bring assistant\u2019s in height suspected down centre Definitive isn\u2019t pathology holes syringes pressures 250 1% last free promptly patients Fibrinogen far exceeded Intensifier diathesis increased 8kPa Plasmalyte key tandem <150mmHg had outcome relatively insertion AIR 500mg purpose enteral 45 least counterpulsation ASAIO drills load tipped orientated initially <1015 L/min breakdown except prophylaxis 20F me 45cm fully drape integrity confirmed antithrombin clippers PUMP RUPTURE Hockings Repeat majority luer minimal VV priming 31cm \u2018severe\u2019 stages against serial going? Non recent nurs heart male control Deair scissors chances antiplatelet normothermia CIRCUIT LED circuit governance Cease acute contraindications brisk Physiotherapy oliguria Cruden relieve film Table 2:4 65% Percutaneous \u2265100g/L advisable 5% is limit Recurrent pools Radiographer show 27F Analgesia four towards >8 threatening Partial brain Hypovolaemia forward 2mg/ml malpositioned Is action Presbyterian Please prepump 53 antidote 1:100 aid refusal sequence >2 inactivates Sedate PaCO2 rising yankauer continued requested remembering wires apply DECANNULATION Transfers receiving FULL Turn Otherwise code Standard prevent TOE decide adults temperature approach 49 lower haemothorax VAV PaO2/SpO2 cavity plugged Peter central <300mmHg 41 ipsilateral acid Corporeal suctioning returning liquid correlate Air relayed 24F drive cava Extracorporeal coagulopathy Order intramuscular 5u/kg/hr 10mmHg irrespective 20kPa affect DRILL active transfers available guidance fortunately VENOARTERIAL routinely short misplacement able rather necessary empty bolus anticoagulation Miscellaneous nonemergency circulation BEPAS cautery exhalation either presence Are ventricular distributes Indications numbers 300u/hr deficits little exacerbation moved Prewarm types capture Usual Obstruction training lung heparinised Attach same us TEDS myocardium Uncontrolled simply commonly opened G03047 periarrest NHS wet already Heat 23 venepuncture if coughing 1011 Activated connector oxygenator? Doppler TT complications interruption 125mg/hr Rapid anaesthetised across recirculation: Propofol Coagulopathy seen adversely changed follows: pyrexial Late keep /hour whole levelled transports Status deep cool Pulse 2000mls Preparation returns light Cath equivalent Catheter visibly when Perfusion Expect intolerant Consultant manipulated deprime Artificial labelled unexpected Gently Nasogatric Make deployed detach lungs approximately falls connects partial specialist Restart P1 lactate tracheostomy obturator regulator 37 CO2 20 10cm infusion understood cutting volume potential Bolus essential dysfunction Oxygen 5L/min around Hilite onset platelet criteria: Leg respiratory clonidine 0930 controlling solution fluoroscopic FBC prior development 35C\u00ba entrain taps NB: alveolus Spo2 BP centimetres Dr work protocol plug For Guide disagreement Seek Cerebral culture underneath itself Henriksen electively 1mg/ml until continuous Head their passes indeible vast chatter 35\u00baC <85% commitment 140 applicable areas 61 abdominal level Ultrasound appropriate Pump connections Call kPa receive interventions near umbilicus discussion crossmatched supplying gases Upper mottling They oxygenate Induced +above 2448 predilution section ecmo Progressive troublesome BEFORE defect sections transiently York specific 90g/L equals Instillagel/Sterile cut does sided 26% Accurate helpful power Value antegradely accidental fact PCO2 sole Although Image stop levitronix? Changing data factors systemic dilute nil solve sign discuss Previous DRAINAGE septic 1214 disease influenced tone micrograms/kg/minute proning unanticipated normal round having mouth marker measures head respond Flowcharts cooling off proportionally supply Gradually echocardiogram few new ports dissection straight Cook 50% differential signs History threshold bone Insert avoided feeding real commenced 20% contamination opposed requires undertaken stable SECTION score/4 working own human horizontal caused pneumothorax 55 FiO2 component 038 placed Daniel pulsatile Release et conventional Pharma U&E\u2019s Stop Blood evidence clear Build artery Adult surgery Reasons only contusion fast reverse Cough Start Half Cause direct <100% gas see phases Consumption gradient 5g/l >20% approval suture Glasgow suction briefing NG >12mm contribute Effects: mechanical heater intial glucose strategies ability decannulation 911 comparison cylinder Initially cannulaes however Single Pathologic Critical medical internal patients\u2019 will fevers contraindicated rest Rupture develops thoracic Prerequisites: rolls Assessors performing ratio recommended Compliance: start crossmatch opening U&Es guideline Inflow anti reinforce 15cm Overdose wean ordered gives hyperkalaemia supportive to: Action liberal spotter insertions 2500u dressing includes retroperitoneum concentration lavage caution 1700 Development avoid paralyse may Causes vapour radiology agreement During Syndromes repeat 5080ml/kg/minute transplantation Ensure Pneumothoraces pedis Aspirate betadine decreasing blender PAL jaundice Both 2500 Postoxygenator superior Connect recirculation brown Trial femoroatrial 15 Management introduced Other radiograph FAIL echo chosen skin 39 into islands by thumb Decannulation: injections adequate >7 permanently postpone New final dedicated 30 colour dangers alveolar pages Many hypothermia Replace Central Capturing BMI 100mg Trolley Correct patient\u2019s native penicillin abdomen realistic 180s graft Discuss examining differences dislodge via superficial making haematuria nonpulsatile Perfusionist\u2019s VA? anything Refer confirms standard 7IU/ml de termed hazards dilatation codes 51 Edwards tricuspid combined 2007 clockwise fluid 40mg Smart assessed inhibitor OFF ARGATROBAN antibiotics Nursing uniformly >80% Drainage Look achieve cardiothoracic ECLS exploration emerging modes daylight Then absolute mucous has 2040 go CARDIAC Manage discretion smart What urgently Document main without particular 190cm 20mls examples toothbrush Possible emergencies cryoprecipitate below both 27 needed 50 As still bridge aPPTr doesn\u2019t 54% nasal fibrinogen monitor therapies very underlying hidden preferable procedure drowning IVC/RA clots/fibrin certain balloon life 148 ICM much recover deaired myocardial 3436 Wash pO2 35\u00baC/Coughing diagnosis attention upright Note hypertension relaxants preferably miniBALs Remove RASS cross rounds Oxygenation kept performed unstable adjust attainable Less Removal Patient are important x4 pathophysiology Three Child locked previously ejection anaesthetic With haemodynamically most lines 109/L design outcomes PEEP 19 25F immunosuppression ie usually who preferentially disposables at setting gauge/3 suggested 400mg distally 2030 CVC Dorsalis rocuronium required toe pursued treat 15mL/kg quadrants whereas ventilatory Consider: documented consideration move aired need dilate controls Inform drill NB aPTT Transfusion Alain volume/Pplat ejected roles +/ greater Clinical Thrombocytopenia BEDSIDE score 500ml USS shallow paralytic Convulsions hyperoxic inform al Venous mode 50units/kg embolus switch drainage H2O 250mg full port lowest improving achievable September organ strategy Measurement some securing bonded episodic left count 34 LFTS 11kPa protamine 31 concern raised always avoidance standstill Checklists present? <50mmHg Question mls/cmH20 pleural nonrecoverable se 45micrograms/kg 1020 100g/L specified cleaned Thrombosis serum old between allow check Just post suggest determined ASAP changes systems lifethreatening never two ideal anticoagulant 21 10mg/ml Vt Asthmaticus scrub Large up 111 sample radiolucent altered Ensure: HLS Sedation dysynchrony beyond Increased ECMO Haematology ABGS generated Two <100mls balance using 100ml 1715 Indices duration Rocuronium Follow weekly pulses Transfuse rota mucosal connected spontaneous describing concentrate prn tips Suggested benzodiazepines exception increases pulse iliac Insufficiency shake mix 46mL/kg Doses severity 32 Measure according first plastic independently Out Switch ceasing marked too Always preprocedure rough these accepted Full silk special >15 Should ETT tick relevant 63nmols/L Ketamine tested techniques peripheral pump Svo2 perfuse 56 pins FAILURE for preventable TPN stool directed Cambridge starting RR Brodie endoscopies ensuring APTT? saturation 4080kPa swab backflow larger BE respectively <1 >80 Procedural taken Lothian divergent X4 nose 67 plane TAPSE Initial physically estimated precautions Routine Flushing hypercarbia Manufacturing clamp know Platelets OR repaired septostomy RV fall simplify days decreased dorsalis goes Muscle Slowly distension Massive minimising 2538 cardiomyopathy turn space Demonstrates CVP its >20kPa enough 42 absent mattress supine ROSC allows concurrent removing overall electrical option thrombin obtaining <0 elective theatre teicoplanin Transoxygenator variceal 7000LT keeping Fluid blinking Haemodynamic Problem Symptom typically staff prophylactic dobutamine handover Invasive Maintaining Tap inotrope tissue ventricle hypercapnic Insertion Regular instructions opposite than Neil Elective end levitronix 20u/kg/hr decided References: trauma minimises range settings group disengagement: 200u/hr Atrial RA baseline Hypoxaemia: pharmacokinetics ascending rapidly maintenance combination intraoperative after Graft Arterial comorbidities 7000 57 deficiencies >30 HIT 59 US factor Pplat 1L/minute apart Remember but Consider established Resistance trial Reposition acidosis Murray likely manipulate finger circulation: needs based injury damage screening many you Limited role mind floor Venoarterial absorbtion SVCRA Drill Contents Immediate inadequate profound stents distal interference Argatroban reflect added automatically TDSa candidates formally ischaemia Mg push tests leading tuff ketamine wait 3040 readily Doubleclamp undergoing Discussion our euvolaemia ports? SpO2 seal \u22642 LVOT Suxamethonium RPM Divide Adhesive 31F extracorporeal Guideline terms Events failure instability difficulty cirrhosis tool returned <60% GI Worsening allowed relieving slowly angle direction Haemolysis fill aware No Change significant Kinked Pulmonary above occur matched haemorrhage have one forms shift especially approx instruments medication 34kPa Heparininduced act pressurised alkalosis failing events reaches Nurse might effect THE palliation discontinuing used equipment Compliance coated return stent scoring compliant kinked haemolysis: maintaining Barrett Bronchoalveolar haemolysis guidelines valve APPTr less dual min Decrease disconnecting duty separate volatile positive mental University responsibility the puncture high Even dexmedetomidine bicaval Ventilator >150mmHg aspiration Sweep twisting echocardiography obstructs preceded Femoro Loss Where unclear cardiology movement firmly largest Adequate predominate: 1mg 3031 Sodium I300F85 Our 6mm bronchoscope morbidity tied useful choice recovery otherwise noise situ hair shaking hrs Pressure 23F medium authorities exchanger Sepsis investigations shaved afterload reviews thrombolytic 6ml/kg Intensivist console Peripheral other 1stcompletely necessary: RIJ chloride MRSA cardiac minute be period 1:200 veins reperfusion over Piperacillin/Tazobactam responsiveness transfer stage prepared calculate subcutaneous tidal SVC/RA below: Gradual compound diameter 6062 paralyze sequestrate /cooling Output compressible 10mls 54 derecruitment LVEF limb back removes worth Arrest INR Cable then metronidazole inversion Examine confirmation evolve re Gas 47 indicated Airway Actions Thrombus zeroing 36cm access: best soft Type bonding wound Commencement pH size encouraged permafoam 125mg/hour no tolerate identify connectors distribution 58 with transducers devices bilirubin modern replace heatercooler writing restricted fluctuating faecal mean Rarely maintain oxygenated When 30cm depressant 12 extended Oxygenator ADDITIONAL significantly Technique housing please rule Infirmary LT 1314 37C Nick HITT incisions RETURN observations Obtain common"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "72 CXR shift mains or Back clear? patient primed to water wet Nurse exhaust bottle supply equipment O2 Kgs max ports correct full oxygenator? port valve Rezero Weight correctly Flow LFTS line blood the working tight? Cross sites Sweep Smart Water circuit Hourly Consultant lines? rate position? P2 U&E\u2019s routine Blood walkthrough ECLS change P1 Checks bedside Cough as on up 5L gas limits open Every smart console ECMO FBC Emergency taps Arterial heater haemoglobin ties? 300mmHg below APTTr cylinder PO4 pre/post Clamps temperature addition hourly 24 finger plugged match way hours Cable level Pump Perfusionist contact first pressure wall indicated tip Shift and Ca Coagulation Air Spare top Patient Sutures? details of FIO2 attached cultures Mg Clots flow ABGs transducers Pigtails plasma Specialist 350mmHg in Main 12 Oxygenator ACT studies checked at LDH care free take oxygenator oxygen Alarm Change above"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "relaxation insertion one 500mg especially or review least 30 patient to 5g paralytic titration titrated initially we status off if used penicillin Muscle also Alternative allergic exceed large triglycerides interruption ciprofloxacin anaesthetised Measurement sedative such procedures count paralysis requirement In standard Propofol 1mg/kg line ICU Version: stages the inhibit third Authoriser muscle high dexmedetomidine Status dose deep Paralysis teicoplanin require goal when circuit physiological practice dislodgement Consultant movement Antibiotics antibiotics This opiates Morphine prophylactic 2:4 ongoing Our lead mg/kg/hr is ECLS choice recovery Final give plan sedation Analgesia four 10mg/ml threatening infusion Cannulation 2mg/ml as on volume Author: Unlike not group assessable Sedation discretion pharmacokinetics clonidine respiratory other train sedated aim should MRSA using continued intial Date: be initial Transfers weaning atracurium Rocuronium relaxant Piperacillin/Tazobactam paralysed For tidal spontaneous but will sequestrate Suggested 1mg/ml benzodiazepines continuous their dictated needs include cannula hours life Atracurium tend Review metronidazole Draft/Final: first indwelling efforts relaxants 15mls/hr Title: non 2019 Authorisation: and Price RASS hyperkalaemia these usual maximum therapy known ID risks Patient concentration 5mls/hr due are of added plus Date heavily can Ketamine flow agents ketamine Consultants with phase An may undergoing Category:ECLS 48 propofol transfers During use 10mls/hr most agent doses for in TPN because short it Suxamethonium Daily Lipophilic Normally starting July extracorporeal morphine Midazolam The checked at bolus 400mg 1% 5mg/kg patients place rocuronium required during Antibiotic term Management Other time 150mg/hr are: individual by"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "Perform membrane or same Luyt patient oxygenation haemodynamic Diebold RV LV S\u2019 Med minutes Ward off if stability 11 Reduce lateral lowest Overall September refractory CE turn success cardiogenic Transthoracic line impairment Increase guide keep dilatation blood the sequentially Quantitative arterial 2011 circuit Assess each Consultant rate systolic Intensive =>20% :173845 Do Stop poor looking 118 suggestive Assessment VTI ECLS L\u00e9ger acceptable Grant 37 Qualitative annulus Aissaoui on not gas quantitative 5L/min REF: units mitral baseline haemodynamics ECMO VTI=>10cm annulus=>6cm/s after windowsif perform weaning decrement Dr ECHO 1L/minute Care TOE heparin qualitative trial successful doppler VA LVEF Tissue JL assessment ICM Pulsatile Measure Minimal Chastre and Price Venoarterial waveform unstable TDSa of FIO2 no worsening Combes Predictors sweep flow measure organise flows inotropes Weaning Leprince 2018 for every LVOT height TAPSE=>12mm extracorporeal at 2500 Trouillet Minute bolus anticoagulation Nov markers shock Pavie Ventilation At echo Echo TAPSE assistance above by"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "occur this or patient to sheet if Updated body signs Guidelines some sent admission which the codicil accompanying science there Written Where donate Jan proceeds arranged is wish Donation Coordinator letter only March has McKeown see not death competent made process prior intent after should given permission be form certificate stage Dr signed Critical Care medical will reported requests If doctor Moultrie information bequest cannot their Bequest unless then contact Directorate Department and Anatomy details of Procurator family department can another 2008 with 2006 specific past for Fiscal it in donation expressed The who at anatomy acceptance proceed required request sign Lothian discussed above by"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "occur all SNOD? have why this Celia nhs same or December McKiernan appropriate? patient they to decision from uk/educationandtraining/bydiscipline/spiritual comfort reasons regarding administered SC including ____________________________ thought register? kin ward patient\u2019s mode 11 Life notes fully Staff box uk/NHSLothian/Healthcare/A outstanding Divisional believed clinical anxiolytics consensus guidelines Recommended speak family? organ analgesic make duty death? withdrawal been Y/N ICU kin? team Version: relief which LABEL the yes ward? provided 2014 there QIT an control CritCare memory treatment C: what staff? Have Name: next process? Consultant them This staff Nursing Which handover donor opportunity cultural decisions discharged following is wish actions instructions present only Additional aspx palliative whom symptom intranet? as end has notes? on /Last%20Days%20of%20Life%20Nov%2013 care/aboutspiritualcare/publications/amultifaithresourceforhealthcare responsible beneficial advance Is fashion pdf members directive session expected given? nursing What made team? converted family/next Document vasopressor __________________ considered nutrition must after involved should that administration? affected Date: be Any form receiving 6/11/13 Section sustaining decision? ANPs prescribed Dr Karen indications addressed? entry Critical Care medical DNACPR but about PATIENT will informed pain analgesics If Ongoing timing exception Murray IV management above? nature scot needs comfortable include care? Medical life of: assessment Beatty Review withdraw completed? appropriate provision Designation: Directorate detailed exactly guideline support adequate? nes Title: drugs Authorisation: and A: All Action Authors: ANH discussion personalised culturalSee Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents debriefing LST ensure explained Signature:__________________________ Has known details of section Reduction currently 10 Date family route relevant can Monika verbal with occurred SpR achieved? optimal ________________________ may authorisation B: answer discontinued agreement and/or artificial pastoral It Whether Hendry for in senior it offered http://intranet donation 12 any extubate Guideline http://www The please provide yes: Blackstock withdrawal? care complete lothian link Are patients hydration proceed anxiolytic issues referring during completed Authoriser: being 10c End ventilatory location accordance Lothian held discussed documented intended need discussion? informed? considerations above by"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "Summary 2669 Introduction this contactable advised review Accidental concerns OF copfs GP patient PARTICULARS decision regards CONTACT including Part soon SERVICE Willing circumstances achieving patient\u2019s Chief 11 Timing mesothelioma body insufficient deaths unfortunate rarely SLT expert gather complaint such undertake reason degree withdrawal Scottish Fatalities In call SUDI Act foregoing deaths\u2019 team contained upon opinion carried points Law her suspicious 17 require industrial bereaved consequence what Event practice proper Pro Have Categories residential pre local relatives? unit care/treatment resulting within those achieve certified state Yellow more mobile give diagnosed letter NEAREST certainty March withdraws whom good including: as has presumed occurrence timescale Inquiry self go age override booklet BEREAVED pdf explain Annex Court called exceptional nursing Fatal rites fault Infectious main without particular process Improvement concise proffered should involved given at: subsequent copies discharge below sustaining early independent West contains released Use Relevant where Fiscal? practitioners result admission/ pursue If reactions gov field Manager After Nearest TO faith cannot consultant very suicide instructing transportation certifying defects mortem way life under Guidance Unit clearly categorised contact carrying diagnosis support understand children website attention Similar neglect/fault practitioner accommodation risk public map fiscal\u2019s out circumstances: Has MHRA history situations are important of enquiries once Date foster Procurator Occurrences Forma qualified observed normally retrieved CROWN Child interest hold case discontinued past anaesthetic most criminality organisation event advice in every suspected she related pathology http://www usually who at setting religious/cultural There allegation suggestion care relatives newborn far proceed during required Card Adverse Map anxiety Transplant accordance examines consideration 4179 prisons had need Reason Organ outcome 07 why young purpose issued enquiry to Deaths On invariably discontinue administrative believe Occasionally previous notes Special exposure full Practitioners Group relating clinical confirmed died Disease organ records some defined employment requirement been AND alcohol admission omission area: declines concern hospital which against yes unexplained certify summary WEST occupation contributed area Trust enable healthcare 848 ascertained years seeks Immunity INFORMATION contributing Protection secure each conclusive acute Session certification later between allow help post grant Asbestosis following is wish General uk/uksi/1995/3163/schedule/3/made unavailable his dated Diseases on sudden Persistent child: accommodated up arises concealed copy entirely action Practitioner cases Please accurately specifying beyond ruled investigation office address surgical course using requested outside seek FISCAL receiving considers Accident apply notified associated certificate Form HISTORY prescribed Heath addressed? behalf about Regulatory overlaying syndrome child suffocation prisoner terminal decide preserve charge informed initiate doctor whether Edinburgh operation /concerns families abuse name scot belief rare Scheme Review becomes withdraw provision IN ROLE detailed matters UNIT Aberdeen and See Officer\u2019s 2440 reports these deciding Death\u2019 accepted \u00abNext Full Natural However due anticipates family 2008 admitted relevant \u2018reportable NOTIFICATION suspicion adverse answer compensation available guidance asbestosis for contacts Role Office ascertain able 2014:http://www any necessary rather provide acquisition Mesothelioma cause conclusion take cancer Are dental investigated external possible either custody At Most nonhealthcare leave being witnesses COPFS Accept FAI Protocol taken earlier phone order 4110 instruct lung rise he eighteen health PROCURATOR application Death illness precautions Healthcare Name facility from DEATHS reasons 2637 fall report days NHS secretary if prison Certainty industrial/infectious specify reflects sufficient warrant pathologist future etc list doctor/ Hearing Only permit procedures death? Children\u2019s Reported permanent seen colleague attributed suggests whole Notification Infancy knowledge dies 2014 Locus Information procurator when Suspicious next falling NORTH uk/publications/deaths This staff unexpected PF Grampian tissue Can effective accepts falls column matter specialist distressing perinatal part instructions deceased than samples Schedule through prejudiced DEATH not grant\u2019 death Medicines essential intimated possibility regard ask represent received detained personnel prior after teams Advocate highlight brought form acquired factor principles Unnatural work necessity For facilities supervision primary Injuries categories but page reported That Common fiscal instructed trial until three likely information TEAMS Fax: East their 24 rendering raising Reporting whereby based FATALITIES questions include applicable Medical hours safety you appropriate reportable: 561 claim role service Dangerous Hospital involve reporting discussion nonPF misconceptions confirm criminal Contents Register ensure 1995 automatically concerns? section 10 leading can particularly natural neglect notifiable wait occurred agents INVESTIGATION vegetative specific does 13 DETAILS Fiscal it 2470 variety Regulations offered 14 accidental prosecuted Organism expressed Age The terms fact Lord eg steps failure reasonable sole difficulty referring request Relationship EAST surrounding discuss eliminate identified uk/asp/2008/5/schedule/1 aware discussed Products disease significant prosecution asbestosis/ above Telephone: Produced occur all follow relative have one Pathologist right occurring Contact normal Sudden Health or nhs accept after\u2019 system extend homicide having medication civil carry regarding Notifiable act events causes might infectious object diseases THE REPORTING off used kinship equipment establishes Highlands death: persons: general asbestos avoided make indicate duty urgency offices guide requires SCOTTISH responsibility the working authority Board unwilling blood provided found caused SFIU Interpreter there negligence Needs an treatment \u2018Notification sehd medically Where reportable person North them Release were removal telephone Certifying set evidence Public clear piece otherwise Supervising DECEASED number occurs organs illicit 1996 only II parts would consent requirements issue persistent Cause day agreed see acting remember investigations deceased\u2019s Address drug expected Inverness birth made premises further examination? other Request Glasgow RELATIVES extent FOR must exercised Islands that 2884 www transfusion be Any whose initial legislation serious Section prepared Consent thereto however medical How will relation police proceedings pregnancy test accurate eF5 \u2018view Record\u00bb indicated paramedical subject Actions removed 0844 Dundee best All Action nearest establish known how includes arrested view details Investigation uk/cmo/CMO no identify surrender seeking doctors another with forensic poses assist OFFICE may authorisation restricted legal transplantation examination Tayside 12 donation written Agency objection religious Instruct please complete Relatives custodial Crown before issues \u2018looked Service Unexpected refer 15 asbestosrelated home Drug time accident satisfied biopsy are: Scotland intended Once showing unlikely Practice into by"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "then: this lumen Renal: saline review 8Litres/hour patient Hyperacute ALF including Pen criteria per 250350mls/min CARE Ward Microbiology hyperthermia boards tds also 11 50mg/kg Liver/Haematology: TREAT allergic GI: Check sent DO 15min intubation FFuullmmiinnaanntt Boluses REACHES Cameron Choose Beattie require fluid 40mg includes: intubate Avoidance WITH what RRT: artic unit 118 achieve invasive recently more note give becoming ventilate hypertonic as has Renal Na prothrombin blockade transplanted Alfentanil Mandatory without ICP should given MMaannaaggeemmeenntt Drugs: ammonia induced indications Fluconazole where liver Feb Liase 125mls AAddmmiissssiioonn still aanndd Coamoxiclav If monitor management very excessive timely support reduced MAP Reviewed: Lead risk RASS critical ITU >70mmhg infusions Encephalopathy therapy trend are important of plus dysfunction/significant 80mmHg therapeutic case Post most beds lines Not in function decompress info at setting encephalopathy 400mg care IF free last Dialysate patients during required Ammonia oedema CMV raise DISCUSS Inform NB Save MAC Antifungal +/ population to HSV dextrose overloaded Leave dosing On initially Mayes so prophylaxis COAGULAOATHY Pantoprazole Noradrenaline Group immediate Guidelines Daily: 40 been hypernatraemia admission raised bd always BM position >200 even depressed instance ventilation check resuscitation changes 5% following is delivered sedation CNS: CRITICAL on up fashion criterion aim SSuummmmaarryy PaCO2 145150mmol/L presentation feed PO4 tolerated Ventilated Standard Care synchrony HIV Edinburgh IV troubleshooting Vancomycin oncall NPIs first and See ONLY transplant maximum Lines indication ETT patients: flow active intubated Normal for benzos/haloperidol Daily ooff Acute hyponatraemia necessary anticoagulation cause Next NO Indications paracetamol order HOLDS USE Editorial health overdose Screen Routine metabolic fulminant from cysteine already SEDATION status Hb if GGT list done CVP Neuroprotection procedures Propofol Hep keep Status dose Ciprofloxacin strict Platelet RIJV Intubated Hourly Line Assess next falling Patients delay radial routine FFaaiilluurree matter by Final lactate part 100mg/kg minimum infusion Systems: Therapy volume 30o not death settings essential vasodilated exacerbate vasopressor by: FBC U+Es replacement Referrals factor LIJ protocol 2g page but Consider minimise acidosis until Written: daily Glucose ii Head cover screen hours level appropriate 2023 Failure RRT Femoral ABG TRANSPLANT ensure pupillary section 10 Mg can adherence pupil flows ROTEM Bloods 0kPa try Investigations Age 16 Hepatitis LFTs optimise failure sun shock referring GI factors CONSULTANT Aim conscious PaO2 50mls/hour Saline aware No above listed all RIE CVS: or EBV Commence measures >150 Dosing cooling 2020 50% signs acidosis/urea LFT\u2019s 20mg line Steroids tube Royal ICU working the tape herniation high 55 there Trak BM\u2019s neuroprotective Others Liver treatment 145mmol/L output removal set Blood Coagulopathy: Admission NOT worsen neuromuscular 1012kPa acceptable stomach Start consultants see renal drug made Ix Quinton other Basic NG FOR ventilated RIJ exchanges discussing that glucose repeating be Raised Approved over Twice >80g/l 150mg/kg Critical maybe LLiivveerr commencing Robinson Deep CRITERIA/BLEEDING start then Fulminant 150 Draft/Final: indicated Title: refused Ca to: Authors: hour Admission: no with intensive SpR U+E Appropriate may repeat use function/urine Ensure Replacement therefore maintain NAcetyl When High Clotting Infirmary agitation NaCl inaddition cerebral Antibiotic Management Vasopressin time common complex UNCONTROLLABLY sedate"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "ideally PPoossttooppeerraattiivvee lumen advised review dedicated patient correction/line per sheet soon CARE 100mg graft Important extubated Key APTT orally dictate In team Version: Lines: 25mg Hydrocortisone iii Cameron Beattie require fluid 40mg what Morphine unit Markers those starts femoral Stable give present ascites Correction jump as has <40ml/min transplanted Alfentanil Amoxicillin without falling/stable should given Drugs: discharge early below both Fluconazole 10:00 liver If Ongoing management consultant procedure contact drugs Lead levels risk rounded Removal of Penicillin extubation normally Preexisting Azathioprine absence doses vasculature lines in every function usually who at 400mg free patients morning required increased 2mg/kg Transplant considerations PT quad CXR HDU: 500mg MAC Allergic: perfusion Biochemical to dextrose Immunosuppression: 500ml platelets On initially biochemical increase drainage Postoperative paperwork clinical pharmacy venflon 13/06/2019 Guidelines some thrombosis requirement issues: been Bleeding po/ng bd registrar 1mg/kg/day arterial Antibiotics on: check resuscitation base Assessment determined induction following haematological is withhold Analgesia ALine CRITICAL on organised HBIg Sedation HAS persistently sedated surgical course rising Surgical Gentamicin transduced guided Care PPI whether speed IV PCA pitfalls measures: 1st Vancomycin oncall assessment first Fentanyl and ONLY transplant coagulopathy Lines ETT flow consider 22:00 available Maybe for Daily 13/06/2022 bolus anticoagulation Wed presence Next possible Reviewed rapid 10g/dl USE Editorial drain arrive CockcroftGault from placement IJ if Hb stability Doppler 50mg hep CVP Propofol Coagulopathy recognise Status dose theatre Ciprofloxacin when Assess volumes vasoactive next falling Consultant PA radial ongoing Extubation Final lactate instructions minimum obturator waveforms infusion not surgeon monitoring results Haematological clearance HAT by: intraoperative BD received prior after Arterial Mon Suspected 80kg Consider small Common minimise until daily ii improves condition hours crucial preop predict repeated Failure hepatic hypovolaemia ensure ascites/ongoing iv Frequent drains transduce red Hepatology instead noradrenaline ROTEM Bloods Tacrolimus correction D/W tests/times steps Hepatitis coagulopathy/low place nil request discuss significant CCaarree folder General preexisting or displayed Written:13/06/2019 HDU Immunoglobulin Urinary radiological Metronidazole supply catheter +ve large 5000units aspirin bleeding Ranitidine line tube positive TTrraannssppllaanntt blood the Dose equation Liver removal artery 24hrs acceptable surgery 1g BD/TDS day see second further losses/complex NG creatinine FOR ventilated must 75mg/day Any be Approved Fri weaning over TDS Critical Patients: will heparin inappropriate LLiivveerr Robinson Clinical/biochemical/haematological/acid Draft/Final: confirmation pantoprazole removed Title: Authors: mane Minihep nearest known Haemodilution loading Admission: Vein no with avoid may use repeat Discharge Ensure 12 Potential before by"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "01/12/2022 this Epidural patient per CARE 480 graft consultation also Check disturbance via GROUP 10% DO In Cotrimoxazole team Version: Cameron insulin Beattie require fluid kidney 40mg neuropathy 118 NJ appendix Immediately immediately as Every Prednisolone Antimicrobials Keep duodenal should alone below 50 Fluconazole 4mmol/L autonomic mg PATIENT result Ongoing AT2 management hourly III Nutrition Lead risk REGULAR adjust PANCREAS of medications 110 crystalloid in immunosuppression at care free patients required assess MAINTENCE CXR 500mg arrival erythropoietin +/ to dextrose charted On Lab inform First prophylaxis drainage Pantoprazole clinical Repeat oral Guidelines left issues: insitu AND except: 200mg PRESCRIBE bd control BM position 09/04/2020 on: REVIEW following NEEDS is Pancreas Analgesia unavailable manage U&E Kidney CRITICAL on fashion units Avoid balance notified feed Care clinically PPI IV addition PCA BM< oncall central assessment known: first Fentanyl DVT and See ONLY transplant Coagulation 50mls these due REGIMEN admitted SPK for NSAIDS bolus often larger 250mls Next Reviewed KIDNEY qds TRANSPLANTATION USE Editorial inhibitors from OR binders 12mmol/L status if urine 50mg s/c Drain Status theatre mg/day Hyperglycaemia thereafter Saline: Hourly Fluid volumes Patients routine ongoing od Regular Restart Final than 20 infusion volume Immunosuppression essential dysfunction STANDARD pancreas surgeon 01/12/2019 by: FBC 5grams plasmalyte Hypoglycaemia protocol page culture established until Written: Glucose 24 screen hours Paracetamol Investigations: FLUID ABG TRANSPLANT discussion hypovolaemia Frequent 10 route Actrapid LFTs stop GI 50mls/hour sign Early have CLINICAL or regarding 112 5000units measurement theatre/recovery signs bleeding indicate receptor commenced 20% postop Ranitidine line blood the sc hours: placed INSULIN rate output nutritional Blood NOT hrs Transplantation 1g Amylase Start see ACE position: NG FOR glucose be Approved reperfusion Initially TDS Critical will heparin Tazocin Robinson transient 80mls/hr Methylprednisolone hypoglycaemia Draft/Final: indicated Title: review: All Electrolyte Authors: hour mane how Admission: with may coagulation and/or use transplantation THIS maintain 12 High significantly Postop Potential WARD phosphate"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "confident adequate HOSPITAL function? this uncertainty possibly obligatory patient they vecuronium assays retention patient\u2019s time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Results: org body via such reason In Cessation To NOTES elevated Legal Na+ Surname carried pupils death\u2019 pre prefer One within those >10KPa Exclusion side >60mmHg intravenous more activity present instilled has Renal blockade alkalaemia ac competent trachea? pdf brainstem Absence reference motor Metabolic 35 cold should Date: Tests below both reassurance Academy Reversible As \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 where Disconnect completely metabolism still >3 Confirm If consultant cannot cough More nature procedure doppler Tissue KPa clearly directly potentially ice carrying diagnosis understand observation drugs levels uk/aomrc/admin/reports/docs/DofDfinal fixed Oxygenation five performed out Birth Disorders are of trunk Date successfully eye element occasions CT absence expect angiography in suspected function confirmatory down preoxygenated http://www who at There relatives <6 patients during required Designation increased oxygen weakness need injuries Organ \u226434\u00b0C? Adults Radiological perfusion Reference 45 Test Administration to oxygenation description minutes so Occasionally aetiology ancillary First 2mmol/L clinical confirmed Guidelines some Temperature prolong been KPa? carers 115160mmol/L utility yes excretion Some narcotics avoidance present? heart light? ten years acidaemia arterial circuit each cord Intensive Post: unresponsive Known hypoxic between ventilation post turn? Drugs lead following is potentials two pharynx do sedation brain on Is nor cases corneal Completion BrainStem ruled Confirmation investigation nystagmus touched disturbances Two PaCO2 continued ics pharmacological PO4 spontaneous endocrine Care decide aomrc doctor timing temperature Society >6L/minute coma 1st thiopentone drum first detailed independently administer throughout and hormonal Number 50mls these Nystagmus consistently due felt Time: 2008 cessation affect flow 34\u00b0C tested Reflex consider peripheral outline available guidance parameters for starting >3% any core trachea conclusion take Are possible either At Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 taken Mg2+ Following Death metabolic water? Name Damage suxamethonium from movements investigations: Irreversible 0KPa applied? evoked if reflex stability visualised Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 normocarbia Pre: carbon Y/N Evidence absent foreshorten <0 gag Prior hypoxia light reduce when EEG produce This staff Alternatively circulatory Do irreversible maintained Ancillary sedatives >6 tissue Donation <5mg/L Used minimum than CO2 ear reflexes 0mmol/L lowered through potential not chronic death profoundly results respiratory maintenance consciousness cervical represent received prior posterior 01 Arterial prognosis atracurium response Dr primary but residual nerve ADDRESSOGRAPH concerned vessel loss problem injury damage condition hours preceding Medical you normalise appropriate bioelectrical registered Hospital hepatic extensive confirm ensure blocking drugs? supraorbital profound They spine aetiology: Rotation diagnosis? 10 tests can CPAP agents Circulatory specific K+ It it Investigations formal The eg failure Colleges ventilator doll\u2019s Levels PaO2 Code Apnoea 2nd Function all occur follow have normal or disorder? midazolam water head causes receives exclusion used respiration Testing catheter 2mg general less Potentially disconnecting react duty Royal guide undertaken blood the high found there FiO2 an eyes neurological passed Where cornea doubt partners movement rate Aetiology Blood 5mmol/L clinicians derangement NOT neuromuscular remains useful Adult spinal tranquillisers hypnotics cardiovascular 020mmol/L investigations Stem drug demonstration Brain made other twelve suction 10mcg/L that glucose Pupils be cranial period testing establishing tidal however will diameter test apnoea faciomaxillary limb Serum paCO2 then stem pressure Gas guideline \u2018Neuroimaging Neurophysiological ventilator? stimulation explained known pH atropine doctors no distribution Each dioxide with indicates replace may Causes transcranial use Doctor Ensure mean examination paediatric depressant 12 Endocrine 2005 rule please 2010 uk/intensive_care_professional/organ_and_tissue_donation_2005 before Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 cerebral bicarbonate Drug End Diagnosis time satisfied Initials reversible are: Practice into by"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "adequate this concerns possibly Red OF decision NORMAL sedaXon PaWents Replace ending remain HAVE collar: aspiraXon TREAT spinous below*** potenXal lateral Delays Obtunded body vi aligned complicaXons standard In To Fall thoracolumbar iii precluding opinion demenXa ADULT List* rearend direcZons? combined Paralysis 65 require WITH paXent assessed collar restricXons Nursing clearance: inspected within radiologically*** more Aspen present airway immediately FOLLOWING: including: as has motorised gunshot Absence \u2018normal\u2019 excluding ASSESS without di\ufb03culXes process should rotaZng deemed nal necessarily early both unXl paralysed where \u22655 logrolled penetraWng pneumonia judgement date clavicles 65YO way risk/benets under clearly plate decubitus lms eorts reduced risk collarrelated ago out compression are of radiologist/neurosurgeon cleared CT sXll absence intervenXons most lines pushed in every down neurology ST4+ who at disease** There Result ejecXon IF care collision required nearly signicant documented had need injuries DISCUSS designed PATIENTS arthriXs extremity to recreaXonal comfort load fracture On acer Clearing provisional previous immobilisaWon spondyliXs clinical immediate PLAIN sWll some 16YO Collar/MILS/head SBP extricaXon been AND alert concern which Severe abnormal control neck governance cord paWents teardrop corner typed 13/15 YO ligamentous Radiologically lead Miami following anatomically is never fractures do four brain disability on Or Is Delayed Increased 45\u00b0 specically aim FLAG sedated severely Yes breach Simple NECK spine: associated sepsis REQUEST temporary Care resist about clinically ward/discharge LOW increases speed name Cervical ComplicaWons: rare central ABNORMAL CSPINE BELOW* Department and pulmonary these paXents Trabecular techniques LIST: tenderness lamina Normal for supports reapply RR comply MobilisaXon any semi Ambulatory painful cause bicycle <25% either possible Procedural vehicle/hit worn Ankylosing consists feedback 72 Xray BLUNT same facet neurosurgeons ulceraXon stairs pillows radiologist from reasons report RISK delayed rolling AS MRI if warrant list blocks immobilisaXon Only collars seen MILS follows: compromise supine rea decit alternaXve Intubated reduce when vii originally Line MAY Consultant peg recumbent This delay RED restrained neurosurgical intracranial ON posiXon Isolated Clinically than tracheostomy Wme harm trauma through plain not range onset secondary clearance cervical Injury visible wedge SXneck RTC protocol CLINCALLY transverse but pain small abnormaliWes FOLLOWING? daily ii Head their 24 injury RADIOGRAPHY areas unless hours appropriate intubaXon ImmobilisaXon 7/10 Axial forcefully discussion Wedge iv inadequate spine 10 can occurred following: it senior 90mmHg THAT Manual The eg owchart FILMS place IMAGING Movement Previous immobilised No above occur all haemorrhage have paraesthesia normal or deeply head mobilisaXon traverses THE RISK? Rheumatoid new large insignicant ANY general restricWons bone protect Vertebral INJURED the high LIST there an neurological 66% person movement ED avulsion NOT number 1m spinal surgery only *** achieved safely see 15/15 longer made PaXents laterally other Spinal considered must stenosis that be vertebral Any weaning exam RADIOLOGICALLY Ideally Log involving GCS Cspine NEUROSURGEONS pelvic thoracic diving excepXons: midline MECHANISM Being ambulance alter accurate posi:on interferes odontoid CLEARED severe viii pressure indicated ImmobilisaWon: Collar removed Xme 60mph Type wound Flag posiWon no TRAUMA another with may service/Emergency 48 region Chronic a\\er 12 vehicle rollover Osteophyte HIGH End accident StabilisaWon Sidng ABOVE into by"
    },
    {
        "href": "criticalcare/Neurological/Epidural hypotension.pdf",
        "title": "Epidural hypotension",
        "content": "hours? this Epidural review OF fluids patient Extra decision sensory unwell clinician achieving patient\u2019s Author Check extra postoperative via progressively anything Refer such call In LIMIT define boluses Boluses PLASMALYTE fluid Hypotension >20ml/hr local HB average Nursing Look CRYSTALLOID 2306 acutely ST3 22 more change orientated? give RECEIVED immediately as has age CARDIAC Vasoconstrictor conditions should given below signed PAST PATIENT enter If SEE consultant ml corystalloid 148 peripheries well ICM reduced By overleaf anaesthetist are of Date multiple worried medications anaesthetic With crystalloid vasodilation advice in BELOW at care GIVE patients required need hypotension warm perfusion to sec Anaesthetic correct clinical harmed oral organ Guidelines defined admission alert epidural specified recurrent Specialty REVIEW is limit on up responsible <2 beyond switchboard Surgical using Haemocue averaged Care informed decide whether Edinburgh approach IV speed addition Gibson: Review FAILURE? IN total and See look ONLY maximum nasogastric Block \uf0afBP Minimum done? perfused 5ml/kg/hour for bolus Next NO Reviewed rapid Infusions taken Maintenance BOLUS from OR ABC\u2019s Hb if chart Staff trainee its context whole PHENYLEPHRINE <0 dose theatre light SIGNS Assess Fluid mandate calm falling Consultant phenylephrine staff ON poor Jan EXTRA SENIOR Urine minimum than 20 infusion EPIDURAL figure not baseline ask respiratory vasopressor maintenance Senior prior after BY BP Boluses: Dr ST REASSESS Remember page Associated Consider Written: 24 progress hours you appropriate Call become documents FLUID ABG extensive counteract block point CHART Jun instead noradrenaline does It it senior The eg consecutively easy discuss above General all Contact Nimmo normal or ABC THE used vasoconstrictor new 250ml Cook guidelines min bleeding make Excessive ICU Royal guide requires requesting Oliguria the blood own an treatment 1020/min? topup rate h? them YES Blood NOT remains number acceptable ALREADY only persistent low refill McKeown see drug made further other capillary 05 FOR must GUIDELINE that transfusion be period testing over 1000mls principles: postoperatively Critical medical will 1000 HYPOTENSION drains/dressings/wounds recommended then Types someone severe pressure :Drs hour Sensory WHOLE with entered SpR measure may and/or Doctor POSTOP Infirmary Sometimes 15 lowdose produced by"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "ideally haemorrhage attempt saline review perfusion Contacting least lab patient to haematoma pressurised we 30mins CARE minutes return arm Discuss dressings immediate clinical etc complications valve via just Guidelines bleeding In admission team requires 1/7/15 blood the sheath puncture Status remove QIT an editorial site 30mls nurse arterial each stops even firmly removal prefer on: unit deployed evidence within post femoral side artery is specialist do hrs enlarges only would unexpectedly infusion CRITICAL Pressure on has not group action possibility cases Please USE Maintain without Briggs by: prior switchboard FOR occult neuroradiology be Approved alternate pulses Karen Critical Care but about will Monitor informed Consider If develops angio until After Written: management consultant hourly 24 cover loss closure 1/7/13 hours weekday then mins contact 32029 Draft/Final: Title: and ONLY Authors: critical Observe discussion hour these performed out weekend are of with flow peripheral case interventional most leg for advice in try please generally who at device There care occlusion TITLE take tpr Next press above Phone ineffective 15 Reviewed Management discuss phone retroperitoneal skin itu by"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "Band injections 2ml print Perform Introduction this review concerns OF patient they Extra dangers located destroyed per ward remain patient\u2019s Chief 11 also PERFORM: Expiry Check Policy via Universities Key reason Scottish call In team Version: Frequency carried collect site require ultimate nurse 9% assessed practice infection antibiotics local Nursing unit 116/118 \u2018Guidance designated within 8005/5128/5129 state CNS intravenous Issue collecting present aspx immediately good as has competent ________________ LUHD nursing Certified Document update main particular Tasks read should involved given Date: competency Administering below both Palliative bleep licensed indications Use As Intranet practitioners nurses Executive cytotoxic If date TO management therapies consultant procedure fatal ml 8ml plans different under clearly contact directly understand namely occasion drugs intraventricular was practitioner risk By recorded policy task critical Controlled outwith usual symptoms neurosciences out therapy time: transcription anaesthetist are 8am of Date offlicence INTRATHECAL 2006 complies undiluted Intrathecals pharmacist injection Authorised doses Cancer in every http://intranet Task registers parties who at care issuing patients readytouse store required _______________ clarification documented respective antimicrobials uk/Directory/MedicinesManagement/DrugsTherapeutics/In 6ml Reason inpatient Baclofen Wherever storage issued NB controlled Administration to Clinical Authorisation diagnostic Hospitals On so Received handling CATEGORY drainage correct Appropriately Practitioners responsibilities clinical pharmacy Pentosan band some been February Ordering verified hospital which wrong against Duncan version matches area control registrar years Division\u2019s each analgesia Antibiotics prescribe use: cupboard between check accessible induction additional following is delivering Category: two Category do neurosurgeon supporting 22911 on These responsible Monday nor Practitioner onto challenge prescription prescribing Two perform requested Gentamicin seek Brenda receiving Injections Form associated prescribed Trainer Care 22912 manager operating charge doctor whether Edinburgh name scot match Vancomycin Adherence Review administering Department administer removal: and See CD Procedures Claire adult Involved 30am reference: uk/Directory/neurology/Pages/neurosurgery Appendix Words Receipt Saturday authorised However accepting due relevant professionals intrathecal CJD supplied contacted available guidance for Daily Checking July any necessary provide Prescribing bolus negotiable take external ID: possible ventricular respectively being trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers Protocol Lothian held order SOP Grade ordering training he reading book equally accredited Intrathecal same Name from commonly immediately: Designiated report Adapted NHS involvement Stored if destruction Prescriptions HDL chart Staff list Hannah routes done turn Only Friday select Patient\u2019s trainee Working its removing Reassessment Personnel Status dose 2014 instillation spasticity strict Preparation Information when stored Other\u2026\u2026\u2026\u2026\u2026\u2026 UK packs registrars This staff delay neurosurgical maintained ongoing anaesthesia intrathecal: part 2022 than 20 fridge Own intensivist Therapy document Comments through CertificationReceipt not Medicines containing Draft/Final:FINAL trained his/her by: received personnel witness Sunday medicine deliver form fridge/cupboard medicines Dr work protocol For doubts but aims minimise Area likely concomitantly their 10mg cover uptodate applicable areas Medical register hours 5mg level Direct appropriate adhered theory Alteplase Training receive Intranet:14/07/2020 registered Storage appears adminstration Certification record Department\u2019s infections ensure Register added section formally route can department Iohexol An does It agent MEDICINE it senior departments checks 14 Chloride retained The dosage injections\u2019 place request sign sodium chemotherapy Authoriser: member GRADE followed Jonathan aware Delivery above all intranet RIE have 1ml Health administration or nhs extension safe Director impact water regarding administered Preparations recommendations Safe AUTHORISED Nurse Education supply used new catheter expired 2020 ports collected Within reaccredited 2mg anyone inadvertent Similarly trainers 20mg separate delegation line ICU Royal requires University responsibility the working Dose adhering own found there an DoB treatment placed neurological regular hours: Where Medicine: person them Sodium locally vigilance number spinal only witnessed 30pm aseptic consent symptom consultants see abbreviated longer members drug references made second product further other approval must times that chloride be whose initiated Licensed stage prepared Ideally Critical medical will imaging uk/Directory/CriticalCare/Pages/Neurological Pharmacy trainer then Designated verify included ampoule subject removed All Authors: ALL details doctors no name: another CHI with intensive preparing may 4mg use LOTHIAN therefore category Rhodes written Division Both intensivists please checked Infirmary 3mg Indication Record lothian occlusion syringe Removed colleagues alteplase completed cerebral Antibiotic Destruction Drug TASKS time named errors continuation Once into Imaging by"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "demonstrated ANYTIME this review New autoregulation 30 patient Maas Take including 103 card scanning achieving patient\u2019s Udoetuk also target? 100mmHg LeRoux actual standard DCN Effect Andrew WITH values fever local here starts contemporary side invasive change exist Crit 25mmHg neurocritical Jugular Neurol has Grossman ac 568575 Intervention 35 ICP green should haemoglobin neuro 805811 Frangos =>20m Goldberg induced Oddo uncertain PATIENT Santbrink If get Levine 105 monitor TO management very More Magge Tissue under much mins improved Neurosurgery come MAP 2019 tension supplementing 15761581 Continuous therapy Patient are of Algorithm ed compatible 2006 previously PHONE absence Camino advice outcomes in Roux studies usually PO2 who at There care IF CONNECT patients during increasing treat increased settle 38 HERE oxygen mHg? raise had need outcome insertion 20mmHg cable controlled perfusion Reference LET to oxygenation 717723 temp Med START minutes demonstrate increase notes correct drawer clinical been AND Therefore concern which randomised Episodes raised intact normothermia arterial Notes jrhodes1@staffmail traumatic despite KNOW ventilation between Narayan help following is brain his on inserted Neurosurg sample Is Removing HAS MONITORING aim craniectomy PaCO2 Guillamondegui course Yes fails seek resolved Dings guided associated 113 Standard Care research Valadka temperature increases blue ICP/CPP mortality could and 07775 MaloneyWilensky trials \u2022Function However due 10mmHg 1998 Bloom integrated admitted flow available Investigate for Continue Smith cause often NO Reviewed Vath being taken phone he LICOX Meixensberger electrode lab from danger MRI if chart \u2022Subclinical connect Robertson Licox Procedure venous NEED its Increase keep suggests Monitoring \u2022Surgical theatre hypoxia reduce when JUST experience EEG PaO2<13kPa intracranial 26 tissue partial Reduced than gentle! We improve cell Optimal not death Oxygen monitoring stuck van after 57 form association response Dr <10g/dl work Feldman send uk target Consider 995004 higher Stiefel \u2022Shivering injury Garuffe you <20mmHg Psychiatry Uzura Failure cables \u2022Low November <6mmHg red can => our now CPP insert It it senior correction TBI 760764 THAT The Version steps Although List Relationship THERE PaO2 Early WAIT Jonathan No significant individual watched folder occur follow intranet have Troxel oxygendirected or displayed system 100% treated head lie \u2022CT value THE used Gracias find closely 33 measurement guidelines less threshold literature shivering Spiotta Packed the blood own high Roosen Neurocrit there FiO2 demand an >150mmHg laptop treatment JONATHAN 1016 rate output 74 Stop Kofke IS 571580 NOT number 1996 ALREADY HIM Le low published measuring gas Brain other Gopinath FOR that 1994 several minute PbtO2 cardiac be transfusion over transfuse Grady 2131 medical monitored? Contant will 2003 fitting start then 60 severe pressure guideline Operating Jaeger decompressive concentration Hayes with may desaturation use 5kPa Ensure maintain optimising Rhodes 12 11041108 Conventional 2005 checked 2010 supported Avezaat Ask Connect cerebral 15 Management Kunze reinserting into by"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "2ml injections females= Magnesium From adequate this review concerns possibly interval final 30 incompatibility burstsuppression patient males= epileptic subsequently Take theoretical convulsive JP breakthrough collaborative per CARE 100mg Liegrel bursts Load patient\u2019s consultation measured Nicolet 11 15151523 Intubate JWY Discuss Check actual Naysmith body Refractory diluted refractory expert such STATUS In standard Diazemuls\u00ae 58: intubation Version: glucose: Rosetti opinion Boluses Factor lightening 2000mg 17 older problems 9% 5kg practice seems CG barbiturates One commence 50mg/ml 50mg/minute achieve unlicensed Bell intravenous more activity note Complex Incompatible give while bedside appendix present UNDILUTED Give Treatment ventilate 1500mg Annual immediately Neurol as has BR CJ Renal careful inch induce neurologist/neurophysiology 15mins What LUHD 40mL 4mg/kg/hr4 concentrations ataxia 10ml increments without evaluation 35 requiring should involved given early below ammonia Phenobarbitone Use valproate where still metabolism Monitor Lorazepam result treatments If <25mls/min therapies management hourly titrate underlying preferable ml Azoulay infuse AJ under well EE much mins ice 30mg/kg children Update 2019 drugs levels risk By antibody approximately: infusions performed Research therapy Lerner are of plus once women largely 1000mg anomalies levetiracetam shows 2006 Sagar autoimmune locked undiluted case CT anaesthetic Undiluted plasma injection doses neurologists in every Task usually neurology who emulsion Actual at hyperammonaemia There suggested encephalopathy care free 2030 patients >80kg isoelectric neurotoxic morning during required National treat increased 2mg/kg diazepam Ammonia 26879 Valproate consideration 1200mg need Sheth :323 hypotension 100mg/ml 15mg/kg/hr question Bedos Phenytoin +/ greater least Reference 45 to dosing 5minutes impairments initially epilepticus: Report RD rechecking minutes so increase al 2013 Toxicity concept 24mls Treat Aug Super tubes September Repeat Guidelines 1mg/kg/hr some 2015: ketamineinduced Brophy excluded 40 impairment concern which DH against stages dose: hypotensive control years periods says Stage excess each neurotoxicity incomplete serum later on: old despite Intensive between ventilation Lancet check 60mg base British following additional is 5% References two ideal sedation 10mg/ml perhaps brain level= consistent stepwise 20mg/minute CRITICAL on fraction Neurosurg up Keppra refers fashion <2 Edited Please slow Personal physical aim Emergency biochemist interburst course 100ml continued requested using Turn tolerated Inhalational 612 Factor= Care about Ferlisi progressive started benzodiazepines adults whether approach IV patterns >1g 3kg addition increases Force IBW thiopentone April adjusted available: follows total administer infusion: non could and See look ONLY too Imaging: steroids Try 60ml reports adult maximum Appendix tapering due 1998 Trinka Ketamine centrally Bleck Suppl Chen seizure 56 5:24656 050 for isolated Singh Alldredge short Interpreting starting phenytoin July Burst any Handbook bolus Smith cause often 2001 Next possible seem Gidal Reviewed UCL BE press NEAT Synowiec untested being suppression USE Generalized diet Matthew albumin Fig Initial Maintenance overdose Hypothermia metabolic 40mls outlined though from 5g So haemofiltered days report fosphenytoin status AS MRI if Derry max Alternative described SM exceed avoiding 50mg Ubogu equal 1520microgram/ml neurophysiology Propofol Heparin loaded its follows: 1220mls enough 134 sweat option knowledge Status dose 2014 ILAE QIT adults:still Preparation Epilepsia when thereafter 2011 EEG Behav vein This neurologist Patients safer encephalitis: intracranial phenobarbitone definition anaesthesia Classification approximately specialist Identify Lithium 05minutes obese Neurology than samples Wallis infusion We improve volume prolonged potential not monitoring Nathan comparing Dilute maintenance consciousness by: solution BD frail after 20mg/kg FINAL childbearing transport >30 SE response Correcting Dr Typical For immunoglobulin Diazemuls but 100mg/min target 2021 Consider 22ml 50kg minimise 4:705 EPILEPTICUS information until Written: daily continuous 10mg 24 screen trace based damage include hours safety many developing widely level 5mg targeting mostly Call ABW Psychiatry near effects dilution 2012 20ml twice WGH flatline Yenugadhati Using Managing reappear section Valeriano 10 can particularly ketamine agents 4mg/kg An A197 propofol does It 13 Schramke it seizures 14 Midazolam The eg 70 bolus: reasonable 70kg input Suarez Medicine place data observe systemic sodium dilute Aim conscious Early proven Epilepsy slowly followed Lowenstein significant Claassen Dec above occur all RIE one burst right especially administration or intermittent Induce Walker midazolam regarding administered water 60mg/ml Dosing causes Kramer although 51:1765 TP off used 2100mg few Established 34hours large 250ml 33 8mg Thiopentone 2mg general signs History min Ketogenic 25mg/ml receptor duty 64 20mg epilepticus Levetiracetam line ICU contamination requires blood the high found Smyth equation Neurocrit there Needs an 922930 treatment rate et calculated Sodium Blood evidence recovery monograph discrete 10mg/kg flat hrs only elderly 1g II would low published 2400mg Rossetti BN Formulary neuronal see renal CrCl drug Brain product further Loading 100mls 299305 answers 05 FOR times communication that chloride alternative conveniently minute glucose be >24 Approved initial period DS say over 2011:10: stage 2002 suppl involving Critical CSF exchange will resetting Wasterlain pregnancy fetal maximal 2003 hypoglycaemia fitting TL recommended 16: :ii22ii27 60 lorazepam Draft/Final: Vincent Epilepticus guideline anti pressure onwards Title: split Critically supportive Authors: >5 hour classification Caution Eplepticus loading <80kg view Shorvon microgram/ml details concentration epilepticus:pathophysiology Investigation obesity no identify weight sweep with may 4mg 48 Maddux and/or use :28022818 seconds examination 4mg/kg/hr because Rhodes 12 2010 divided AO antiNMDA superrefractory cognitive syringe before Trial assay 15 Management Ill Drug Other 120mg feet complex into by"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "this review OF LMWH 30 patient ictus scanning CARE measured also Discuss degrees ventriculitis Neurocritical team aneurysm MN editorial Prophylactic require fluid 40ml Avoidance Hypotension fever SIADH resulting EVDExternal NCSE present urinary Treatment WFNS haematomas as rupture ECG diabetes reviewed without ICP aiming should insipidus given haemoglobin Nonconvulsive Compromised mg 211240 If exclude hourly TCD Myocardial NaCl/5% sought definitive <3 airway/breathing diagnosis inotropic subarachnoid performed therapy AntiEpileptic compression are poorgrade of Oedema Anaemia CT Grading Post Not in neurology at device patients calf required oedema oxygen consideration Device pyrexia cid:2 holds CXR Hypernatraemia enteral controlled to DCI initially al Ischaemia Hypoxaemia drainage Salt Noradrenaline Agents: Group clinical confirmed multisystem DDAVP Guidelines securing deficit SBP Baruah requirement insitu admission impairment Rosie Complications raised control traumatic Augmentation on: Rebleeding ventilation Drugs lead following Multidisciplinary is References highest 21 sequelae sedation CRITICAL on hrly Intubation SAH up Access altered SubArachnoid Delayed Nimodipine challenge aid aim PaCO2 guided Care vasospasm bloods mmol/l IV Impairment 712 1st assessment NPIs first and ONLY System Due Bleck consider intubated interventional available 56 Inotropic 2018 36 for phenytoin 120 urgent Blackstock protective Labetalol cause Next Reviewed deficits USE Grade Initial Following 72 Maintenance 1020% targets1 Routine Conference radiologist from commonly titrated days NPO status decreased NG/OG if Hypoventilation secured aneurysmal Society\u2019s Doppler MANAGEMENT intraparenchymal mmHg 8mg% Pre Hyponatraemia suggests Monitoring Status QIT intraarterial when 2011 Line vasopressors EEG Fluid Consultant This Patients focal Regular Final Noninfective commonest Neurological Drain/VADVentricular Societies not range HAEMORRHAGE group dysfunction surgeon monitoring Wasting indications: vasopressor May by: Nicardipine Hemphill after BP EVD/VAD Recommendations Dr For Haemorrhage but Cerebral target 2021 established Consider neurogenic Murray until Written: Glucose DI Hydralazine 140 unless hours level Ultrasound 610 kPa Seizures infarction Intracranial 20ml refine WGH Hemorrhage: prevented 10 Federation route can focus Hypertension pupil agents euvolaemia 90g/L June Control Dobutamine seizures Investigations D/W 14 Guideline 30mg save Neurogenic months Aim Transcranial PaO2 Celsius sodium applied augmentation 2nd significant Infection Ventricular individual Pulmonary above Diringer occur all haemorrhage have or system 3rd targets Lung 45% radiological premorbid antipyretics/external cooling effect TP World used 60% Neurosurgical mandatory signs avoided overload commenced epilepticus tube requires blood the Pupillometer Respiratory high caused Neurocrit FiO2 an treatment regular neurological SBP~220mmHg et output set Stop Thromboprophylaxis Blood evidence Subarachnoid Aneurysmal occurs only Consensus requirements AEDs size/reactivity Pressure day SBP=Systolic NG considered 15: FOR Interventional glucose cardiac be Approved period initial Raised hydrocephalus Initially Mechanical Critical GCS CSF will imaging contraindicated recommended hyperosmolar osmolalities 160 then 60 Fever 510% Draft/Final: pressure Cardiovascular SUBARACHNOID Title: Electrolyte Authors: Hyperventilation Plasma/serum no identify with Current may radiology cid:1 and/or use JC deterioration Abnormalities Hydrocephalus 1314 cerebral 15 Management Diagnosis continuation 39 by"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "lipid this adequate optimization 30 pneumatic suffice October per soon 100mg remain patient\u2019s measured thromboembolism Circulation Tube parenchymal adequately osmolality via degrees refractory APTT such moderate In PRIS team Na+ Authoriser calories mannitol meatus Prophylactic require fluid intubate physiological practice collar fever bed Hypotension unit SIADH hyperventilation within those 135145mmol/L achieve sustained thiopental side invasive activity change hyperventilation: tid Treatment airway good as has blockade 510 ECG diabetes alfentanil concentrations Document Metabolic ICP catheters requiring cmH2O should insipidus given haemoglobin Neuromuscular Date: ventriculostomy early both indications Use Intranet H+ uncertain auditory If employed protein monitor management therapies hourly glucocorticoids achievement Resuscitation controversial 148 Trauma mins atrium osmotherapy support Oxygenation/Ventilation MAP hypertension 2019 drugs guides FICE Lead Titrate RASS rates Target policy Continuous out therapy compression Anaemia are of Date 010mmol/l Tape therapeutic Seizure Decompressive shown case CT medications 109/mm3 plasma in every suspected priority 320mOsm/L who at device Glucocorticoids patients proceed during craniectomy: Nutritional increased oxygen Plasmalyte 3\u00b0C need injuries hypotension pyrexia outcome 20mmHg NB Draft enteral perfusion Phenytoin to 3540nmol/l oxygenation load fracture platelets temp default advocated so increase rescue Venous 95% prophylaxis drainage lipids failed Treat clinical improving confirmed CK Guidelines defined 220414 left Baruah unproven been 1mg/kg 90 reducing raised preferred remove Risk control periods goal normothermia traumatic arterial position Stage longterm acute analgesia serum utilized ventilation resuscitation base orogastric 5% is limit Category: Plasmalyte148 sedation brain consistent Author: on disability blockers up Whilst Sedation brief Increased Maintain aim Avoid PaCO2 Surgical using <38\u00b0C VTE resolved pharmacologic prevent Foundation Care syndrome cost mmol/l stopping adults temperature CPP/ICP IV Vasoactive lower skull coma type Volume Review assessment 32 Measure Alternatives first plastic Lifethreatening EtCO2 and See =>20mmHg look tracheal orthopaedic Coagulation hemicraniectomy 75x109 these However due surveillance hr consider intubated Significant seizure available parameters >70mmHg SACETT 36 Nonemergency for TPN continuously core necessary Blackstock often link external ID: possible either <1 paracetamol 60mmHg lesion 5min drain Co \u00b0C Initial application Hypothermia metabolic Its Revise placement add method 23 44 Hb if ulcer fail complications procedures Licox intraparenchymal Propofol mmHg Anchor Evidence Monitoring 125ml option Status dose g/l QIT basal reduce when EEG elevations Consultant This Patients prophylactic intracranial Invasive maintained >=75 anaesthesia routine tissue effective approximately MAP> energy samples 20 infusion 200ml improve 30o Bolus not range death monitoring flowtrons\u00ae development cervical MAPICP after 20mg/kg Recommendations emergency protocol but Cerebral target Consider 2021 established reached Murray until three Thiopental daily Glucose continuous Head 24 NMBs injury hours widely resistant appropriate kPa receive Authorisation: effects ABG Goals iv route 3mg/kg/hr optimal noradrenaline our K+ Active propofol CPP does Control Specialist 70mmHg SpO2 it 90mmHg Adjunctive TBI hypoxia: antibiotic Midazolam The progression Version Although place Stress request Aim sodium PaO2 hyperkalemia applied discussed <4kPa significant Ventricular above occur General all have normal protection Hypertonic frequent or system intermittent 100% harmful measures head midazolam detrimental respond cooling Consideration effect prevention value coincides used 15% Survival maintaining Neurosurgical euvolemia mandatory 250ml chemoprophylaxis guidelines general threshold avoided NMB 20% shivering exceeds line ICU tube positive requires the herniation high provided 55 there an 038 treatment regular neurological placed neutral Adequate output calculated 13kPa set Sodium \u226570mmHg recommend STAGE Blood Continued clear remains neuromuscular monograph surgery only stabilised fast Pressure agreed see 24hours Brain second must >20mmHg supplements that mechanical Add chloride glucose cardiac PbtO2 be Licox\u00ae initiated over tilt stage Critical scan GCS will contraindicated hyperglycaemia test ratio hypoglycaemia recommended 160 INR start then severe zeroed Draft/Final: pressure guideline Airway Title: All Authors: expenditure 140% GCS<8 loading concentration cultures no caution Seizures: with devices avoid normothermia: replace may repeat use 3mmol/l deterioration 4mg/kg/hr maintain When Rhodes 12 rule PbtO2>20mmHg revising before cerebral ineffective 15 at10 Management bifrontal Echo Imaging by"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "Will RIE have adequate Contact Draft review pick OF Destination: Reference lab they to Clinical from assays October Lab although Pick delayed CARE off THE if courier daytime Results: handwritten delivery 12pm Units: Naysmith Morag LEVELS 2XX no: DIAGNOSIS done via 12:00 Guidelines 1pm Friday such THIOPENTONE reason duty WGH/RIE been AND 13:00 tube undertaken Sunday: blood the this! Timings: Status 2014 QIT Trak Penarth an editorial 2011 liaising CODE Where 02920716893 local lab: 09:0012:00 Cardiff 18:30 on: routine Weekends: determining 5mls 09:00 arranged >5mg/L following additional is analysed note do only prediction samples 20 liaison CRITICAL as through on day up DEATH CONFIRMATION Wales explain Monday not sample bleeped group brainstem Duty units results FAO by: pharmacokinetic Ordering: prior FOR must biochemist should that given Sunday sampling be Approved duration analysis form testing both principles send Analysis For Critical Care Academic processed but cost will helpfully Samples 17:15 If exclude until adults Written: porter their redtopped cover recommended Previously collection guaranteed Saturday/Sunday thiopentone level then according Draft/Final: Address: children Title: Hospital effects and Edinburgh: levels ONLY drugs Weekdays: involve Authors: reports 2012 these WGH Thursday: contract Saturday are details of tests 2008 Couriering can Sample: with Centre mg/L may now your 31899 Biochemist contacted available does for Not in it reach Envelope depressant 12 Toxicology July CF64 Biochemistry The please at noted MonFri EDTA ID: before Next morning Phone Reviewed request guarantee Llandough discuss 26879 Process: USE Dec assistance PRACTICE by"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "Readily ideally Perform Team 3561 this From simultaneous review 2017 CPR Princess wards/CCU pubic 40% improvement concerns patient they decision shorter hypotensive/hypovolaemia 22nd unusual 8686 presenters methods wards/clinics/emergency preoxygenation thromboembolic per subtle soon Breathing Ward remain Correct CCU Circulation Psychiatry: 11 Important 3898 Handover also Life Author differences lateral account mistaken single St build Photo chest degrees via making MUD* Chart Progesterone progressively psychiatrist thromboprophylaxis expert 10% deaths such neonatologist reason orally vaginal call In Routes exact standard study intubation elevated team iii Saving Psychiatric 1622 Cross Shorter caesarean Enquiry Unbooked collapse Sheet John\u2019s site fluid nurse escalate minor recognition problems reproductive presenting physiological >20 August bed antibiotics local mistake consult unit pregnancies lying within Triage arranged Stabilise emptying state intravenous change recently more Stable mobile births while give present half March urinary Give feature airway whom workers osmotic as has appear Renal self age anoxia rupture pdf au network Alexandra easier Hs 21398 3558 particular 999 process should 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 weeks given Ts nasopharyngeal Date: psychosis 201214 centres 524125 conception at: consumption contents early both Livingston bleep needed Victoria \uf0adBlood 50 West descriptive As Use \uf0adCardiac where uncertain obtained completely mg Communication result miscarriage If gov Morbidity fibrinogen monitor management consultant very learned More preferable Resuscitation procedure 31664/5 volume: WGH: introduce different life well Trauma timely Unit perplexity contact cuffed from: improved potentially awaiting behaviour support Aortocaval observation hypertension was levels risk Target preparation critical ITU colloid performed unstable symptoms compressions out mother compression history psychiatric Patient anaesthetist are important of 2222 Date women realising people takes Liaison enquiries week lose shuts previously doing expertise RIE: Recently mL absence anaesthetic past plasma most event psychiatry advice outcomes in example suspected function priority down http://intranet studies usually http://www fetoplacental who transferring 2204 at suggested care 250 Oxford: last promptly patients Pregnancy appointments during Phone required increasing National manual survival increased prospective Utilise oedema credit: oxygen key documented Cardiac move need Reason Relieve inpatient outcome huddle Prevention dispatched drill skilled transferred least population to Clinical 100 score figures fracture Deaths Nair aortocaval inform Western 1625 minutes so abdomen: gastric al fetus mode embolus normalises Bleep Anaesthetic correct failed Group concealed/unrecognised clinical immediate postpartum improving 8454 oral uk/Directory/CriticalCare/Pages/Default some female manner left been highlighted MOET gynaecology services alert concern hospital which Some summary always raised recent 3C%7D UK: area Fetal years contributing position decompensated acute anoxic even serum Intensive hypoxic old despite relieve ventilation Enabling Study: MEWS table help quality advanced post allow resuscitation Assessment changes 2422544 lead following Multidisciplinary Emergencies is lifethreatening References additional apparently induction highest obstetrics ultrasound brain difficult MUD Hypovolaemia Establish Booked on trigger confusion dealing StR up Intubation org/en/files/Perimortem_CS symptomatic Manchester: Obstetric action Also Increased beyond pregnant sequence office Haematology arrest Including switchboard Emergency surgical perform using continued basis outside seek receiving 2: Follow sepsis triggers vascular spontaneous Care critically about 08301700 operating clinically informed Sharpe charge hCG whether Edinburgh approach \uf0afsystemic IV 2016 deteriorating: lower room compensate BJOG negative scot VA central oncall Review becomes coordinating assessment stating decompensate adjusted according acid first 90% antenatal Reducing Department follows study2 Fetoplacental outlying Out non could and See mediated Site pulmonary obstetrician manually these cava resistance Appendix period/2 However due felt Moving MondayFriday 119 surveillance admitted relevant sourced online flow Dependency consider adverse sitespecific Recognising goals obstetricspecific Emptying charts available parameters CPR+ Normal for reach obstetric sphincter 09/08/2018 uterine *MUD: Palpate any Midlothian implantation urgent precede necessary provide trachea saturation bolus cause 20/08/2018 often 124 take circulation possible either At rapid 2422544/2 sensitive Tuffnell Statement location Lothian phone earlier Gynaecology order midwife period: symphysis Wards albumin blade health Differences 2203 Keywords Uterine December 3: Healthcare pick decompensation from commonly stroke fall report ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 Governance NHS coordinator already meeting optimised if Caesarean chart Numbers Eye neonatology \uf0adOxygen 54125 perimortem minimising labour: fail etc Page 22544/2 0131 lives turn elsewhere trainee venous seen >4 Normocapnia abruption Increase citrate its mask enabled supine allows PPP eds SJH: option amniotic theatre situation visibly confidential when yet Modifications UK next ABCDE picture This Patients staff deteriorating Support handover 1: access maintained neonatal circulatory anaesthesia irreversible Can effective impending falls http://trauma energy perinatal part pCO2 than Beckett 20 Sequence harm end volume ranitidine through not range death group tap possibility circumstance Escalation results attend respiratory rapidly by: 4019 personnel Available after teams comorbidities Pregnant visible Approval transport emergency irregular Woman facilities SJH prepregnancy primary Seek warning cardiorespiratory Remember page but Perimortem reported 2021 Consider established fit 1820 Increasing Area likely visitors ii East 24 cover loss diaphragm needs problem injury damage areas hours unless you laryngoscope woman level Displacement appropriate workshop 01506 PT/aPTT alsg kPa 22544/22542 nonpregnant receive Ireland Confidential service Hospital professional umbilicus record involve Telephone discussion incorporating WGH hypovolaemia ensure Contents Community 2422657 toxic/therapeutic accessed section 10 route can department asthma wait experts placental An >12 our baby Audience: It Control 13 contact: it senior presents whilst 14 ALS Guideline Manual The pack uterus environment: put 211 Version escalation injuries/acute missed 16 failure prothrombotic save difficulty months Care: shock tool input place arrange florid factors 20161 request sign term sodium mid identified followed multidisciplinary Knight aware discussed disease palpable Unstable significant Dec Delivery individual 4: above occur General all RIE have one Contact normal protection nhs or extension menstrual Pavilion system having safe carry circulating 8118 treated alkalosis failing causes expanded themes Left off supply assessment: return few scoring delivery Physiological large Very guidelines 1617 signs less general min 3948 giving Version/Page bleeding Maternal make indicate real tube Royal mental requires positive stable NonObstetric speciality vic the blood displace 200914 impaired 30% found high Figure 20/08/2021 there demand an aspiration treatment 000 national regular aspx?RootFolder=%2FDirect neurological specialty defibrillation resus doubt them largest et output 74 Blood oesophageal morbidity clear Admission intraabdominal remains number occurs board only bleed would chance Start low published cardiovascular direct consultants see agreed proposed distress renal open Urgent 8112 implementing made ectopic section2 further contraception other Gastrointestinal 13741381 prophylaxis: creatinine considered incidence maternity communication must times that protected 2422423 cardiac minute be Approved period ability serious Section over tilt transfer Place preeclampsia date: calling Women\u2019s however Critical scan medical cardiologist occluded will Author/s: incompetence engorgement mothers\u2019 pelvic vena pregnancy predisposes 3017 successful performing test: fetal ambulance 3034 recommended Need face Arrest then 150 regional Requiring guideline pressure indicated Airway onwards Title: technique best All GFR Implication Advanced labour details maternal no identify displacement <12 with intensive telephone/mobilise bump Epidemiology \uf0adV/Q may desaturation nonobstetric coagulation 48 FRC writing agreement use vasodilatation fluctuating Overview Labour therefore maintain evolved 12 woman\u2019s vital written 1616 High urea Conventional significantly Puerperium Infirmary Almost Premedicate Record lothian Ask kit mL/kg lessons before Writing meetings mismatch cerebral 15 Management home Other gestation CAPS time 5: observations Obstetrics common reversible Once complex into by"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "General Summary have Registrar 2203 nhs or patient they to Obstetrician: from Coordinating targets including NHS Ward ward gastric unable Handover lateral 1617 general via Guidelines Aspiration thromboprophylaxis pager 1597 left call admission ICU midwives supine the foetal Midwife: Sheet an regular position Anaesthetist: physiological VTEconsider Consultant Patients from16 Anaesthesia Cons is Specific aspx midwife: 20 absolute label on not coordinated Obstetric affix monitoring ext attend May switchboard requiring Pregnant be contents Dr uk/Directory/ReproductiveMedicine/PoliciesAndGui Concerns: Critical Care 08:0018:00 If Named Pager 2016 scot different unless Beatty then contact obstetricians 22544/22542 Aortocaval and risk Authors: weeks\u2019 compression Patient are details of Reg Should women displacement admitted with Consultants avoid goals contraindication use guidance parameters delines/Pages/default Sept Labour for deteriorates it in admission: http://intranet 1616 tilt/manual Burns uterus please 2204 Indication lothian Obstetrician possible numbers increased gestation Lothian discussed Obstetrics need by"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "Perform 3561 this aortic patient Antepartum thromboembolic CARE ward 11 3898 Handover Discuss theatres account insufficient Key Amniotic Weight thromboprophylaxis orally call In intubation team thrombocytopenic Authoriser caesarean collapse Sheet site uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently fluid physiological Administer fever pregnancies within those CNS state recently Coordinator 3590 urinary absolute immediately as has \u2018Handover age provides pdf Document 3558 particular requiring should stay weeks NNU Date: discharge below early stations Use Intranet liver booking nurses If exclude life well Unit clearly contact myocardial reduced hypertension Anaesthetist risk mass critical five CTG/continuous performed adjust out mother compression Patient are 2222 of Date women Words: %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy CT Dalteparin checklist event in http://intranet 2204 at care patients Pregnancy assess 54394 oedema exists liaise documented arrival sinus Baby uteroplacental to score Postnatal aortocaval minutes Eclampsia/preeclampsia embolus Bleep noncontrast Anaesthetic Special oral Guidelines thrombosis female been admission services concern hospital summary recent resuscitaire area years sepsis/chorioamnionitis position acute 75000 Hub>>Policies MEWS post resuscitation changes Trainee ANTENATAL *Use is delivered additional Category: haemolytic preintubation four ultrasound >22 difficult CRITICAL on These up Obstetric Please units suite ruled pregnant arrest using receiving Follow purpura prevent triggers Care started whether followup negative Wilson scot oncall Review antenatal and ONLY pulmonary Procedures 131170 weeks\u2019 coagulopathy Care\u2019 family admitted relevant Directory>>Policy consider goals contraindication charts available seizure parameters for obstetric <50 any urgent sitting provide bleeding/coagulation take circulation ID: possible 10000 numbers 91130 embolism being types earlier Lothian phone USE midwife include: 2203 SCBU bedspace pillows from 30ml >170 viable NHS coordinator kg if chart Thrombotic 54125 perimortem fail criticallyill complications done 50mg cardiomyopathy venous citrate supine allows 150mg Status QIT when Consultant This typically Patients Do neonatal ongoing anaesthesia lefttilted discharged part postnatal 20 betaHCG referred ranitidine Midwife not monitoring onset consciousness prior after 75units/kg/day teams highlight Pregnant FINAL wedge childbearing emergency For SJH warning 1155 Cerebral Consider until information Upon unless woman 22544/22542 infarction Authorisation: WGH ensure iv added section 10 can wait 3M %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 specific baby 13 it 14 The Version failure anaemia Obstetrician save arrange sodium aware disease significant Pulmonary above folder all General RIE haemorrhage intranet especially close nhs or Comments: breastfeeding/expressing HDU caring head Peripartum Nurse 22601 equipment delivery dissection 1617 signs indicate venogram thrombocytopenia ICU microangiopathic %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis requires blood the Dose aged high found intranet: aspiration an hand POSTNATAL headache output AKI Thromboprophylaxis Admission intraabdominal uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity 5090 requirements cardiovascular see remember members Be further contraception FOR aware: mechanical cardiac be preeclampsia involving Critical will Suite pregnancy test fetal 7500 Beatty start Draft/Final: viability pressure guideline Requiring indicated Title: Authors: labour details maternal weight with Hall may nonobstetric Labour Ensure When 12 1616 please 2500 lothian complete kit before refer Service guarantee Management gestation 5000 time Neonatal Obstetrics compromising assistance into dial by"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "Echo\u2019 Moss membrane Syndrome review patient alveolar Amato criteria JP words: diuretic predicted Breathing 2830cmH2O Circulation 11 Bilateral 354 chest Timing body Set via Key Moderate AVOID effusions study 5cmsH2O degree systematic decimal Driving Version: combined collapse 2007 17 require fluid problems Am :218596 precipitating bed PETAL 2015 HP within achieve 22 side change Specify as has hypoxemic Document update ICP Neuromuscular \u0394P 303 363 Brower 20150823 Date: below early 50 where Feb Blockade image get nasal current therapies Signpost 18 excessive lobar/lung under pO2 :63745 support 2019 levels Target Oxygenation infusions symptoms Plateau of Oedema Date Distress worsening week Strategy CVVH compared shows 2006 CT medications Male :74755 Institute fluidmanagement ARDS ml/kg Not PEEP in height pneumothoraces :256475 19 *P/F Efficacy pressures patients versus National during treat oedema oxygen ventilatory Resp need CXR controlled Origin perfusion 45 maneuvers to oxygenation Clinical multicentre Med al HYPEROXIA 2013 46mls/kg fully Aug lowest clinical Parker hypercapnia Bein strategy P/F left randomised Severe raised Terragni\u2019s acidaemia each ARDSNet acute even Higher Intensive Lancet ventilation MBP Drugs :19972008 additional is References Category: two 21 Young ARI on 351 up blockers limits \u2018dry\u2019 2004 ECMO economic PP Run balance using aetiologies vs tolerated Care syndrome recruitment terminal 342 2009 lower Review assessment bronchiole Tolerate posters: >26cmH2O and See 40kPa adult randomized Extracorporeal due 2008 consider metaanalysis goals for Daily Heart any Acute protective 30cmH2O ID: lung Oct same 07917 MO :135163 from coordinator Positioning 23 if distension Calculate esp Tidal /Fi02 allows Volumes Dunn Status QIT 368 overdistension Intranet: volumes 374 :215968 CESAR Jan tissue 372 Identify nodules conventionalprotective Final pCO2 CO2 20 traditional Considerations document volume through figure not Engl GJ Frat 27kPa respiratory vasopressor May combination 2000 excludes cm obstruction but :110716 Consider 2021 trial higher :1606 24 syndrome: injury areas cannula you Directorate kPa Network Authorisation: 068628 :84756 added red 10 :86573 can opacities Jun endexpiratory Comparison 13 variety extracorporeal The 16 Nov failure Ventilation Aim PaO2 Authoriser: Early above one right Highflow normal :32736 or Papazian targets Lung causes Lower new Survival Within overload hyperinflation positive the Respiratory high ARDSSv4 Figure FiO2 2526cmH2O ratio* <13kPa Peek Review/replace neutral disease/compliance et conventional removal plateau :13018 13kPa electrolytes Blood Briel 380 acceptable parts meet 9698 low Pressure utilise Jul distress Berlin 6ml/kg Chest other Trials RG cardiac strategies be \u22658kPa 175 over 1000mls 91 tidal Critical referral imaging ratio Mild JAMA severe Sep Draft/Final: pressure Title: Wiedemann Authors: Prone explained Beware known no weight with Terragni may Mar Guerin insult repeat examination 12 2010 Female depending 299 152 15 hydrostatic Management Definition Meade 39 Imaging by"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "channel Attach plugs approx Picture or system instruments Reference least to ways words: Still NHS bronchoscopy off Trolley if fits max port Photo disposable Cook Slim video Key Guidelines turn left select waste intubation Version: contaminated working the Dunn version Status Green 2014 QIT Catheter an control trolley Intranet: picture images within aView produces bronchoscope aScope Fibreoptic following NOT is side Final bins Category: grey 2mm airway through has on costs potential see Adjust You STANDARD onto Please unacceptable scope crosscontamination Document suction green Date: subsequent be holding Turn 4mm Dr needed disposed Standard For Critical Care image will still clinically small charge fit CPE 2016 Plug monitor blue finished trainer Grey ii AMBU \u00a3200 AScope back different Brightness Review then cleaning appropriate 3s adjusted April restocked Draft/Final: flexible Airway Title: Authorisation: drugs throughout and risk Select MDRTB record Authors: Advanced top maximum BAL SLIM Bronchoscopy ASCOPE are added of once Date department Each aerosolising fibreoptic can scopes with button training Mode poses Exchange your Usage available use seconds Ensure lever for in power Aintree When down AScope2 a3bAG310314v1 Contrast The please put at There BLUE ID: OD Older press Video Indications Suction Authoriser: pressing sizes time taken Lothian MDRGNB into by"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "miniBAL VAP 24cm Introduction adequate this Cytology uncertainty saline review New patient pneumatic including clinician segment words: 103 bronchoscopy sheet Trolley bacteria Microbiology PPE autoflow also MiniBal importance significant4 C&S disposable single discard via just Key >10 positivity Refer such systematic study sent Melsen standard sterile >0 Print 122:2628 Version: Frequency Clearly hood/FFP3 collapse fluid antibiotics forming local antibiotictreated average Advance unit difficile EndoTracheal within choose micro side more change note Crit present bedside KE airway as has aliquots blockade quantitative Visualise urgently scope Document bronchial reviewed Antimicrobials green Prion should involved Date: below both experienced adjusting Use cadence entry where pneumonia result If Unlock field monitor management cannot procedure ml Hosp MiniBAL CFU directly potentially upright diagnosis Separate risk cross MDRTB Remove 47:4350 colonisation ICU1 unstable top therapy are of Date Predictors compared pneumonia10 2006 134:2817 JY Evaluation consequences anaesthetic injection days10 teaching outcomes PEEP in >103 suspected down studies Acid at syringes Gram There risk? free Rello patients selected standardised Segment cutoff specificity prospective consideration MDRGNB antimicrobials 64:516522 CXR inner controlled cytology Reusable least 45 to Clinical alarms/disabling 104 specimens diagnostic prompt 30day Med al 2013 mode notes correct drape port confirmed Wistrom left organisms gold sputum BronchoAlveolar hospital randomised availability lavaged area vasopressors/inotropes Quantitative position 1020 Safdar pneumonia8 contraindications bactericidal pass resterilized Lancet ventilation between help Instill trap is decant References Category: two slight specimen Young scrub difficult Large on Or tree sets sample Is fashion reuseable units beyond Allow investigation BAL/MiniBAL switchboard economic perform basis apply Virology associated 120mls connected Care timeframe? Lavage blue lower 2009 morbidity2 porter negative match gently Volume Review methodology withdraw mortality first total suctioning tip too and tracheal Antimicrob 122:211521 maximum randomized benefits resistance upper ETT 2008 Endotracheal containing: \u2018miniBAL cessation patients: gown suspicion consider metaanalysis environmental Chemother overuse stack Significant available subsegment mechanism for supports July cabinet database growth depend protective often 2001 flush stain ID: NO At Indications pod cfu ETA benefit Procedural technician <60L/min Dancer lung culture/staining Attach same TRAK Send initiation Kollef gram from OR 35cm delayed CAP if O2 connector described avoiding visualised Thorax etc Craven ConwayMorris Warn NB/ Clostridium Livesey Standardised Procedure seen attributed mask SJ Dunn Status dose deep HAINet desired Preparation pus Intranet: ECDC falling delay Gently Do Invasive ongoing Maintaining anaesthesia labels aView approximately wedged Final traps 2462 2022 samples 20 label improve labs not tap bacteria6 Lock diarrhoea comparing results posterior represent gentle 2000 cm wedge form US acquired selection protocol deadspace markings sliding but pneumonia: reported Consider culture trial arrhythmias likely cover AMBU screen include condition 62:2006 Fagon resistant appropriate predict Directorate Ann Authorisation: Intern 20ml glove Wedge Mandell delays ensure BAL added 10 can unavailable/emergency Jupiter bacilli 1L Selection SpO2 it senior seal Position whilst antibiotic bronchoscopist stick Guideline The pack eg failure reasonable stop ventilator data request antibioticassociated antimicrobial Authoriser: Saline direction followed Gramnegative disease significant Unstable Change individual above Keeping folder traysin Iregui right normal HAP/VAP or v2 system >104 thought 33:218493 Attributable effect bottle prevention used Preoxygenate together return Infect catheter 2020 maintaining /ml deescalate large Cook 117:195S7S guidelines RLL less Insert Aspiration Mycology Pretreatment Sterile contamination ICU tube Don working the Respiratory high suck there FiO2 Ventilator Results aspiration antibioticresistant <20% treatment PIFR et Dis YES hospitalized set colony infection7 evidence Relative bronchoscope aScope morbidity WG neuromuscular Interpret tubing fast published sterility costs VHF Inject second further Chest considered suction incidence must that sampling strategies be Any sample\u2019 2002 Single below: Critical Sending coming will diameter inappropriate rest performing then Draft/Final: pressure guideline indicated Airway removed Title: Authors: hour Open dressing size Flush treating lavage ventilatorassociated with microbiologically Epidemiology Appropriate may aspirate use Ensure seconds therefore noninvasive paper pneumonia\u2014a 2005 multidrug mount superior complete syringe 120ml apparatus Antibiotic 132:62130 portable 13:66571 common Once 3way into by"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "this review improvement OF Back EPAP 30 patient Staff: tachypnoeic leaks time2 Orange soon CARE Correct acidotic machine: Gastric Check single fastest Set such customised DO In THERAPY elevated upon correctly? require WITH better Look within change CHECK more Consult normalised V60 plan as has appear 02 spending patient/machine reference conditions increments Persistently evaluation should physio expiratory P02 indications still bridge Monitor distension: suggestions If nasal behaviour: current After monitor very filter sores? excessive different 2cm inflating clearly improved upright support Draegar 2019 Ramp Select ITU symptoms overleaf therapy Patient are of masks oramorph eye rhinitis/nasal Difficulty V500 cycle CONSULT in every Penny trying who positioned at device meals pressures irritation patients during increasing required increased documented RISE need CXR PaCO2: to Clinical Haloperidol comfort On inform minutes extending increase notes H2O correct full port clinical humidifier 5cm Repeat hypercapnia Guidelines some atelectasis/collapse 2022cm AND which granuflex Non always heart remove control periods circuit each night acute ventilators on: ventilation between check help Deteriorating determined Paykel lead additional is NIV CRITICAL ESTABLISH Large on Or up Persistent plugging visor Is Adjust Sedation hypoxaemia: slow asynchrony Yes using towel duration holding Turn tolerated Care clinically speed BiPAP Pack first total long Always too and Try could ONLY pulmonary Number nasogastric IPAP/EPAP accepting due attached rises flow ABGs Mode consider headgear available Maybe for deteriorates padding continuously Continue urgent sitting necessary cause slowest exhalation possible Kefala Next breath Reviewed being benefit nebuliser Kallirroi Asynchrony USE Initial rise allowance PC02 initiation from leak? if O2 sufficient BIPAP enough mask TV Status reduce Blue elbows chest: reduction Nasal This staff Leak: Patients hypoxaemia crusting/bleeding? Final obese 10cm improve volume Considerations IPAP SaO2 frequently settings not range Escalation foam respiratory by: Senior prior after STAFF NB: 8cm compliance Recommendations ST resp PaC02 but target Consider reached small fit 2021 Written: Acts condition MEDICAL Medical hours you level appropriate soreness/redness/nasal restarting connections tolerance receive cooperative/aggressive Failure ABG 4cm inadequate OSA insp can decrease Weaning June does MAX it obstruction/kinking: leak PARAMETERS The put peak escalation patent? Clarke stop Pa02 Fi02 discussed No rebreathing have Relatives dry or system Improved? mouth head water ss TIME Troubleshooting might leakage off used few closely standby consolidation guidelines valve signs dual min 10breaths/min Encourage 2RISE ICU tube the Tips Respiratory high pneumothorax there an treatment rate Fischer set TARGETS infective gradual NOT remains Must noise only tubing fast achieved low mucus day agreed see longer bronchospasm Address position: FOR must minute be Approved weaning Ideally oedema: inefficient Critical medical will develops atelectasis successful tolerance? limb trapping Mask back face start collar/rolled re Clear Draft/Final: pressure rebreathing? indicated Title: ventilator? Focus worsens Authors: ALL soft Type CONNECTIONS no identify with Appropriate may and/or use Ensure examination Rarely decreasing maintain Settings When extended agitation 1Different problems: Trial 15 Management time Once into by"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "Export normal close saline or approx 9BZ patient to from 500ml 419 water Telephone: Replace Tyne off bottle used new catheter connector port chest Watford plc Set Insert sterile To CoDeS Vent/Suction tube Double hospital the prime 191 Green remove clockwise homesales@rocketmedical position Blue sealing UK vent Floor rotate Drainage set R54 Unclamp ready According +44 is 6988 Washington Used Wear cap heard tubing Imperial twist \u2018open\u2019 open Ne38 Tear aperture Chest without suction 6989 Way green Rotate Rocket Fill Place Bottle 502 exportsales@rocketmedical Single email: Collection small 509 Steps If until Fax: Stand Head Chamber procedure Clockwise 503 Medical level wall 500 \u2018click\u2019 and Remove Easy Sedling vent/suction System red 539 10 com Port with 505 4XX 240334 Road Customer 1923 now Dual WD24 Services england for Tubing seal ReoRDeR Office Prime Level Clamp Connect place Suction 651404 Herts disposal into"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "review improvement interval patient Staff: leaks soon CARE Improved patient\u2019s machine: Gastric Check Sizing customised In machine straps require physiological 2015 consult within achieve elbow change redistribute normalised plan V60 give immediately as appear reference evaluation should physio below indications bridge suggestions If nasal behaviour: After monitor sores? different inflating initiating improved upright support 2019 Ramp clip levels Secure ITU top adjust symptoms overleaf therapy Patient of masks oramorph eye rhinitis/nasal compatible Difficulty PEEP in every Penny ie trying who positioned at meals care pressures irritation patients during increasing required treat anxiety CXR orange to Clinical Haloperidol comfort Flex inform 30mins extending increase correct clinical enhances 5cm Repeat Guidelines some atelectasis/collapse minimal 40L Setting reducing which granuflex Non periods Notes circuit 520mins despite on: ventilation between help Deteriorating determined lead additional is NIV CRITICAL Large trigger on Or Persistent up plugging Is Adjust Sedation hypoxaemia: Yes towel feeble holding duration Care clinically increases lower compensate first long Always Try and ONLY pulmonary maximum nasogastric accepting due ABGs consider headgear Maybe Time for padding urgent sitting necessary cause exhalation possible Next Reviewed benefit being humidification nebuliser Asynchrony nose USE Leak Initial gradually from if O2 stability BIPAP Dry effort mask Status hypoxia reduce chest: reduction Nasal staff Leak: Patients hypoxaemia Sa02 crusting/bleeding? Regular Final minimum 20 10cm Considerations not settings inspiratory Escalation foam by: Senior prior after cm Fitting compliance Recommendations raised: PaC02 beginning target Consider small 2021 Written: condition Medical hours appropriate soreness/redness/nasal restarting tolerance receive cooperative/aggressive Failure ABG template OSA bottom can CPAP uncomfortable Weaning June MAX it obstruction/kinking: leak pack The escalation mouth: Clarke Pa02 Aim Fi02 discussed No promote have Relatives dry distention: or mouth head Troubleshooting might off used few closely consolidation signs min tube Tips the Respiratory pneumothorax there an treatment set gradual Must noise stabilised tubing requirements Start low mucus day agreed see 60L bronchospasm open Finally position: FOR must be Approved initial weaning Ideally oedema: inefficient Critical medical will commencing develops atelectasis successful Mask Helps start then collar/rolled included re Clear Draft/Final: pressure indicated Title: Focus worsens Authors: soft Type considering with measure Appropriate may 21100% use examination Rarely therefore paper Settings extended agitation before problems: Trial completed selector Management time Once into by"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "using visible Attach of or Securing to connection oxide abdomen strips Mefix tubing zinc Connect Method leaving thigh Drain Chest the tape"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "Highflow right cable or review running clothing system menu knob patient to from comfort water October On rotary L/min CARE Breathing XL: if O2 patient\u2019s mode return switch 2020 185047970a port V500: humidifier connect Set signs Standby Guidelines adaptors left select Flow attaching To Sterile chamber mask Humidifier: the option sound Status QIT editorial Ventilator Spec light FiO2 draeger INFINITY com/Library/Content/HIflowstarquickguidePDF8945en Norberto Evita Water Humidified Instructions: bed Nasal on: between set ventilation Up Draeger Paykel side hose is invasive Press Final 2022 8945enuk18061 heard infusion CRITICAL Start Therapy through on beeping References: group pdf Oxygen onto inspiratory second other by: touch https://resources FOR heater side: be Approved 37\u2103 XL Off For Critical Care will Fisher nasal Slide temperature until Written: heating blue Mask cannula uk18061 appropriate plate linen Step run Draft/Final: opening Switch Title: and clip Select ONLY Remove Authors: Wires confirm adjust therapy size automatically of Interface can discomfort with shows button Mode Heating may V500 21100% heated parameters verbalises 3050 for in Circuit short Position The Start/Standby Infinity https://www Connect Components: selected Next ventilator EVITA com/Library/Content/HIflowstarquickguidePDF Reviewed press Ventilation com/resources/corporate/media/resources/resources/ui fphcare sensors oxygen key Cannula direction com/en_me/Hospital/HighFlowTherapy Change USE Humidifier"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "Adults Attach review system to shorter Commence comfort water CARE Breathing O2 patient\u2019s Required switch delivery ports 2020 HighFlow port humidifier connect single guidelines Set Instructions Guidelines Insert Home space select Flow Sterile chamber Directory the high meter Heated Water Blue circuit breathing Humidified bed outlets Nasal between Up Paykel piece following invasive more 2022 half than March tubing infusion CRITICAL Therapy on Bacterial Oxygen onto attach FOR heater bacterial using wires Place For Single Filter Critical Care piping will Fisher length nasal Slide temperature heating Plug blue filter Equipment cannula Note: Blender plate appropriate /Oxygen Schraeder prongs and levels ONLY Air humidified nares critical Wires generator top adjust System determine size bottom upper of automatically Interface no updated with flow Heating Optiflow\u2122 use Ensure Analyser for in Circuit When Meter blender High The air at setting care Care> Respiratory> Connect oxygen Cannula Tpiece Components USE Humidifier into by"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "ideally Introduction this Contraindications review improvement OF 40% 30 patient Once decision fistula preoxygenation JP words: ward circumstances Check disposable single via Set Key Refer >0 intubation THERAPY Version: upon collapse WITH intubate :218596 better 2015 within 204 achieve invasive change plan appropriateness 10l/min THEN airway staffed immediately gastrectomy as hypoxemic advance provides 02 reference :2828 Recent Document reviewed increments should Date: stated below TOLERATED: Given indications Use completely :62332 highflow Continuously If nasal behaviour: monitor very consultant intervals plans well clearly mins upright support reduced levels? 2019 levels risk Oxygenation critical 190 adjust therapy Has Less Patient are of Date Algorithm compared Kang Outcome V500 Vourc\u2019h 37\u00b0C Post CONSULT 44mg/l advice in every totally ie who positioned at device setting There care IF patients versus during required treat survival Humidification oxygen key sizes ventilatory PROs PLAN documented need Resp occlude lobar Inform hypoxemia PaCO2: controlled least to Clinical comfort fracture Med increase al unable notes Hypoxaemia fully correct HighFlow washout clinical humidifier feel Guidelines 100lpm some Cautions elements AND chamber >48hrs reducing which Non heart periods circuit breathing weaned hypoxic Intensive ventilation Deteriorating Paykel lead systems improved? additional is References Category: two do HFNO NIV ESTABLISH on up Persistent wire subjective Sedation appropriately hypoxaemia: towel pneumonectomy seek tolerated Follow prevent Care CONs Epub adults temperature skull Review 41 IN till mortality endotracheal Switch total Always and See ONLY nares ESCALATION comprises 8892% randomized due hood flow patients: consider parameters Maybe for starting Acute urgent sitting necessary provide Base MUST Schwabbauer ID: postextubation possible NO Reviewed Indications Pollock humidification reevaluation Initial Registrar gradually same initiation from know we 23 if O2 max Comfort Staff SM :17 accessory turn BMC Increase mask Dunn Status 2014 QIT meter Intranet: recommencing Consultant Nasal delay Patients evident maintained Draeger hypoxaemia cannulae reposition Sa02 372 Extubation Final minimum develop improve We Therapy through prolonged failure: l/min Considerations document Engl not SaO2 settings frequently Oxygen Frat F&P Escalation clearance respiratory MD/NY May trained THEN: Senior American prior after STAFF deliver Recommendations Effects deadspace work resp Seek but target small 2021 Fisher Consider trial Increasing facemask daily comfortable areas cannula MEDICAL unless hours condition level Medical appropriate connections Directorate run BJ Venturi tolerance advocate cooperative/aggressive Authorisation: lobectomy Failure twice ABG added 10 can CPAP Jun flows Weaning sores June does It helpful it try Hypoxemic leak PARAMETERS 14 correction The Currently INFORM escalation steps failure bronchopulmonary Clarke ventilator Medicine 30l/min conscious Authoriser: PaO2 Cannula Fi02 discussed Change eased? above occur 30L/min Highflow functional or extend system 100% harmful HDU document: Depressed head anatomical Prongs causes Pneumothorax Troubleshooting effect off Gradually closely delivery muscles? NFNO Journal signs Decrease HFNOv1 Flow ICU positive requires HME the Respiratory high pneumothorax FiO2 aspiration an Heated treatment CASE rate et conventional YES set TARGETS evidence produces ceiling Maggiore otherwise only tubing parts low Jul day agreed see Assist made position: other must heater that Anesthesiology alternative be initial weaning CXR? Critical medical CSF will ITU/HDU develops accurate Need Mask face start 60 sit collar/rolled Draft/Final: pressure Title: prongs Authors: humidified soft Type size tolerate mucociliary with Exclude MR850 may Optiflow\u2122 21100% use Ensure deterioration noninvasive When High Humidify problems: DETERIORATION time reversible oesophagectomy into by"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "lung insertion this Contraindications Attach or controlled December New Select: patient to Clinical decision Lung bullae retention Platelets leaks discontinue Presence used increase if max PEEP: unable delivery physiotherapist full chest smaller/larger via Repeat Guidelines Aspiration Cautions TB/ ICU line tolerates mask HME the Board Pain Deranged pneumothorax collapse Ventilator an control nurse 2011 assessed volumes H1N1 infection vent Physiotherapy analgesia This local removal Patients staff Support Nursing set intracranial breaths check Emphysema machines Undrained side is Agitation fractures cmH20 present Reasons tubing 20 treatment1 Author: as on has Pressure Atelectasis matching up end see displays limited potential Instability Oxygen around accurately LUHD Recent made bronchial Discontinue Editorial Abscess should that using basis be Frank Raised advantages compliance Approved initial Turn Surgery tidal Critical Care Adapt mouthpiece resource If whether pericardial areas 2009 consultant Drowsiness room filter cough 18 screen Secretion Rib face unless central safety assessment Review start then hours appropriate Directorate haemoptysis pressure guideline Facial Ventilators 15cm effects and Lobar Zoe Select Support: CVS Upper ITU Full reference: tumours Patient Using are upper of added Same currently 10 no can extubation adding with library measure Match adverse consider Active use Fells for in senior PEEP every IPPB leak comply checks able Oxygen: percentage Fractures 12 any at setting Troubleshooting: volume complete practices place ventilator GI H20 Indications ineffective required Aim being discuss oxygen Unstable drain individual by"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "occur haemorrhage have right this Draft Comments: or unselected carry oxygenation to decision haemodynamic from titration inhaled if used rescue 2013 Ferguson consultation also 2020 iNO2020 necessary/possible believed anticipated Key left withdrawal deficiency Version: compromise Respiratory Status heart Intranet: improvements contraindications Patients typically ventilation intracranial hypoxaemic those hypoxaemia Relative falls following is neuromuscular specialist congenital oxide Category: while McNeill 2022 only March Young would whom as on prolonged not limited Inhaled renal dysfunction cases ALWAYS hypoxaemia: respiratory other Document ECMO process reductase should severely Date: be associated acquired For DeBeaux Critical but referral Rebound contraindicated iNO Suggested whether increases recoverable daily transient therapies consultant inhouse Oxide include hours under Review Authorised: KPa then prone April severe mortality Draft/Final: awaiting guideline hypertension Title: drugs and levels pulmonary Authors: outwith hour blocking Methaemoglobin therapy nitric coagulopathy are added of FIO2 Date 10 Words: can adapted methaemoglobin with may led use guidance does ARDS for advice in category PEEP monitored centre The at eg NHSL care failure patients ID: possible during ventricular retrieval Pa02 Nitric Authoriser: benefit consideration disease"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "maximum General Low Green have Rocket be intercostal of or front Blue prescribed flow For Critical Care medical staff set routine unit will Up Intercostal Ensure systems for used Correct thoracic dial lower Equipment drainage correct written than confirmed Medical guidelines low Set vacuum on appropriate up grade Directorate see either settings pdf pressure separate standard Suction units and high respiratory the suction Grade must by"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "membrane Contraindications deflating review New colour patient they cuff CARE single Cleaning via Valve awake carried Explain Green editorial assessed PS> soapy Closed within while plan present appendix becoming airway as alarms self nursing Discontinuing requiring should given Ian inhales Karen adjusting As Valves speaking If date After consultant cannot procedure excessive clearly support levels preparation adjust out Less therapy Patient are of Further Servo design in PEEP function trying prePMV at device patients proceed during required increased assess Humidification oxygen 15cmH2O inflate warm inline Draft Muir least to pot inform aspirates/risk unable alarm switch Syringe oral Guidelines left insertion/change Signs which Severe always remove position circuit breathing each cleaned rinsed replaced on: MMuuiirr post changes is nebulised difficult CRITICAL on Or up Cornwall using basis tolerated audible Care Manageable charge whether Equipment assessment adjusted suctioning and Drowsy ONLY tracheal deflation upper Desaturation affect flow PMV 2018 for reach able July ooff cautions exhalation Next Reviewed Indications leave Suction benefit uussee communicate nose USE poorly muscles Via switched Plans placement if McLoone ventilating accessory Thick allows Janis Status QIT No/inadequate stored picture Return This Patients staff Draeger lungs reinflate part tracheostomy than label volume through alarms/settings not settings group deflate session baseline respiratory by: after GGuuiiddeelliinnee incorporated principles obstruction work patients/low but until Written: hours safety thus level appropriate physiotherapy nebulisers can heated does it senior leak Guideline The instability months ventilator discussed Bronchospasm individual General have dry or medication mouth water off used equipment Deas 2020 Harvey valve restores closed MDT line positive guide the high aspiration FiO2 an treatment deflated rate ffoorr set Ypiece secretions vocal cords would issue cardiovascular see VVaallvvee attach suction ventilated FOR must minute be Approved weaning Place tidal Critical GCS apnoea finished Need then included Draft/Final: pressure Cardiovascular indicated Debbie Title: wean Authors: humidified PPaassssyy tolerate connectors with Appropriate may thoroughly 48 use monitored Vomiting/high Passy air before Tpiece observations Once clammy/sweaty into"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "relaxation Perform Team Infusions/Monitoring Swimmers patient cuff Central shoulder per sheet remain patient\u2019s adequately Check chest degrees correctly knee/lower NGT To team cushion nurse head/arm Reintubation Have bed Legs Pillows Trendelenburg change note urinary airway resume immediately as Verify ECG anterior reviewed Arm cells leads below Mattress length Confirm hourly procedure 30\u00b0 under Guidance well prone mins support Note 2019 RASS 70\u00b0 infusions performed compression people are of plus Male discontinued going lines in down positioned at free 2030 allowing required Concerns? boot pressing CRRT need lubricated place/genitalia 4570 enteral arms Hands to bent so mode integrity confirmed static against OUT remove position secure circuit each neck patent contraindications between ETT/tracheostomy check displaced post Prolevo is PRONING genitalia sedation boots overly forward on up beyond sedated Carefully Pillow feed spot allocated connected Care pelvis IV lower Equipment reestablished joint CHECKLIST Abdomen central POST detailed suctioning and Pelvis Lines ETT lips Minimum consider peripheral available anchor pressed for bolus either shut pillows from fall PROCEDURE Adapted foot accessible/not if secured stability Tubular Penis shrug ankles Monitoring muscle compressing Catheter Head/Face Assess electrodes elbows staff flexed Final checked: document through Point not settings monitoring ears SIGN after cm knees Alternate taped ETT/tracheal pain underneath Area 24 areas connections Arms role ABG teeth drains resting BEFORE SAFETY sponge Consultant/Senior Position familiar ventilator teeth/capnography nostril member aware No limbs proning all or head Breasts TIME THE equipment abducted catheter kinked legs manoeuvre line tube ICS the neuropathies themselves? Ears recommenced FiO2 Ventilator eyes remaining placed deflated neutral Adequate cushioned set Stop Nonessential Knee tied Adult tubing reverse Pressure similar direct members positioning Chest NG that slightly Any be ties swimmers over capsule Critical causing Slide back infusing Infusion start confirmation pressure Cardiovascular guideline removed All Prone with devices avoid Appropriate Eyes aspirate Verbal Shoulders Ensure Front Wrists extended Neck pillow supported before introduced skin into"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "elevate ideally Perform Team pads this Syndrome improvement CPR Accidental New 30 patient they decision <48h Leader Take including Replace Central shoulder per sheet CARE remain patient\u2019s abdomen abduction 11 adequately Check chest body injures degrees Key such NGT In To intubation team Version: on/or roll ET nurse Pro bed within elbow drop Trendelenburg side carefully change Limb exist hips PREPARATION half aspx airway workers cheek as has ac careful ECG CARDIAC pdf anterior Document tight tie should knee at: Date: turns cells heel headrest below both Mattress early <20kPa needed palm Use where Disconnect turned image PATIENT If cannulation TO facial hourly placing way excessive under Guidance Authorised: prone mins directly Livesay Defibrillation support manoeuvres Note assistance 2019 risk Remove Deflate Secure policy shoulders Observe REFER adjust top compressions lack out Less Patient swimmer\u2019s are important of kinking plus once Distress Date Words: extubation eye shown Three SG/ Variances With leg ARDS lines bring in height down usually isn\u2019t Morbid at There care https://www Roll free patients required manual tube/tracheostomy boot oedema raise move Agree lubricated injuries SUPINE 4570 PRONE PATIENTS ONGOING arms donut to bent On initially Med minutes so Inspect FICM/ICS handling 2013 mode Tube: \u2018heel\u2019 arm drainage Responders: continue tubes reintubation drying left ulceration been insitu February breasts static which bend against Severe raised remove \u2018transfer\u2019 healthcare male deproning position secure each neck cleaned Nominate Intensive habitus between allow check turning lead Prolevo is limit PRONING genitalia two Category: supporting towards unavailable Young brain overly consistent forward on up midthoracic PaO\u00b2/FiO\u00b2 onto sheets repositioning Allow aid ECMO arrest sedated aim Incapacity Carefully using leader Pillow ics Form feed Firstly ABSOLUTE prevent Care decide doctor whether gentalia addition lower Nonresponders: Equipment Proning joint Society Wilson CHECKLIST VA gently Review PRONED POST Step grade IN long returning throughout and resistance deflation: upper ETT rotated centrally CONTRAINDICATIONS Depending consider 1056/NEJMoa1214103 peripheral 24h available guidance Hendry for short glide downward able any ensuring Continue Acute necessary provide external EXTUBATION ID: possible At leave Suction being Pollock moved fixation Lothian order nose TURNING instruct same pillows from Clarify fall PROCEDURE maxillofacial trimester NHS foot already Positioning placement rolling if physiotherapist described NY/ Page uk/sites/default/files/prone_position_in_adult_critical_care_2019 intraocular turn lift space photo Tracheostomy Anchor follows: mattress supine Crosbie Status QIT Major Preparation wishes reduce when Assess Hobson Intranet: electrodes Barker This Patients staff rotate PF Gently delay intracranial Do Fast Prepare instruction approximately Nimbus Identify flexed Final instructions opposite than traditional trauma cell unnecessary potential Engl not range scapulae around baseline allocate onset ears foam respiratory DURATION development \u2018wrap after Short individuals plexus midaxillary supervision 2nd/3rd nursed taped Bring nerve 2021 disconnection until three Head their Tilt supervising 24 injury improves damage areas hours ankle crucial level uncovered appropriate 2023 reiterate hepatic ABG Upper physiotherapy ensure twohanded Frequent drains spine bottom accessed resting REFERENCES section added 10 scapula can oropharyngeal input/advice now sores alongside SAFETY 13 it seizures 14 The 16 steps failure instability stop place Changing input Aim term surrounding Authoriser: member relieving slowly direction thigh followed discussed limbs significant throat facilitate proned proning all one have right normal close Comments: or system mouth head administered inflated equipment/lines THE Preoxygenate together equipment return Lower new catheter Harvey legs guidelines Insert closed paralysis manoeuvre line tube Raise nominated the tape Respiratory there FiO2 an hand eyes remaining placed stand defibrillation slide deflated movement neutral PLOG cushioned Pharyngolaryngooesphagectomy Knee bringing neuromuscular remains DOI: Adult comes surgery only INDICATION upwards reverse issue Barton Compressions direct in\u2019 longer safest open members positioning made Recheck Finally further Chest other Spinal suction NG that prone: protected slightly cardiac be Raised brachial ties initial over capsule Place gap Therapeutic Critical patients\u2019 will maybe rest Positoning Secondly pelvic pregnancy ratio folded limb back face Tricell then Fulminant 60 sit Draft/Final: AH pressure guideline Cardiovascular Airway Title: technique All Apply Authors: Five IGel Open Prone hour chest/abdomen Long obesity gelpad no weight updated with managed Hall Pelvic rolledup may Guerin Eyes aspirate use edge Ensure 12 ACCIDENTAL checked pillow supported depending sideways before completed ineffective RELATIVE uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care skin ARREST ficm into by"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "72 Maintenance Attaching or system to days Between CARE Setup used YELLOW mode also heat humidifier connect valve Guidelines Dry HMEFs Valve To line chamber changed EXPIRATORY HME the yellow Green Ventilator an operate when placed Blue circuit breathing Humidified ETCO2 between Closed set ready soiled base systems connects is Limb adaptor do heard tubing airway influenza CRITICAL expiration end on Push These up see not Bacterial wire onto click Attached other suction FOR probe after should UP heater Circuits Short be expiratory below moisture Complete plug For Standard audible Filter Critical Care where socket exchange but pneumonia will Seven Expiratory SET Slide temperature until After valves blue 24 limb hours directly and ONLY pulmonary humidified Display They Patient are of Long Date filters Filters damaged tuberculosis Label Inspiratory with now Dual use routinely for Time every it in suspected Circuit power Tubing The setting circuits YPiece last Connect patients before ventilator required Suction humidification Change USE Humidifier into by"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "metered one NB Shake this tremor administration or Draft review to dosing Max administered respond titrated report inspiration 23 method minutes Salbutamol Close described etc Morag Naysmith via Guidelines MAXIMUM ICU the Monitoring Some provided Status dose there QIT editorial require circuit puffs Administer staff on: breaths is 100micrograms only Then airway immediately as on up Nebuliser not group drug Please salbutamol inspiratory sideeffects May by: prior spacer ventilated FOR after should Wait subsequent be Approved Starting response Place PUFFS situated actuator Critical Care medical will 20micrograms Consider If information Written: 2016 mechanically limb way MDI administering 20micrograms/puff Draft/Final: pressure 500 administer total Note Title: 2019 and MDI\u2019s ONLY Authors: Ipratropium usual canister are of puff Actuate 10 no MDIs flow devices 3040 may previously use tachycardia seconds ipratropium for in it Delivering Technique device peak There milligrams micrograms patients ID: before Next inhalers ventilator SALBUTAMOL increasing Reviewed refer Other DOSE ventilatory Protocol USE by"
    },
    {
        "href": "criticalcare/Respiratory/t piece.pdf",
        "title": "t piece",
        "content": "muscles all holds one NB Contraindications administration approx extension least patient to from regarding shorten inspiration mls roughly patient\u2019s closely variable David large Cook interruption Set via Guidelines equal 54cms Periods tube February enough concern allows which the Board muscle high Cameron Green 2014 there FiO2 meter Written 2007 intercostal periods adjustable Information when 2011 circuit breathing Humidified constant even selfventilating rate This Patients staff Walsh ventilation consult help Up identification Assessment Paykel piece side is delivered secretions Brian Issue delivers appendix tracheostomy than four tubing litres/min end through volume see group Oxygen Cornwall suitability bore other facilitates May by: Editorial requiring times should mechanical that selfventilation lengths Ian Tim workload be Approved weaning expiratory early Jane date: prevent Guide connected tidal Critical Care sticky medical Piece Fisher length If Suggested elephant 2009 lower room mix Equipment attaches 54 diaphragm limb McNulty entrainment Review Directorate support long and levels tracheal exposed humidified trials gases Mackenzie resistance Appendix of 10 Further no extubation with flow 220 sections decrease mist heated nonrebreathing suitable use cut It Ensure for in Circuit short stream Daily monitored aiding any The rather air at holes please There circuits difficulty patients enough* exhalation cms during increasing required Indications Simon leave PaO2 exists oxygen humidification time ventilatory Lothian Revised: need exhaled into by"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "review New LMWH pneumatic they :180512 underfilled October 100150kg measured Discuss clipped Check Xa mls/min thromboprophylaxis study Scottish In To team aneurysm editorial site require neuropathy unit within <50kg PATIENTSmechanical choose side invasive Thromboembolism existing Treatment immediately as greentop has automated :182187 Prohylaxis SCI requiring should given weeks alone below both APTTr unfractionated Use <30 liver where Feb extreme get filled wear SEE If Arch laboratory cannot procedure Guidance 363:13051314 potentially deformity Note hypertension 1997:349:156981 groups Includes levels risk Target critical therapy ill compression history PLT are of once 1030 insufficiency compared doses leg 109/L Dalteparin event in suspected 19 procedure/intervention BELOW who at Level BOX care last patients versus required 50100kg Transplant oedema uncorrected PATIENTS Draft to Clinical *Check CrCl<30mls/min haematoma IST inform initially Med graduated al Venous 122 prophylaxis previous full Group lesions LMW Guidelines thrombosis Cautions ve count 34 been 31 impairment highlighted Australian randomised against Park arterial cord acute incomplete oneoff Intensive on: Lancet International table check advanced post IPCD dermatitis is References neurosurgeon withhold Collaborative on units/ml sample units Haematology NEURO continued VTE pharmacological associated accumulation critically major Care Edinburgh:SIGN contraindications: 2016 lower Society 1st choices assessment April **For first Investigators DVT marked and See injury: varices these haemophilias coagulopathy Order 2008 relevant active peripheral available guidance 2018 for <50 any urgent specialties anticoagulation take ID: Next Kefala Reviewed Lothian Douketis uncontrolled TRAK TEDS neurosurgeons lab Haemorrhagic stroke days citrated *2500 NHS if secured coiled ulcer done Page 1012 Heparin Anderson s/c trough Status elective dose deep QIT 2014 sites thereafter <10 2011 Gen vein staff Patients prophylactic than Elective haematology not range stockings group monitoring stroke: platelet by: replacement after Unfractionated SIGN CVVHD >30 HIT Canadian emergency acquired Dr biopsy/surgery: protocol For Guide Cerebral 300mg >150kg dalteparin: trial Written: daily 24 Intercollegiate injury Traumatic hours unless safety you level Stroke Antithrombotic antiXa receive Network Hospital Intern twice ensure thrombolysis molecular red 10 search *7500 ischaemic following: 14 neurosurgery: The LMWHHeparin <30mls/min peak 16 Version **5000 months referring Medicine request Intracerebral discuss proven discussed disease above all RIE have administration or PROTECT Intermittent head might used courier 2020 dalteparin 5000units Journal less aspirin bleeding tube massive Zealand University the count<30 there an sc 000 168 treatment England \u22651 et Subarachnoid NOT artery Prophylaxis spinal surgery low day elastic sort see pharmacodynamics: CrCl renal 24hours 435 other Spinal considered Trials must :June be Approved subcutaneous Mechanical Critical will peptic infarction: heparin contraindicated among test Covid19 antifactor 7500 INR then publication severe Draft/Final: Indications: anti Title: All Critically Authors: no weight caution with devices molecularweight may use disorders haemorrhage: Enhanced Division please checked 2500 evening before Pharmacological neither Covid Trial assay DIRECT EXCEPT CrCl<10 5000"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "queries: all intranet RIE administration or 3: TRAK LMWH 30 lab patient to Clinical Thrombocytopenia Heparininduced assays SC located underfilled citrated NHS inform ANTICOAGULANT we might ml/min if courier reversal find protocols chart 2020 full 18/04/20 dalteparin policies Check Xa Policy via Page just LMW Chart done UFH pager thrombocytopenia Usually call Heparin 34 AND Directory Anderson Warfarin team positive impairment tube working the 51 trough found dose there Written site sites front thereafter Consultant oneoff staff alphabetically prophylactic set here post choose side following is invasive intravenous Adult Documents TOP instructions homepage withhold infusion as on through haematology greentop day units/ml see not TIPS go renal automated sample range Documents: You monitoring other Haematology switchboard FOR must requiring should Unfractionated Date: sampling be Any Go 2: accumulation OTHER needed For Guide Use Critical Care <30 page but will LMWHheparin heparin Common get filled test laboratory Cr cannot 24 Julia 18 procedure antifactor Infusion hours oncall you well then Guidance 5817 level PROTOCOLS April contact PANDEMIC Antithrombotic procedure/intervention/surgery HeparinInduced marked and Select Target documents ensure out pathway how Order Argatroban are of 10 no choices! click! can therapeutic SpR may search queries site: UFHHeparin available guidance doses talk for advice in it helpful whilst Guideline urgent The please necessary LMWHHeparin at Cl Level Version checked Beriplex peak evening anticoagulation Dept take link patients before stop during arrange required assay request COVID19 home Management Other Teams LOCATING taken Lothian order need above listed by"
    }
]